Autonomous Communities Employee strata Cohorts ERTEs Demographic Concepts Periodo Total National Total Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2022QI 1.175.582 National Total Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2021QI 1.136.561 National Total Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2020QI 1.190.870 National Total Total Cohort January 1 Total Survival in the first trimester 2022QIV "" National Total Total Cohort January 1 Total Survival in the first trimester 2022QIII "" National Total Total Cohort January 1 Total Survival in the first trimester 2022QII "" National Total Total Cohort January 1 Total Survival in the first trimester 2022QI 1.110.581 National Total Total Cohort January 1 Total Survival in the first trimester 2021QIV "" National Total Total Cohort January 1 Total Survival in the first trimester 2021QIII "" National Total Total Cohort January 1 Total Survival in the first trimester 2021QII "" National Total Total Cohort January 1 Total Survival in the first trimester 2021QI 1.074.320 National Total Total Cohort January 1 Total Survival in the first trimester 2020QIV "" National Total Total Cohort January 1 Total Survival in the first trimester 2020QIII "" National Total Total Cohort January 1 Total Survival in the first trimester 2020QII "" National Total Total Cohort January 1 Total Survival in the first trimester 2020QI 1.050.404 National Total Total Cohort January 1 Total Survival in the second trimester 2022QIV "" National Total Total Cohort January 1 Total Survival in the second trimester 2022QIII "" National Total Total Cohort January 1 Total Survival in the second trimester 2022QII 1.062.357 National Total Total Cohort January 1 Total Survival in the second trimester 2022QI "" National Total Total Cohort January 1 Total Survival in the second trimester 2021QIV "" National Total Total Cohort January 1 Total Survival in the second trimester 2021QIII "" National Total Total Cohort January 1 Total Survival in the second trimester 2021QII 1.035.575 National Total Total Cohort January 1 Total Survival in the second trimester 2021QI "" National Total Total Cohort January 1 Total Survival in the second trimester 2020QIV "" National Total Total Cohort January 1 Total Survival in the second trimester 2020QIII "" National Total Total Cohort January 1 Total Survival in the second trimester 2020QII 1.014.398 National Total Total Cohort January 1 Total Survival in the second trimester 2020QI "" National Total Total Cohort January 1 Total Survival in the third trimester 2022QIV "" National Total Total Cohort January 1 Total Survival in the third trimester 2022QIII 1.024.559 National Total Total Cohort January 1 Total Survival in the third trimester 2022QII "" National Total Total Cohort January 1 Total Survival in the third trimester 2022QI "" National Total Total Cohort January 1 Total Survival in the third trimester 2021QIV "" National Total Total Cohort January 1 Total Survival in the third trimester 2021QIII 1.003.536 National Total Total Cohort January 1 Total Survival in the third trimester 2021QII "" National Total Total Cohort January 1 Total Survival in the third trimester 2021QI "" National Total Total Cohort January 1 Total Survival in the third trimester 2020QIV "" National Total Total Cohort January 1 Total Survival in the third trimester 2020QIII 983.011 National Total Total Cohort January 1 Total Survival in the third trimester 2020QII "" National Total Total Cohort January 1 Total Survival in the third trimester 2020QI "" National Total Total Cohort January 1 Total Survival in the third trimester 2022QIV 994.419 National Total Total Cohort January 1 Total Survival in the third trimester 2022QIII "" National Total Total Cohort January 1 Total Survival in the third trimester 2022QII "" National Total Total Cohort January 1 Total Survival in the third trimester 2022QI "" National Total Total Cohort January 1 Total Survival in the third trimester 2021QIV 976.592 National Total Total Cohort January 1 Total Survival in the third trimester 2021QIII "" National Total Total Cohort January 1 Total Survival in the third trimester 2021QII "" National Total Total Cohort January 1 Total Survival in the third trimester 2021QI "" National Total Total Cohort January 1 Total Survival in the third trimester 2020QIV 952.502 National Total Total Cohort January 1 Total Survival in the third trimester 2020QIII "" National Total Total Cohort January 1 Total Survival in the third trimester 2020QII "" National Total Total Cohort January 1 Total Survival in the third trimester 2020QI "" National Total Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 National Total Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 National Total Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,47 National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,52 National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 88,2 National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,37 National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,11 National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 85,18 National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 87,15 National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,3 National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 82,55 National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 84,59 National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,93 National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,98 National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.116.307 National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 972.382 National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.053.423 National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 915.073 National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.006.960 National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 879.880 National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 970.603 National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 850.920 National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 941.626 National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 827.437 National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,37 National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,11 National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,2 National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,49 National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,95 National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,51 National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 84,35 National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,09 National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 59.275 National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 164.179 National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 57.158 National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 159.247 National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 55.397 National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 155.695 National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 53.956 National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 152.616 National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 52.793 National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 149.155 National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,43 National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97 National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,46 National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,83 National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,03 National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,96 National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,06 National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,85 National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total Total Cohort April 1 Total Number at the start of the quarter 2022QII 1.180.282 National Total Total Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total Total Cohort April 1 Total Number at the start of the quarter 2021QII 1.137.018 National Total Total Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total Total Cohort April 1 Total Number at the start of the quarter 2020QII 1.102.738 National Total Total Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total Total Cohort April 1 Total Survival in the first trimester 2022QIV "" National Total Total Cohort April 1 Total Survival in the first trimester 2022QIII "" National Total Total Cohort April 1 Total Survival in the first trimester 2022QII 1.119.786 National Total Total Cohort April 1 Total Survival in the first trimester 2022QI "" National Total Total Cohort April 1 Total Survival in the first trimester 2021QIV "" National Total Total Cohort April 1 Total Survival in the first trimester 2021QIII "" National Total Total Cohort April 1 Total Survival in the first trimester 2021QII 1.087.341 National Total Total Cohort April 1 Total Survival in the first trimester 2021QI "" National Total Total Cohort April 1 Total Survival in the first trimester 2020QIV "" National Total Total Cohort April 1 Total Survival in the first trimester 2020QIII "" National Total Total Cohort April 1 Total Survival in the first trimester 2020QII 1.059.378 National Total Total Cohort April 1 Total Survival in the first trimester 2020QI "" National Total Total Cohort April 1 Total Survival in the second trimester 2022QIV "" National Total Total Cohort April 1 Total Survival in the second trimester 2022QIII 1.073.841 National Total Total Cohort April 1 Total Survival in the second trimester 2022QII "" National Total Total Cohort April 1 Total Survival in the second trimester 2022QI "" National Total Total Cohort April 1 Total Survival in the second trimester 2021QIV "" National Total Total Cohort April 1 Total Survival in the second trimester 2021QIII 1.047.638 National Total Total Cohort April 1 Total Survival in the second trimester 2021QII "" National Total Total Cohort April 1 Total Survival in the second trimester 2021QI "" National Total Total Cohort April 1 Total Survival in the second trimester 2020QIV "" National Total Total Cohort April 1 Total Survival in the second trimester 2020QIII 1.022.614 National Total Total Cohort April 1 Total Survival in the second trimester 2020QII "" National Total Total Cohort April 1 Total Survival in the second trimester 2020QI "" National Total Total Cohort April 1 Total Survival in the third trimester 2022QIV 1.034.840 National Total Total Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total Total Cohort April 1 Total Survival in the third trimester 2022QII "" National Total Total Cohort April 1 Total Survival in the third trimester 2022QI "" National Total Total Cohort April 1 Total Survival in the third trimester 2021QIV 1.013.467 National Total Total Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total Total Cohort April 1 Total Survival in the third trimester 2021QII "" National Total Total Cohort April 1 Total Survival in the third trimester 2021QI "" National Total Total Cohort April 1 Total Survival in the third trimester 2020QIV 986.485 National Total Total Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total Total Cohort April 1 Total Survival in the third trimester 2020QII "" National Total Total Cohort April 1 Total Survival in the third trimester 2020QI "" National Total Total Cohort April 1 Total Survival in the third trimester 2022QIV "" National Total Total Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total Total Cohort April 1 Total Survival in the third trimester 2022QII "" National Total Total Cohort April 1 Total Survival in the third trimester 2022QI 976.815 National Total Total Cohort April 1 Total Survival in the third trimester 2021QIV "" National Total Total Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total Total Cohort April 1 Total Survival in the third trimester 2021QII "" National Total Total Cohort April 1 Total Survival in the third trimester 2021QI 950.014 National Total Total Cohort April 1 Total Survival in the third trimester 2020QIV "" National Total Total Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total Total Cohort April 1 Total Survival in the third trimester 2020QII "" National Total Total Cohort April 1 Total Survival in the third trimester 2020QI "" National Total Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 National Total Total Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 National Total Total Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 National Total Total Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,87 National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,63 National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,07 National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,98 National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,14 National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,73 National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,68 National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,13 National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,46 National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,91 National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 86,15 National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.122.675 National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 981.798 National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 852.306 National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.064.037 National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 935.775 National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 812.240 National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.019.625 National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 899.208 National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 781.490 National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 982.021 National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 868.703 National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 753.187 National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 835.962 National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 724.018 National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,78 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,31 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,3 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,82 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,59 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,69 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,47 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,48 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,37 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,15 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,95 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 57.607 National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 155.220 National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 250.432 National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 55.749 National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 151.566 National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 247.138 National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 54.216 National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 148.430 National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 241.124 National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 52.819 National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 144.764 National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 233.298 National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 140.853 National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 225.996 National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,77 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,65 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,68 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,11 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,63 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,28 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,69 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,26 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,16 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,74 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,24 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total Total Cohort July 1 Total Number at the start of the quarter 2022QIII 1.200.910 National Total Total Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total Total Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total Total Cohort July 1 Total Number at the start of the quarter 2021QIII 1.175.049 National Total Total Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total Total Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total Total Cohort July 1 Total Number at the start of the quarter 2020QIII 1.141.253 National Total Total Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total Total Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total Total Cohort July 1 Total Survival in the first trimester 2022QIV "" National Total Total Cohort July 1 Total Survival in the first trimester 2022QIII 1.133.593 National Total Total Cohort July 1 Total Survival in the first trimester 2022QII "" National Total Total Cohort July 1 Total Survival in the first trimester 2022QI "" National Total Total Cohort July 1 Total Survival in the first trimester 2021QIV "" National Total Total Cohort July 1 Total Survival in the first trimester 2021QIII 1.112.584 National Total Total Cohort July 1 Total Survival in the first trimester 2021QII "" National Total Total Cohort July 1 Total Survival in the first trimester 2021QI "" National Total Total Cohort July 1 Total Survival in the first trimester 2020QIV "" National Total Total Cohort July 1 Total Survival in the first trimester 2020QIII 1.085.053 National Total Total Cohort July 1 Total Survival in the first trimester 2020QII "" National Total Total Cohort July 1 Total Survival in the first trimester 2020QI "" National Total Total Cohort July 1 Total Survival in the second trimester 2022QIV 1.077.291 National Total Total Cohort July 1 Total Survival in the second trimester 2022QIII "" National Total Total Cohort July 1 Total Survival in the second trimester 2022QII "" National Total Total Cohort July 1 Total Survival in the second trimester 2022QI "" National Total Total Cohort July 1 Total Survival in the second trimester 2021QIV 1.060.988 National Total Total Cohort July 1 Total Survival in the second trimester 2021QIII "" National Total Total Cohort July 1 Total Survival in the second trimester 2021QII "" National Total Total Cohort July 1 Total Survival in the second trimester 2021QI "" National Total Total Cohort July 1 Total Survival in the second trimester 2020QIV 1.033.148 National Total Total Cohort July 1 Total Survival in the second trimester 2020QIII "" National Total Total Cohort July 1 Total Survival in the second trimester 2020QII "" National Total Total Cohort July 1 Total Survival in the second trimester 2020QI "" National Total Total Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total Total Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total Total Cohort July 1 Total Survival in the third trimester 2022QII "" National Total Total Cohort July 1 Total Survival in the third trimester 2022QI 1.018.275 National Total Total Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total Total Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total Total Cohort July 1 Total Survival in the third trimester 2021QII "" National Total Total Cohort July 1 Total Survival in the third trimester 2021QI 991.293 National Total Total Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total Total Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total Total Cohort July 1 Total Survival in the third trimester 2020QII "" National Total Total Cohort July 1 Total Survival in the third trimester 2020QI "" National Total Total Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total Total Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total Total Cohort July 1 Total Survival in the third trimester 2022QII 987.625 National Total Total Cohort July 1 Total Survival in the third trimester 2022QI "" National Total Total Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total Total Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total Total Cohort July 1 Total Survival in the third trimester 2021QII 966.184 National Total Total Cohort July 1 Total Survival in the third trimester 2021QI "" National Total Total Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total Total Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total Total Cohort July 1 Total Survival in the third trimester 2020QII "" National Total Total Cohort July 1 Total Survival in the third trimester 2020QI "" National Total Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 National Total Total Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total Total Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 National Total Total Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total Total Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 National Total Total Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total Total Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,39 National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,68 National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,08 National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,71 National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,29 National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,53 National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,66 National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,86 National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 84,05 National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,66 National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.166.975 National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.123.921 National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 962.702 National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.100.667 National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.062.703 National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 910.591 National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.045.250 National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.012.815 National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 865.189 National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 971.426 National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 828.387 National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 941.834 National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 806.621 National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,32 National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,55 National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,59 National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,57 National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,11 National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,87 National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,43 National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,05 National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,8 National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,79 National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 33.935 National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 51.128 National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 178.551 National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 32.926 National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 49.881 National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 174.462 National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 32.041 National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 48.173 National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 167.959 National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 46.849 National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 162.906 National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 45.791 National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 159.563 National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,03 National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,56 National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,71 National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,42 National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,22 National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,07 National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,63 National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,24 National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 89,56 National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 89,37 National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort October 1 Total Number at the start of the quarter 2022QIV 1.189.333 National Total Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total Total Cohort October 1 Total Number at the start of the quarter 2021QIV 1.173.766 National Total Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total Total Cohort October 1 Total Number at the start of the quarter 2020QIV 1.149.469 National Total Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total Total Cohort October 1 Total Survival in the first trimester 2022QIV 1.121.025 National Total Total Cohort October 1 Total Survival in the first trimester 2022QIII "" National Total Total Cohort October 1 Total Survival in the first trimester 2022QII "" National Total Total Cohort October 1 Total Survival in the first trimester 2022QI "" National Total Total Cohort October 1 Total Survival in the first trimester 2021QIV 1.108.131 National Total Total Cohort October 1 Total Survival in the first trimester 2021QIII "" National Total Total Cohort October 1 Total Survival in the first trimester 2021QII "" National Total Total Cohort October 1 Total Survival in the first trimester 2021QI "" National Total Total Cohort October 1 Total Survival in the first trimester 2020QIV 1.080.193 National Total Total Cohort October 1 Total Survival in the first trimester 2020QIII "" National Total Total Cohort October 1 Total Survival in the first trimester 2020QII "" National Total Total Cohort October 1 Total Survival in the first trimester 2020QI "" National Total Total Cohort October 1 Total Survival in the second trimester 2022QIV "" National Total Total Cohort October 1 Total Survival in the second trimester 2022QIII "" National Total Total Cohort October 1 Total Survival in the second trimester 2022QII "" National Total Total Cohort October 1 Total Survival in the second trimester 2022QI 1.058.391 National Total Total Cohort October 1 Total Survival in the second trimester 2021QIV "" National Total Total Cohort October 1 Total Survival in the second trimester 2021QIII "" National Total Total Cohort October 1 Total Survival in the second trimester 2021QII "" National Total Total Cohort October 1 Total Survival in the second trimester 2021QI 1.031.022 National Total Total Cohort October 1 Total Survival in the second trimester 2020QIV "" National Total Total Cohort October 1 Total Survival in the second trimester 2020QIII "" National Total Total Cohort October 1 Total Survival in the second trimester 2020QII "" National Total Total Cohort October 1 Total Survival in the second trimester 2020QI "" National Total Total Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total Total Cohort October 1 Total Survival in the third trimester 2022QIII "" National Total Total Cohort October 1 Total Survival in the third trimester 2022QII 1.020.827 National Total Total Cohort October 1 Total Survival in the third trimester 2022QI "" National Total Total Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total Total Cohort October 1 Total Survival in the third trimester 2021QIII "" National Total Total Cohort October 1 Total Survival in the third trimester 2021QII 1.000.340 National Total Total Cohort October 1 Total Survival in the third trimester 2021QI "" National Total Total Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total Total Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total Total Cohort October 1 Total Survival in the third trimester 2020QII "" National Total Total Cohort October 1 Total Survival in the third trimester 2020QI "" National Total Total Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total Total Cohort October 1 Total Survival in the third trimester 2022QIII 988.984 National Total Total Cohort October 1 Total Survival in the third trimester 2022QII "" National Total Total Cohort October 1 Total Survival in the third trimester 2022QI "" National Total Total Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total Total Cohort October 1 Total Survival in the third trimester 2021QIII 973.266 National Total Total Cohort October 1 Total Survival in the third trimester 2021QII "" National Total Total Cohort October 1 Total Survival in the third trimester 2021QI "" National Total Total Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total Total Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total Total Cohort October 1 Total Survival in the third trimester 2020QII "" National Total Total Cohort October 1 Total Survival in the third trimester 2020QI "" National Total Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 National Total Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 National Total Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 National Total Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,26 National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,41 National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,97 National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,17 National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,7 National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 86,97 National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,03 National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,26 National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,67 National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.160.407 National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.109.995 National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 962.114 National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.092.834 National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.046.546 National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 899.731 National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 998.931 National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 855.977 National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 963.203 National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 828.952 National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 932.892 National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 805.210 National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,18 National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,28 National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,52 National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,99 National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,97 National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 86,78 National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,16 National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,04 National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,69 National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 28.926 National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 63.771 National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 187.355 National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 28.191 National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 61.585 National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 180.462 National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 59.460 National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 175.045 National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 57.624 National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 171.388 National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 56.092 National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 168.056 National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,46 National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,57 National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,32 National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,24 National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,43 National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 90,36 National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 91,48 National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,96 National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 89,7 National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 874.114 National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 855.490 National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 886.684 National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 812.905 National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 796.794 National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 756.210 National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 769.343 National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 761.641 National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 723.750 National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 734.959 National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 732.347 National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 695.670 National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 707.744 National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 708.023 National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 668.592 National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,14 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 85,29 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,01 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,03 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 81,62 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 84,08 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 85,61 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 78,46 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 80,97 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 82,76 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 75,4 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 837.215 National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 768.170 National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 777.875 National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 713.559 National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 735.791 National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 681.184 National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 702.623 National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 654.274 National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 676.390 National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 632.648 National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,91 National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,89 National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,89 National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 88,68 National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 83,92 National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 85,17 National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 80,79 National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 82,36 National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 36.899 National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 87.320 National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 35.030 National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 83.235 National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 33.552 National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 80.457 National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 32.336 National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 78.073 National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 31.354 National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 75.375 National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,93 National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,32 National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,93 National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,14 National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,63 National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,41 National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 84,97 National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 86,32 National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 874.197 National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 854.310 National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 825.970 National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 818.113 National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 808.026 National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 785.210 National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 775.542 National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 771.127 National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 751.083 National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 740.395 National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 740.136 National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 718.066 National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 707.163 National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 685.318 National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,58 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,58 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,07 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,71 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,26 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 90,93 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 84,69 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,64 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 86,94 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 82,78 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 82,97 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 838.776 National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 769.732 National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 676.830 National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 784.297 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 726.460 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 638.724 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 743.050 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 692.118 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 609.668 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 709.047 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 664.072 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 583.024 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 634.180 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 556.127 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,5 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,38 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,37 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,59 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,92 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,08 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,53 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,27 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,14 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,39 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 82,17 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 35.421 National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 84.578 National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 149.140 National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 33.816 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 81.566 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 146.486 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 32.492 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 79.009 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 141.415 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 31.348 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 76.064 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 135.042 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 72.983 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 129.191 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,47 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,44 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,22 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,73 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,42 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,82 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,5 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 89,93 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 90,55 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 86,29 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 86,62 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 883.149 National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 874.571 National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 853.778 National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 820.049 National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 815.824 National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 800.979 National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 771.171 National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 770.295 National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 754.275 National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 731.887 National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 716.603 National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 704.284 National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 694.215 National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,86 National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,28 National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,82 National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,32 National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 88,08 National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,35 National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 83,69 National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 83,93 National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 80,53 National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 81,31 National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 861.875 National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 846.766 National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 759.705 National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 799.681 National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 789.096 National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 710.308 National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 751.489 National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 744.825 National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 668.408 National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 707.461 National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 634.589 National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 680.705 National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 614.694 National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,78 National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,19 National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,5 National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,19 National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,96 National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 87,98 National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 83,55 National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 83,53 National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 80,39 National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 80,91 National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 21.274 National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 27.805 National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 94.073 National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 20.368 National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 26.728 National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 90.671 National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 19.682 National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 25.470 National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 85.867 National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 24.426 National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 82.014 National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 23.579 National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 79.521 National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,74 National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,13 National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,38 National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 92,52 National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 91,6 National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 91,28 National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 87,85 National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 87,18 National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 84,8 National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 84,53 National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 876.949 National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 873.692 National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 861.639 National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 814.659 National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 813.113 National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 796.865 National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 767.484 National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 751.794 National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 733.651 National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 724.273 National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 704.836 National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 699.781 National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,9 National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,07 National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,48 National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 87,84 National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,25 National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 83,97 National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 84,06 National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 80,67 National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 81,22 National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 859.355 National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 832.620 National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 764.014 National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 797.673 National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 773.929 National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 704.637 National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 730.155 National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 663.810 National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 697.930 National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 639.048 National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 670.420 National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 617.075 National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,82 National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,95 National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,23 National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 87,69 National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 86,88 National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 83,82 National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 83,64 National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 80,52 National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 80,77 National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 17.594 National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 41.072 National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 97.625 National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 16.986 National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 39.184 National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 92.228 National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 37.329 National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 87.984 National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 35.721 National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 85.225 National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 34.416 National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 82.706 National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,54 National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,4 National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 94,47 National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 90,89 National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 90,12 National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 86,97 National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 87,3 National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 83,79 National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 84,72 National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 124.549 National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 116.998 National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 125.748 National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 122.442 National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 115.037 National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 119.746 National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 119.929 National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 113.082 National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 117.857 National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 118.092 National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 111.610 National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 116.016 National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 116.475 National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 110.232 National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 114.126 National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,31 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,32 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 95,23 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,29 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,65 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 93,72 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,82 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,39 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 92,26 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,52 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,22 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 90,76 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 116.252 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 89.900 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 114.291 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 88.368 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 111.916 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 86.777 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 110.189 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 85.631 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 108.663 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 84.625 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,31 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,3 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,27 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,53 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,78 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,25 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,47 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,13 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 8.297 National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 27.098 National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 8.151 National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 26.669 National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 8.013 National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 26.305 National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 7.903 National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 25.979 National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 7.812 National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 25.607 National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,24 National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,42 National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,58 National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,07 National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 95,25 National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,87 National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,15 National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,5 National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 125.746 National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 117.333 National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 113.956 National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 123.339 National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 115.449 National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 112.601 National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 121.490 National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 113.946 National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 111.102 National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 119.297 National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 112.122 National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 109.297 National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 110.064 National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 107.283 National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,09 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,39 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,81 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,62 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,11 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,5 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,87 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,56 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,91 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,8 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,14 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 117.702 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 92.334 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 73.717 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 115.409 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 90.772 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 72.663 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 113.675 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 89.553 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 71.705 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 111.618 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 88.101 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 70.739 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 86.453 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 69.483 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,05 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,31 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,57 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,58 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,99 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,27 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,83 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,42 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,96 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,63 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,26 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 8.044 National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 24.999 National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 40.239 National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 7.930 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 24.677 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 39.938 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 7.815 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 24.393 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 39.397 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 7.679 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 24.021 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 38.558 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 23.611 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 37.800 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,58 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,71 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,25 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,15 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,58 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,91 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,46 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,09 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,82 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94,45 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 93,94 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 130.132 National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 124.765 National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 119.956 National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 127.777 National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 122.694 National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 117.978 National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 123.924 National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 119.394 National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 114.960 National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 116.989 National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 112.670 National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 115.333 National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 111.210 National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,19 National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,34 National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,35 National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 95,23 National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 95,7 National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 95,84 National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 93,77 National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 93,93 National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 92,44 National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 92,71 National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 125.390 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 116.697 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 90.074 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 123.085 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 114.694 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 88.484 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 119.321 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 111.607 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 86.341 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 109.334 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 84.652 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 107.792 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 83.598 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,16 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,28 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,23 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 95,16 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 95,64 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 95,86 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 93,69 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 93,98 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 92,37 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 92,81 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 4.742 National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 8.068 National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 29.882 National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4.692 National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 8.000 National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 29.494 National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4.603 National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 7.787 National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 28.619 National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 7.655 National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 28.018 National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 7.541 National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 27.612 National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,95 National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,16 National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,7 National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,07 National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,52 National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,77 National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 94,88 National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,76 National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,47 National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,4 National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 127.463 National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 123.997 National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 119.747 National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 124.148 National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 121.155 National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 117.016 National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 118.849 National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 114.737 National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 116.838 National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 113.058 National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 115.212 National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 111.718 National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,4 National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,71 National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,72 National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 95,85 National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 95,82 National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 94,23 National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 94,41 National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 92,92 National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,3 National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 123.328 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 115.622 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 88.359 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 120.065 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 112.939 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 86.418 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 110.785 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 84.738 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 108.872 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 83.486 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 107.369 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 82.513 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,35 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,68 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,8 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 95,82 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 95,9 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 94,16 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,48 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 92,86 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,38 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4.135 National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 8.375 National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 31.388 National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4.083 National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 8.216 National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 30.598 National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 8.064 National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 29.999 National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 7.966 National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 29.572 National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 7.843 National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 29.205 National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,74 National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,1 National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,48 National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,29 National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,57 National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,12 National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,21 National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 93,65 National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,05 National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 163.320 National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 151.266 National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 164.940 National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 161.717 National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 149.762 National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 161.052 National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 159.625 National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 148.171 National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 159.443 National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 158.127 National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 146.961 National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 158.052 National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 156.876 National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 145.782 National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 156.571 National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,02 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,01 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,64 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,74 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,95 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,67 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,82 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,15 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,82 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,05 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,37 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,93 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 150.543 National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 106.288 National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 149.040 National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 105.181 National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 147.087 National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 103.991 National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 145.695 National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 103.131 National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 144.529 National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 102.326 National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99 National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,96 National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,7 National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,84 National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,78 National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,03 National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,01 National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,27 National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 12.777 National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 44.978 National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 12.677 National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 44.581 National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 12.538 National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 44.180 National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 12.432 National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 43.830 National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 12.347 National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 43.456 National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,22 National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,12 National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,13 National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,23 National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,3 National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,45 National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,63 National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,62 National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 166.450 National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 152.636 National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 150.040 National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 164.493 National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 151.161 National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 148.830 National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 163.054 National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 149.932 National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 147.755 National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 161.455 National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 148.639 National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 146.511 National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 147.097 National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 144.878 National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,82 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,03 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,19 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,96 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,23 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,48 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,38 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,65 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,37 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,56 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 153.606 National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 111.384 National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 93.261 National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 151.785 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 110.222 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 92.383 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 150.432 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 109.269 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 91.698 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 148.945 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 108.311 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 91.053 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 107.167 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 90.090 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,81 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,96 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,06 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,93 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,1 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,32 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,97 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,24 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,63 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,21 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,6 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 12.844 National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 41.252 National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 56.779 National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 12.708 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 40.939 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 56.447 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 12.622 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 40.663 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 56.057 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 12.510 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 40.328 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 55.458 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 39.930 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 54.788 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,94 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,24 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,42 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,27 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,57 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,73 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,4 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,76 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,67 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,8 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,49 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 173.380 National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 162.690 National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 155.017 National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 171.583 National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 161.089 National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 153.646 National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 168.075 National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 158.391 National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 151.519 National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 156.573 National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 149.706 National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 155.225 National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 148.479 National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,96 National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,02 National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,12 National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,94 National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,36 National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,74 National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,24 National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,57 National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,41 National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,78 National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 166.164 National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 148.996 National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 105.363 National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 164.417 National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 147.492 National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 104.280 National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 161.016 National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 145.023 National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 102.959 National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 143.349 National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 101.717 National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 142.095 National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 100.927 National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,95 National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,99 National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,97 National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,9 National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,33 National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,72 National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,21 National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,54 National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,37 National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,79 National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 7.216 National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 13.694 National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 49.654 National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 7.166 National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 13.597 National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 49.366 National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 7.059 National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 13.368 National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 48.560 National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 13.224 National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 47.989 National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 13.130 National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 47.552 National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,31 National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,29 National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,42 National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,82 National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,62 National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,8 National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,57 National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,65 National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,88 National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,77 National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 170.547 National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 162.696 National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 155.216 National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 167.898 National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 160.551 National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 153.508 National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 158.833 National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 151.765 National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 157.160 National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 150.320 National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 155.826 National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 149.131 National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,45 National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,68 National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,9 National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,63 National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,78 National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,6 National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,85 National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,78 National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,08 National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 163.975 National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 149.747 National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 102.151 National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 161.397 National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 147.739 National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 101.131 National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 146.137 National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 99.937 National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 144.590 National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 98.954 National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 143.354 National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 98.189 National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,43 National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,66 National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99 National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,59 National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,83 National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,56 National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,87 National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,73 National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,12 National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 6.572 National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 12.949 National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 53.065 National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 6.501 National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 12.812 National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 52.377 National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 12.696 National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 51.828 National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 12.570 National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 51.366 National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 12.472 National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 50.942 National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,92 National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,94 National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,7 National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,05 National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,67 National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,07 National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 96,8 National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,32 National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96 National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 8.758 National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 8.219 National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 8.715 National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 8.715 National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 8.160 National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 8.634 National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 8.673 National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 8.128 National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 8.600 National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 8.617 National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 8.088 National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 8.549 National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 8.576 National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 8.046 National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 8.509 National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,51 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,28 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,07 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,03 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,89 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,68 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,39 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,41 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,1 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,92 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,9 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,64 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 7.908 National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 5.257 National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 7.866 National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 5.213 National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 7.829 National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 5.187 National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 7.780 National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 5.161 National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 7.743 National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 5.129 National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,47 National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,16 National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99 National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,67 National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,38 National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,17 National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,91 National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,57 National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 850 National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2.962 National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 849 National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2.947 National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 844 National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.941 National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 837 National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.927 National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 833 National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.917 National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,88 National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,49 National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 99,29 National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,29 National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 98,47 National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,82 National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 98 National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,48 National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 8.978 National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 8.170 National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 8.183 National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 8.942 National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 8.148 National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 8.155 National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 8.878 National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 8.094 National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 8.119 National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 8.830 National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 8.052 National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 8.078 National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 8.012 National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 8.025 National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,6 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,73 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,66 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,89 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,07 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,22 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,35 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,56 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,72 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,07 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,07 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 8.143 National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 5.493 National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 5.426 National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 8.108 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 5.475 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 5.402 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 8.050 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 5.435 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 5.375 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 8.004 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 5.402 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 5.344 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 5.377 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 5.309 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,57 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,67 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,56 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,86 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,94 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,06 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,29 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,34 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,49 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,89 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,84 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 835 National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2.677 National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.757 National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 834 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2.673 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.753 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 828 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2.659 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.744 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 826 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2.650 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.734 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2.635 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.716 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,88 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,85 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,85 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,16 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,33 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,53 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,92 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,99 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 99,17 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,43 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,51 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 9.297 National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 8.416 National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 8.063 National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 9.247 National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 8.379 National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 8.025 National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 9.198 National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 8.331 National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 7.991 National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 8.288 National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 7.932 National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 8.257 National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 7.907 National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,46 National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,56 National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,53 National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,94 National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,99 National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,11 National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,48 National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,38 National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,11 National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,07 National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 8.817 National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 7.463 National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 4.935 National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 8.769 National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 7.429 National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 4.907 National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 8.721 National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 7.385 National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 4.885 National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 7.346 National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 4.848 National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 7.318 National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 4.828 National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,46 National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,54 National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,43 National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,91 National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,95 National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,99 National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,43 National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,24 National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,06 National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,83 National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 480 National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 953 National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 3.128 National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 478 National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 950 National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 3.118 National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 477 National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 946 National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3.106 National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 942 National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 3.084 National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 939 National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 3.079 National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,58 National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,69 National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,68 National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 99,38 National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,27 National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,3 National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 98,85 National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,59 National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 98,53 National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,43 National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 9.311 National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 8.634 National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 8.288 National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 9.273 National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 8.585 National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 8.247 National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 8.541 National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 8.189 National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 8.509 National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 8.164 National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 8.459 National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 8.128 National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,59 National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,43 National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,51 National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,92 National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,81 National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,55 National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,5 National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,97 National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,07 National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 8.889 National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 7.774 National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 4.950 National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 8.854 National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 7.726 National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 4.920 National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 7.683 National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 4.881 National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 7.654 National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 4.861 National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 7.608 National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 4.840 National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,61 National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,38 National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,39 National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,83 National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,61 National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,46 National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,2 National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,86 National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,78 National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 422 National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 860 National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 3.338 National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 419 National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 859 National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 3.327 National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 858 National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 3.308 National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 855 National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 3.303 National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 851 National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 3.288 National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,29 National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,88 National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,67 National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 99,77 National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,1 National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 99,42 National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,95 National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 98,95 National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,5 National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 4.841 National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 4.588 National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 4.783 National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 4.802 National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 4.567 National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 4.762 National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 4.787 National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 4.553 National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 4.748 National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 4.764 National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 4.530 National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 4.724 National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 4.748 National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 4.509 National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 4.704 National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,19 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,54 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,56 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,88 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,24 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,27 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,41 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,74 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,77 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,08 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,28 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,35 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 4.389 National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.767 National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 4.351 National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.752 National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 4.337 National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.741 National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 4.316 National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.723 National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 4.301 National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.709 National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,13 National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,46 National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,82 National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 99,06 National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,34 National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,41 National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,99 National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,9 National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 452 National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.821 National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 451 National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.815 National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 450 National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.812 National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 448 National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.807 National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 447 National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.800 National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,78 National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,67 National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 99,56 National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,51 National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 99,12 National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 99,23 National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 98,89 National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,85 National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 4.911 National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 4.569 National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 4.589 National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 4.899 National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 4.557 National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 4.582 National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 4.877 National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 4.539 National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 4.555 National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 4.863 National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 4.518 National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 4.533 National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 4.479 National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 4.510 National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,76 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,74 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,85 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,31 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,34 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,26 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 99,02 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,88 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,78 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,03 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,28 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 4.448 National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.855 National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3.072 National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 4.438 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.846 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3.068 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 4.418 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.833 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3.044 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 4.407 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.817 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3.027 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.785 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3.009 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,78 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,68 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,87 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,33 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,23 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,09 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 99,08 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,67 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,54 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,55 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,95 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 463 National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.714 National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.517 National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 461 National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.711 National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.514 National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 459 National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.706 National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.511 National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 456 National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.701 National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.506 National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.694 National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.501 National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,57 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,82 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,8 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,14 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,53 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,6 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,49 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 99,24 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 99,27 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,83 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,95 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 4.952 National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 4.607 National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 4.439 National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 4.937 National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 4.598 National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 4.425 National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 4.923 National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 4.577 National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 4.403 National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 4.538 National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 4.382 National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 4.526 National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 4.373 National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,7 National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,8 National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,68 National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,41 National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,35 National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,19 National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,5 National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,72 National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,24 National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,51 National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 4.729 National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.999 National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.625 National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 4.715 National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3.992 National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.612 National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 4.703 National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3.975 National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.596 National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3.936 National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.581 National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3.924 National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.574 National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,7 National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,82 National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,5 National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,45 National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,4 National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,9 National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,42 National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,32 National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,12 National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98,06 National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 223 National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 608 National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.814 National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 222 National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 606 National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.813 National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 220 National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 602 National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.807 National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 602 National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.801 National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 602 National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.799 National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,55 National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,67 National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,94 National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,65 National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,01 National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,61 National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 99,01 National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 99,28 National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 99,01 National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 99,17 National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 5.063 National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 4.747 National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 4.579 National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 5.047 National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 4.727 National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 4.557 National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 4.684 National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 4.537 National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 4.669 National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 4.525 National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 4.651 National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 4.508 National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,68 National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,58 National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,52 National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,67 National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99,08 National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,36 National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,82 National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,98 National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,45 National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 4.860 National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 4.232 National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.640 National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 4.845 National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 4.213 National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.625 National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 4.171 National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.611 National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 4.157 National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.603 National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 4.141 National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.593 National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,69 National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,55 National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,43 National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,56 National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,9 National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,23 National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,6 National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,85 National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,22 National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 203 National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 515 National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.939 National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 202 National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 514 National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.932 National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 513 National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.926 National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 512 National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.922 National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 510 National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.915 National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,51 National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,81 National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,64 National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 99,61 National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,33 National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 99,42 National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 99,12 National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 99,03 National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,76 National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2022QI 191.980 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2021QI 182.747 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2020QI 194.451 01 Andalucía Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 01 Andalucía Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 01 Andalucía Total Cohort January 1 Total Survival in the first trimester 2022QII "" 01 Andalucía Total Cohort January 1 Total Survival in the first trimester 2022QI 179.191 01 Andalucía Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 01 Andalucía Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 01 Andalucía Total Cohort January 1 Total Survival in the first trimester 2021QII "" 01 Andalucía Total Cohort January 1 Total Survival in the first trimester 2021QI 170.464 01 Andalucía Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 01 Andalucía Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 01 Andalucía Total Cohort January 1 Total Survival in the first trimester 2020QII "" 01 Andalucía Total Cohort January 1 Total Survival in the first trimester 2020QI 160.827 01 Andalucía Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 01 Andalucía Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 01 Andalucía Total Cohort January 1 Total Survival in the second trimester 2022QII 170.279 01 Andalucía Total Cohort January 1 Total Survival in the second trimester 2022QI "" 01 Andalucía Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 01 Andalucía Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 01 Andalucía Total Cohort January 1 Total Survival in the second trimester 2021QII 163.254 01 Andalucía Total Cohort January 1 Total Survival in the second trimester 2021QI "" 01 Andalucía Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 01 Andalucía Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 01 Andalucía Total Cohort January 1 Total Survival in the second trimester 2020QII 154.596 01 Andalucía Total Cohort January 1 Total Survival in the second trimester 2020QI "" 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2022QIII 163.289 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2021QIII 157.326 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2020QIII 149.229 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2022QIV 157.605 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2021QIV 152.453 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2020QIV 143.626 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,34 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,28 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 82,71 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,7 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,33 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 79,5 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,06 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 86,09 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 76,74 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 82,09 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 83,42 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 73,86 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 182.880 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 160.033 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 170.430 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 148.500 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 161.821 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 141.800 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 155.076 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 136.328 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 149.583 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 131.964 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,19 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,79 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,48 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 88,61 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 84,8 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 85,19 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 81,79 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 82,46 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 9.100 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 22.714 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 8.761 01 Andalucía Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 21.964 01 Andalucía Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 8.458 01 Andalucía Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 21.454 01 Andalucía Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 8.213 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 20.998 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 8.022 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 20.489 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,27 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,7 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,95 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,45 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,25 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,45 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,15 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,2 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2022QII 193.805 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2021QII 183.937 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2020QII 170.456 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 01 Andalucía Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 01 Andalucía Total Cohort April 1 Total Survival in the first trimester 2022QII 181.965 01 Andalucía Total Cohort April 1 Total Survival in the first trimester 2022QI "" 01 Andalucía Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 01 Andalucía Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 01 Andalucía Total Cohort April 1 Total Survival in the first trimester 2021QII 174.132 01 Andalucía Total Cohort April 1 Total Survival in the first trimester 2021QI "" 01 Andalucía Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 01 Andalucía Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 01 Andalucía Total Cohort April 1 Total Survival in the first trimester 2020QII 162.695 01 Andalucía Total Cohort April 1 Total Survival in the first trimester 2020QI "" 01 Andalucía Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 01 Andalucía Total Cohort April 1 Total Survival in the second trimester 2022QIII 173.042 01 Andalucía Total Cohort April 1 Total Survival in the second trimester 2022QII "" 01 Andalucía Total Cohort April 1 Total Survival in the second trimester 2022QI "" 01 Andalucía Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 01 Andalucía Total Cohort April 1 Total Survival in the second trimester 2021QIII 166.433 01 Andalucía Total Cohort April 1 Total Survival in the second trimester 2021QII "" 01 Andalucía Total Cohort April 1 Total Survival in the second trimester 2021QI "" 01 Andalucía Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 01 Andalucía Total Cohort April 1 Total Survival in the second trimester 2020QIII 156.218 01 Andalucía Total Cohort April 1 Total Survival in the second trimester 2020QII "" 01 Andalucía Total Cohort April 1 Total Survival in the second trimester 2020QI "" 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2022QIV 165.252 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2022QI "" 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2021QIV 159.659 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2021QI "" 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2020QIV 149.414 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2022QI 153.267 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2021QI 143.259 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 01 Andalucía Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,89 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,67 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,45 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,29 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,48 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,65 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 85,27 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,8 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 87,66 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 83,33 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 84,04 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 184.968 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 163.833 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 137.494 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 173.445 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 154.546 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 130.126 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 164.796 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 147.291 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 124.463 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 157.280 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 141.030 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 118.883 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 135.171 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 113.745 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 01 Andalucía Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,77 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,33 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,64 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,09 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,9 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,52 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 85,03 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,08 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,46 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,51 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 82,73 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 8.837 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 20.104 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 32.962 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 8.520 01 Andalucía Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 19.586 01 Andalucía Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 32.569 01 Andalucía Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 8.246 01 Andalucía Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 19.142 01 Andalucía Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 31.755 01 Andalucía Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 7.972 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 18.629 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 30.531 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 18.096 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 29.514 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 01 Andalucía Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,41 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,42 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,81 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,31 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,21 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,34 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90,21 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 92,66 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 92,62 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,01 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 89,54 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2022QIII 198.387 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2021QIII 192.438 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2020QIII 184.439 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 01 Andalucía Total Cohort July 1 Total Survival in the first trimester 2022QIII 184.680 01 Andalucía Total Cohort July 1 Total Survival in the first trimester 2022QII "" 01 Andalucía Total Cohort July 1 Total Survival in the first trimester 2022QI "" 01 Andalucía Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 01 Andalucía Total Cohort July 1 Total Survival in the first trimester 2021QIII 179.576 01 Andalucía Total Cohort July 1 Total Survival in the first trimester 2021QII "" 01 Andalucía Total Cohort July 1 Total Survival in the first trimester 2021QI "" 01 Andalucía Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 01 Andalucía Total Cohort July 1 Total Survival in the first trimester 2020QIII 172.836 01 Andalucía Total Cohort July 1 Total Survival in the first trimester 2020QII "" 01 Andalucía Total Cohort July 1 Total Survival in the first trimester 2020QI "" 01 Andalucía Total Cohort July 1 Total Survival in the second trimester 2022QIV 173.476 01 Andalucía Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 01 Andalucía Total Cohort July 1 Total Survival in the second trimester 2022QII "" 01 Andalucía Total Cohort July 1 Total Survival in the second trimester 2022QI "" 01 Andalucía Total Cohort July 1 Total Survival in the second trimester 2021QIV 169.264 01 Andalucía Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 01 Andalucía Total Cohort July 1 Total Survival in the second trimester 2021QII "" 01 Andalucía Total Cohort July 1 Total Survival in the second trimester 2021QI "" 01 Andalucía Total Cohort July 1 Total Survival in the second trimester 2020QIV 161.934 01 Andalucía Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 01 Andalucía Total Cohort July 1 Total Survival in the second trimester 2020QII "" 01 Andalucía Total Cohort July 1 Total Survival in the second trimester 2020QI "" 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2022QII "" 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2022QI 161.542 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2021QII "" 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2021QI 154.283 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2022QII 156.177 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2022QI "" 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2021QII 149.851 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2021QI "" 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,09 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,32 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,71 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,44 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 87,96 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 87,8 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 83,94 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 83,65 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 81,16 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 81,25 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 192.820 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 185.602 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 158.194 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 179.295 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 172.919 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 147.240 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 168.292 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 162.787 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 137.272 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 155.269 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 130.438 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 150.057 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 126.510 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,99 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,17 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,08 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,28 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,71 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 86,77 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 83,66 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 82,45 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 80,85 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 79,97 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 5.567 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 6.836 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 26.245 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 5.385 01 Andalucía Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 6.657 01 Andalucía Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 25.596 01 Andalucía Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 5.184 01 Andalucía Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 6.477 01 Andalucía Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 24.662 01 Andalucía Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 6.273 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 23.845 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 6.120 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 23.341 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,73 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,38 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,53 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,12 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,75 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,97 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,76 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 90,86 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 89,53 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,94 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2022QIV 196.005 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2021QIV 191.941 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2020QIV 186.659 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort October 1 Total Survival in the first trimester 2022QIV 181.815 01 Andalucía Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 01 Andalucía Total Cohort October 1 Total Survival in the first trimester 2022QII "" 01 Andalucía Total Cohort October 1 Total Survival in the first trimester 2022QI "" 01 Andalucía Total Cohort October 1 Total Survival in the first trimester 2021QIV 178.257 01 Andalucía Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 01 Andalucía Total Cohort October 1 Total Survival in the first trimester 2021QII "" 01 Andalucía Total Cohort October 1 Total Survival in the first trimester 2021QI "" 01 Andalucía Total Cohort October 1 Total Survival in the first trimester 2020QIV 171.250 01 Andalucía Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 01 Andalucía Total Cohort October 1 Total Survival in the first trimester 2020QII "" 01 Andalucía Total Cohort October 1 Total Survival in the first trimester 2020QI "" 01 Andalucía Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 01 Andalucía Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 01 Andalucía Total Cohort October 1 Total Survival in the second trimester 2022QII "" 01 Andalucía Total Cohort October 1 Total Survival in the second trimester 2022QI 168.949 01 Andalucía Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 01 Andalucía Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 01 Andalucía Total Cohort October 1 Total Survival in the second trimester 2021QII "" 01 Andalucía Total Cohort October 1 Total Survival in the second trimester 2021QI 161.967 01 Andalucía Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 01 Andalucía Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 01 Andalucía Total Cohort October 1 Total Survival in the second trimester 2020QII "" 01 Andalucía Total Cohort October 1 Total Survival in the second trimester 2020QI "" 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2022QII 162.311 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2021QII 156.533 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2022QIII 156.603 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2022QII "" 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2021QIII 151.687 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2021QII "" 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,76 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 92,87 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 91,74 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,02 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 86,77 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,56 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 83,86 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 81,59 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 81,26 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 191.145 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 182.035 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 162.488 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 177.124 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 168.713 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 148.003 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 159.746 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 139.486 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 153.420 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 134.539 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 147.980 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 130.150 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,66 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,68 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 91,09 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 87,76 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 85,84 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,28 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 82,8 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 81,29 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 80,1 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4.860 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 9.906 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 24.171 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4.691 01 Andalucía Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 9.544 01 Andalucía Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 23.247 01 Andalucía Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 9.203 01 Andalucía Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 22.481 01 Andalucía Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 8.891 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 21.994 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 8.623 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 21.537 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,52 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,35 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,18 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,9 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,01 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 89,75 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,99 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,05 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 89,1 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 147.123 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 142.412 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 149.516 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 135.008 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 130.754 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 118.283 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 126.941 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 124.144 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 112.653 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 120.541 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 118.661 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 107.786 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 115.410 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 114.215 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 102.851 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 91,77 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 91,81 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 79,11 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 86,28 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 87,17 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 75,35 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 81,93 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 83,32 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 72,09 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 78,44 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 80,2 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 68,79 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 141.065 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 129.874 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 129.249 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 118.853 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 121.441 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 112.651 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 115.251 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 107.521 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 110.292 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 103.472 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 91,62 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 91,51 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 86,09 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 86,74 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 81,7 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 82,79 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 78,19 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 79,67 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 6.058 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 12.538 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 5.759 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 11.901 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 5.500 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 11.493 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 5.290 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 11.140 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 5.118 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 10.743 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,06 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 94,92 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,79 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 91,67 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,32 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 88,85 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 84,48 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 85,68 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 148.128 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 142.964 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 132.240 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 137.085 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 133.738 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 124.872 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 128.759 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 126.519 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 118.799 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 121.792 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 120.374 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 112.576 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 114.615 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 107.019 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 01 Andalucía From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 92,54 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 93,55 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,43 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 86,92 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 88,5 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 89,84 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 82,22 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 84,2 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 85,13 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 80,17 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 80,93 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 142.325 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 131.460 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 112.454 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 131.554 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 122.661 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 105.398 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 123.469 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 115.801 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 100.022 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 116.723 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 110.055 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 94.762 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 104.720 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 90.023 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 92,43 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 93,31 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 93,73 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 86,75 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 88,09 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 88,94 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 82,01 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 83,72 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 84,27 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 79,66 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 80,05 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 5.803 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 11.504 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 19.786 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 5.531 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 11.077 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 19.474 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 5.290 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 10.718 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 18.777 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 5.069 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 10.319 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 17.814 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 9.895 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 16.996 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,31 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,29 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,42 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,16 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,17 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,9 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 87,35 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 89,7 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 90,03 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 86,01 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 85,9 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 150.191 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 147.718 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 142.376 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 137.304 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 135.565 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 131.454 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 127.585 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 126.468 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 121.689 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 119.519 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 114.807 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 114.692 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 110.832 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 91,42 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 91,77 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 92,33 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 84,95 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 85,61 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 85,47 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 80,91 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 80,64 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 77,64 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 77,84 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 146.528 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 143.739 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 127.994 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 133.808 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 131.741 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 117.633 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 124.236 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 122.775 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 108.567 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 115.988 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 102.322 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 111.280 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 98.722 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 91,32 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 91,65 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 91,91 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 84,79 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 85,42 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 84,82 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 80,69 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 79,94 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 77,42 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 77,13 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3.663 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 3.979 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 14.382 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3.496 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 3.824 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 13.821 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3.349 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 3.693 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 13.122 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 3.531 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 12.485 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 3.412 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 12.110 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,44 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,1 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,1 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 91,43 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,81 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 91,24 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 88,74 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 86,81 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 85,75 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 84,2 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 148.943 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 147.392 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 144.505 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 135.996 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 134.750 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 130.071 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 126.183 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 121.536 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 120.190 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 116.624 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 114.998 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 112.192 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 91,31 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 91,42 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 90,01 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 85,61 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 84,11 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 81,54 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 80,71 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 78,02 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 77,64 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 145.815 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 140.631 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 131.484 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 132.998 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 128.294 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 117.794 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 120.024 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 109.876 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 114.305 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 105.339 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 109.337 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 101.259 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 91,21 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 91,23 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 89,59 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 85,35 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 83,57 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 81,28 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 80,12 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 77,75 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 77,01 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 3.128 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 6.761 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 13.021 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2.998 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 6.456 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 12.277 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 6.159 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 11.660 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 5.885 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 11.285 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 5.661 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 10.933 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 95,84 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,49 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 94,29 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,1 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 89,55 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 87,04 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 86,67 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 83,73 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 83,96 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 19.862 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 18.153 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 19.882 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 19.456 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 17.787 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 18.361 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 18.973 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 17.430 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 18.018 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 18.613 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 17.182 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 17.736 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 18.297 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 16.947 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 17.371 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 97,96 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,98 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 92,35 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,52 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,02 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 90,62 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 93,71 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,65 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 89,21 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 92,12 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 93,36 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 87,37 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 18.634 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 14.267 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 18.255 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 13.961 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 17.795 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 13.653 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 17.454 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 13.446 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 17.150 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 13.268 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 97,97 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,86 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 95,5 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 95,7 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 93,67 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 94,25 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 92,04 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.228 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 3.886 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.201 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 3.826 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.178 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 3.777 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.159 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 3.736 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.147 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 3.679 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,8 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,46 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 95,93 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,2 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 94,38 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,14 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 93,4 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,67 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 20.184 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 18.444 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 17.010 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 19.730 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 18.108 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 16.800 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 19.359 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 17.833 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 16.553 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 18.866 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 17.448 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 16.208 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 17.060 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 15.870 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 01 Andalucía From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,75 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,18 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,77 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 95,91 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,69 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,31 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 93,47 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 94,6 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,29 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 92,5 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 93,3 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 18.990 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 15.130 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 11.564 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 18.557 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 14.838 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 11.396 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 18.211 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 14.603 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 11.221 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 17.748 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 14.276 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 11.026 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 13.954 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 10.796 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,72 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,07 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,55 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 95,9 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,52 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,03 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 93,46 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 94,36 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,35 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 92,23 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 93,36 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.194 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 3.314 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 5.446 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.173 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 3.270 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 5.404 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.148 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 3.230 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 5.332 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.118 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 3.172 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 5.182 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 3.106 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 5.074 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,24 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,67 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,23 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 96,15 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,47 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,91 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 93,63 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,72 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,15 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 93,72 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 93,17 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 21.149 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 19.906 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 18.932 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 20.651 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 19.497 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 18.521 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 19.861 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 18.851 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 17.843 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 18.404 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 17.410 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 18.095 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 17.157 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,65 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,95 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 97,83 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 93,91 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 94,7 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 94,25 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 92,45 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 91,96 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 90,9 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 90,62 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 20.397 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 18.830 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 14.494 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 19.909 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 18.428 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 14.134 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 19.135 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 17.799 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 13.584 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 17.376 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 13.242 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 17.091 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 13.057 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,61 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,87 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 97,52 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 93,81 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 94,52 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 93,72 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 92,28 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 91,36 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 90,76 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 90,09 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 752 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.076 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 4.438 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 742 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.069 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 4.387 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 726 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.052 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 4.259 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.028 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 4.168 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.004 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 4.100 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,67 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,35 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,85 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 96,54 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,77 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,97 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,54 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,92 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,31 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,38 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 20.738 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 19.827 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 19.090 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 20.017 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 19.200 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 18.444 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 18.752 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 18.006 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 18.377 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 17.716 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 18.072 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 17.491 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 96,52 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 96,84 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 96,62 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 94,58 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 94,32 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 92,69 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 92,8 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 91,15 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 91,62 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 20.069 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 18.565 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 14.847 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 19.360 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 17.965 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 14.308 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 17.543 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 13.951 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 17.188 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 13.719 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 16.911 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 13.543 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 96,47 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 96,77 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 96,37 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 94,5 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 93,97 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 92,58 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 92,4 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 91,09 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 91,22 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 669 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.262 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 4.243 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 657 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.235 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 4.136 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.209 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 4.055 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.189 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 3.997 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.161 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 3.948 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,21 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,86 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,48 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 95,8 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,57 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 94,22 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,2 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 92 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,05 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 23.644 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 20.947 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 23.731 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 23.387 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 20.698 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 22.878 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 23.030 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 20.461 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 22.628 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 22.807 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 20.272 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 22.420 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 22.574 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 20.084 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 22.119 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,91 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,81 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,41 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,4 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,68 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,35 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,46 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,78 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,48 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,47 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,88 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,21 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 21.942 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 15.018 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 21.698 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 14.821 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 21.361 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 14.636 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 21.154 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 14.507 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 20.928 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 14.372 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,89 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,69 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,35 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,46 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,41 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,6 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,38 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,7 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.702 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 5.929 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.689 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 5.877 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.669 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 5.825 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.653 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 5.765 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.646 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 5.712 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,24 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,12 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,06 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,25 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,12 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,23 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,71 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,34 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 24.120 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 21.315 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 20.003 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 23.782 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 21.077 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 19.829 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 23.563 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 20.880 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 19.680 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 23.237 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 20.642 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 19.447 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 20.404 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 19.194 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 01 Andalucía From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,6 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,88 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,13 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,69 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,96 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,39 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,34 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,84 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,22 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 95,73 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,96 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 22.387 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 16.353 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 12.613 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 22.073 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 16.161 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 12.477 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 21.862 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 16.007 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 12.373 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 21.559 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 15.823 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 12.250 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 15.628 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 12.087 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,6 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,83 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,92 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,65 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,88 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,1 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,3 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,76 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,12 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,57 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,83 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.733 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 4.962 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 7.390 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.709 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 4.916 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 7.352 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.701 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 4.873 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 7.307 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.678 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 4.819 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 7.197 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 4.776 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 7.107 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,62 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,07 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,49 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,15 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,21 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,88 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,83 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,12 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,39 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,25 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,17 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 25.626 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 23.570 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 21.990 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 25.311 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 23.275 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 21.727 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 24.621 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 22.713 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 21.271 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 22.397 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 20.943 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 22.169 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 20.742 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,77 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,75 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,8 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,08 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 96,36 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,73 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,02 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,24 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,06 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,32 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 24.534 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 21.906 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 14.957 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 24.224 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 21.628 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 14.730 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 23.572 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 21.098 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 14.380 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 20.800 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 14.139 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 20.582 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 13.998 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,74 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,73 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,48 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,08 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,31 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,14 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 94,95 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,53 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 93,96 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 93,59 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1.092 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.664 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 7.033 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1.087 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.647 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 6.997 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1.049 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.615 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 6.891 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.597 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 6.804 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.587 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 6.744 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,54 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,98 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,49 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 96,06 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,06 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,98 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,97 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,74 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,37 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,89 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 24.886 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 23.412 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 21.826 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 24.372 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 23.007 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 21.503 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 22.724 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 21.203 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 22.457 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 20.973 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 22.252 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 20.787 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,93 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,27 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,52 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,06 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,15 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,92 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,09 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,05 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,24 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 23.875 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 21.637 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 15.314 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 23.388 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 21.262 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 15.063 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 20.997 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 14.829 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 20.747 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 14.652 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 20.558 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 14.521 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,96 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,27 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,36 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,04 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,83 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,89 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,68 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,01 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,82 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1.011 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.775 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 6.512 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 984 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.745 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 6.440 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.727 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 6.374 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.710 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 6.321 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.694 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 6.266 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,33 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,31 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,89 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,3 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,88 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,34 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,07 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,44 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,22 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 900 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 825 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 891 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 896 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 816 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 877 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 892 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 812 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 873 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 889 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 805 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 868 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 885 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 801 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 866 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,56 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,91 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,43 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,11 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,42 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,98 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,78 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,58 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,42 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,33 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,09 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,19 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 825 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 585 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 821 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 577 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 818 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 574 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 815 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 569 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 811 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 567 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,52 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,63 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,15 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,12 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,79 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,26 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,3 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,92 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 75 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 240 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 75 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 239 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 74 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 238 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 74 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 236 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 74 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 234 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,58 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,67 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,17 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 98,67 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,33 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 98,67 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,5 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 908 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 808 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 795 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 905 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 804 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 788 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 902 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 797 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 787 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 898 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 791 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 785 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 790 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 778 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 01 Andalucía from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,67 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,5 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,12 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,34 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,64 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,99 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,9 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,9 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,74 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,77 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,86 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 837 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 599 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 556 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 834 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 596 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 550 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 831 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 591 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 549 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 827 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 587 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 548 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 586 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 542 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,64 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,5 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,92 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,28 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,66 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,74 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,81 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,56 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,83 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,48 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 71 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 209 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 239 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 71 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 208 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 238 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 71 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 206 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 238 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 71 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 204 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 237 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 204 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 236 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,52 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,58 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,56 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,58 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,61 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 99,16 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,61 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,74 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 981 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 850 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 776 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 975 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 845 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 771 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 970 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 838 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 769 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 833 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 761 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 832 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 758 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,39 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,41 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,36 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,88 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,59 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,1 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,07 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,88 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,68 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 940 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 769 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 506 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 934 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 764 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 502 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 929 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 757 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 501 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 752 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 495 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 751 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 493 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,36 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,35 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,21 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,83 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,44 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 99,01 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,79 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,83 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,66 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,43 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 41 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 81 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 270 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 41 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 81 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 269 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 41 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 81 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 268 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 81 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 266 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 81 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 265 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,63 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,26 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,52 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,15 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 989 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 890 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 840 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 982 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 880 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 834 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 877 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 824 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 875 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 822 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 871 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 819 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,29 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,88 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,29 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,54 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,1 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,31 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,86 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,87 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,5 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 954 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 812 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 574 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 947 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 802 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 569 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 799 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 561 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 798 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 560 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 794 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 558 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,27 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,77 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,13 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,4 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,74 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,28 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,56 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,78 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,21 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 35 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 78 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 266 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 35 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 78 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 265 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 78 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 263 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 77 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 262 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 77 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 261 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,62 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,87 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 98,72 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,5 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 98,72 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,12 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 451 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 410 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 431 01 Andalucía De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 444 01 Andalucía De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 409 01 Andalucía De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 428 01 Andalucía De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 443 01 Andalucía De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 407 01 Andalucía De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 424 01 Andalucía De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 439 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 406 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 419 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 439 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 406 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 419 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,45 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,76 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,3 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,23 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,27 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,38 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,34 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 99,02 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,22 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,34 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 99,02 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,22 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 414 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 289 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 407 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 288 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 406 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 286 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 402 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 285 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 402 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 285 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,31 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,65 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,07 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,96 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,1 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,62 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,1 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,62 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 37 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 121 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 37 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 121 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 37 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 121 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 37 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 121 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 37 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 121 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 465 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 406 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 408 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 463 01 Andalucía De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 405 01 Andalucía De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 406 01 Andalucía De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 459 01 Andalucía De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 404 01 Andalucía De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 399 01 Andalucía De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 459 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 404 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 398 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 398 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 398 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 01 Andalucía De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,57 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,75 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,51 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,71 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,51 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,79 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,71 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 99,51 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,55 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,03 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,55 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 429 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 291 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 307 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 427 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 290 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 305 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 423 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 289 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 298 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 423 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 289 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 297 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 283 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 297 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,53 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,66 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,35 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,6 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,31 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,07 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,6 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 99,31 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,74 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,25 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,74 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 36 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 115 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 101 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 36 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 115 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 101 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 36 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 115 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 101 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 36 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 115 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 101 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 115 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 101 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 01 Andalucía De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 440 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 394 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 365 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 439 01 Andalucía De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 394 01 Andalucía De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 363 01 Andalucía De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 439 01 Andalucía De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 394 01 Andalucía De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 362 01 Andalucía De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 389 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 362 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 389 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 362 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,77 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,45 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,77 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,18 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,73 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 99,18 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,73 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 99,18 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 421 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 358 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 243 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 420 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 358 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 241 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 420 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 358 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 240 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 353 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 240 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 353 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 240 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,76 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,18 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,76 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,77 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,6 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,77 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,6 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98,77 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 19 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 36 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 122 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 19 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 36 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 122 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 19 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 36 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 122 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 36 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 122 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 36 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 122 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 449 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 420 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 398 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 448 01 Andalucía De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 420 01 Andalucía De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 398 01 Andalucía De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 413 01 Andalucía De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 398 01 Andalucía De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 412 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 398 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 410 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 398 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,78 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,33 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,1 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,62 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 432 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 390 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 269 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 431 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 390 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 269 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 383 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 269 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 382 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 269 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 380 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 269 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,77 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,21 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,95 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,44 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 17 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 30 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 129 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 17 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 30 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 129 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 30 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 129 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 30 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 129 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 30 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 129 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Andalucía De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2022QI 32.517 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2021QI 31.714 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2020QI 33.323 02 Aragón Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 02 Aragón Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 02 Aragón Total Cohort January 1 Total Survival in the first trimester 2022QII "" 02 Aragón Total Cohort January 1 Total Survival in the first trimester 2022QI 30.921 02 Aragón Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 02 Aragón Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 02 Aragón Total Cohort January 1 Total Survival in the first trimester 2021QII "" 02 Aragón Total Cohort January 1 Total Survival in the first trimester 2021QI 30.281 02 Aragón Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 02 Aragón Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 02 Aragón Total Cohort January 1 Total Survival in the first trimester 2020QII "" 02 Aragón Total Cohort January 1 Total Survival in the first trimester 2020QI 30.202 02 Aragón Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 02 Aragón Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 02 Aragón Total Cohort January 1 Total Survival in the second trimester 2022QII 29.638 02 Aragón Total Cohort January 1 Total Survival in the second trimester 2022QI "" 02 Aragón Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 02 Aragón Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 02 Aragón Total Cohort January 1 Total Survival in the second trimester 2021QII 29.290 02 Aragón Total Cohort January 1 Total Survival in the second trimester 2021QI "" 02 Aragón Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 02 Aragón Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 02 Aragón Total Cohort January 1 Total Survival in the second trimester 2020QII 29.231 02 Aragón Total Cohort January 1 Total Survival in the second trimester 2020QI "" 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2022QIII 28.656 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2021QIII 28.527 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2020QIII 28.410 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2022QIV 27.914 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2021QIV 27.851 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2020QIV 27.662 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Aragón Total Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Aragón Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 02 Aragón Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,09 02 Aragón Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,48 02 Aragón Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 90,63 02 Aragón Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,15 02 Aragón Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,36 02 Aragón Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 87,72 02 Aragón Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 88,13 02 Aragón Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,95 02 Aragón Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 85,26 02 Aragón Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 85,84 02 Aragón Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 87,82 02 Aragón Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 83,01 02 Aragón Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 31.562 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 28.602 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 29.993 02 Aragón Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 27.268 02 Aragón Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 28.740 02 Aragón Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 26.338 02 Aragón Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 27.784 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 25.632 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 27.051 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 25.024 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,03 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 95,34 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 91,06 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 92,08 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 88,03 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,62 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 85,71 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 87,49 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 955 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 3.112 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 928 02 Aragón Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 3.013 02 Aragón Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 898 02 Aragón Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.952 02 Aragón Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 872 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.895 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 863 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.827 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,17 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,82 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 94,03 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,86 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,31 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,03 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 90,37 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,84 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2022QII 32.386 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2021QII 31.738 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2020QII 31.357 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 02 Aragón Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 02 Aragón Total Cohort April 1 Total Survival in the first trimester 2022QII 30.833 02 Aragón Total Cohort April 1 Total Survival in the first trimester 2022QI "" 02 Aragón Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 02 Aragón Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 02 Aragón Total Cohort April 1 Total Survival in the first trimester 2021QII 30.488 02 Aragón Total Cohort April 1 Total Survival in the first trimester 2021QI "" 02 Aragón Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 02 Aragón Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 02 Aragón Total Cohort April 1 Total Survival in the first trimester 2020QII 30.222 02 Aragón Total Cohort April 1 Total Survival in the first trimester 2020QI "" 02 Aragón Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 02 Aragón Total Cohort April 1 Total Survival in the second trimester 2022QIII 29.661 02 Aragón Total Cohort April 1 Total Survival in the second trimester 2022QII "" 02 Aragón Total Cohort April 1 Total Survival in the second trimester 2022QI "" 02 Aragón Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 02 Aragón Total Cohort April 1 Total Survival in the second trimester 2021QIII 29.548 02 Aragón Total Cohort April 1 Total Survival in the second trimester 2021QII "" 02 Aragón Total Cohort April 1 Total Survival in the second trimester 2021QI "" 02 Aragón Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 02 Aragón Total Cohort April 1 Total Survival in the second trimester 2020QIII 29.291 02 Aragón Total Cohort April 1 Total Survival in the second trimester 2020QII "" 02 Aragón Total Cohort April 1 Total Survival in the second trimester 2020QI "" 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2022QIV 28.767 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2022QI "" 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2021QIV 28.703 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2021QI "" 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2020QIV 28.434 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2022QI 27.776 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2021QI 27.540 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Aragón Total Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 02 Aragón Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,2 02 Aragón Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,06 02 Aragón Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,38 02 Aragón Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,59 02 Aragón Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,1 02 Aragón Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,41 02 Aragón Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 88,83 02 Aragón Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,44 02 Aragón Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,68 02 Aragón Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 87,52 02 Aragón Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,83 02 Aragón Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 31.460 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 28.795 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 26.296 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 29.946 02 Aragón Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 27.600 02 Aragón Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 25.255 02 Aragón Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 28.800 02 Aragón Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 26.726 02 Aragón Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 24.434 02 Aragón Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 27.923 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 25.950 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 23.707 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 25.088 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 22.939 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 02 Aragón Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,19 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,85 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,04 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,54 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,81 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,92 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 88,76 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 90,12 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 90,15 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 87,13 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 87,23 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 926 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2.943 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 5.061 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 887 02 Aragón Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2.888 02 Aragón Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 4.967 02 Aragón Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 861 02 Aragón Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2.822 02 Aragón Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 4.857 02 Aragón Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 844 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2.753 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 4.727 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2.688 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 4.601 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 02 Aragón Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,79 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,13 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,14 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,98 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,89 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,97 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,14 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,54 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,4 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,34 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,91 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2022QIII 32.595 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2021QIII 32.406 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2020QIII 31.952 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 02 Aragón Total Cohort July 1 Total Survival in the first trimester 2022QIII 30.887 02 Aragón Total Cohort July 1 Total Survival in the first trimester 2022QII "" 02 Aragón Total Cohort July 1 Total Survival in the first trimester 2022QI "" 02 Aragón Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 02 Aragón Total Cohort July 1 Total Survival in the first trimester 2021QIII 30.934 02 Aragón Total Cohort July 1 Total Survival in the first trimester 2021QII "" 02 Aragón Total Cohort July 1 Total Survival in the first trimester 2021QI "" 02 Aragón Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 02 Aragón Total Cohort July 1 Total Survival in the first trimester 2020QIII 30.578 02 Aragón Total Cohort July 1 Total Survival in the first trimester 2020QII "" 02 Aragón Total Cohort July 1 Total Survival in the first trimester 2020QI "" 02 Aragón Total Cohort July 1 Total Survival in the second trimester 2022QIV 29.699 02 Aragón Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 02 Aragón Total Cohort July 1 Total Survival in the second trimester 2022QII "" 02 Aragón Total Cohort July 1 Total Survival in the second trimester 2022QI "" 02 Aragón Total Cohort July 1 Total Survival in the second trimester 2021QIV 29.757 02 Aragón Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 02 Aragón Total Cohort July 1 Total Survival in the second trimester 2021QII "" 02 Aragón Total Cohort July 1 Total Survival in the second trimester 2021QI "" 02 Aragón Total Cohort July 1 Total Survival in the second trimester 2020QIV 29.383 02 Aragón Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 02 Aragón Total Cohort July 1 Total Survival in the second trimester 2020QII "" 02 Aragón Total Cohort July 1 Total Survival in the second trimester 2020QI "" 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2022QII "" 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2022QI 28.711 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2021QII "" 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2021QI 28.390 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2022QII 27.990 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2022QI "" 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2021QII 27.794 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2021QI "" 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Aragón Total Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Aragón Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,76 02 Aragón Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,46 02 Aragón Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,7 02 Aragón Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,12 02 Aragón Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 91,83 02 Aragón Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,96 02 Aragón Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 88,6 02 Aragón Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 88,85 02 Aragón Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 86,37 02 Aragón Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 86,99 02 Aragón Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 32.023 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 31.562 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 28.457 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 30.337 02 Aragón Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 30.108 02 Aragón Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 27.155 02 Aragón Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 29.161 02 Aragón Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 28.956 02 Aragón Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 26.050 02 Aragón Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 27.928 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 25.151 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 27.222 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 24.613 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,74 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,39 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,42 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,06 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,74 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,54 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,49 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 88,38 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 86,25 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 86,49 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 572 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 844 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 3.495 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 550 02 Aragón Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 826 02 Aragón Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 3.423 02 Aragón Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 538 02 Aragón Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 801 02 Aragón Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3.333 02 Aragón Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 783 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 3.239 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 768 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 3.181 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,15 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,87 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,94 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,06 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,91 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,36 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,77 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,68 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 91 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,02 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2022QIV 32.270 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2021QIV 32.378 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2020QIV 31.981 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort October 1 Total Survival in the first trimester 2022QIV 30.801 02 Aragón Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 02 Aragón Total Cohort October 1 Total Survival in the first trimester 2022QII "" 02 Aragón Total Cohort October 1 Total Survival in the first trimester 2022QI "" 02 Aragón Total Cohort October 1 Total Survival in the first trimester 2021QIV 30.894 02 Aragón Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 02 Aragón Total Cohort October 1 Total Survival in the first trimester 2021QII "" 02 Aragón Total Cohort October 1 Total Survival in the first trimester 2021QI "" 02 Aragón Total Cohort October 1 Total Survival in the first trimester 2020QIV 30.395 02 Aragón Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 02 Aragón Total Cohort October 1 Total Survival in the first trimester 2020QII "" 02 Aragón Total Cohort October 1 Total Survival in the first trimester 2020QI "" 02 Aragón Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 02 Aragón Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 02 Aragón Total Cohort October 1 Total Survival in the second trimester 2022QII "" 02 Aragón Total Cohort October 1 Total Survival in the second trimester 2022QI 29.673 02 Aragón Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 02 Aragón Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 02 Aragón Total Cohort October 1 Total Survival in the second trimester 2021QII "" 02 Aragón Total Cohort October 1 Total Survival in the second trimester 2021QI 29.261 02 Aragón Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 02 Aragón Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 02 Aragón Total Cohort October 1 Total Survival in the second trimester 2020QII "" 02 Aragón Total Cohort October 1 Total Survival in the second trimester 2020QI "" 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2022QII 28.711 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2021QII 28.490 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2022QIII 27.904 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2022QII "" 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2021QIII 27.842 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2021QII "" 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Aragón Total Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Aragón Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,45 02 Aragón Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,42 02 Aragón Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,04 02 Aragón Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,65 02 Aragón Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 91,49 02 Aragón Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 88,67 02 Aragón Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 89,08 02 Aragón Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 86,18 02 Aragón Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 87,06 02 Aragón Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 31.801 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 31.393 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 28.819 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 30.341 02 Aragón Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 29.931 02 Aragón Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 27.326 02 Aragón Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 28.733 02 Aragón Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 26.292 02 Aragón Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 27.796 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 25.571 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 27.006 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 24.978 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,41 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,34 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,82 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,53 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 91,23 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 88,54 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 88,73 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 86,03 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 86,67 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 469 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 985 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 3.162 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 460 02 Aragón Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 963 02 Aragón Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 3.069 02 Aragón Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 940 02 Aragón Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.969 02 Aragón Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 915 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.919 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 898 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.864 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,08 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,77 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,06 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 95,43 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,9 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 92,89 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,31 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 91,17 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90,58 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 23.867 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 23.661 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 24.619 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 22.370 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 22.301 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 21.748 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 21.229 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 21.411 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 20.891 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 20.332 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 20.725 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 20.156 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 19.659 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 20.107 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 19.489 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,73 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,25 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 88,34 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,95 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,49 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 84,86 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,19 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,59 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 81,87 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 82,37 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 84,98 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,16 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 23.328 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 22.084 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 21.851 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 20.807 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 20.735 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 19.964 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 19.860 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 19.323 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 19.195 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 18.760 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,67 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,22 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,88 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,4 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,13 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,5 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 82,28 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 84,95 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 539 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.577 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 519 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.494 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 494 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.447 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 472 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.402 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 464 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.347 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,29 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 94,74 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 91,65 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 91,76 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,57 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 88,9 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 86,09 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 85,42 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 23.699 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 23.589 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 23.272 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 22.283 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 22.441 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 22.232 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 21.185 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 21.577 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 21.363 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 20.374 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 20.804 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 20.574 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 19.963 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 19.768 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 02 Aragón From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,03 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,13 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,53 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,39 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,47 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,8 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 85,97 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,19 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,41 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 84,63 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 84,94 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 23.195 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 22.123 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 20.462 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 21.814 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 21.016 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 19.488 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 20.739 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 20.204 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 18.718 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 19.943 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 19.488 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 18.035 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 18.692 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 17.325 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,05 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,24 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,41 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,33 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,48 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 85,98 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,09 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,14 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,49 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,67 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 504 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.466 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.810 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 469 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.425 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.744 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 446 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.373 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.645 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 431 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.316 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.539 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.271 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.443 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 93,06 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,2 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,65 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 88,49 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,66 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,13 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 85,52 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 89,77 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 90,36 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 86,7 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 86,94 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 23.815 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 23.900 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 23.754 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 22.186 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 22.507 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 22.445 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 21.124 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 21.425 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 21.333 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 20.486 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 20.431 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 19.826 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 19.887 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,16 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,17 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,49 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,7 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,64 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 89,81 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,72 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,01 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 82,95 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 83,72 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 23.471 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 23.469 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 22.033 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 21.862 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 22.091 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 20.783 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 20.810 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 21.031 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 19.738 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 20.106 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 18.908 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 19.460 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 18.411 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,14 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,13 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,33 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,66 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,61 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,58 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,67 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 85,82 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 82,92 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,56 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 344 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 431 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.721 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 324 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 416 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.662 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 314 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 394 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.595 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 380 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.523 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 366 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.476 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 94,19 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,52 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,57 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 91,28 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 91,42 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 92,68 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 88,17 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 88,5 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 84,92 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 85,76 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 23.555 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 23.887 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 23.788 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 22.182 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 22.486 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 22.278 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 21.363 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 21.228 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 20.490 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 20.536 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 19.751 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 19.961 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,17 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,13 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,65 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,43 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,24 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,78 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,33 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 82,69 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,91 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 23.283 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 23.308 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 22.288 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 21.918 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 21.925 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 20.853 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 20.819 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 19.879 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 19.969 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 19.221 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 19.246 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 18.688 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,14 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,07 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,56 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,32 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,19 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,67 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,24 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 82,57 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,85 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 272 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 579 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.500 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 264 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 561 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.425 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 544 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.349 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 521 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.315 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 505 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.273 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,06 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,89 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,96 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 89,93 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 89,98 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 87,67 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,22 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 84,87 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 3.517 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 3.272 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 3.525 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 3.464 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 3.232 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 3.408 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 3.385 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 3.176 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 3.353 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 3.335 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 3.132 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 3.309 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 3.301 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 3.106 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 3.261 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,49 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,78 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,68 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,25 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,07 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,12 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,83 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,72 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 93,87 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,86 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,93 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 92,51 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.378 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.761 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3.329 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.729 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3.253 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.678 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3.205 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.638 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3.172 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.617 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,55 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,84 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,3 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,99 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,88 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,55 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,9 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,78 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 139 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 511 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 135 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 503 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 132 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 498 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 130 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 494 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 129 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 489 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,12 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,43 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 94,96 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,46 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 93,53 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,67 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 92,81 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,69 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 3.505 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 3.320 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 3.307 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 3.431 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 3.264 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 3.257 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 3.391 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 3.219 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 3.228 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 3.343 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 3.181 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 3.183 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 3.138 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 3.133 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 02 Aragón From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,89 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,31 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,49 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,75 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,96 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,61 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,38 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,81 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,25 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,52 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,74 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3.374 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.860 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.482 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 3.303 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.810 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.444 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 3.264 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.772 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.417 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 3.216 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.739 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.386 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.703 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.350 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,9 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,25 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,47 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,74 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,92 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,38 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,32 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,77 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,13 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,51 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,68 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 131 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 460 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 825 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 128 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 454 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 813 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 127 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 447 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 811 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 127 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 442 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 797 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 435 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 783 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,71 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,7 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,55 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 96,95 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,17 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,3 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,95 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,09 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,61 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94,57 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,91 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 3.495 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 3.474 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 3.350 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 3.445 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 3.427 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 3.317 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 3.371 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 3.375 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 3.263 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 3.317 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 3.206 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 3.279 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 3.171 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,57 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,65 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,01 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,45 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,15 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,4 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,48 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,7 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,39 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,66 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3.429 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.345 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.767 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3.380 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3.299 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.738 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3.306 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3.250 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.697 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3.193 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.652 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3.156 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.622 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,57 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,62 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,95 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,41 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,16 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,47 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,46 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,84 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,35 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,76 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 66 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 129 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 583 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 65 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 128 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 579 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 65 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 125 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 566 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 124 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 554 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 123 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 549 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,48 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,22 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,31 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,48 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,9 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,08 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,12 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,03 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,35 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 94,17 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 3.457 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 3.421 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 3.306 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 3.404 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 3.380 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 3.257 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 3.325 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 3.211 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 3.278 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 3.162 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 3.240 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 3.125 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,47 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,8 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,52 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,19 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,13 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,82 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,64 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 94,71 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 94,53 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 3.403 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3.280 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.784 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 3.350 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3.241 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.744 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3.189 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.712 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3.143 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.671 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3.106 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.639 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,44 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,81 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,56 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,23 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,41 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,82 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,94 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 94,7 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,79 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 54 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 141 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 522 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 54 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 139 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 513 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 136 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 499 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 135 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 491 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 134 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 486 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,58 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,28 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,45 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,59 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,74 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,06 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,04 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,1 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 4.758 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 4.429 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 4.808 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 4.714 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 4.397 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 4.684 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 4.652 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 4.353 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 4.625 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 4.620 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 4.321 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 4.585 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 4.585 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 4.291 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 4.553 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,08 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,28 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,42 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,77 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,28 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,19 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,1 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,56 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,36 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,36 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,88 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,7 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 4.514 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 3.506 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 4.473 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 3.481 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 4.413 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 3.446 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 4.383 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 3.422 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 4.348 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3.399 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,09 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,29 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,76 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,29 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,1 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,6 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,32 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,95 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 244 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 923 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 241 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 916 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 239 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 907 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 237 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 899 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 237 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 892 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,77 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,24 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,95 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,27 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,13 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,4 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,13 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,64 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 4.802 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 4.480 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 4.435 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 4.740 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 4.434 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 4.390 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 4.709 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 4.404 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 4.359 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 4.674 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 4.373 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 4.337 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 4.332 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 4.300 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 02 Aragón From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,71 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,97 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,99 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,06 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,3 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,29 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,33 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,61 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,79 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,7 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,96 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 4.545 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 3.561 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3.124 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 4.484 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 3.523 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3.095 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 4.455 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 3.500 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3.073 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 4.422 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 3.476 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3.061 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 3.447 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3.039 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,66 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,93 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,07 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,02 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,29 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,37 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,29 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,61 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,98 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,8 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,28 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 257 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 919 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.311 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 256 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 911 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.295 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 254 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 904 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.286 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 252 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 897 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.276 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 885 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.261 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,61 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,13 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,78 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,83 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,37 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,09 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,05 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,61 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,33 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,3 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,19 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 4.899 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 4.672 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 4.501 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 4.873 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 4.641 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 4.471 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 4.821 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 4.601 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 4.444 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 4.555 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 4.411 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 4.533 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 4.394 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,47 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,34 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,33 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,41 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,48 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,73 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,5 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,02 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,62 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 4.749 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 4.421 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3.425 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 4.724 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 4.392 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 3.404 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 4.674 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 4.352 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3.387 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 4.308 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3.363 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 4.286 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 3.352 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,47 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,34 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,39 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,42 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,44 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,89 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,44 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,19 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,95 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,87 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 150 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 251 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.076 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 149 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 249 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.067 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 147 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 249 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.057 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 247 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.048 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 247 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.042 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,33 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,2 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,16 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,2 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,23 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 98,41 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,4 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 98,41 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,84 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 4.865 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 4.702 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 4.536 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 4.822 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 4.663 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 4.510 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 4.624 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 4.473 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 4.582 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 4.443 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 4.554 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 4.409 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,12 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,17 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,43 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,34 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,61 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,45 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,95 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,85 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,2 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 4.733 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 4.473 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3.501 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 4.691 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 4.436 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3.484 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 4.400 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3.456 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 4.359 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3.434 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 4.331 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3.408 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,11 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,17 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,51 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,37 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,71 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,45 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,09 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,83 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,34 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 132 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 229 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.035 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 131 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 227 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.026 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 224 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.017 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 223 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.009 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 223 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.001 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,24 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,13 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,13 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,82 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,26 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,38 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,49 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 97,38 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,71 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 252 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 237 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 256 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 251 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 236 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 247 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 250 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 235 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 247 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 247 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 235 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 245 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 247 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 235 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 244 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,6 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,58 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,48 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,21 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,16 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,48 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,02 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 99,16 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,7 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,02 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 99,16 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 95,31 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 232 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 175 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 231 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 175 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 230 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 174 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 227 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 174 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 227 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 174 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,57 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,14 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 99,43 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,84 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 99,43 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,84 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 99,43 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 20 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 62 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 20 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 61 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 20 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 61 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 20 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 61 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 20 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 61 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,39 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,39 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,39 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,39 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 254 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 235 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 227 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 253 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 235 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 227 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 250 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 235 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 225 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 250 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 234 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 224 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 233 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 223 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 02 Aragón from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,61 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,43 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,12 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,43 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 99,57 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,68 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 99,15 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,24 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 234 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 174 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 156 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 233 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 174 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 156 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 230 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 174 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 154 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 230 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 173 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 153 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 173 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 153 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,57 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,29 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,72 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,29 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 99,43 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,08 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 99,43 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 98,08 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 20 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 61 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 71 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 20 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 61 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 71 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 20 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 61 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 71 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 20 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 61 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 71 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 60 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 70 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,36 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,59 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 264 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 244 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 233 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 261 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 244 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 231 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 261 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 243 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 229 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 241 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 228 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 240 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 228 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,86 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,14 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,86 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,59 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,28 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,77 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,85 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,36 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,85 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 256 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 223 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 164 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 253 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 223 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 162 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 253 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 222 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 160 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 221 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 160 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 220 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 160 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,83 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,78 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,83 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,55 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,56 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 99,1 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,56 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,65 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,56 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 8 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 21 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 69 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 8 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 21 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 69 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 8 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 21 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 69 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 20 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 68 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 20 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 68 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,24 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,55 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,24 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,55 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 260 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 248 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 237 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 260 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 247 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 236 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 244 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 235 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 244 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 235 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 242 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 234 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,6 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,58 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,39 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99,16 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,39 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 99,16 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,58 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,73 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 253 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 228 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 174 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 253 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 227 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 173 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 224 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 173 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 224 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 173 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 222 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 172 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,56 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,43 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,25 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 99,43 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,25 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 99,43 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,37 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,85 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 7 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 20 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 63 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 7 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 20 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 63 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 20 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 62 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 20 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 62 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 20 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 62 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,41 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,41 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,41 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 123 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 115 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 115 02 Aragón De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 122 02 Aragón De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 115 02 Aragón De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 115 02 Aragón De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 122 02 Aragón De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 115 02 Aragón De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 115 02 Aragón De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 122 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 114 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 115 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 122 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 112 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 115 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Aragón De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,19 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,19 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 99,19 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 99,13 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 99,19 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,39 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 110 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 76 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 109 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 76 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 109 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 76 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 109 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 75 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 109 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 74 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,09 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,09 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 99,09 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,68 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 99,09 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,37 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 13 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 39 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 13 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 39 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 13 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 39 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 13 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 39 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 13 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 38 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,44 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 126 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 114 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 116 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 126 02 Aragón De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 114 02 Aragón De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 116 02 Aragón De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 126 02 Aragón De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 113 02 Aragón De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 116 02 Aragón De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 126 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 111 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 116 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 110 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 116 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 02 Aragón De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,12 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,37 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,49 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 112 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 77 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 72 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 112 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 77 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 72 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 112 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 76 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 72 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 112 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 74 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 72 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 73 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 72 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 02 Aragón De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,7 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,1 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,81 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 14 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 37 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 44 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 14 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 37 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 44 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 14 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 37 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 44 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 14 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 37 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 44 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 37 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 44 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 02 Aragón De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 122 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 116 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 114 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 122 02 Aragón De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 115 02 Aragón De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 114 02 Aragón De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 122 02 Aragón De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 113 02 Aragón De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 114 02 Aragón De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 112 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 114 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 112 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 114 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Aragón De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,14 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,41 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,55 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,55 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 118 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 104 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 68 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 118 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 103 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 68 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 118 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 101 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 68 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 100 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 68 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 100 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 68 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,04 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,12 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,15 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,15 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 4 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 12 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 46 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 12 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 46 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 12 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 46 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 12 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 46 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 12 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 46 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 133 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 120 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 114 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 133 02 Aragón De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 118 02 Aragón De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 114 02 Aragón De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 117 02 Aragón De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 114 02 Aragón De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 117 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 114 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 117 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 113 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Aragón De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,33 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,5 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,5 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,5 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 99,12 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 129 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 104 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 72 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 129 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 102 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 72 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 101 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 72 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 101 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 72 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 101 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 71 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,08 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,12 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,12 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,12 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,61 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 16 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 42 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 16 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 42 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 16 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 42 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 16 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 42 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 16 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 42 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Aragón De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2022QI 24.026 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2021QI 23.402 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2020QI 24.500 03 Asturias, Principado de Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the first trimester 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the first trimester 2022QI 22.763 03 Asturias, Principado de Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the first trimester 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the first trimester 2021QI 22.239 03 Asturias, Principado de Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the first trimester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the first trimester 2020QI 22.090 03 Asturias, Principado de Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the second trimester 2022QII 21.761 03 Asturias, Principado de Total Cohort January 1 Total Survival in the second trimester 2022QI "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the second trimester 2021QII 21.463 03 Asturias, Principado de Total Cohort January 1 Total Survival in the second trimester 2021QI "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the second trimester 2020QII 21.448 03 Asturias, Principado de Total Cohort January 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2022QIII 21.033 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2021QIII 20.878 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2020QIII 20.840 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2022QIV 20.386 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2021QIV 20.309 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2020QIV 20.228 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,74 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,03 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 90,16 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,57 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,71 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 87,54 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 87,54 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,21 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 85,06 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 84,85 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 86,78 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 82,56 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 22.873 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 20.307 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 21.649 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 19.229 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 20.696 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 18.508 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 19.997 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 17.981 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 19.380 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 17.480 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,65 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,69 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,48 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,14 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 87,43 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 88,55 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 84,73 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 86,08 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.153 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 3.095 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.114 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 3.010 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.065 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.955 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.036 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.897 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.006 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.829 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,62 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,25 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,37 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,48 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 89,85 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,6 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 87,25 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 91,41 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2022QII 23.955 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2021QII 23.336 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2020QII 22.988 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the first trimester 2022QII 22.724 03 Asturias, Principado de Total Cohort April 1 Total Survival in the first trimester 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the first trimester 2021QII 22.342 03 Asturias, Principado de Total Cohort April 1 Total Survival in the first trimester 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the first trimester 2020QII 22.216 03 Asturias, Principado de Total Cohort April 1 Total Survival in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the second trimester 2022QIII 21.869 03 Asturias, Principado de Total Cohort April 1 Total Survival in the second trimester 2022QII "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the second trimester 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the second trimester 2021QIII 21.636 03 Asturias, Principado de Total Cohort April 1 Total Survival in the second trimester 2021QII "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the second trimester 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the second trimester 2020QIII 21.523 03 Asturias, Principado de Total Cohort April 1 Total Survival in the second trimester 2020QII "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2022QIV 21.052 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2021QIV 20.948 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2020QIV 20.826 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2022QI 20.214 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2021QI 20.109 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 03 Asturias, Principado de Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,86 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,74 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,64 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,29 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,72 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,63 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,88 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,77 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,6 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 86,62 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,48 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 22.824 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 20.233 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 18.009 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 21.629 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 19.291 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 17.316 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 20.806 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 18.645 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 16.729 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 20.021 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 18.029 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 16.154 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 17.372 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 15.577 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,76 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,34 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,15 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,16 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,15 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,89 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,72 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,11 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,7 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,86 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 86,5 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.131 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 3.103 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 4.979 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.095 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 3.051 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 4.900 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.063 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2.991 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 4.794 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.031 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2.919 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 4.672 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2.842 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 4.532 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 03 Asturias, Principado de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,82 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,32 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,41 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,99 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,39 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,28 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,16 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,07 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,83 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,59 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,02 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2022QIII 24.276 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2021QIII 24.075 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2020QIII 23.579 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the first trimester 2022QIII 22.946 03 Asturias, Principado de Total Cohort July 1 Total Survival in the first trimester 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the first trimester 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the first trimester 2021QIII 22.894 03 Asturias, Principado de Total Cohort July 1 Total Survival in the first trimester 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the first trimester 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the first trimester 2020QIII 22.528 03 Asturias, Principado de Total Cohort July 1 Total Survival in the first trimester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the second trimester 2022QIV 21.779 03 Asturias, Principado de Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the second trimester 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the second trimester 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the second trimester 2021QIV 21.832 03 Asturias, Principado de Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the second trimester 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the second trimester 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the second trimester 2020QIV 21.530 03 Asturias, Principado de Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the second trimester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2022QI 20.986 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2021QI 20.733 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2022QII 20.359 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2021QII 20.238 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,52 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,09 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,54 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,71 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,68 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,31 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 87,17 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 87,93 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 84,56 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 85,83 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 23.538 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 23.209 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 20.656 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 22.229 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 22.044 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 19.664 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 21.086 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 21.008 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 18.730 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 20.191 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 18.014 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 19.586 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 17.563 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,44 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,98 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,2 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,58 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,52 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,68 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 87 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 87,21 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 84,39 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 85,03 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 738 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 866 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.923 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 717 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 850 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.864 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 693 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 824 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2.800 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 795 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.719 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 773 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.675 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,15 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,15 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,98 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,9 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,15 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,79 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,8 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,02 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 89,26 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,52 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2022QIV 24.015 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2021QIV 24.078 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2020QIV 23.870 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the first trimester 2022QIV 22.595 03 Asturias, Principado de Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the first trimester 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the first trimester 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the first trimester 2021QIV 22.721 03 Asturias, Principado de Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the first trimester 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the first trimester 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the first trimester 2020QIV 22.416 03 Asturias, Principado de Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the first trimester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the second trimester 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the second trimester 2022QI 21.732 03 Asturias, Principado de Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the second trimester 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the second trimester 2021QI 21.488 03 Asturias, Principado de Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the second trimester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2022QII 20.957 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2021QII 20.868 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2022QIII 20.344 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2021QIII 20.368 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,09 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,36 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,91 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,26 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,02 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,04 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,42 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,49 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 85,33 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 23.341 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 22.849 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 20.721 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 21.943 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 21.542 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 19.342 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 20.606 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 18.494 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 19.868 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 17.927 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 19.276 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 17.483 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,01 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,28 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,34 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,18 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,25 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 86,95 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,52 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,36 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,37 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 674 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.229 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 3.149 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 652 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.179 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 3.074 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.126 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.994 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.089 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.941 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.068 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.885 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,74 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,93 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,62 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,62 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,08 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 88,61 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,39 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 86,9 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 91,62 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 18.671 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 18.410 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 19.043 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 17.485 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 17.295 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 16.755 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 16.560 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 16.582 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 16.162 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 15.893 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 16.045 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 15.597 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 15.290 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 15.513 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 15.029 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,65 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,94 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 87,99 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,69 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,07 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 84,87 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,12 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,15 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 81,9 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 81,89 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 84,26 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 78,92 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 17.874 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 16.628 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 16.725 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 15.587 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 15.841 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 14.922 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 15.200 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 14.432 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 14.623 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 13.955 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,57 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,74 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,63 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,74 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,04 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,79 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 81,81 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,92 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 797 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.782 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 760 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.708 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 719 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.660 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 693 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.613 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 667 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.558 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,36 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,85 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,21 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,15 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 86,95 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 90,52 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 83,69 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 87,43 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 18.561 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 18.319 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 17.995 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 17.411 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 17.395 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 17.266 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 16.618 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 16.733 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 16.608 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 15.861 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 16.084 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 15.948 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 15.424 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 15.277 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,8 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,96 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,95 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,53 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,34 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,29 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 85,45 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,8 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,62 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 84,2 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 84,9 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 17.765 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 16.528 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 14.857 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 16.648 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 15.652 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 14.191 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 15.885 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 15.043 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 13.628 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 15.158 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 14.455 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 13.073 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 13.859 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 12.520 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,71 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,7 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,52 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,42 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,02 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,73 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 85,33 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,46 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,99 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 83,85 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,27 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 796 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.791 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3.138 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 763 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.743 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3.075 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 733 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.690 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.980 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 703 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.629 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.875 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.565 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.757 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,85 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,32 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,99 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,09 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,36 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,96 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,32 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,95 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,62 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 87,38 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,86 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 18.646 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 18.737 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 18.439 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 17.381 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 17.608 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 17.433 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 16.325 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 16.641 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 16.499 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 15.879 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 15.754 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 15.291 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 15.303 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,22 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,97 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,54 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,55 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 88,81 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 89,48 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 84,75 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 85,44 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 81,61 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 82,99 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 18.121 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 18.213 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 16.881 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 16.876 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 17.100 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 15.927 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 15.843 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 16.154 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 15.046 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 15.417 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 14.368 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 14.849 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 13.952 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,13 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,89 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,35 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,43 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 88,69 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,13 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 84,65 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 85,11 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 81,53 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 82,65 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 525 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 524 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.558 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 505 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 508 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.506 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 482 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 487 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.453 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 462 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.386 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 442 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.351 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,19 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,95 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,66 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 91,81 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,94 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,26 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 88,17 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 88,96 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 84,35 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 86,71 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 18.491 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 18.705 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 18.644 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 17.137 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 17.402 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 17.240 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 16.490 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 16.366 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 15.773 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 15.802 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 15.215 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 15.346 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,68 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,03 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,47 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,16 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,78 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,33 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 84,76 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 81,34 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 82,31 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 18.027 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 17.857 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 16.948 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 16.695 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 16.600 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 15.610 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 15.735 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 14.801 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 15.051 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 14.279 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 14.512 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 13.869 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,61 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,96 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,11 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,12 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,33 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,29 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84,25 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 81,27 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 81,83 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 464 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 848 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.696 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 442 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 802 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.630 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 755 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.565 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 722 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.523 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 703 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.477 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 95,26 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 94,58 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,11 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 89,03 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,28 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 85,14 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 89,8 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 82,9 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 87,09 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 2.285 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 2.133 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 2.390 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 2.238 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 2.103 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 2.309 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 2.193 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 2.068 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 2.283 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 2.163 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 2.038 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 2.258 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 2.137 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 2.015 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 2.229 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 97,94 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,59 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,61 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,97 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,95 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,52 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,66 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,55 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,48 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,52 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,47 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,26 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.146 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.601 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.100 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.576 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.058 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.545 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.030 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.523 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.005 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.508 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 97,86 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,44 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 95,9 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,5 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,59 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,13 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,43 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,19 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 139 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 532 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 138 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 527 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 135 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 523 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 133 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 515 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 132 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 507 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,28 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,06 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,12 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,31 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 95,68 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,8 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,96 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,3 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 2.288 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 2.156 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 2.139 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 2.239 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 2.114 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 2.114 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 2.210 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 2.084 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 2.092 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 2.173 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 2.058 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 2.069 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 2.007 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 2.045 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,86 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,05 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,83 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,59 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,66 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,8 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,97 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,45 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,73 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,09 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,61 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.159 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.636 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.325 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.110 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.595 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.309 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.081 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.570 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.292 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.045 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.550 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.278 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.505 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.264 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,73 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,49 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,79 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,39 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 95,97 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,51 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,72 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 94,74 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,45 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 91,99 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,4 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 129 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 520 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 814 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 129 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 519 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 805 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 129 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 514 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 800 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 128 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 508 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 791 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 502 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 781 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,81 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,89 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,85 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,28 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 99,22 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,69 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,17 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,54 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,95 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 2.412 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 2.321 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 2.252 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 2.372 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 2.287 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 2.219 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 2.304 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 2.218 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 2.172 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 2.162 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 2.140 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 2.138 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 2.114 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,34 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,54 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,53 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 95,52 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 95,56 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,45 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 93,15 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,03 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 92,12 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,87 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.318 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.189 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.707 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.278 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.155 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.678 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.211 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.090 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.637 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.038 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.612 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.014 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.591 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,27 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,45 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,3 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 95,38 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 95,48 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 95,9 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 93,1 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,43 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 92,01 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 93,2 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 94 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 132 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 545 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 94 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 132 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 541 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 93 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 128 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 535 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 124 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 528 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 124 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 523 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,27 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,94 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,97 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,17 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,94 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,88 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,94 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,96 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 2.315 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 2.299 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 2.268 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 2.275 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 2.261 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 2.237 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 2.214 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 2.206 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 2.182 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 2.172 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 2.156 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 2.145 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,27 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,35 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,63 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,3 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,27 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 94,91 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,77 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 93,78 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 94,58 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.219 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.133 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.720 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.179 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.098 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.693 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.055 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.668 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.023 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.640 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.998 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.617 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,2 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,36 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,43 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,34 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,98 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 94,84 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,35 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 93,67 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,01 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 96 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 166 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 548 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 96 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 163 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 544 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 159 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 538 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 159 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 532 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 158 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 528 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,19 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,27 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 95,78 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,18 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,78 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,08 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,18 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,35 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 2.874 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 2.669 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 2.874 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 2.844 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 2.651 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 2.834 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 2.812 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 2.623 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 2.812 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 2.782 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 2.607 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 2.794 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 2.765 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 2.593 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 2.779 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,96 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,33 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,61 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,84 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,28 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,84 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,8 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,68 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,22 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,21 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,15 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,69 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.675 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.953 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.646 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.941 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.619 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.916 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.590 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.903 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.576 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.894 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,92 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,39 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,91 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,11 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,82 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,44 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,3 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,98 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 199 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 716 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 198 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 710 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 193 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 707 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 192 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 704 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 189 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 699 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,5 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,16 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,98 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,74 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,48 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,32 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,97 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,63 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 2.900 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 2.665 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 2.669 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 2.868 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 2.637 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 2.651 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 2.836 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 2.625 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 2.638 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 2.814 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 2.612 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 2.624 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 2.589 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 2.602 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,9 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,95 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,33 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,79 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,5 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,84 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,03 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,01 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,31 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,15 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,49 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.714 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.935 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.693 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.685 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.910 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.682 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.655 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.900 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.675 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.634 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.892 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.669 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.876 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.659 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,93 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,71 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,35 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,83 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,19 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,94 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,05 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,78 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,58 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,95 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,99 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 186 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 730 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 976 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 183 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 727 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 969 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 181 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 725 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 963 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 180 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 720 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 955 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 713 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 943 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,39 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,59 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,28 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,31 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,32 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,67 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,77 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,63 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,85 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,67 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,62 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 3.009 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 2.823 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 2.701 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 2.985 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 2.807 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 2.689 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 2.943 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 2.781 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 2.672 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 2.753 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 2.652 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 2.738 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 2.634 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,2 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,43 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,56 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,81 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,51 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,93 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,52 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,19 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,99 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,52 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.903 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.627 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.940 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.880 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.611 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.931 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.838 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.586 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.919 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.558 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.906 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.545 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.892 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,21 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,39 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,54 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,76 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,44 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,92 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,37 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,25 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,88 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,53 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 106 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 196 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 761 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 105 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 196 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 758 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 105 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 195 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 753 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 195 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 746 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 193 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 742 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,06 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,61 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 99,06 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,49 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,95 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 99,49 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,03 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 98,47 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,5 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 3.003 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 2.881 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 2.767 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 2.978 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 2.865 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 2.748 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 2.835 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 2.725 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 2.809 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 2.703 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 2.781 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 2.688 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,17 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,44 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,31 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,4 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,48 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,5 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,69 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,53 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,14 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.901 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.681 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.930 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.876 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.666 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.916 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.638 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.902 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.616 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.885 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.589 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.876 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,14 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,44 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,27 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,4 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,55 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,58 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,67 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,57 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,2 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 102 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 200 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 837 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 102 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 199 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 832 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 197 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 823 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 193 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 818 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 192 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 812 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,5 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,4 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,5 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,33 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,5 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,73 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,01 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 134 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 128 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 127 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 134 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 128 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 127 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 134 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 128 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 126 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 133 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 127 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 126 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 133 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 127 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 126 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,21 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 99,25 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 99,22 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 99,21 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 99,25 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 99,22 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 99,21 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 120 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 89 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 120 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 89 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 120 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 89 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 119 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 88 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 119 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 88 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 99,17 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,88 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 99,17 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,88 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 14 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 39 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 14 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 39 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 14 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 39 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 14 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 39 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 14 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 39 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 142 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 134 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 123 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 142 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 134 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 123 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 141 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 133 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 123 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 141 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 133 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 123 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 133 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 123 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,3 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,25 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 99,3 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 99,25 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 99,25 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 127 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 95 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 90 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 127 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 95 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 90 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 126 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 94 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 90 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 126 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 94 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 90 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 94 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 90 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,21 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,95 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 99,21 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,95 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 98,95 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 15 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 39 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 33 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 15 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 39 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 33 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 15 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 39 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 33 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 15 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 39 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 33 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 39 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 33 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 147 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 133 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 130 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 146 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 132 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 130 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 146 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 132 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 130 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 132 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 130 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 132 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 130 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,32 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,25 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,32 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,25 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99,25 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 99,25 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 138 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 125 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 87 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 137 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 124 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 87 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 137 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 124 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 87 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 124 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 87 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 124 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 87 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,28 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,2 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,28 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,2 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 99,2 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 99,2 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 9 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 8 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 43 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 9 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 8 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 43 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 9 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 8 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 43 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 8 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 43 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 8 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 43 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 139 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 131 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 130 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 139 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 131 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 130 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 131 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 130 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 131 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 130 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 130 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 129 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 99,24 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 99,23 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 131 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 122 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 88 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 131 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 122 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 88 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 122 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 88 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 122 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 88 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 121 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 87 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 99,18 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,86 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 8 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 9 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 42 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 8 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 9 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 42 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 9 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 42 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 9 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 42 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 9 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 42 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 62 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 62 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 66 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 62 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 62 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 65 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 62 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 62 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 65 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 62 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 61 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 65 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 61 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 61 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 65 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,48 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,48 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,39 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,48 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,39 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,39 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,48 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 58 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 36 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 58 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 36 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 58 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 36 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 58 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 35 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 57 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 35 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,22 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,28 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,22 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 4 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 26 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 4 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 26 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 4 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 26 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 4 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 26 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 4 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 26 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 64 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 62 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 62 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 64 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 62 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 62 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 64 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 61 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 62 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 63 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 61 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 62 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 61 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 62 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,39 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,44 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,39 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,39 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 59 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 39 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 44 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 59 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 39 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 44 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 59 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 38 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 44 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 58 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 38 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 44 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 38 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 44 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,44 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,31 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,44 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,44 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 5 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 23 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 18 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 5 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 23 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 18 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 5 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 23 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 18 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 5 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 23 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 18 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 23 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 18 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 62 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 61 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 57 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 62 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 60 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 57 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 61 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 60 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 57 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 60 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 57 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 60 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 57 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,36 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,39 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,36 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,36 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,36 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 58 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 55 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 41 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 58 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 54 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 41 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 57 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 54 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 41 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 54 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 41 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 54 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 41 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,18 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,28 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,18 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,18 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,18 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 4 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 6 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 16 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 6 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 16 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 6 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 16 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 6 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 16 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 6 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 16 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 67 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 62 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 61 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 66 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 62 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 61 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 62 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 61 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 62 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 61 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 62 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 60 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,51 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,36 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 63 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 56 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 35 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 62 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 56 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 35 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 56 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 35 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 56 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 35 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 56 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 34 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,41 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,14 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 6 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 26 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 6 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 26 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 6 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 26 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 6 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 26 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 6 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 26 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Asturias, Principado de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2022QI 33.288 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2021QI 32.023 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2020QI 34.322 04 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 04 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 04 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2022QII "" 04 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2022QI 31.182 04 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 04 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 04 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2021QII "" 04 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2021QI 29.995 04 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2020QII "" 04 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2020QI 30.573 04 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 04 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 04 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2022QII 29.863 04 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2022QI "" 04 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 04 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 04 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2021QII 28.916 04 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2021QI "" 04 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2020QII 29.544 04 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2022QIII 28.832 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2021QIII 28.086 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2020QIII 28.523 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2022QIV 27.653 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2021QIV 27.084 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2020QIV 26.886 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,67 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,67 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 89,08 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,71 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,3 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 86,08 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,61 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,71 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 83,1 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,07 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 84,58 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 78,33 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 31.816 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 25.693 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 29.774 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 23.922 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 28.499 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 22.965 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 27.501 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 22.227 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 26.375 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 21.438 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,58 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,11 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,57 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,38 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,44 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,51 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 82,9 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,44 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.472 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 6.330 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.408 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 6.073 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.364 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 5.951 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.331 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 5.859 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.278 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 5.646 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,65 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,94 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,66 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,01 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,42 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,56 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 86,82 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,19 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2022QII 35.038 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2021QII 32.278 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2020QII 33.451 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 04 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 04 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2022QII 33.330 04 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2022QI "" 04 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 04 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 04 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2021QII 30.906 04 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2021QI "" 04 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 04 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 04 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2020QII 32.101 04 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2020QI "" 04 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 04 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2022QIII 31.994 04 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2022QII "" 04 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2022QI "" 04 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 04 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2021QIII 29.829 04 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2021QII "" 04 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2021QI "" 04 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 04 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2020QIII 30.758 04 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2020QII "" 04 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2022QIV 29.161 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2021QIV 28.166 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2020QIV 28.059 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2022QI 27.037 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2021QI 26.834 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 04 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,13 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,75 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,96 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,31 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,41 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,95 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 83,23 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,26 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 83,88 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 83,76 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 80,22 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 33.535 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 25.544 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 24.206 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 31.868 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 24.307 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 23.005 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 30.569 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 23.343 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 21.931 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 27.887 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 22.050 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 20.290 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 21.098 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 19.372 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 04 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,03 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,16 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,04 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,16 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,38 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,6 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 83,16 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,32 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 83,82 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,59 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 80,03 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.503 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 6.734 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 9.245 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.462 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 6.599 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 9.096 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.425 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 6.486 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 8.827 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.274 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 6.116 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 7.769 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 5.939 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 7.462 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 04 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,27 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,39 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,81 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,32 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,48 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 84,76 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,82 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 84,03 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 88,19 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 80,71 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2022QIII 40.810 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2021QIII 38.501 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2020QIII 36.918 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 04 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2022QIII 38.310 04 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2022QII "" 04 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2022QI "" 04 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 04 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2021QIII 36.338 04 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2021QII "" 04 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2021QI "" 04 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 04 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2020QIII 34.742 04 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2020QII "" 04 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2020QI "" 04 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2022QIV 30.997 04 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 04 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2022QII "" 04 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2022QI "" 04 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2021QIV 30.207 04 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 04 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2021QII "" 04 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2021QI "" 04 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2020QIV 29.248 04 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 04 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2020QII "" 04 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2022QI 28.680 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2021QI 27.807 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2022QII 27.816 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2021QII 27.078 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,87 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,38 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,11 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 75,95 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 78,46 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 79,22 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 74,49 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 75,32 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 72,25 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 73,35 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 40.203 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 36.567 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 27.196 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 37.721 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 34.465 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 25.322 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 30.470 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 28.833 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 21.749 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 27.356 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 20.608 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 26.515 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 20.012 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,83 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,25 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,11 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 75,79 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 78,85 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 79,97 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 74,81 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 75,78 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 72,51 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 73,58 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 607 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.934 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 9.722 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 589 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.873 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 9.420 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 527 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.374 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 7.499 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.324 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 7.199 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.301 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 7.066 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,03 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,85 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,89 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 86,82 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 71,04 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 77,13 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 68,46 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 74,05 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 67,27 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 72,68 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2022QIV 40.038 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2021QIV 38.595 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2020QIV 36.940 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2022QIV 32.235 04 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 04 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2022QII "" 04 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2022QI "" 04 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2021QIV 31.600 04 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 04 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2021QII "" 04 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2021QI "" 04 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2020QIV 30.588 04 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2020QII "" 04 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2020QI "" 04 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 04 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 04 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2022QII "" 04 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2022QI 29.856 04 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 04 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 04 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2021QII "" 04 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2021QI 28.879 04 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 04 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2020QII "" 04 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2022QII 28.793 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2021QII 28.001 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2022QIII 27.917 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2021QIII 27.299 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 80,51 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 81,88 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 82,8 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 77,36 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 78,18 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 74,6 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 75,8 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 72,33 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 73,9 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 39.560 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 36.755 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 28.303 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 31.805 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 30.098 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 23.825 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 28.421 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 22.399 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 27.392 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 21.639 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 26.547 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 21.032 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 80,4 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 81,89 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 84,18 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 77,33 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 79,14 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 74,53 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 76,45 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 72,23 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 74,31 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 478 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.840 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 8.637 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 430 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.502 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 6.763 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.435 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 6.480 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.401 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 6.362 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.370 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 6.267 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 89,96 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 81,63 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 78,3 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 77,99 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 75,03 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 76,14 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 73,66 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 74,46 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 72,56 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 25.327 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 24.640 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 25.805 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 23.334 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 22.715 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 22.292 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 22.117 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 21.717 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 21.357 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 21.166 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 20.960 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 20.428 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 20.080 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 20.037 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 18.957 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,13 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,19 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 86,39 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,33 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 88,14 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 82,76 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 83,57 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 85,06 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 79,16 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 79,28 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 81,32 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 73,46 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 24.362 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 20.938 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 22.423 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 19.235 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 21.243 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 18.332 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 20.319 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 17.649 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 19.278 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 16.910 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,04 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 91,87 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,2 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 87,55 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 83,4 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 84,29 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 79,13 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 80,76 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 965 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 3.702 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 911 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 3.480 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 874 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 3.385 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 847 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 3.311 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 802 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 3.127 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,4 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 94 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,57 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 91,44 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,77 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,44 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 83,11 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 84,47 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 25.945 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 24.661 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 25.034 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 24.351 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 23.373 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 23.760 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 23.107 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 22.370 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 22.509 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 20.689 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 20.851 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 20.136 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 19.817 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 19.044 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 04 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,86 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,78 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,91 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,06 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,71 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 89,91 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 79,74 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 84,55 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 80,43 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 80,36 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 76,07 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 25.018 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 20.668 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 19.546 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 23.460 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 19.490 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 18.398 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 22.246 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 18.583 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 17.384 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 19.948 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 17.387 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 15.846 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 16.503 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 14.996 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,77 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,3 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,13 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,92 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,91 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 88,94 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 79,73 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 84,13 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 81,07 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 79,85 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 76,72 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 927 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 3.993 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 5.488 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 891 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 3.883 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 5.362 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 861 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 3.787 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 5.125 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 741 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 3.464 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 4.290 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 3.314 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 4.048 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,12 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,25 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,7 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,88 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,84 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 93,39 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 79,94 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 86,75 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 78,17 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 83 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 73,76 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 29.272 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 28.195 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 27.189 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 26.911 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 26.169 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 25.133 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 21.374 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 21.266 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 20.633 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 19.906 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 19.359 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 19.123 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 18.730 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 91,93 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,81 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 92,44 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 73,02 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 75,42 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 75,89 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 70,6 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 71,2 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 67,82 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 68,89 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 28.926 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 27.174 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 22.277 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 26.580 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 25.202 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 20.475 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 21.082 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 20.602 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 17.219 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 19.282 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 16.162 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 18.517 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 15.616 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 91,89 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,74 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 91,91 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 72,88 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 75,82 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 77,29 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 70,96 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 72,55 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 68,14 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 70,1 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 346 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.021 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 4.912 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 331 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 967 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 4.658 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 292 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 664 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3.414 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 624 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 3.197 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 606 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 3.114 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,66 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 94,71 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 94,83 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 84,39 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 65,03 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 69,5 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 61,12 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 65,09 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 59,35 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 63,4 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 28.950 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 28.385 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 27.501 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 22.691 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 22.581 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 22.073 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 21.009 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 20.528 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 20.040 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 19.752 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 19.250 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 19.123 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 78,38 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 79,55 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 80,26 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 74,01 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 74,64 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 70,6 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 71,82 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 67,82 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 69,54 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 28.686 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 27.256 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 23.160 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 22.456 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 21.697 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 18.996 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 20.179 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 17.653 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 19.238 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 16.951 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 18.475 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 16.394 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 78,28 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 79,6 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 82,02 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 74,04 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 76,22 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 70,58 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 73,19 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 67,78 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 70,79 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 264 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.129 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 4.341 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 235 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 884 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 3.077 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 830 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.875 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 802 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.801 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 775 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.729 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 89,02 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 78,3 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 70,88 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 73,52 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 66,23 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 71,04 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 64,52 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 68,64 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 62,87 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 3.450 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 3.291 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 3.760 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 3.379 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 3.222 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 3.605 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 3.330 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 3.191 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 3.554 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 3.288 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 3.149 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 3.494 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 3.234 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 3.105 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 3.391 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 97,94 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,9 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 95,88 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,52 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,96 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 94,52 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,3 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,69 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 92,93 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,74 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,35 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 90,19 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.256 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.329 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3.192 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.281 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3.147 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.259 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3.107 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.226 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3.056 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.198 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,03 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,94 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,65 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,99 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,42 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,58 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,86 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,38 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 194 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 962 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 187 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 941 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 183 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 932 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 181 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 923 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 178 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 907 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,39 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,82 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 94,33 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,88 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 93,3 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,95 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 91,75 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,28 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 3.887 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 3.355 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 3.663 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 3.826 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 3.312 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 3.623 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 3.776 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 3.274 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 3.563 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 3.514 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 3.177 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 3.360 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 3.123 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 3.278 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,43 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,72 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,91 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,14 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,59 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,27 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 90,4 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 94,69 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 91,73 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,08 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 89,49 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3.681 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.352 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.264 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 3.621 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.319 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.233 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 3.574 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.290 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.191 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 3.330 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.223 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.122 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.183 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.079 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,37 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,6 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,63 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,09 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,36 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,78 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 90,46 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 94,52 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 93,73 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 92,81 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 91,83 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 206 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.003 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.399 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 205 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 993 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.390 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 202 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 984 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.372 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 184 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 954 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.238 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 940 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.199 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,51 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,36 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,06 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,11 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,07 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 89,32 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,11 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 88,49 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 93,72 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 85,7 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 4.657 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 4.298 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 4.164 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 4.577 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 4.221 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 4.083 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 3.749 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 3.572 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 3.517 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 3.480 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 3.424 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 3.433 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 3.379 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,28 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,21 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,05 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 80,5 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 83,11 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 84,46 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 80,97 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 82,23 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 79,87 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 81,15 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 4.570 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.986 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.505 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 4.490 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3.911 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.453 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3.673 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3.355 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.226 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3.266 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.174 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3.222 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.149 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,25 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,12 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 97,92 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 80,37 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 84,17 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 88,86 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 81,94 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,79 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 80,83 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 85,79 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 87 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 312 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.659 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 87 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 310 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.630 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 76 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 217 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.291 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 214 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.250 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 211 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.230 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,36 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,25 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 87,36 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 69,55 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 77,82 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 68,59 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 75,35 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 67,63 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 74,14 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 4.487 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 4.248 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 4.009 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 3.746 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 3.622 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 3.483 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 3.525 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 3.385 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 3.476 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 3.338 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 3.427 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 3.301 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 83,49 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 85,26 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 86,88 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 82,98 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 84,44 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 81,83 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 83,26 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 80,67 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 82,34 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 4.426 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3.991 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.581 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 3.691 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3.411 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.373 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3.321 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.317 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3.274 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.288 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3.226 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.259 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 83,39 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 85,47 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 91,94 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 83,21 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,77 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 82,03 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 88,65 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 80,83 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 87,52 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 61 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 257 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.428 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 55 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 211 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.110 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 204 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.068 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 202 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.050 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 201 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.042 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 90,16 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 82,1 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 77,73 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 79,38 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 74,79 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 78,6 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 73,53 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 78,21 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 72,97 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 4.252 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 3.854 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 4.492 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 4.211 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 3.821 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 4.412 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 4.159 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 3.771 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 4.369 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 4.124 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 3.743 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 4.338 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 4.089 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 3.708 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 4.276 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,04 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,14 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,22 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,81 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,85 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,26 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,99 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,12 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,57 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,17 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,21 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 95,19 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.963 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.331 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3.925 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.311 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3.876 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.279 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3.845 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.257 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3.814 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.235 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,04 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,14 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,8 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,77 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,02 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,83 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,24 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,88 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 289 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.523 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 286 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.510 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 283 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.492 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 279 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.486 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 275 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.473 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,96 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,15 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,92 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,96 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,54 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,57 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 95,16 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,72 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 4.907 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 4.020 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 4.480 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 4.854 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 3.979 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 4.444 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 4.815 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 3.946 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 4.413 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 4.667 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 3.899 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 4.291 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 3.859 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 4.241 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 04 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,92 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,98 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,2 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,13 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,16 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,5 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,11 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,99 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,78 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,67 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 4.561 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.419 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.280 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 4.512 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.393 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.258 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 4.476 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.365 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.241 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 4.341 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.335 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.208 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.308 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.183 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,93 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,93 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,04 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,14 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,77 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,29 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,18 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,53 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,84 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,41 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,75 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 346 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.601 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.200 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 342 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.586 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.186 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 339 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.581 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.172 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 326 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.564 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.083 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.551 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.058 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,84 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,06 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,36 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,98 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,75 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,73 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 94,22 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,69 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,68 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,88 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 93,55 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 6.444 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 5.656 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 5.228 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 6.387 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 5.600 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 5.190 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 5.447 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 5.024 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 4.765 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 4.950 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 4.692 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 4.917 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 4.637 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,12 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,01 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,27 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 84,53 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 88,83 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,14 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 87,52 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 89,75 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 86,93 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 88,7 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 6.292 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 5.101 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.329 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 6.237 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 5.050 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.310 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 5.309 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 4.576 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.220 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 4.509 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.188 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 4.478 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.163 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,13 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,18 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 84,38 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,71 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 95,32 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,39 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 93,95 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 87,79 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 92,87 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 152 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 555 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.899 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 150 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 550 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.880 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 138 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 448 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2.545 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 441 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.504 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 439 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.474 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,68 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,1 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,34 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 90,79 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 80,72 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 87,79 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 79,46 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 86,37 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 79,1 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 85,34 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 6.174 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 5.597 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 5.108 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 5.376 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 5.034 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 4.713 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 4.960 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 4.648 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 4.916 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 4.593 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 4.881 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 4.560 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 87,07 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 89,94 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,27 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,62 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,99 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,83 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 89,92 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 87,21 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 89,27 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 6.039 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 5.169 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.469 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 5.254 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 4.653 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.363 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 4.585 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.336 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 4.545 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.307 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 4.512 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.286 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 87 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 90,02 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 95,71 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,7 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 94,61 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,93 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 93,44 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 87,29 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 92,59 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 135 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 428 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2.639 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 122 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 381 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2.350 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 375 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.312 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 371 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.286 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 369 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.274 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 90,37 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 89,02 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 89,05 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 87,62 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 87,61 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 86,68 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 86,62 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 86,21 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 86,17 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 188 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 171 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 184 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 188 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 170 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 183 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 187 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 170 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 183 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 184 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 167 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 182 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 180 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 167 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 181 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,42 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,46 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,47 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,42 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,46 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,87 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,66 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,91 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,74 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,66 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,37 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 171 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 69 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 171 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 69 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 170 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 69 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 167 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 69 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 164 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 69 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,42 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,66 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,91 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 17 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 102 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 17 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 101 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 17 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 101 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 17 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 98 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 16 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 98 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,02 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,02 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,08 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,12 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,08 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 213 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 175 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 194 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 213 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 175 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 194 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 210 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 172 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 193 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 206 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 172 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 192 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 172 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 191 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,59 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,29 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,48 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,71 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,29 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,97 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,29 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,45 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 198 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 75 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 85 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 198 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 75 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 85 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 196 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 75 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 84 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 192 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 75 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 83 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 75 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 83 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,99 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,82 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,97 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,65 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,65 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 15 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 109 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 15 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 109 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 14 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 97 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 109 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 14 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 97 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 109 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 97 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 108 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,33 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 93,33 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 99,08 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 303 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 249 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 234 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 301 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 246 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 233 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 293 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 243 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 230 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 243 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 229 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 242 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 229 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,34 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,8 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,57 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,7 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,59 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,29 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,59 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,86 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,19 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,86 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 288 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 225 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 59 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 287 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 222 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 58 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 279 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 220 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 58 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 220 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 58 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 219 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 58 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,65 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,67 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,31 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,88 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,78 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,31 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,78 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,31 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,33 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98,31 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 15 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 24 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 175 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 14 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 24 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 175 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 14 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 23 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 172 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 23 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 171 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 23 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 171 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 93,33 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,33 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,83 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,29 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,83 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,71 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,83 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,71 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 296 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 261 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 223 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 292 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 260 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 220 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 260 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 219 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 259 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 219 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 257 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 217 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,65 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,62 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,65 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,62 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,21 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 99,23 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,21 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,47 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,31 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 284 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 247 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 68 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 280 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 246 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 68 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 246 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 68 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 245 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 68 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 244 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 68 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,59 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,6 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 99,6 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 99,19 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,79 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 12 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 14 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 155 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 12 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 14 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 152 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 14 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 151 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 14 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 151 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 13 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 149 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,06 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,42 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,42 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 92,86 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,13 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 71 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 67 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 81 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 70 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 67 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 81 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 70 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 67 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 81 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 70 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 67 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 81 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 70 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 67 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 81 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,59 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,59 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,59 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,59 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 64 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 26 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 63 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 26 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 63 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 26 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 63 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 26 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 63 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 26 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,44 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,44 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,44 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,44 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 7 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 41 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 7 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 41 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 7 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 41 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 7 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 41 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 7 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 41 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 86 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 67 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 80 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 86 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 67 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 80 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 86 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 67 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 80 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 85 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 67 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 80 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 66 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 80 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 04 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,84 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,51 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 77 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 30 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 31 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 77 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 30 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 31 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 77 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 30 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 31 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 76 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 30 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 31 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 29 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 31 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,7 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,67 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 9 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 37 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 49 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 9 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 37 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 49 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 9 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 37 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 49 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 9 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 37 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 49 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 37 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 49 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 134 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 103 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 103 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 134 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 102 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 103 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 134 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 102 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 103 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 101 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 103 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 101 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 103 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,03 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,03 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,06 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,06 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 127 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 81 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 26 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 127 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 80 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 26 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 127 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 80 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 26 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 79 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 26 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 79 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 26 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,77 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,77 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,53 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,53 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 7 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 22 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 77 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 7 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 22 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 77 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 7 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 22 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 77 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 22 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 77 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 22 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 77 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 131 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 104 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 99 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 130 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 103 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 99 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 102 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 99 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 102 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 99 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 102 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 98 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,24 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,04 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,08 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,08 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,08 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,99 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 125 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 92 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 25 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 124 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 91 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 25 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 90 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 25 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 90 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 25 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 90 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 25 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,2 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,91 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,83 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,83 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,83 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 6 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 12 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 74 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 6 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 12 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 74 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 12 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 74 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 12 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 74 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 12 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 73 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,65 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2022QI 53.706 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2021QI 51.837 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2020QI 55.634 05 Canarias Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 05 Canarias Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 05 Canarias Total Cohort January 1 Total Survival in the first trimester 2022QII "" 05 Canarias Total Cohort January 1 Total Survival in the first trimester 2022QI 50.651 05 Canarias Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 05 Canarias Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 05 Canarias Total Cohort January 1 Total Survival in the first trimester 2021QII "" 05 Canarias Total Cohort January 1 Total Survival in the first trimester 2021QI 48.683 05 Canarias Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 05 Canarias Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 05 Canarias Total Cohort January 1 Total Survival in the first trimester 2020QII "" 05 Canarias Total Cohort January 1 Total Survival in the first trimester 2020QI 47.879 05 Canarias Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 05 Canarias Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 05 Canarias Total Cohort January 1 Total Survival in the second trimester 2022QII 48.261 05 Canarias Total Cohort January 1 Total Survival in the second trimester 2022QI "" 05 Canarias Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 05 Canarias Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 05 Canarias Total Cohort January 1 Total Survival in the second trimester 2021QII 46.930 05 Canarias Total Cohort January 1 Total Survival in the second trimester 2021QI "" 05 Canarias Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 05 Canarias Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 05 Canarias Total Cohort January 1 Total Survival in the second trimester 2020QII 45.984 05 Canarias Total Cohort January 1 Total Survival in the second trimester 2020QI "" 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2022QIII 46.373 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2021QIII 45.390 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2020QIII 44.574 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2022QIV 45.022 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2021QIV 44.077 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2020QIV 43.228 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Canarias Total Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Canarias Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 05 Canarias Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,31 05 Canarias Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,92 05 Canarias Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 86,06 05 Canarias Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,86 05 Canarias Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,53 05 Canarias Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 82,65 05 Canarias Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,35 05 Canarias Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,56 05 Canarias Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 80,12 05 Canarias Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,83 05 Canarias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,03 05 Canarias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 77,7 05 Canarias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 51.142 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 41.525 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 48.184 05 Canarias Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 38.720 05 Canarias Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 45.879 05 Canarias Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 37.197 05 Canarias Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 44.059 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 35.854 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 42.769 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 34.809 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,22 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,25 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,71 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,58 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,15 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,34 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,63 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,83 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2.564 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 10.312 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2.467 05 Canarias Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 9.963 05 Canarias Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2.382 05 Canarias Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 9.733 05 Canarias Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2.314 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 9.536 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2.253 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 9.268 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,22 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,62 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,9 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,39 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,25 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,47 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 87,87 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,88 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2022QII 53.693 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2021QII 51.119 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2020QII 50.177 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 05 Canarias Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 05 Canarias Total Cohort April 1 Total Survival in the first trimester 2022QII 50.731 05 Canarias Total Cohort April 1 Total Survival in the first trimester 2022QI "" 05 Canarias Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 05 Canarias Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 05 Canarias Total Cohort April 1 Total Survival in the first trimester 2021QII 48.900 05 Canarias Total Cohort April 1 Total Survival in the first trimester 2021QI "" 05 Canarias Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 05 Canarias Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 05 Canarias Total Cohort April 1 Total Survival in the first trimester 2020QII 47.968 05 Canarias Total Cohort April 1 Total Survival in the first trimester 2020QI "" 05 Canarias Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 05 Canarias Total Cohort April 1 Total Survival in the second trimester 2022QIII 48.478 05 Canarias Total Cohort April 1 Total Survival in the second trimester 2022QII "" 05 Canarias Total Cohort April 1 Total Survival in the second trimester 2022QI "" 05 Canarias Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 05 Canarias Total Cohort April 1 Total Survival in the second trimester 2021QIII 47.072 05 Canarias Total Cohort April 1 Total Survival in the second trimester 2021QII "" 05 Canarias Total Cohort April 1 Total Survival in the second trimester 2021QI "" 05 Canarias Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 05 Canarias Total Cohort April 1 Total Survival in the second trimester 2020QIII 46.342 05 Canarias Total Cohort April 1 Total Survival in the second trimester 2020QII "" 05 Canarias Total Cohort April 1 Total Survival in the second trimester 2020QI "" 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2022QIV 46.944 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2022QI "" 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2021QIV 45.606 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2021QI "" 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2020QIV 44.826 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2022QI 43.885 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2021QI 42.999 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Canarias Total Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 05 Canarias Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,48 05 Canarias Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,66 05 Canarias Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,6 05 Canarias Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,29 05 Canarias Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,08 05 Canarias Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,36 05 Canarias Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,43 05 Canarias Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,22 05 Canarias Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,34 05 Canarias Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,85 05 Canarias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,69 05 Canarias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 51.194 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 44.183 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 37.174 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 48.328 05 Canarias Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 42.156 05 Canarias Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 35.128 05 Canarias Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 46.148 05 Canarias Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 40.483 05 Canarias Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 33.767 05 Canarias Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 44.663 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 39.219 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 32.571 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 37.700 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 31.172 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 05 Canarias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,4 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,41 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,5 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,14 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,63 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,83 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,24 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,76 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,62 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,33 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 83,85 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2.499 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 6.936 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 13.003 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2.403 05 Canarias Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 6.744 05 Canarias Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 12.840 05 Canarias Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2.330 05 Canarias Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 6.589 05 Canarias Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 12.575 05 Canarias Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2.281 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 6.387 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 12.255 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 6.185 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 11.827 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 05 Canarias Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,16 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,23 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,75 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,24 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,71 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,28 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 92,08 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,25 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 89,17 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,96 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2022QIII 53.722 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2021QIII 51.769 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2020QIII 50.704 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 05 Canarias Total Cohort July 1 Total Survival in the first trimester 2022QIII 50.873 05 Canarias Total Cohort July 1 Total Survival in the first trimester 2022QII "" 05 Canarias Total Cohort July 1 Total Survival in the first trimester 2022QI "" 05 Canarias Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 05 Canarias Total Cohort July 1 Total Survival in the first trimester 2021QIII 49.336 05 Canarias Total Cohort July 1 Total Survival in the first trimester 2021QII "" 05 Canarias Total Cohort July 1 Total Survival in the first trimester 2021QI "" 05 Canarias Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 05 Canarias Total Cohort July 1 Total Survival in the first trimester 2020QIII 48.544 05 Canarias Total Cohort July 1 Total Survival in the first trimester 2020QII "" 05 Canarias Total Cohort July 1 Total Survival in the first trimester 2020QI "" 05 Canarias Total Cohort July 1 Total Survival in the second trimester 2022QIV 49.051 05 Canarias Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 05 Canarias Total Cohort July 1 Total Survival in the second trimester 2022QII "" 05 Canarias Total Cohort July 1 Total Survival in the second trimester 2022QI "" 05 Canarias Total Cohort July 1 Total Survival in the second trimester 2021QIV 47.578 05 Canarias Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 05 Canarias Total Cohort July 1 Total Survival in the second trimester 2021QII "" 05 Canarias Total Cohort July 1 Total Survival in the second trimester 2021QI "" 05 Canarias Total Cohort July 1 Total Survival in the second trimester 2020QIV 46.665 05 Canarias Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 05 Canarias Total Cohort July 1 Total Survival in the second trimester 2020QII "" 05 Canarias Total Cohort July 1 Total Survival in the second trimester 2020QI "" 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2022QII "" 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2022QI 45.634 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2021QII "" 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2021QI 44.619 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2022QII 44.085 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2022QI "" 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2021QII 43.416 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2021QI "" 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Canarias Total Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Canarias Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,7 05 Canarias Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,3 05 Canarias Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,74 05 Canarias Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,31 05 Canarias Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 91,9 05 Canarias Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 92,03 05 Canarias Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 88,15 05 Canarias Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 88 05 Canarias Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 85,16 05 Canarias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 85,63 05 Canarias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 52.529 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 49.265 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 39.524 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 49.716 05 Canarias Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 46.906 05 Canarias Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 37.578 05 Canarias Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 47.919 05 Canarias Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 45.225 05 Canarias Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 35.968 05 Canarias Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 43.355 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 34.282 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 41.867 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 33.299 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,64 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,21 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,08 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,22 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,8 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,74 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 84,98 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,25 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1.193 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 2.504 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 11.180 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1.157 05 Canarias Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 2.430 05 Canarias Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 10.966 05 Canarias Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1.132 05 Canarias Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 2.353 05 Canarias Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 10.697 05 Canarias Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 2.279 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 10.337 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 2.218 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 10.117 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,98 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,04 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,09 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,89 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,97 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,68 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,01 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,46 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 88,58 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 90,49 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2022QIV 53.852 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2021QIV 52.577 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2020QIV 51.791 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort October 1 Total Survival in the first trimester 2022QIV 51.498 05 Canarias Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 05 Canarias Total Cohort October 1 Total Survival in the first trimester 2022QII "" 05 Canarias Total Cohort October 1 Total Survival in the first trimester 2022QI "" 05 Canarias Total Cohort October 1 Total Survival in the first trimester 2021QIV 50.226 05 Canarias Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 05 Canarias Total Cohort October 1 Total Survival in the first trimester 2021QII "" 05 Canarias Total Cohort October 1 Total Survival in the first trimester 2021QI "" 05 Canarias Total Cohort October 1 Total Survival in the first trimester 2020QIV 49.248 05 Canarias Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 05 Canarias Total Cohort October 1 Total Survival in the first trimester 2020QII "" 05 Canarias Total Cohort October 1 Total Survival in the first trimester 2020QI "" 05 Canarias Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 05 Canarias Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 05 Canarias Total Cohort October 1 Total Survival in the second trimester 2022QII "" 05 Canarias Total Cohort October 1 Total Survival in the second trimester 2022QI 47.913 05 Canarias Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 05 Canarias Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 05 Canarias Total Cohort October 1 Total Survival in the second trimester 2021QII "" 05 Canarias Total Cohort October 1 Total Survival in the second trimester 2021QI 46.763 05 Canarias Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 05 Canarias Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 05 Canarias Total Cohort October 1 Total Survival in the second trimester 2020QII "" 05 Canarias Total Cohort October 1 Total Survival in the second trimester 2020QI "" 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2022QII 46.034 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2021QII 45.322 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2022QIII 44.406 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2022QII "" 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2021QIII 43.988 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2021QII "" 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Canarias Total Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Canarias Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,63 05 Canarias Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,53 05 Canarias Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,09 05 Canarias Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,13 05 Canarias Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,29 05 Canarias Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,56 05 Canarias Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,51 05 Canarias Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,46 05 Canarias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,93 05 Canarias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 53.044 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 49.237 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 40.950 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 50.707 05 Canarias Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 47.008 05 Canarias Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 38.676 05 Canarias Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 44.811 05 Canarias Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 36.543 05 Canarias Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 43.066 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 35.328 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 41.542 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 34.195 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,59 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,47 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,45 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,01 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,24 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,47 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,27 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,37 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,5 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 808 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 3.340 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 10.841 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 791 05 Canarias Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 3.218 05 Canarias Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 10.572 05 Canarias Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 3.102 05 Canarias Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 10.220 05 Canarias Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2.968 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 9.994 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2.864 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 9.793 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,9 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,35 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,52 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,87 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,27 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 88,86 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,19 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 85,75 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90,33 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 39.633 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 38.733 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 40.891 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 36.790 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 35.773 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 33.756 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 34.622 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 34.167 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 32.041 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 32.940 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 32.761 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 30.784 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 31.744 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 31.598 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 29.609 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,83 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,36 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 82,55 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,36 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 88,21 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 78,36 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 83,11 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 84,58 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 75,28 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 80,09 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 81,58 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 72,41 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 37.964 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 33.358 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 35.206 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 30.677 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 33.111 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 29.252 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 31.483 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 27.999 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 30.339 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 27.049 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,74 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 91,96 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,22 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 87,69 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 82,93 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 83,93 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 79,92 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 81,09 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.669 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 5.375 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.584 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 5.096 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.511 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 4.915 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.457 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 4.762 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.405 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 4.549 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,91 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 94,81 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,53 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 91,44 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,3 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 88,6 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 84,18 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 84,63 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 39.587 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 38.261 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 37.291 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 36.836 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 36.181 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 35.182 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 34.773 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 34.489 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 33.660 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 33.399 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 33.166 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 32.292 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 31.642 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 30.665 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 05 Canarias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,05 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,56 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,34 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 87,84 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,14 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 90,26 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 84,37 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,68 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 86,59 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 82,7 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 82,23 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 37.992 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 34.306 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 30.007 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 35.328 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 32.383 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 28.035 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 33.328 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 30.824 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 26.742 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 31.997 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 29.677 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 25.633 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 28.309 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 24.342 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 92,99 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,39 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 93,43 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 87,72 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,85 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 89,12 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,22 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,51 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 85,42 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,52 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 81,12 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.595 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 3.955 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 7.284 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.508 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 3.798 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 7.147 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.445 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 3.665 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 6.918 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.402 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 3.489 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 6.659 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 3.333 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 6.323 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 94,55 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,03 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,12 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 90,6 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 92,67 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,98 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 87,9 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 88,22 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,42 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 84,27 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 86,81 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 39.506 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 38.538 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 37.659 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 36.831 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 36.217 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 35.597 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 35.162 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 34.610 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 33.879 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 32.876 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 32.032 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 31.500 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 30.957 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,23 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,98 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,52 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,81 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 89,96 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,31 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 85,06 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 81,74 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 82,2 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 38.678 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 37.039 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 31.945 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 36.036 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 34.788 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 30.073 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 34.390 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 33.246 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 28.565 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 31.573 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 26.991 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 30.247 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 26.083 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,17 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,92 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,14 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,91 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,76 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,42 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,24 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 84,49 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 81,66 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 81,65 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 828 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.499 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 5.714 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 795 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.429 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 5.524 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 772 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.364 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 5.314 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.303 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 5.041 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.253 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 4.874 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,01 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,33 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,67 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,24 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 90,99 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 86,92 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 88,22 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 83,59 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 85,3 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 39.491 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 38.879 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 38.546 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 37.270 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 36.657 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 36.142 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 34.561 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 33.866 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 32.872 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 32.571 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 31.437 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 31.380 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,38 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,28 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,76 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,89 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,86 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,55 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 84,5 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 80,86 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 81,41 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 38.963 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 36.487 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 32.915 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 36.759 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 34.381 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 30.734 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 32.394 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 28.731 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 30.826 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 27.607 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 29.479 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 26.565 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,34 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,23 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,37 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,78 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,29 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,48 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 83,87 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 80,79 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 80,71 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 528 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2.392 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 5.631 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 511 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2.276 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 5.408 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2.167 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 5.135 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2.046 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 4.964 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.958 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 4.815 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,78 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,15 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,04 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 90,59 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 91,19 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 85,54 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 88,15 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 81,86 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 85,51 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 6.183 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 5.820 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 6.439 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 6.062 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 5.692 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 6.034 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 5.926 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 5.603 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 5.925 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 5.805 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 5.516 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 5.830 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 5.713 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 5.425 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 5.735 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,04 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,8 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 93,71 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,84 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,27 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 92,02 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 93,89 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,78 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 90,54 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 92,4 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 93,21 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 89,07 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 5.832 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 4.096 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 5.718 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 4.007 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 5.590 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 3.941 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 5.476 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 3.880 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 5.390 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3.821 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,05 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,83 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 95,85 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,22 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 93,9 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 94,73 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 92,42 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,29 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 351 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.724 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 344 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.685 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 336 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.662 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 329 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.636 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 323 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.604 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,01 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,74 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 95,73 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,4 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 93,73 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,9 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 92,02 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 93,04 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 6.130 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 5.705 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 5.598 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 5.999 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 5.617 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 5.533 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 5.890 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 5.523 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 5.463 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 5.796 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 5.433 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 5.370 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 5.316 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 5.253 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 05 Canarias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,86 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,46 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,84 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,08 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,81 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,59 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,55 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,23 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,93 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,18 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 93,84 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 5.774 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 4.675 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3.427 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 5.647 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 4.608 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3.373 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 5.544 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 4.531 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3.328 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 5.454 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 4.456 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3.273 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 4.365 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3.204 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,8 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,57 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,42 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,02 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,92 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,11 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,46 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,32 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,51 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,37 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 93,49 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 356 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.030 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.171 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 352 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.009 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.160 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 346 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 992 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.135 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 342 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 977 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.097 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 951 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.049 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,88 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,96 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,49 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,19 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,31 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,34 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,07 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,85 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,59 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 92,33 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,38 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 6.167 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 5.870 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 5.708 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 6.068 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 5.794 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 5.648 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 5.976 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 5.704 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 5.549 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 5.575 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 5.431 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 5.470 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 5.346 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,39 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,71 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,95 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,9 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,17 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,21 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 94,97 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,15 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 93,19 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,66 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 6.025 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 5.502 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3.774 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 5.928 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 5.429 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 3.729 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 5.838 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 5.347 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3.662 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 5.225 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3.594 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 5.126 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 3.541 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,39 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,67 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,81 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,9 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,18 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,03 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 94,97 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,23 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 93,17 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 93,83 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 142 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 368 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.934 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 140 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 365 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.919 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 138 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 357 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.887 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 350 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.837 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 344 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.805 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,59 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,18 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,22 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,18 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,01 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,57 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,11 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,98 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,48 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 93,33 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 6.132 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 6.015 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 5.823 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 6.054 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 5.947 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 5.733 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 5.815 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 5.599 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 5.701 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 5.505 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 5.588 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 5.416 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,73 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,87 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,45 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,67 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,15 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 94,78 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 94,54 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 92,9 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,01 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 6.032 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 5.633 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 4.004 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 5.954 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 5.568 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3.941 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 5.439 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3.853 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 5.331 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3.791 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 5.226 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3.732 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,71 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,85 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,43 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,56 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,23 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 94,64 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,68 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 92,77 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,21 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 382 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.819 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 100 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 379 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.792 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 376 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.746 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 370 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.714 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 362 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.684 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,21 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,52 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,43 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,99 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,86 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,23 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 94,76 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,58 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 7.331 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 6.769 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 7.716 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 7.242 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 6.706 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 7.503 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 7.157 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 6.648 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 7.434 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 7.074 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 6.602 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 7.376 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 7.015 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 6.543 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 7.303 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,79 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,07 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,24 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,63 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,21 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,35 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,49 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,53 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,59 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,69 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,66 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,65 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 6.824 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 3.866 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 6.740 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 3.833 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 6.659 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 3.801 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 6.583 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 3.773 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 6.527 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3.737 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,77 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,15 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,58 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,32 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,47 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,59 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,65 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,66 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 507 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2.903 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 502 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2.873 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 498 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.847 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 491 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.829 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 488 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.806 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,01 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,97 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,22 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,07 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,84 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,45 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,25 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,66 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 7.392 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 6.651 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 6.765 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 7.313 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 6.601 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 6.731 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 7.236 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 6.561 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 6.697 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 7.174 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 6.508 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 6.644 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 6.431 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 6.564 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 05 Canarias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,93 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,25 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,5 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,89 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,65 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,99 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,05 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,85 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,21 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,69 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,03 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 6.877 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 4.919 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3.519 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 6.803 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 4.883 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3.499 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 6.730 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 4.848 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3.476 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 6.669 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 4.806 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3.444 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 4.747 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3.407 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,92 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,27 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,43 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,86 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,56 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,78 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,98 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,7 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,87 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,5 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,82 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 515 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.732 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3.246 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 510 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.718 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3.232 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 506 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.713 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 3.221 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 505 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.702 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 3.200 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.684 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 3.157 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,03 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,19 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,57 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,25 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,9 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,23 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,06 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,27 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,58 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,23 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,26 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 7.477 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 6.874 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 6.830 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 7.403 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 6.838 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 6.792 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 7.346 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 6.777 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 6.731 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 6.699 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 6.653 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 6.631 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 6.610 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,01 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,48 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,44 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,25 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,59 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,55 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,45 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,41 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,46 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,78 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 7.270 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 6.310 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3.623 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 7.197 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 6.275 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 3.594 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 7.140 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 6.218 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3.559 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 6.146 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3.517 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 6.083 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 3.495 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,45 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,2 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,21 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,54 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,23 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,4 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,07 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,4 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,47 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 207 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 564 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 3.207 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 206 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 563 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 3.198 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 206 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 559 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3.172 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 553 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 3.136 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 548 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 3.115 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,52 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,82 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,72 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 99,52 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,11 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,91 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 98,05 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,79 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,16 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,13 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 7.630 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 7.151 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 6.905 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 7.577 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 7.091 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 6.857 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 7.009 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 6.785 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 6.933 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 6.733 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 6.855 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 6.679 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,31 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,16 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,3 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,01 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,26 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,95 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,51 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,86 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,73 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 7.463 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 6.628 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3.834 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 7.410 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 6.571 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3.804 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 6.493 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3.764 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 6.424 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3.735 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 6.354 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3.703 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,29 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,14 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,22 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,96 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,17 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,92 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,42 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,87 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,58 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 167 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 523 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 3.071 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 167 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 520 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 3.053 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 516 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 3.021 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 509 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.998 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 501 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.976 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,43 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,41 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,66 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,37 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,32 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,62 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,79 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,91 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 383 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 372 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 424 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 382 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 370 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 422 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 382 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 370 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 420 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 380 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 369 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 420 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 377 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 369 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 418 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,74 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,46 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,53 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,74 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,46 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,06 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 99,22 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 99,19 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 99,06 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,43 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 99,19 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,58 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 358 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 153 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 357 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 152 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 357 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 152 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 355 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 151 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 352 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 151 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,72 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,35 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,72 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 99,35 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 99,16 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,69 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,32 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,69 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 25 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 219 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 25 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 218 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 25 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 218 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 25 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 218 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 25 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 218 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,54 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,54 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 99,54 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 99,54 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 409 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 361 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 371 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 408 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 361 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 370 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 404 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 359 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 370 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 401 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 359 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 369 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 357 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 367 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 05 Canarias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,76 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,73 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,78 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,45 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,73 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,04 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 99,45 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 99,46 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,89 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,92 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 386 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 214 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 162 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 385 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 214 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 162 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 381 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 212 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 162 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 378 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 212 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 162 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 212 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 161 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,74 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,7 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,07 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,93 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 99,07 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 99,07 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 99,38 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 23 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 147 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 209 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 23 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 147 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 208 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 23 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 147 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 208 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 23 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 147 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 207 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 145 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 206 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,52 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,52 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 99,04 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,64 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,56 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 393 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 343 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 356 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 392 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 343 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 356 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 388 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 343 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 356 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 341 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 354 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 341 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 354 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,75 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,73 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99,42 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 99,44 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 99,42 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 99,44 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 382 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 302 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 134 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 381 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 302 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 134 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 377 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 302 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 134 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 300 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 133 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 300 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 133 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,74 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,69 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 99,34 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 99,25 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 99,34 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 99,25 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 11 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 41 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 222 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 11 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 41 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 222 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 11 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 41 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 222 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 41 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 221 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 41 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 221 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 99,55 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 99,55 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 413 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 371 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 370 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 411 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 370 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 370 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 368 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 368 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 368 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 368 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 366 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 368 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,52 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,73 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,19 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99,46 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 99,19 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 99,46 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,65 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 99,46 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 406 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 350 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 148 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 404 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 349 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 148 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 347 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 147 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 347 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 147 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 345 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 147 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,51 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,71 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 99,14 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 99,32 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 99,14 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 99,32 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,57 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 99,32 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 7 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 21 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 222 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 7 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 21 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 222 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 21 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 221 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 21 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 221 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 21 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 221 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,55 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 99,55 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 99,55 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 176 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 143 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 164 05 Canarias De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 175 05 Canarias De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 142 05 Canarias De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 164 05 Canarias De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 174 05 Canarias De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 142 05 Canarias De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 164 05 Canarias De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 174 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 142 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 164 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 173 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 142 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 163 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Canarias De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,43 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,3 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,86 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,3 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,86 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 99,3 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,3 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 99,3 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 99,39 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 164 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 52 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 163 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 51 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 162 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 51 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 162 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 51 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 161 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 51 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,39 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,08 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,78 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,08 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,78 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,08 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,17 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,08 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 12 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 91 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 12 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 91 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 12 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 91 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 12 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 91 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 12 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 91 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 175 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 141 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 152 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 175 05 Canarias De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 140 05 Canarias De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 152 05 Canarias De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 175 05 Canarias De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 140 05 Canarias De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 152 05 Canarias De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 174 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 140 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 151 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 139 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 150 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 05 Canarias De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,29 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,29 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 99,43 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 99,29 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 99,34 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,58 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,68 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 165 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 69 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 59 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 165 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 68 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 59 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 165 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 68 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 59 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 165 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 68 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 59 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 67 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 58 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 05 Canarias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,55 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,55 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,55 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,1 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 98,31 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 10 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 72 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 93 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 10 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 72 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 93 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 10 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 72 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 93 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 9 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 72 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 92 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 72 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 92 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 05 Canarias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,92 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,92 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 179 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 144 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 151 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 179 05 Canarias De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 144 05 Canarias De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 151 05 Canarias De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 179 05 Canarias De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 144 05 Canarias De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 150 05 Canarias De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 143 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 149 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 143 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 149 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Canarias De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,34 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99,31 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,68 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 99,31 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,68 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 174 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 112 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 48 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 174 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 112 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 48 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 174 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 112 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 48 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 111 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 47 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 111 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 47 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 99,11 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,92 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 99,11 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,92 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 5 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 32 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 103 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 5 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 32 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 103 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 5 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 32 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 102 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 32 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 102 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 32 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 102 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,03 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 99,03 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 99,03 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 186 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 161 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 147 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 186 05 Canarias De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 161 05 Canarias De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 146 05 Canarias De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 160 05 Canarias De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 145 05 Canarias De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 160 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 145 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 160 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 145 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Canarias De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,32 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,38 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,64 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 99,38 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,64 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 99,38 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,64 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 180 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 139 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 49 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 180 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 139 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 49 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 138 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 48 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 138 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 48 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 138 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 48 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 99,28 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,96 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 99,28 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,96 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 99,28 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,96 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 6 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 22 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 98 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 6 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 22 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 97 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 22 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 97 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 22 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 97 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 22 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 97 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,98 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,98 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,98 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,98 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Canarias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2022QI 14.388 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2021QI 13.790 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2020QI 14.505 06 Cantabria Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 06 Cantabria Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 06 Cantabria Total Cohort January 1 Total Survival in the first trimester 2022QII "" 06 Cantabria Total Cohort January 1 Total Survival in the first trimester 2022QI 13.710 06 Cantabria Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 06 Cantabria Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 06 Cantabria Total Cohort January 1 Total Survival in the first trimester 2021QII "" 06 Cantabria Total Cohort January 1 Total Survival in the first trimester 2021QI 13.171 06 Cantabria Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 06 Cantabria Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 06 Cantabria Total Cohort January 1 Total Survival in the first trimester 2020QII "" 06 Cantabria Total Cohort January 1 Total Survival in the first trimester 2020QI 13.081 06 Cantabria Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 06 Cantabria Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 06 Cantabria Total Cohort January 1 Total Survival in the second trimester 2022QII 13.152 06 Cantabria Total Cohort January 1 Total Survival in the second trimester 2022QI "" 06 Cantabria Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 06 Cantabria Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 06 Cantabria Total Cohort January 1 Total Survival in the second trimester 2021QII 12.767 06 Cantabria Total Cohort January 1 Total Survival in the second trimester 2021QI "" 06 Cantabria Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 06 Cantabria Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 06 Cantabria Total Cohort January 1 Total Survival in the second trimester 2020QII 12.713 06 Cantabria Total Cohort January 1 Total Survival in the second trimester 2020QI "" 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2022QIII 12.771 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2021QIII 12.442 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2020QIII 12.360 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2022QIV 12.441 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2021QIV 12.152 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2020QIV 11.979 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,29 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,51 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 90,18 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,41 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,58 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 87,65 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 88,76 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 90,22 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 85,21 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 86,47 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 88,12 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 82,59 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 13.915 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 12.529 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 13.252 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 11.940 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 12.701 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 11.550 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 12.329 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 11.249 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 12.003 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 10.985 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,24 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 95,3 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 91,28 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 92,19 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 88,6 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,78 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 86,26 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 87,68 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 473 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.261 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 458 06 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.231 06 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 451 06 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.217 06 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 442 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.193 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 438 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.167 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,83 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,62 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 95,35 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,51 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 93,45 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,61 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 92,6 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,55 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2022QII 14.469 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2021QII 13.963 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2020QII 13.608 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 06 Cantabria Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 06 Cantabria Total Cohort April 1 Total Survival in the first trimester 2022QII 13.796 06 Cantabria Total Cohort April 1 Total Survival in the first trimester 2022QI "" 06 Cantabria Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 06 Cantabria Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 06 Cantabria Total Cohort April 1 Total Survival in the first trimester 2021QII 13.422 06 Cantabria Total Cohort April 1 Total Survival in the first trimester 2021QI "" 06 Cantabria Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 06 Cantabria Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 06 Cantabria Total Cohort April 1 Total Survival in the first trimester 2020QII 13.172 06 Cantabria Total Cohort April 1 Total Survival in the first trimester 2020QI "" 06 Cantabria Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 06 Cantabria Total Cohort April 1 Total Survival in the second trimester 2022QIII 13.321 06 Cantabria Total Cohort April 1 Total Survival in the second trimester 2022QII "" 06 Cantabria Total Cohort April 1 Total Survival in the second trimester 2022QI "" 06 Cantabria Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 06 Cantabria Total Cohort April 1 Total Survival in the second trimester 2021QIII 13.008 06 Cantabria Total Cohort April 1 Total Survival in the second trimester 2021QII "" 06 Cantabria Total Cohort April 1 Total Survival in the second trimester 2021QI "" 06 Cantabria Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 06 Cantabria Total Cohort April 1 Total Survival in the second trimester 2020QIII 12.761 06 Cantabria Total Cohort April 1 Total Survival in the second trimester 2020QII "" 06 Cantabria Total Cohort April 1 Total Survival in the second trimester 2020QI "" 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2022QIV 12.855 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2022QI "" 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2021QIV 12.615 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2021QI "" 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2020QIV 12.305 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2022QI 12.236 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2021QI 11.939 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 06 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,35 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,13 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,8 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,07 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,16 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,78 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 88,85 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,35 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,42 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 87,63 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,74 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 13.987 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 12.643 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 11.340 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 13.323 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 12.117 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 10.936 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 12.857 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 11.726 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 10.578 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 12.402 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 11.359 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 10.186 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 11.008 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 9.870 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 06 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,25 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,84 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,44 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,92 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,75 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 93,28 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 88,67 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,84 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,82 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 87,07 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 87,04 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 482 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.320 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.268 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 473 06 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.305 06 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.236 06 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 464 06 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.282 06 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.183 06 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 453 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.256 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.119 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.228 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.069 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 06 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,13 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,86 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,59 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 96,27 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,12 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,25 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 93,98 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,15 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,43 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 93,03 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,23 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2022QIII 14.857 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2021QIII 14.635 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2020QIII 14.192 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 06 Cantabria Total Cohort July 1 Total Survival in the first trimester 2022QIII 14.036 06 Cantabria Total Cohort July 1 Total Survival in the first trimester 2022QII "" 06 Cantabria Total Cohort July 1 Total Survival in the first trimester 2022QI "" 06 Cantabria Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 06 Cantabria Total Cohort July 1 Total Survival in the first trimester 2021QIII 13.845 06 Cantabria Total Cohort July 1 Total Survival in the first trimester 2021QII "" 06 Cantabria Total Cohort July 1 Total Survival in the first trimester 2021QI "" 06 Cantabria Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 06 Cantabria Total Cohort July 1 Total Survival in the first trimester 2020QIII 13.494 06 Cantabria Total Cohort July 1 Total Survival in the first trimester 2020QII "" 06 Cantabria Total Cohort July 1 Total Survival in the first trimester 2020QI "" 06 Cantabria Total Cohort July 1 Total Survival in the second trimester 2022QIV 13.341 06 Cantabria Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 06 Cantabria Total Cohort July 1 Total Survival in the second trimester 2022QII "" 06 Cantabria Total Cohort July 1 Total Survival in the second trimester 2022QI "" 06 Cantabria Total Cohort July 1 Total Survival in the second trimester 2021QIV 13.165 06 Cantabria Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 06 Cantabria Total Cohort July 1 Total Survival in the second trimester 2021QII "" 06 Cantabria Total Cohort July 1 Total Survival in the second trimester 2021QI "" 06 Cantabria Total Cohort July 1 Total Survival in the second trimester 2020QIV 12.787 06 Cantabria Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 06 Cantabria Total Cohort July 1 Total Survival in the second trimester 2020QII "" 06 Cantabria Total Cohort July 1 Total Survival in the second trimester 2020QI "" 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2022QII "" 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2022QI 12.714 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2021QII "" 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2021QI 12.371 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2022QII 12.378 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2022QI "" 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2021QII 12.125 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2021QI "" 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,47 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,6 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,08 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,8 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,96 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,1 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,87 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 87,17 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 84,58 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 85,44 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 14.691 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 14.282 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 12.831 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 13.875 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 13.500 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 12.164 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 13.186 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 12.830 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 11.487 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 12.386 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 11.100 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 12.053 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 10.870 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,45 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,52 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,8 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,76 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,83 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,53 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,72 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,51 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 84,39 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,72 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 166 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 353 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.361 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 161 06 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 345 06 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.330 06 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 155 06 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 335 06 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.300 06 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 328 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.271 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 325 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.255 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,99 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,73 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,72 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,37 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,9 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,52 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,92 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,39 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 92,07 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,21 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2022QIV 14.642 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2021QIV 14.554 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2020QIV 14.226 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort October 1 Total Survival in the first trimester 2022QIV 13.774 06 Cantabria Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 06 Cantabria Total Cohort October 1 Total Survival in the first trimester 2022QII "" 06 Cantabria Total Cohort October 1 Total Survival in the first trimester 2022QI "" 06 Cantabria Total Cohort October 1 Total Survival in the first trimester 2021QIV 13.682 06 Cantabria Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 06 Cantabria Total Cohort October 1 Total Survival in the first trimester 2021QII "" 06 Cantabria Total Cohort October 1 Total Survival in the first trimester 2021QI "" 06 Cantabria Total Cohort October 1 Total Survival in the first trimester 2020QIV 13.253 06 Cantabria Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 06 Cantabria Total Cohort October 1 Total Survival in the first trimester 2020QII "" 06 Cantabria Total Cohort October 1 Total Survival in the first trimester 2020QI "" 06 Cantabria Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 06 Cantabria Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 06 Cantabria Total Cohort October 1 Total Survival in the second trimester 2022QII "" 06 Cantabria Total Cohort October 1 Total Survival in the second trimester 2022QI 13.159 06 Cantabria Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 06 Cantabria Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 06 Cantabria Total Cohort October 1 Total Survival in the second trimester 2021QII "" 06 Cantabria Total Cohort October 1 Total Survival in the second trimester 2021QI 12.767 06 Cantabria Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 06 Cantabria Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 06 Cantabria Total Cohort October 1 Total Survival in the second trimester 2020QII "" 06 Cantabria Total Cohort October 1 Total Survival in the second trimester 2020QI "" 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2022QII 12.738 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2021QII 12.460 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2022QIII 12.428 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2022QII "" 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2021QIII 12.168 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2021QII "" 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,07 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,01 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,16 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,42 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,74 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,52 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,59 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 85,39 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 85,53 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 14.524 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 14.030 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 12.884 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 13.659 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 13.171 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 11.944 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 12.669 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 11.490 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 12.259 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 11.196 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 11.957 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 10.923 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,04 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,88 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,7 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,3 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,18 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,38 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,9 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 85,22 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,78 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 118 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 524 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.342 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 115 06 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 511 06 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.309 06 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 490 06 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.277 06 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 479 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.264 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 471 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.245 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,46 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,52 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,54 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,51 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,16 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,41 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,19 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 89,89 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,77 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 11.091 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 10.731 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 11.173 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 10.449 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 10.131 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 9.834 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 9.950 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 9.768 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 9.499 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 9.592 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 9.468 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 9.176 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 9.283 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 9.197 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 8.829 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,21 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,41 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 88,02 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,71 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,03 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 85,02 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,48 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,23 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 82,13 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,7 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,7 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,02 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 10.777 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 10.043 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 10.149 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 9.467 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 9.655 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 9.115 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 9.306 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 8.833 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 9.001 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 8.587 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,17 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,26 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,59 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,76 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,35 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,95 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,52 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,5 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 314 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 688 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 300 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 664 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 295 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 653 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 286 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 635 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 282 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 610 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,54 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,51 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,95 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,91 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,08 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,3 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,81 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 88,66 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 11.123 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 10.864 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 10.570 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 10.505 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 10.366 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 10.163 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 10.052 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 9.972 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 9.779 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 9.622 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 9.598 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 9.351 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 9.257 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 9.005 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 06 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,44 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,42 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,15 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,37 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,79 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,52 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,51 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,35 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,47 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,21 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,19 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 10.797 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 10.147 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 9.202 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 10.187 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 9.661 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 8.819 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 9.742 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 9.287 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 8.482 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 9.323 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 8.938 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 8.110 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 8.618 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 7.808 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,35 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,21 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,84 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,23 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,52 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,18 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,35 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,09 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,13 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,93 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,85 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 326 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 717 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.368 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 318 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 705 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.344 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 310 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 685 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.297 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 299 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 660 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.241 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 639 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.197 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,55 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,33 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,25 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 95,09 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,54 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,81 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,72 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 92,05 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 90,72 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 89,12 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,5 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 11.244 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 11.191 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 10.938 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 10.459 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 10.444 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 10.274 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 9.862 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 9.835 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 9.636 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 9.436 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 9.247 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 9.134 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 9.027 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,02 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,32 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,93 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,71 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 87,88 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,1 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 84,32 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 84,54 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 81,62 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 82,53 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 11.112 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 11.015 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 10.254 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 10.331 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 10.276 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 9.617 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 9.739 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 9.676 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 9.003 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 9.282 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 8.639 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 8.983 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 8.431 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,97 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,29 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,79 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,64 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,84 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 87,8 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 84,27 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 84,25 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 81,55 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 82,22 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 132 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 176 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 684 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 128 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 168 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 657 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 123 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 159 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 633 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 154 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 608 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 151 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 596 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,97 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,45 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,05 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,18 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 90,34 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 92,54 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 87,5 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 88,89 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 85,8 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 87,13 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 11.122 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 11.150 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 11.006 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 10.327 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 10.333 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 10.087 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 9.859 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 9.626 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 9.476 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 9.346 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 9.187 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 9.081 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,85 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 92,67 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 91,65 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,42 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,46 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,99 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 84,92 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 82,39 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 82,51 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 11.018 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 10.796 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 10.354 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 10.226 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 9.991 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 9.462 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 9.536 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 9.027 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 9.164 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 8.757 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 8.881 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 8.504 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,81 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,54 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 91,38 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,33 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,18 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,88 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84,58 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 82,26 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 82,13 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 104 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 354 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 652 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 101 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 342 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 625 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 323 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 599 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 312 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 589 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 306 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 577 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,12 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,61 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,86 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,24 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 91,87 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 88,14 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,34 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 86,44 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 88,5 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 1.391 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 1.310 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 1.363 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 1.366 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 1.298 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 1.318 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 1.339 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 1.272 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 1.294 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 1.326 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 1.260 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 1.275 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 1.310 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 1.249 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 1.254 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,2 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,08 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,7 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,26 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,1 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 94,94 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,33 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,18 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 93,54 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 94,18 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,34 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 92 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.321 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.094 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.297 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.086 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.271 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.061 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.258 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.053 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.242 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.042 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,18 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,27 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,21 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,98 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,23 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,25 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,02 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,25 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 70 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 216 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 69 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 212 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 68 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 211 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 68 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 207 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 68 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 207 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,57 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,15 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,14 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,69 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,14 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,83 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,14 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,83 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 1.374 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 1.299 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 1.246 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 1.352 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 1.276 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 1.227 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 1.336 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 1.270 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 1.208 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 1.314 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 1.258 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 1.194 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 1.231 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 1.181 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 06 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,4 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,23 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,48 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,23 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,77 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 96,95 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,63 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,84 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,83 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,77 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,78 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.314 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.078 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 887 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.292 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.056 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 873 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.276 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.051 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 858 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.254 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.039 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 848 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.016 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 839 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,33 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,96 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,42 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,11 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,5 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,73 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,43 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,38 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,6 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,25 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,59 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 60 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 221 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 359 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 60 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 220 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 354 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 60 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 219 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 350 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 60 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 219 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 346 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 215 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 342 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,55 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,61 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,1 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,49 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 99,1 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,38 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,29 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,26 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 1.485 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 1.448 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 1.360 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 1.464 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 1.426 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 1.337 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 1.407 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 1.381 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 1.296 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 1.348 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 1.277 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 1.333 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 1.264 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,59 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,48 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,31 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 94,75 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 95,37 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 95,29 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 93,09 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 93,9 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 92,06 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 92,94 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.470 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.384 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.122 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.450 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.362 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.102 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.394 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.318 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.063 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.287 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.047 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.272 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.036 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,64 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,41 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,22 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 94,83 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 95,23 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 94,74 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 92,99 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 93,32 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 91,91 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 92,34 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 15 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 64 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 238 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 14 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 64 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 235 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 13 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 63 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 233 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 61 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 230 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 61 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 228 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 93,33 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,74 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 86,67 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,44 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,9 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,31 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,64 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,31 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,8 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 1.464 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 1.452 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 1.339 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 1.419 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 1.415 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 1.305 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 1.384 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 1.289 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 1.366 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 1.274 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 1.357 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 1.262 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 96,93 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,45 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,46 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 95,32 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,27 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 94,08 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,15 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 93,46 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 94,25 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.455 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.387 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.093 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.410 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.350 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.065 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.321 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.053 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.303 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.039 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.295 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.031 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 96,91 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,33 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,44 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 95,24 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,34 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 93,94 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,06 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 93,37 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,33 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 9 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 65 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 246 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 9 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 65 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 240 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 63 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 236 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 63 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 235 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 62 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 231 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,56 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,92 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,93 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,92 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,53 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,38 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,9 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 1.781 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 1.629 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 1.837 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 1.770 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 1.622 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 1.798 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 1.738 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 1.607 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 1.789 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 1.728 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 1.594 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 1.781 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 1.723 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 1.587 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 1.769 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,38 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,57 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,88 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,59 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,65 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,39 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,02 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,85 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,95 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,74 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,42 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,3 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.701 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.305 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.690 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.300 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.659 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.287 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.649 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.276 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.644 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.270 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,35 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,62 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,53 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,62 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,94 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,78 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,65 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,32 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 80 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 324 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 80 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 322 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 79 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 320 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 79 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 318 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 79 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 317 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,38 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,75 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,77 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 98,75 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,15 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 98,75 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,84 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 1.840 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 1.679 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 1.673 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 1.807 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 1.659 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 1.663 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 1.801 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 1.645 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 1.657 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 1.787 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 1.639 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 1.644 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 1.628 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 1.637 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 06 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,21 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,81 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,4 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,88 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,97 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,04 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,12 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,62 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,27 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,96 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,85 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.752 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.328 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.163 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.720 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.310 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.156 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.715 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.298 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.151 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.701 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.293 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.142 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.285 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.137 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,17 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,64 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,4 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,89 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,74 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,97 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,09 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,36 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,19 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,76 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,76 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 88 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 351 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 510 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 87 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 349 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 507 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 86 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 347 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 506 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 86 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 346 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 502 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 343 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 500 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,86 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,43 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,41 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,73 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,86 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,22 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,73 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,58 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,43 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,72 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,04 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 2.005 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.874 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.776 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 1.990 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 1.853 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 1.766 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 1.949 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 1.828 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 1.739 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 1.809 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 1.731 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 1.790 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 1.718 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,25 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,88 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,44 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,21 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,55 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,92 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,53 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,47 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,52 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,73 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.986 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.772 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.371 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.971 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.751 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.362 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.930 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.726 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.339 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.707 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.332 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.688 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.321 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,24 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,81 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,34 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,18 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,4 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,67 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,33 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,16 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,26 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,35 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 19 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 102 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 405 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 19 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 102 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 404 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 19 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 102 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 400 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 102 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 399 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 102 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 397 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,75 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,77 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,52 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,02 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.925 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.827 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.759 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 1.897 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 1.810 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 1.740 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 1.792 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 1.731 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 1.772 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 1.719 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 1.760 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 1.704 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,55 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,07 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,92 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,08 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,41 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,99 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,73 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,33 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,87 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.920 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.734 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.354 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.892 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.718 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.335 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.700 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.328 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.680 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.318 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.669 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.306 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,54 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,08 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,6 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,04 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,08 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,89 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,34 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,25 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,45 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 5 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 93 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 405 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 5 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 92 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 405 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 92 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 403 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 92 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 401 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 91 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 398 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,92 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,92 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,51 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 98,92 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 99,01 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 97,85 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,27 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 82 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 78 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 84 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 82 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 78 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 84 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 82 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 78 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 84 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 82 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 78 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 82 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 82 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 78 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 81 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,62 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,43 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 76 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 55 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 76 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 55 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 76 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 55 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 76 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 55 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 76 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 55 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 6 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 23 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 6 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 23 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 6 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 23 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 6 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 23 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 6 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 23 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 89 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 79 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 77 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 89 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 79 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 77 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 89 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 79 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 76 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 89 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 79 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 75 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 79 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 75 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 06 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,7 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,4 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,4 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 84 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 57 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 57 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 84 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 57 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 57 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 84 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 57 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 56 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 84 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 57 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 55 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 57 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 55 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,25 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,49 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,49 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 5 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 22 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 20 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 5 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 22 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 20 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 5 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 22 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 20 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 5 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 22 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 20 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 22 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 20 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 79 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 80 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 78 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 79 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 80 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 77 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 79 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 80 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 76 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 80 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 76 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 80 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 76 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,72 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,44 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,44 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,44 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 79 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 74 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 56 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 79 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 74 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 55 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 79 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 74 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 54 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 74 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 54 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 74 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 54 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,21 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,43 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,43 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,43 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 6 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 22 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 6 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 22 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 6 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 22 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 6 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 22 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 6 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 22 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 0 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 88 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 82 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 78 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 88 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 82 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 77 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 82 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 77 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 82 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 77 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 82 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 77 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,72 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,72 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,72 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,72 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 88 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 75 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 54 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 88 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 75 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 53 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 75 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 53 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 75 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 53 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 75 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 53 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,15 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,15 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,15 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,15 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 7 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 24 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 7 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 24 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 7 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 24 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 7 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 24 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 7 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 24 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 43 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 42 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 48 06 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 43 06 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 42 06 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 47 06 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 43 06 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 42 06 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 47 06 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 43 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 42 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 46 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 43 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 41 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 46 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,92 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,92 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,83 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,62 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 95,83 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 40 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 32 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 40 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 32 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 40 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 32 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 40 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 32 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 40 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 31 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,88 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 3 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 10 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 3 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 10 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 3 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 10 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 3 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 10 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 3 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 10 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 43 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 42 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 42 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 43 06 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 42 06 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 42 06 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 43 06 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 42 06 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 41 06 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 43 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 41 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 41 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 41 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 41 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 06 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,62 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,62 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,62 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,62 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,62 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 40 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 33 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 31 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 40 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 33 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 31 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 40 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 33 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 31 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 40 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 32 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 31 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 32 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 31 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,97 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,97 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 3 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 9 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 11 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 3 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 9 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 11 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 3 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 9 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 10 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 3 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 9 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 10 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 9 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 10 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 06 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 90,91 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 90,91 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,91 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 44 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 42 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 40 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 44 06 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 42 06 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 40 06 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 44 06 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 41 06 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 40 06 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 41 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 40 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 41 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 40 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,62 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,62 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,62 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 44 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 37 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 28 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 44 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 37 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 28 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 44 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 36 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 28 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 36 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 28 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 36 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 28 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,3 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,3 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,3 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 5 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 12 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 5 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 12 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 5 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 12 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 5 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 12 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 5 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 12 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 0 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 43 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 43 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 44 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 43 06 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 42 06 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 44 06 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 42 06 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 44 06 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 42 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 44 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 42 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 44 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,67 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,67 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,67 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,67 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 43 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 38 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 29 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 43 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 37 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 29 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 37 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 29 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 37 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 29 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 37 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 29 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,37 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,37 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,37 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,37 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 5 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 15 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 5 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 15 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 5 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 15 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 5 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 15 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 5 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 15 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2022QI 55.901 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2021QI 54.487 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2020QI 57.537 07 Castilla y León Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 07 Castilla y León Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 07 Castilla y León Total Cohort January 1 Total Survival in the first trimester 2022QII "" 07 Castilla y León Total Cohort January 1 Total Survival in the first trimester 2022QI 53.306 07 Castilla y León Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 07 Castilla y León Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 07 Castilla y León Total Cohort January 1 Total Survival in the first trimester 2021QII "" 07 Castilla y León Total Cohort January 1 Total Survival in the first trimester 2021QI 52.076 07 Castilla y León Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 07 Castilla y León Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 07 Castilla y León Total Cohort January 1 Total Survival in the first trimester 2020QII "" 07 Castilla y León Total Cohort January 1 Total Survival in the first trimester 2020QI 52.081 07 Castilla y León Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 07 Castilla y León Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 07 Castilla y León Total Cohort January 1 Total Survival in the second trimester 2022QII 51.361 07 Castilla y León Total Cohort January 1 Total Survival in the second trimester 2022QI "" 07 Castilla y León Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 07 Castilla y León Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 07 Castilla y León Total Cohort January 1 Total Survival in the second trimester 2021QII 50.488 07 Castilla y León Total Cohort January 1 Total Survival in the second trimester 2021QI "" 07 Castilla y León Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 07 Castilla y León Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 07 Castilla y León Total Cohort January 1 Total Survival in the second trimester 2020QII 50.435 07 Castilla y León Total Cohort January 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2022QIII 49.854 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2021QIII 49.235 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2020QIII 49.080 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2022QIV 48.490 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2021QIV 48.129 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2020QIV 47.764 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,36 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,58 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 90,52 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,88 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,66 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 87,66 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 89,18 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 90,36 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 85,3 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 86,74 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 88,33 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 83,01 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 53.590 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 47.544 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 51.076 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 45.286 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 49.173 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 43.851 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 47.725 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 42.715 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 46.409 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 41.706 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,31 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 95,25 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 91,76 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 92,23 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 89,06 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,84 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 86,6 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 87,72 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2.311 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 6.943 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2.230 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 6.790 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2.188 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 6.637 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2.129 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 6.520 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2.081 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 6.423 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,5 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,8 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 94,68 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,59 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 92,12 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,91 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 90,05 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,51 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2022QII 55.838 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2021QII 54.554 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2020QII 53.930 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 07 Castilla y León Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 07 Castilla y León Total Cohort April 1 Total Survival in the first trimester 2022QII 53.399 07 Castilla y León Total Cohort April 1 Total Survival in the first trimester 2022QI "" 07 Castilla y León Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 07 Castilla y León Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 07 Castilla y León Total Cohort April 1 Total Survival in the first trimester 2021QII 52.515 07 Castilla y León Total Cohort April 1 Total Survival in the first trimester 2021QI "" 07 Castilla y León Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 07 Castilla y León Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 07 Castilla y León Total Cohort April 1 Total Survival in the first trimester 2020QII 52.020 07 Castilla y León Total Cohort April 1 Total Survival in the first trimester 2020QI "" 07 Castilla y León Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 07 Castilla y León Total Cohort April 1 Total Survival in the second trimester 2022QIII 51.579 07 Castilla y León Total Cohort April 1 Total Survival in the second trimester 2022QII "" 07 Castilla y León Total Cohort April 1 Total Survival in the second trimester 2022QI "" 07 Castilla y León Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 07 Castilla y León Total Cohort April 1 Total Survival in the second trimester 2021QIII 50.959 07 Castilla y León Total Cohort April 1 Total Survival in the second trimester 2021QII "" 07 Castilla y León Total Cohort April 1 Total Survival in the second trimester 2021QI "" 07 Castilla y León Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 07 Castilla y León Total Cohort April 1 Total Survival in the second trimester 2020QIII 50.483 07 Castilla y León Total Cohort April 1 Total Survival in the second trimester 2020QII "" 07 Castilla y León Total Cohort April 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2022QIV 49.933 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2021QIV 49.546 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2020QIV 49.009 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2022QI 48.140 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2021QI 47.510 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 07 Castilla y León Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,63 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,26 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,46 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,37 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,41 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,61 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 89,42 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,82 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,88 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 88,24 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 88,1 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 53.637 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 47.825 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 42.206 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 51.254 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 45.937 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 40.463 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 49.489 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 44.499 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 39.176 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 47.892 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 43.187 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 37.984 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 41.901 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 36.731 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 07 Castilla y León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,56 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 96,05 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,87 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 92,27 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 93,05 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,82 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 89,29 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 90,3 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 90 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 87,61 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 87,03 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2.201 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 6.729 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 11.724 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2.145 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 6.578 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 11.557 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2.090 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 6.460 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 11.307 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2.041 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 6.359 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 11.025 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 6.239 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 10.779 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 07 Castilla y León Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,46 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,76 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,58 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,96 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,44 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 92,73 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,5 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,04 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 92,72 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,94 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2022QIII 56.702 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2021QIII 56.024 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2020QIII 55.021 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 07 Castilla y León Total Cohort July 1 Total Survival in the first trimester 2022QIII 53.778 07 Castilla y León Total Cohort July 1 Total Survival in the first trimester 2022QII "" 07 Castilla y León Total Cohort July 1 Total Survival in the first trimester 2022QI "" 07 Castilla y León Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 07 Castilla y León Total Cohort July 1 Total Survival in the first trimester 2021QIII 53.390 07 Castilla y León Total Cohort July 1 Total Survival in the first trimester 2021QII "" 07 Castilla y León Total Cohort July 1 Total Survival in the first trimester 2021QI "" 07 Castilla y León Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 07 Castilla y León Total Cohort July 1 Total Survival in the first trimester 2020QIII 52.673 07 Castilla y León Total Cohort July 1 Total Survival in the first trimester 2020QII "" 07 Castilla y León Total Cohort July 1 Total Survival in the first trimester 2020QI "" 07 Castilla y León Total Cohort July 1 Total Survival in the second trimester 2022QIV 51.563 07 Castilla y León Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 07 Castilla y León Total Cohort July 1 Total Survival in the second trimester 2022QII "" 07 Castilla y León Total Cohort July 1 Total Survival in the second trimester 2022QI "" 07 Castilla y León Total Cohort July 1 Total Survival in the second trimester 2021QIV 51.387 07 Castilla y León Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 07 Castilla y León Total Cohort July 1 Total Survival in the second trimester 2021QII "" 07 Castilla y León Total Cohort July 1 Total Survival in the second trimester 2021QI "" 07 Castilla y León Total Cohort July 1 Total Survival in the second trimester 2020QIV 50.615 07 Castilla y León Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 07 Castilla y León Total Cohort July 1 Total Survival in the second trimester 2020QII "" 07 Castilla y León Total Cohort July 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2022QI 49.745 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2021QI 48.961 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2022QII 48.533 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2021QII 47.921 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,84 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,3 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,73 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 90,94 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 91,72 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,99 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 88,79 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 88,99 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 86,63 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 87,1 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 55.665 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 54.120 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 47.264 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 52.773 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 51.534 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 45.068 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 50.588 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 49.569 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 43.187 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 47.954 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 41.683 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 46.773 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 40.782 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,8 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,22 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,35 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 90,88 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,59 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,37 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,61 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 88,19 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 86,42 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 86,29 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1.037 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.904 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 7.757 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1.005 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.856 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 7.605 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 975 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.818 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 7.428 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.791 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 7.278 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.760 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 7.139 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,91 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,48 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,04 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,02 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,48 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,76 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 94,07 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,82 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 92,44 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,03 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2022QIV 55.874 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2021QIV 55.865 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2020QIV 55.370 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort October 1 Total Survival in the first trimester 2022QIV 53.106 07 Castilla y León Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 07 Castilla y León Total Cohort October 1 Total Survival in the first trimester 2022QII "" 07 Castilla y León Total Cohort October 1 Total Survival in the first trimester 2022QI "" 07 Castilla y León Total Cohort October 1 Total Survival in the first trimester 2021QIV 53.194 07 Castilla y León Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 07 Castilla y León Total Cohort October 1 Total Survival in the first trimester 2021QII "" 07 Castilla y León Total Cohort October 1 Total Survival in the first trimester 2021QI "" 07 Castilla y León Total Cohort October 1 Total Survival in the first trimester 2020QIV 52.464 07 Castilla y León Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 07 Castilla y León Total Cohort October 1 Total Survival in the first trimester 2020QII "" 07 Castilla y León Total Cohort October 1 Total Survival in the first trimester 2020QI "" 07 Castilla y León Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 07 Castilla y León Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 07 Castilla y León Total Cohort October 1 Total Survival in the second trimester 2022QII "" 07 Castilla y León Total Cohort October 1 Total Survival in the second trimester 2022QI 51.267 07 Castilla y León Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 07 Castilla y León Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 07 Castilla y León Total Cohort October 1 Total Survival in the second trimester 2021QII "" 07 Castilla y León Total Cohort October 1 Total Survival in the second trimester 2021QI 50.546 07 Castilla y León Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 07 Castilla y León Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 07 Castilla y León Total Cohort October 1 Total Survival in the second trimester 2020QII "" 07 Castilla y León Total Cohort October 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2022QII 49.797 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2021QII 49.287 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2022QIII 48.542 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2021QIII 48.206 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,05 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,22 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,75 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,77 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 91,29 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 89,14 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 89,01 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 86,89 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 87,06 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 54.972 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 53.399 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 47.715 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 52.230 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 50.779 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 44.998 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 48.924 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 43.224 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 47.514 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 42.117 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 46.314 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 41.158 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,01 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,09 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,31 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,62 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,59 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 88,98 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 88,27 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 86,73 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 86,26 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 902 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2.466 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 7.655 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 876 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2.415 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 7.466 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2.343 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 7.322 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2.283 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 7.170 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2.228 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 7.048 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,12 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,93 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,53 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 95,01 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,65 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 92,58 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,66 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 90,35 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,07 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 42.812 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 42.319 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 44.225 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 40.342 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 40.024 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 39.027 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 38.555 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 38.557 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 37.535 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 37.176 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 37.396 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 36.303 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 35.907 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 36.360 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 35.104 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,23 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,58 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 88,25 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,06 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,11 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 84,87 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,84 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,37 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 82,09 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,87 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,92 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,38 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 41.301 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 38.384 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 38.904 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 36.220 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 37.147 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 34.877 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 35.819 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 33.806 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 34.593 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 32.857 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,2 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,36 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,94 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,86 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,73 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 88,07 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,76 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,6 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.511 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 3.935 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.438 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 3.804 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.408 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 3.680 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.357 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 3.590 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.314 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 3.503 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,17 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,67 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,18 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,52 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 89,81 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 91,23 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 86,96 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,02 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 42.598 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 42.205 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 41.664 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 40.322 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 40.293 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 39.870 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 38.624 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 38.828 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 38.431 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 37.084 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 37.491 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 37.044 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 36.203 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 35.674 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 07 Castilla y León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,66 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,47 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,69 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,67 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,24 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,06 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,83 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,91 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,78 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,62 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 41.215 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 38.410 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 34.377 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 38.983 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 36.622 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 32.720 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 37.332 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 35.254 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 31.492 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 35.833 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 34.011 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 30.347 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 32.810 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 29.184 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,58 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,34 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,18 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,58 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,78 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,61 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,94 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,55 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,28 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,42 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,89 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.383 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 3.795 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 7.287 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.339 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 3.671 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 7.150 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.292 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 3.574 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 6.939 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.251 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 3.480 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 6.697 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 3.393 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 6.490 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,82 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,73 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,12 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,42 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,18 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,22 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90,46 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 91,7 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,9 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 89,41 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 89,06 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 43.052 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 43.120 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 42.635 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 40.286 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 40.607 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 40.391 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 38.231 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 38.714 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 38.446 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 37.198 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 36.927 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 36.076 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 35.984 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,58 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,17 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,74 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,8 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,78 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,17 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,27 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,61 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,66 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,4 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 42.333 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 42.050 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 38.340 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 39.592 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 39.581 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 36.224 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 37.563 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 37.723 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 34.423 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 36.228 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 33.028 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 35.127 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 32.192 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,53 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,13 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,48 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,73 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,71 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,78 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,15 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,15 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,54 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,96 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 719 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.070 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 4.295 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 694 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.026 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 4.167 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 668 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 991 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 4.023 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 970 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 3.899 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 949 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 3.792 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,52 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,89 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,02 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 92,91 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,62 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,67 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90,65 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 90,78 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 88,69 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,29 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 42.422 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 42.888 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 42.826 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 39.802 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 40.308 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 40.027 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 38.516 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 38.243 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 37.158 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 37.087 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 36.011 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 36.095 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,82 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,98 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,46 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,81 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,3 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 86,64 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,6 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 83,97 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,28 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 41.791 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 41.250 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 38.646 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 39.193 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 38.717 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 36.004 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 36.985 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 34.339 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 35.680 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 33.304 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 34.579 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 32.405 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,78 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,86 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,16 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,66 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,86 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 86,5 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,18 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 83,83 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,85 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 631 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.638 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 4.180 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 609 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.591 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 4.023 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.531 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 3.904 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.478 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 3.783 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.432 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 3.690 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,51 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,13 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,24 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,47 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,4 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 90,23 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,5 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,42 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 88,28 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 5.586 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 5.252 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 5.778 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 5.526 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 5.183 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 5.621 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 5.433 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 5.116 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 5.527 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 5.359 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 5.067 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 5.455 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 5.306 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 5.027 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 5.392 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,93 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,69 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,28 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,26 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,41 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,66 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,94 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,48 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,41 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 94,99 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,72 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,32 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 5.260 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 4.121 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 5.204 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 4.064 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 5.119 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 4.011 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 5.050 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 3.981 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 5.000 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3.947 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,94 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,62 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,32 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,33 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,01 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,6 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,06 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,78 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 326 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.131 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 322 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.119 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 314 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.105 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 309 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.086 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 306 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.080 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,77 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,94 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,32 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,7 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 94,79 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,02 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 93,87 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,49 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 5.696 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 5.368 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 5.310 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 5.598 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 5.300 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 5.238 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 5.527 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 5.247 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 5.177 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 5.461 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 5.200 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 5.125 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 5.136 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 5.040 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,28 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,73 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,64 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,03 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,75 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,5 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,87 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,87 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,52 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 95,68 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,92 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 5.381 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 4.260 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3.456 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 5.288 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 4.205 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3.402 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 5.220 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 4.166 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3.368 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 5.157 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 4.123 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3.340 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 4.075 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3.284 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,27 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,71 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,44 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,01 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,79 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,45 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,84 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,78 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,64 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,66 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,02 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 315 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.108 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.854 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 310 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.095 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.836 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 307 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.081 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.809 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 304 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.077 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.785 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.061 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.756 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,41 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,83 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,03 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,46 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,56 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,57 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,51 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,2 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,28 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95,76 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,71 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 5.914 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 5.587 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 5.381 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 5.812 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 5.507 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 5.318 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 5.717 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 5.445 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 5.253 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 5.383 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 5.161 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 5.332 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 5.108 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,28 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,57 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,83 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,67 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,46 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,62 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,35 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,91 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,44 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,93 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 5.790 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 5.290 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 4.082 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 5.691 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 5.212 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 4.036 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 5.597 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 5.151 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3.990 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 5.091 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3.916 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 5.044 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 3.877 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,29 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,53 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,87 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,67 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,37 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,75 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,24 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,93 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,35 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,98 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 124 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 297 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.299 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 121 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 295 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.282 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 120 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 294 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.263 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 292 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.245 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 288 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.231 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,58 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,33 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,69 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 96,77 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,99 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,23 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 98,32 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,84 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,97 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 94,77 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 5.746 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 5.589 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 5.465 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 5.658 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 5.539 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 5.405 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 5.472 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 5.322 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 5.413 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 5.264 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 5.353 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 5.221 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,47 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,11 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,9 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,91 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,38 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,85 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,32 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,78 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,54 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 5.649 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 5.253 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 4.148 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 5.562 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 5.206 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 4.099 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 5.145 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 4.031 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 5.089 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3.988 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 5.036 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3.962 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,46 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,11 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,82 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,94 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,18 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,88 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,14 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,87 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,52 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 97 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 336 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.317 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 96 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 333 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.306 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 327 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.291 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 324 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.276 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 317 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.259 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,97 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,11 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,16 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,32 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,03 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,43 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 96,89 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 94,35 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 95,6 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 7.027 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 6.451 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 7.069 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 6.965 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 6.407 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 6.972 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 6.902 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 6.355 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 6.913 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 6.849 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 6.315 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 6.864 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 6.809 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 6.289 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 6.811 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,12 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,32 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,63 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,22 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,51 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,79 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,47 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,89 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,1 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,9 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,49 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,35 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 6.588 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 4.727 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 6.530 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 4.692 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 6.471 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 4.655 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 6.421 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 4.622 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 6.383 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 4.598 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,12 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,26 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,22 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,48 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,47 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,78 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,89 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,27 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 439 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.724 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 435 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.715 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 431 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.700 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 428 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.693 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 426 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.691 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,09 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,48 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,18 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,61 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,49 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,2 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,04 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,09 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 7.064 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 6.536 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 6.512 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 7.001 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 6.478 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 6.469 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 6.951 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 6.443 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 6.434 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 6.913 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 6.415 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 6.400 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 6.364 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 6.359 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 07 Castilla y León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,11 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,11 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,34 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,4 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,58 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,8 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,86 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,15 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,28 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,37 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,65 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 6.600 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 4.848 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 4.097 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 6.544 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 4.804 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 4.066 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 6.499 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 4.775 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 4.042 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 6.465 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 4.749 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 4.023 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 4.715 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3.991 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,15 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,09 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,24 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,47 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,49 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,66 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,95 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,96 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,19 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,26 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,41 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 464 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.688 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.415 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 457 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.674 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.403 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 452 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.668 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.392 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 448 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.666 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.377 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.649 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.368 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,49 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,17 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,5 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,41 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,82 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,05 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,55 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,7 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,43 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,69 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,05 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 7.257 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 6.862 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 6.566 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 7.202 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 6.823 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 6.527 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 7.139 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 6.776 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 6.480 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 6.715 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 6.440 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 6.677 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 6.399 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,24 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,43 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,41 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,37 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,75 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,69 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,86 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,08 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,3 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,46 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 7.079 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 6.374 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 4.562 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 7.028 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 6.337 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 4.529 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 6.967 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 6.292 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 4.495 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 6.235 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 4.462 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 6.203 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 4.439 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,28 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,42 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,28 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,42 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,71 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,53 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,82 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,81 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,32 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,3 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 178 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 488 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.004 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 174 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 486 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.998 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 172 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 484 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.985 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 480 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.978 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 474 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.960 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,75 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,59 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,7 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 96,63 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,18 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,05 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 98,36 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,7 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,13 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,8 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 7.216 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 6.925 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 6.626 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 7.158 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 6.884 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 6.580 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 6.819 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 6.532 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 6.767 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 6.490 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 6.720 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 6.447 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,2 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,41 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,31 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,47 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,58 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,72 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,95 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,04 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,3 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 7.055 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 6.473 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 4.629 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 6.999 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 6.433 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 4.603 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 6.374 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 4.564 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 6.326 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 4.538 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 6.281 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 4.506 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,21 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,38 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,44 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,47 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,6 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,73 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,03 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,03 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,34 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 161 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 452 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.997 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 159 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 451 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.977 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 445 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.968 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 441 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.952 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 439 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.941 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,76 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,78 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,45 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,55 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,57 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,75 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 97,12 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,2 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 312 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 310 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 312 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 309 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 308 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 308 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 307 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 307 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 308 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 307 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 304 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 307 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 307 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 300 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 306 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,04 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,35 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,72 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,4 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,03 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,72 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,4 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,06 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,4 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,4 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,77 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,08 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 291 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 213 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 288 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 212 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 286 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 211 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 286 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 209 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 286 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 207 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,97 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,53 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,28 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 99,06 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,28 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,12 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,28 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,18 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 21 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 97 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 21 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 96 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 21 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 96 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 21 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 95 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 21 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 93 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,97 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,97 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,94 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,88 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 313 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 289 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 296 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 311 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 288 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 295 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 311 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 285 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 294 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 311 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 284 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 293 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 281 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 291 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 07 Castilla y León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,36 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,65 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,66 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,36 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,62 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,32 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 99,36 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,27 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,99 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,23 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,31 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 292 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 205 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 181 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 290 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 204 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 180 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 290 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 202 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 180 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 290 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 202 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 180 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 199 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 179 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,32 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,51 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,45 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,32 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,54 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,45 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 99,32 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,54 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 99,45 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,07 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 98,9 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 21 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 84 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 115 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 21 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 84 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 115 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 21 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 83 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 114 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 21 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 82 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 113 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 82 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 112 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,81 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,13 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,62 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,26 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,62 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,39 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 318 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 305 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 295 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 318 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 303 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 294 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 318 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 302 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 293 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 299 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 291 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 298 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 289 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,34 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,66 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,02 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,32 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,03 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,64 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,7 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,97 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 311 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 276 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 187 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 311 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 274 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 187 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 311 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 273 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 187 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 270 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 186 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 269 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 184 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,28 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,91 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,83 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 99,47 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,46 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98,4 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 7 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 29 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 108 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 7 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 29 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 107 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 7 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 29 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 106 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 29 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 105 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 29 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 105 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,07 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,15 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,22 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,22 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 327 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 308 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 299 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 326 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 308 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 298 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 305 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 296 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 304 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 294 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 304 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 291 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,69 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,67 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,03 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,7 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,33 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,7 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,32 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 321 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 284 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 197 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 321 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 284 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 197 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 281 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 196 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 280 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 194 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 280 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 192 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,94 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 99,49 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,59 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,48 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,59 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,46 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 6 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 24 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 102 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 5 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 24 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 101 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 24 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 100 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 24 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 100 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 24 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 99 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 83,33 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,02 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,04 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,04 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,06 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 164 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 155 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 153 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 164 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 154 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 153 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 164 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 153 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 152 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 163 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 153 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 151 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 161 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 153 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 151 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,35 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,71 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,35 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 99,39 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,71 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,69 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,17 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,71 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,69 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 150 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 99 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 150 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 98 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 150 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 97 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 149 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 97 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 147 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 97 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,99 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,98 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 99,33 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,98 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,98 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 14 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 56 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 14 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 56 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 14 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 56 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 14 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 56 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 14 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 56 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 167 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 156 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 148 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 167 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 156 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 148 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 166 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 156 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 147 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 164 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 156 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 147 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 156 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 146 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 07 Castilla y León De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,4 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,32 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,2 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 99,32 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,65 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 149 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 102 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 95 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 149 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 102 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 95 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 148 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 102 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 94 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 147 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 102 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 94 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 102 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 93 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,33 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,95 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,66 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,95 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,89 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 18 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 54 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 53 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 18 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 54 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 53 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 18 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 54 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 53 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 17 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 54 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 53 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 54 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 53 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 94,44 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 161 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 150 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 144 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 160 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 150 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 143 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 158 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 150 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 143 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 150 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 142 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 150 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 141 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,38 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,31 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,14 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,31 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,61 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,92 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 152 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 130 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 93 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 151 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 130 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 92 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 150 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 130 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 92 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 130 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 91 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 130 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 90 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,34 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,92 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,68 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,92 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,85 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,77 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 9 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 20 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 51 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 9 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 20 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 51 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 8 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 20 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 51 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 20 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 51 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 20 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 51 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 88,89 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 163 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 155 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 154 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 162 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 155 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 154 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 155 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 153 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 155 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 152 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 154 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 152 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,39 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99,35 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,7 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 99,35 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,7 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 156 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 139 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 95 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 155 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 139 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 95 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 139 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 94 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 139 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 93 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 138 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 93 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,36 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,95 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,89 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 99,28 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,89 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 7 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 16 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 59 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 7 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 16 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 59 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 16 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 59 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 16 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 59 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 16 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 59 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Castilla y León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2022QI 46.037 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2021QI 44.347 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2020QI 46.329 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the first trimester 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the first trimester 2022QI 43.385 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the first trimester 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the first trimester 2021QI 41.879 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the first trimester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the first trimester 2020QI 40.060 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the second trimester 2022QII 41.425 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the second trimester 2022QI "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the second trimester 2021QII 40.387 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the second trimester 2021QI "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the second trimester 2020QII 38.804 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2022QIII 39.925 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2021QIII 39.070 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2020QIII 37.668 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2022QIV 38.784 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2021QIV 38.045 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2020QIV 36.630 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,24 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,43 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 86,47 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,98 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,07 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 83,76 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,72 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,1 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 81,31 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 84,25 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,79 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,06 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 43.834 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 39.282 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 41.257 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 36.942 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 39.371 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 35.540 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 37.922 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 34.323 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 36.819 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 33.375 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,12 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,04 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,82 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,47 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,51 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,38 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 84 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 84,96 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2.203 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 5.065 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2.128 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 4.937 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2.054 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 4.847 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2.003 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 4.747 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.965 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 4.670 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,6 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,47 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,24 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,7 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,92 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,72 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,2 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,2 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2022QII 46.024 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2021QII 44.593 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2020QII 41.915 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the first trimester 2022QII 43.534 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the first trimester 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the first trimester 2021QII 42.510 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the first trimester 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the first trimester 2020QII 40.375 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the second trimester 2022QIII 41.669 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the second trimester 2022QII "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the second trimester 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the second trimester 2021QIII 40.809 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the second trimester 2021QII "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the second trimester 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the second trimester 2020QIII 39.048 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the second trimester 2020QII "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2022QIV 40.280 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2021QIV 39.466 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2020QIV 37.851 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2022QI 38.056 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2021QI 36.568 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 08 Castilla - La Mancha Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,59 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,33 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,33 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,54 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,51 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,16 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,52 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,5 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,3 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,34 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,24 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 43.856 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 39.749 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 32.703 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 41.455 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 37.765 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 31.250 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 39.642 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 36.167 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 30.113 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 38.299 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 34.907 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 29.129 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 33.613 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 28.083 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,53 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,01 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,56 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,39 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,99 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,08 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,33 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,82 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,07 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,56 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,87 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2.168 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 4.844 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 9.212 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2.079 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 4.745 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 9.125 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2.027 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 4.642 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 8.935 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.981 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 4.559 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 8.722 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 4.443 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 8.485 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,89 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,96 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,06 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,5 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,83 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,99 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,37 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,12 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,68 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,72 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 92,11 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2022QIII 46.371 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2021QIII 45.956 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2020QIII 44.240 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the first trimester 2022QIII 43.547 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the first trimester 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the first trimester 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the first trimester 2021QIII 43.134 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the first trimester 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the first trimester 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the first trimester 2020QIII 41.894 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the first trimester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the second trimester 2022QIV 41.732 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the second trimester 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the second trimester 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the second trimester 2021QIV 41.305 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the second trimester 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the second trimester 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the second trimester 2020QIV 40.047 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the second trimester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2022QI 39.656 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2021QI 38.521 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2022QII 38.488 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2021QII 37.623 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,91 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,86 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,7 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 90 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,88 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,52 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,29 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 87,07 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,75 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 85,04 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 45.548 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 44.207 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 38.447 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 42.753 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 41.429 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 36.215 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 40.954 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 39.634 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 34.496 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 38.026 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 33.106 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 36.900 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 32.293 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,86 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,72 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,19 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,91 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,66 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,72 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,02 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,11 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,47 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,99 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 823 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.749 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 5.793 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 794 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.705 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 5.679 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 778 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.671 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 5.551 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.630 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 5.415 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.588 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 5.330 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,48 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,48 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,03 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,53 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,54 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,82 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,2 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,47 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,79 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,01 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2022QIV 45.739 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2021QIV 45.619 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2020QIV 44.509 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the first trimester 2022QIV 43.329 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the first trimester 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the first trimester 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the first trimester 2021QIV 43.151 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the first trimester 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the first trimester 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the first trimester 2020QIV 41.924 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the first trimester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the second trimester 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the second trimester 2022QI 41.224 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the second trimester 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the second trimester 2021QI 40.057 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the second trimester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2022QII 39.770 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2021QII 38.924 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2022QIII 38.540 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2021QIII 37.849 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,73 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,59 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,19 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,37 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,18 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,45 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,48 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 85,04 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 45.032 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 43.252 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 38.829 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 42.635 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 40.852 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 36.382 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 39.006 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 34.647 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 37.636 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 33.606 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 36.463 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 32.631 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,68 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,45 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,7 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,18 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,23 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,02 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,55 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,3 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,04 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 707 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2.367 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 5.680 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 694 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2.299 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 5.542 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2.218 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 5.410 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2.134 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 5.318 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2.077 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 5.218 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,16 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,13 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,57 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,71 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,25 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 90,16 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,63 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,75 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 91,87 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 35.182 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 34.345 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 35.538 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 32.667 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 31.999 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 29.693 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 30.903 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 30.624 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 28.570 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 29.513 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 29.404 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 27.549 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 28.455 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 28.475 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 26.621 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,85 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,17 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 83,55 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,84 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,17 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 80,39 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 83,89 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 85,61 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 77,52 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 80,88 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 82,91 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 74,91 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 33.761 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 31.563 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 31.314 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 29.320 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 29.614 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 28.019 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 28.269 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 26.876 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 27.245 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 26.005 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,75 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,89 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,72 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 88,77 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 83,73 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 85,15 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 80,7 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 82,39 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.421 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2.782 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.353 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2.679 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.289 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.605 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.244 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.528 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.210 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.470 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,21 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,3 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,71 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,64 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,54 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 90,87 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 85,15 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 88,79 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 35.130 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 34.504 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 32.473 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 32.819 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 32.551 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 31.021 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 31.076 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 30.954 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 29.776 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 29.778 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 29.722 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 28.659 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 28.428 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 27.490 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,42 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,34 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,53 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,46 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 89,71 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,69 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 84,77 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,14 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,25 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 82,39 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 84,65 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 33.766 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 31.736 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 26.745 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 31.534 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 29.865 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 25.367 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 29.837 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 28.351 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 24.282 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 28.577 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 27.182 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 23.349 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 25.990 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 22.367 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,39 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,1 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,85 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,36 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,33 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,79 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,63 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 85,65 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,3 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 81,89 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 83,63 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.364 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2.768 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 5.728 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.285 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2.686 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 5.654 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.239 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2.603 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 5.494 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.201 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2.540 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 5.310 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2.438 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 5.123 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 94,21 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,04 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,71 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 90,84 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,04 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,91 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,05 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 91,76 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 92,7 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 88,08 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 89,44 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 35.233 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 35.316 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 34.193 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 32.573 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 32.636 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 31.955 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 30.887 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 30.946 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 30.235 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 29.428 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 28.863 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 28.364 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 28.051 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,45 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,41 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,45 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,66 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 87,63 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,42 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 83,33 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 84,41 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 80,31 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 82,04 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 34.628 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 34.290 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 31.123 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 31.994 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 31.648 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 28.978 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 30.321 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 29.986 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 27.361 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 28.501 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 26.084 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 27.474 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 25.334 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,39 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,3 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,11 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,56 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,45 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 87,91 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 83,12 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 83,81 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 80,12 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 81,4 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 605 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.026 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 3.070 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 579 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 988 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.977 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 566 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 960 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2.874 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 927 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.779 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 890 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.717 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,7 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,3 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,97 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,55 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,57 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,62 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90,35 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 90,52 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 86,74 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,5 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 34.744 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 34.960 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 34.334 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 32.455 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 32.620 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 31.872 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 30.839 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 30.146 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 29.525 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 29.107 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 28.381 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 28.114 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,41 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,31 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,83 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,21 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,8 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,45 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 84,78 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 81,18 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 81,88 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 34.234 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 33.377 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 31.258 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 31.956 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 31.098 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 28.912 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 29.390 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 27.286 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 28.148 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 26.321 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 27.057 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 25.407 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,35 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,17 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,49 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,05 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,29 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,33 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84,21 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 81,06 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 81,28 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 510 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.583 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 3.076 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 499 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.522 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2.960 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.449 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.860 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.377 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.786 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.324 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.707 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,84 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,15 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,23 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,54 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,98 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 86,99 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,57 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 83,64 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 88 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 4.809 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 4.400 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 4.745 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 4.723 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 4.340 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 4.496 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 4.616 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 4.285 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 4.431 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 4.554 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 4.227 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 4.369 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 4.504 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 4.171 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 4.302 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,21 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,64 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 94,75 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,99 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,39 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 93,38 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,7 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,07 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 92,08 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,66 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,8 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 90,66 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 4.486 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 3.517 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 4.404 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 3.468 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 4.305 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 3.419 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 4.246 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 3.374 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 4.198 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3.325 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,17 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,61 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 95,97 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,21 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,65 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,93 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,58 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,54 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 323 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 883 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 319 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 872 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 311 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 866 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 308 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 853 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 306 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 846 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,76 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,75 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,28 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,07 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 95,36 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,6 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,74 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,81 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 4.745 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 4.427 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 4.119 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 4.650 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 4.368 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 4.076 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 4.578 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 4.310 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 4.032 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 4.526 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 4.244 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 3.981 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 4.171 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 3.924 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,67 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,96 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,48 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,36 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,89 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,38 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,87 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,65 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,22 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,27 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 4.410 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 3.625 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.587 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 4.319 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 3.571 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.549 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 4.250 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 3.525 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.518 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 4.204 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 3.468 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.486 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 3.404 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.453 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,94 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,51 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,53 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,37 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,24 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,33 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,33 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,67 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,1 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,9 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,82 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 335 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 802 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.532 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 331 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 797 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.527 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 328 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 785 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.514 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 322 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 776 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.495 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 767 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.471 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,81 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,38 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,67 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,91 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,88 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,83 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,12 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,76 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,58 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95,64 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,02 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 4.846 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 4.701 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 4.436 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 4.754 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 4.625 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 4.384 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 4.675 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 4.548 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 4.296 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 4.473 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 4.215 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 4.420 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 4.168 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,1 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,38 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,83 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,47 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 96,75 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,84 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,15 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,02 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,02 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,96 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 4.744 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 4.403 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3.395 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 4.654 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 4.329 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 3.353 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 4.578 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 4.254 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3.282 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 4.184 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3.221 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 4.134 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 3.183 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,1 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,32 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,76 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,5 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,62 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,67 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,03 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,87 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 93,89 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 93,76 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 102 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 298 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.041 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 100 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 296 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.031 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 97 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 294 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.014 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 289 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 994 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 286 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 985 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,04 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,33 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,04 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,1 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,66 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,41 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,98 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,49 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,97 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 94,62 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 4.753 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 4.658 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 4.405 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 4.677 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 4.585 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 4.328 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 4.497 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 4.253 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 4.422 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 4.209 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 4.376 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 4.168 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,4 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,43 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,25 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,54 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,55 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 94,93 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,55 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 93,95 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 94,62 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 4.663 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 4.332 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3.407 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 4.589 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 4.262 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3.344 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 4.179 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3.287 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 4.110 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3.251 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 4.066 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3.222 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,41 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,38 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,15 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,47 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,48 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 94,88 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,42 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 93,86 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,57 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 90 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 326 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 998 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 88 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 323 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 984 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 318 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 966 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 312 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 958 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 310 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 946 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,78 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,08 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,6 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,55 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,79 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,71 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,99 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,09 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,79 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 5.739 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 5.324 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 5.752 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 5.689 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 5.264 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 5.579 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 5.600 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 5.203 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 5.511 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 5.553 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 5.165 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 5.459 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 5.520 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 5.125 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 5.416 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,13 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,87 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,99 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,58 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,73 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,81 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,76 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,01 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,91 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,18 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,26 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,16 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 5.314 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 4.015 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 5.267 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 3.969 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 5.180 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 3.918 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 5.135 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 3.889 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 5.104 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3.861 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,12 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,85 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,48 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,58 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,63 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,86 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,05 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,16 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 425 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.309 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 422 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.295 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 420 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.285 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 418 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.276 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 416 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.264 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,29 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,93 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,82 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,17 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 98,35 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,48 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,88 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,56 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 5.839 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 5.381 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 5.049 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 5.755 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 5.311 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 5.004 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 5.706 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 5.266 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 4.967 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 5.667 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 5.221 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 4.938 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 5.179 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 4.882 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,56 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,7 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,11 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,72 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,86 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,38 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,05 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,03 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,8 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,25 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,69 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 5.404 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 4.191 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3.170 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 5.326 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 4.133 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3.133 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 5.279 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 4.095 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3.113 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 5.242 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 4.061 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3.094 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 4.024 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3.064 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,56 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,62 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,83 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,69 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,71 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,2 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,9 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,6 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,02 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,66 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 435 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.190 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.879 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 429 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.178 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.871 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 427 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.171 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.854 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 425 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.160 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.844 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.155 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.818 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,62 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,99 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,57 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,16 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,4 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,67 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,7 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,48 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,14 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,06 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,75 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 5.973 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 5.646 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 5.333 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 5.903 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 5.580 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 5.278 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 5.853 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 5.519 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 5.239 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 5.465 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 5.167 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 5.414 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 5.129 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,83 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,83 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,97 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,99 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,75 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,24 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,79 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,89 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,89 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,17 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 5.866 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 5.254 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3.746 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 5.797 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 5.192 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 3.702 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 5.747 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 5.134 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3.671 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 5.083 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3.620 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 5.034 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 3.596 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,82 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,82 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,83 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,97 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,72 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,75 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,64 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,81 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 107 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 392 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.587 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 106 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 388 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.576 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 106 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 385 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.568 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 382 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.547 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 380 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.533 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,07 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,98 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,31 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 99,07 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,21 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,8 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,45 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,48 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,94 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,6 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 5.914 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 5.692 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 5.486 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 5.869 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 5.637 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 5.440 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 5.581 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 5.375 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 5.516 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 5.326 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 5.477 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 5.286 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,24 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,03 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,16 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,05 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,98 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,91 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,08 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,22 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,35 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 5.817 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 5.271 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3.973 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 5.772 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 5.220 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3.935 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 5.167 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3.884 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 5.108 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3.845 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 5.070 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3.813 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,23 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,03 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,04 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,03 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,76 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,91 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,78 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,19 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,97 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 97 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 421 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.513 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 97 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 417 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.505 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 414 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.491 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 408 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.481 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 407 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.473 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,05 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,47 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,34 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,55 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,91 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,88 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,67 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,36 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 213 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 190 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 206 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 212 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 188 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 204 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 212 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 187 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 204 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 211 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 187 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 203 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 211 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 187 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 203 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,53 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,95 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,03 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,53 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,42 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,03 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 99,06 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,42 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,54 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 99,06 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,42 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,54 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 190 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 130 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 189 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 128 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 189 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 127 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 189 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 127 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 189 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 127 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,47 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,46 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,47 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,69 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 99,47 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,69 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 99,47 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,69 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 23 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 60 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 23 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 60 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 23 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 60 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 22 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 60 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 22 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 60 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 95,65 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 95,65 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 215 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 188 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 188 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 215 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 187 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 188 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 214 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 187 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 187 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 214 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 187 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 187 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 186 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 186 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,47 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,53 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,47 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,47 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 99,53 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 99,47 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 99,47 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,94 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,94 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 192 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 136 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 140 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 192 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 135 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 140 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 192 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 135 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 139 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 192 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 135 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 139 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 134 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 138 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,26 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,26 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,29 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 99,26 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 99,29 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 98,53 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 98,57 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 23 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 52 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 48 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 23 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 52 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 48 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 22 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 52 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 48 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 22 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 52 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 48 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 52 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 48 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 95,65 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,65 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 224 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 201 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 190 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 222 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 201 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 189 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 222 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 200 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 189 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 199 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 188 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 199 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 187 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,11 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,47 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,11 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,5 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,47 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,95 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 99 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,42 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 219 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 179 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 129 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 217 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 179 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 128 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 217 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 179 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 128 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 178 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 127 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 178 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 126 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,09 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,22 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,09 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 99,22 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 99,44 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,45 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 99,44 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,67 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 5 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 22 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 61 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 5 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 22 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 61 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 5 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 21 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 61 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 21 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 61 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 21 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 61 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,45 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,45 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,45 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 231 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 212 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 195 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 231 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 212 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 195 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 211 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 194 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 211 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 193 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 210 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 193 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,53 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99,49 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 99,53 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,97 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 99,06 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,97 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 225 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 190 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 136 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 225 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 190 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 136 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 189 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 135 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 189 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 134 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 189 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 134 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 99,47 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 99,26 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 99,47 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,53 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 99,47 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,53 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 6 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 22 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 59 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 6 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 22 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 59 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 22 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 59 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 22 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 59 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 21 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 59 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,45 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 94 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 88 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 88 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 94 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 88 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 88 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 94 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 88 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 88 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 94 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 87 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 88 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 94 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 87 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 88 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,86 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,86 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 83 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 57 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 83 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 57 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 83 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 57 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 83 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 57 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 83 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 57 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 11 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 31 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 11 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 31 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 11 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 31 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 11 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 30 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 11 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 30 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,77 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,77 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 95 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 93 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 86 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 95 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 93 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 86 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 95 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 92 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 86 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 95 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 92 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 86 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 92 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 86 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,92 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,92 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,92 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 84 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 61 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 61 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 84 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 61 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 61 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 84 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 61 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 61 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 84 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 61 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 61 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 61 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 61 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 11 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 32 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 25 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 11 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 32 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 25 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 11 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 31 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 25 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 11 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 31 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 25 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 31 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 25 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,88 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,88 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,88 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 95 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 92 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 88 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 95 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 92 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 88 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 95 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 92 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 88 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 91 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 88 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 91 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 88 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,91 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,91 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 91 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 81 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 54 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 91 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 81 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 54 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 91 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 81 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 54 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 80 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 54 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 80 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 54 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,77 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,77 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 4 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 11 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 34 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 11 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 34 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 11 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 34 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 11 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 34 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 11 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 34 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 97 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 97 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 89 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 97 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 97 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 89 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 96 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 89 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 96 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 89 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 96 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 88 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,97 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,97 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,97 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,88 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 93 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 82 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 55 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 93 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 82 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 55 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 81 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 55 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 81 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 55 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 81 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 55 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,78 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,78 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,78 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 15 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 34 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 15 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 34 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 15 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 34 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 15 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 34 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 15 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 33 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,06 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Castilla - La Mancha De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2022QI 210.756 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2021QI 204.413 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2020QI 212.589 09 Cataluña Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 09 Cataluña Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 09 Cataluña Total Cohort January 1 Total Survival in the first trimester 2022QII "" 09 Cataluña Total Cohort January 1 Total Survival in the first trimester 2022QI 199.652 09 Cataluña Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 09 Cataluña Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 09 Cataluña Total Cohort January 1 Total Survival in the first trimester 2021QII "" 09 Cataluña Total Cohort January 1 Total Survival in the first trimester 2021QI 194.794 09 Cataluña Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 09 Cataluña Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 09 Cataluña Total Cohort January 1 Total Survival in the first trimester 2020QII "" 09 Cataluña Total Cohort January 1 Total Survival in the first trimester 2020QI 192.100 09 Cataluña Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 09 Cataluña Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 09 Cataluña Total Cohort January 1 Total Survival in the second trimester 2022QII 191.518 09 Cataluña Total Cohort January 1 Total Survival in the second trimester 2022QI "" 09 Cataluña Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 09 Cataluña Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 09 Cataluña Total Cohort January 1 Total Survival in the second trimester 2021QII 188.188 09 Cataluña Total Cohort January 1 Total Survival in the second trimester 2021QI "" 09 Cataluña Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 09 Cataluña Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 09 Cataluña Total Cohort January 1 Total Survival in the second trimester 2020QII 185.869 09 Cataluña Total Cohort January 1 Total Survival in the second trimester 2020QI "" 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2022QIII 185.103 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2021QIII 182.565 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2020QIII 180.325 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2022QIV 179.836 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2021QIV 177.784 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2020QIV 175.055 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,73 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,29 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 90,36 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,87 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,06 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 87,43 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 87,83 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,31 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 84,82 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 85,33 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 86,97 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 82,34 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 199.994 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 171.115 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 189.268 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 162.417 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 181.440 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 156.570 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 175.267 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 151.564 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 170.205 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 147.419 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,64 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,92 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,72 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,5 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 87,64 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 88,57 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 85,11 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 86,15 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 10.762 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 33.298 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 10.384 09 Cataluña Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 32.377 09 Cataluña Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 10.078 09 Cataluña Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 31.618 09 Cataluña Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 9.836 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 31.001 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 9.631 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 30.365 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,49 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,23 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,64 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,95 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,4 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,1 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,49 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 91,19 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2022QII 211.480 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2021QII 205.464 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2020QII 201.461 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 09 Cataluña Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 09 Cataluña Total Cohort April 1 Total Survival in the first trimester 2022QII 201.606 09 Cataluña Total Cohort April 1 Total Survival in the first trimester 2022QI "" 09 Cataluña Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 09 Cataluña Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 09 Cataluña Total Cohort April 1 Total Survival in the first trimester 2021QII 197.276 09 Cataluña Total Cohort April 1 Total Survival in the first trimester 2021QI "" 09 Cataluña Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 09 Cataluña Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 09 Cataluña Total Cohort April 1 Total Survival in the first trimester 2020QII 194.050 09 Cataluña Total Cohort April 1 Total Survival in the first trimester 2020QI "" 09 Cataluña Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 09 Cataluña Total Cohort April 1 Total Survival in the second trimester 2022QIII 193.942 09 Cataluña Total Cohort April 1 Total Survival in the second trimester 2022QII "" 09 Cataluña Total Cohort April 1 Total Survival in the second trimester 2022QI "" 09 Cataluña Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 09 Cataluña Total Cohort April 1 Total Survival in the second trimester 2021QIII 190.404 09 Cataluña Total Cohort April 1 Total Survival in the second trimester 2021QII "" 09 Cataluña Total Cohort April 1 Total Survival in the second trimester 2021QI "" 09 Cataluña Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 09 Cataluña Total Cohort April 1 Total Survival in the second trimester 2020QIII 187.595 09 Cataluña Total Cohort April 1 Total Survival in the second trimester 2020QII "" 09 Cataluña Total Cohort April 1 Total Survival in the second trimester 2020QI "" 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2022QIV 187.428 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2022QI "" 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2021QIV 184.474 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2021QI "" 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2020QIV 181.517 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2022QI 177.657 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2021QI 175.269 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 09 Cataluña Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,33 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,01 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,32 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,71 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,67 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,12 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 88,63 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,78 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,1 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 86,47 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 201.049 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 175.694 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 152.088 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 191.485 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 168.237 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 145.272 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 184.067 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 161.936 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 139.992 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 177.772 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 156.626 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 135.286 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 150.562 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 130.331 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 09 Cataluña Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,24 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,76 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,52 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,55 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,17 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,05 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 88,42 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,15 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,95 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,7 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,69 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 10.431 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 29.770 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 49.373 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 10.121 09 Cataluña Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 29.039 09 Cataluña Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 48.778 09 Cataluña Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 9.875 09 Cataluña Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 28.468 09 Cataluña Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 47.603 09 Cataluña Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 9.656 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 27.848 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 46.231 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 27.095 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 44.938 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 09 Cataluña Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,03 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,54 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,79 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,67 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,63 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,42 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 92,57 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,54 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,64 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,01 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,02 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2022QIII 215.003 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2021QIII 211.262 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2020QIII 205.171 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 09 Cataluña Total Cohort July 1 Total Survival in the first trimester 2022QIII 203.931 09 Cataluña Total Cohort July 1 Total Survival in the first trimester 2022QII "" 09 Cataluña Total Cohort July 1 Total Survival in the first trimester 2022QI "" 09 Cataluña Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 09 Cataluña Total Cohort July 1 Total Survival in the first trimester 2021QIII 200.710 09 Cataluña Total Cohort July 1 Total Survival in the first trimester 2021QII "" 09 Cataluña Total Cohort July 1 Total Survival in the first trimester 2021QI "" 09 Cataluña Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 09 Cataluña Total Cohort July 1 Total Survival in the first trimester 2020QIII 195.970 09 Cataluña Total Cohort July 1 Total Survival in the first trimester 2020QII "" 09 Cataluña Total Cohort July 1 Total Survival in the first trimester 2020QI "" 09 Cataluña Total Cohort July 1 Total Survival in the second trimester 2022QIV 194.740 09 Cataluña Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 09 Cataluña Total Cohort July 1 Total Survival in the second trimester 2022QII "" 09 Cataluña Total Cohort July 1 Total Survival in the second trimester 2022QI "" 09 Cataluña Total Cohort July 1 Total Survival in the second trimester 2021QIV 192.383 09 Cataluña Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 09 Cataluña Total Cohort July 1 Total Survival in the second trimester 2021QII "" 09 Cataluña Total Cohort July 1 Total Survival in the second trimester 2021QI "" 09 Cataluña Total Cohort July 1 Total Survival in the second trimester 2020QIV 187.821 09 Cataluña Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 09 Cataluña Total Cohort July 1 Total Survival in the second trimester 2020QII "" 09 Cataluña Total Cohort July 1 Total Survival in the second trimester 2020QI "" 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2022QII "" 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2022QI 184.555 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2021QII "" 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2021QI 180.932 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2022QII 179.007 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2022QI "" 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2021QII 176.441 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2021QI "" 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,85 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,01 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,52 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 90,58 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 91,06 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,54 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 87,36 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 88,19 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 84,73 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 86 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 208.994 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 201.554 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 174.843 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 198.081 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 191.227 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 166.343 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 189.026 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 183.164 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 159.085 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 175.574 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 152.971 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 170.236 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 149.100 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,78 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,88 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,14 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 90,45 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,88 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,99 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 87,11 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 87,49 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 84,46 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 85,28 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 6.009 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 9.708 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 30.328 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 5.850 09 Cataluña Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 9.483 09 Cataluña Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 29.627 09 Cataluña Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 5.714 09 Cataluña Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 9.219 09 Cataluña Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 28.736 09 Cataluña Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 8.981 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 27.961 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 8.771 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 27.341 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,35 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,68 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,69 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,09 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,96 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,75 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,51 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,2 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,35 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 90,15 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2022QIV 212.896 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2021QIV 210.168 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2020QIV 206.008 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort October 1 Total Survival in the first trimester 2022QIV 202.148 09 Cataluña Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 09 Cataluña Total Cohort October 1 Total Survival in the first trimester 2022QII "" 09 Cataluña Total Cohort October 1 Total Survival in the first trimester 2022QI "" 09 Cataluña Total Cohort October 1 Total Survival in the first trimester 2021QIV 200.060 09 Cataluña Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 09 Cataluña Total Cohort October 1 Total Survival in the first trimester 2021QII "" 09 Cataluña Total Cohort October 1 Total Survival in the first trimester 2021QI "" 09 Cataluña Total Cohort October 1 Total Survival in the first trimester 2020QIV 195.418 09 Cataluña Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 09 Cataluña Total Cohort October 1 Total Survival in the first trimester 2020QII "" 09 Cataluña Total Cohort October 1 Total Survival in the first trimester 2020QI "" 09 Cataluña Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 09 Cataluña Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 09 Cataluña Total Cohort October 1 Total Survival in the second trimester 2022QII "" 09 Cataluña Total Cohort October 1 Total Survival in the second trimester 2022QI 191.190 09 Cataluña Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 09 Cataluña Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 09 Cataluña Total Cohort October 1 Total Survival in the second trimester 2021QII "" 09 Cataluña Total Cohort October 1 Total Survival in the second trimester 2021QI 187.554 09 Cataluña Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 09 Cataluña Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 09 Cataluña Total Cohort October 1 Total Survival in the second trimester 2020QII "" 09 Cataluña Total Cohort October 1 Total Survival in the second trimester 2020QI "" 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2022QII 184.609 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2021QII 182.097 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2022QIII 179.088 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2022QII "" 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2021QIII 177.230 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2021QII "" 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,95 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,19 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,86 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,97 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 91,04 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,84 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 88,39 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 85,21 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 86,03 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 207.964 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 198.776 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 165.747 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 197.327 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 188.987 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 156.271 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 180.466 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 149.497 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 174.216 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 144.870 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 168.949 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 140.730 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,89 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,08 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,28 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,79 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,2 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,64 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 87,4 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,99 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,91 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4.932 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 11.392 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 40.261 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4.821 09 Cataluña Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 11.073 09 Cataluña Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 39.147 09 Cataluña Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 10.724 09 Cataluña Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 38.057 09 Cataluña Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 10.393 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 37.227 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 10.139 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 36.500 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,75 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,2 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,23 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,14 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,53 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,23 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,46 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 89 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90,66 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 153.330 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 150.076 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 154.734 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 142.917 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 141.041 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 135.666 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 135.521 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 135.100 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 129.981 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 129.698 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 129.954 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 125.040 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 124.990 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 125.704 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 120.359 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,21 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,98 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 87,68 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,39 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,02 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 84 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 84,59 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 86,59 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 80,81 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 81,52 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 83,76 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 77,78 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 147.134 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 132.973 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 137.053 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 124.701 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 129.910 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 119.339 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 124.288 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 114.673 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 119.750 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 110.897 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,15 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,78 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,29 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,75 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 84,47 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,24 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 81,39 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,4 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 6.196 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 17.103 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 5.864 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 16.340 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 5.611 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 15.761 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 5.410 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 15.281 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 5.240 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 14.807 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,64 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,54 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,56 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,15 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,31 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,35 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 84,57 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 86,58 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 153.013 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 150.520 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 147.023 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 143.814 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 142.925 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 140.029 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 136.720 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 136.541 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 134.076 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 130.885 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 131.260 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 128.548 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 125.158 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 122.977 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 09 Cataluña From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,99 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,95 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,24 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,35 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,71 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,19 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 85,54 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,2 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 87,43 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 83,15 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 83,64 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 147.080 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 135.208 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 118.770 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 138.145 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 128.203 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 112.250 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 131.260 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 122.280 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 107.265 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 125.590 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 117.468 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 102.840 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 111.962 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 98.310 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,93 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,82 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,51 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,24 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,44 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,31 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 85,39 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,88 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,59 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,81 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 82,77 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 5.933 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 15.312 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 28.253 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 5.669 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 14.722 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 27.779 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 5.460 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 14.261 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 26.811 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 5.295 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 13.792 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 25.708 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 13.196 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 24.667 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,55 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,15 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,32 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,03 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,14 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,9 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 89,25 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,07 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 90,99 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 86,18 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,31 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 154.283 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 153.505 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 149.789 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 143.969 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 143.675 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 141.239 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 136.101 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 136.460 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 133.928 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 129.460 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 127.741 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 124.456 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 123.777 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,31 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,6 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,29 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,22 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 88,9 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 89,41 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 84,34 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 85,28 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 81,08 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 82,63 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 150.743 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 148.550 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 134.008 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 140.569 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 138.908 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 126.034 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 132.791 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 131.876 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 119.395 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 125.064 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 113.806 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 120.237 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 110.308 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,25 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,51 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,05 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,09 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 88,78 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,1 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 84,19 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 84,92 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 80,94 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 82,31 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3.540 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 4.955 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 15.781 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3.400 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 4.767 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 15.205 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3.310 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 4.584 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 14.533 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 4.396 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 13.935 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 4.219 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 13.469 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,05 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,21 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,35 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,5 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,51 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 92,09 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 88,72 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 88,3 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 85,15 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 85,35 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 153.640 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 153.068 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 150.891 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 143.820 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 143.769 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 140.991 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 135.653 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 133.806 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 129.715 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 128.969 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 124.728 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 124.566 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,61 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,92 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,44 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,62 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 88,68 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,74 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 85,47 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 81,49 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 82,55 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 150.860 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 146.248 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 130.297 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 141.125 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 137.224 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 121.295 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 129.412 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 114.970 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 123.764 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 110.751 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 118.996 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 106.892 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,55 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,83 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,09 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,49 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,24 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,63 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 85 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 81,37 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 82,04 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2.780 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 6.820 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 20.594 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2.695 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 6.545 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 19.696 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 6.241 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 18.836 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 5.951 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 18.218 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 5.732 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 17.674 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,94 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,97 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,64 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,51 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 91,46 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 87,26 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 88,46 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 84,05 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 85,82 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 22.724 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 21.635 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 22.853 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 22.346 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 21.322 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 22.032 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 21.956 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 20.968 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 21.754 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 21.653 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 20.726 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 21.427 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 21.352 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 20.460 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 21.137 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,34 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,55 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,41 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,62 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,92 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,19 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,29 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,8 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 93,76 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,96 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,57 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 92,49 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 21.192 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 16.314 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 20.845 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 16.073 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 20.475 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 15.804 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 20.192 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 15.618 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 19.905 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 15.421 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,36 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,52 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,62 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,87 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,28 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,73 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,93 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,53 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.532 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 5.321 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.501 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 5.249 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.481 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 5.164 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.461 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 5.108 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.447 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 5.039 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,98 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,65 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,67 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,05 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 95,37 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,45 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,7 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 23.017 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 21.858 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 21.467 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 22.631 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 21.537 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 21.258 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 22.344 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 21.304 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 20.970 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 21.985 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 20.947 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 20.662 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 20.553 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 20.299 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 09 Cataluña From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,32 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,53 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,03 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,08 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,47 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,68 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,52 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,83 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,25 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,03 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,56 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 21.528 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 17.144 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 13.462 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 21.161 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 16.889 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 13.303 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 20.889 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 16.701 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 13.127 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 20.555 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 16.418 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 12.964 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 16.105 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 12.722 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,3 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,51 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,82 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,03 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,42 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,51 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,48 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,77 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,3 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,94 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,5 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.489 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 4.714 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 8.005 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.470 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 4.648 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 7.955 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.455 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 4.603 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 7.843 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.430 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 4.529 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 7.698 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 4.448 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 7.577 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,72 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,6 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,38 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,72 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,65 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,98 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,04 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,08 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,16 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94,36 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,65 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 23.870 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 22.954 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 22.031 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 23.469 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 22.555 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 21.653 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 22.808 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 21.957 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 21.187 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 21.491 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 20.804 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 21.203 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 20.539 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,32 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,26 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,28 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 95,55 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 95,66 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,17 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 93,63 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,43 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 92,37 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,23 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 22.986 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 21.466 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 17.224 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 22.591 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 21.085 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 16.910 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 21.949 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 20.523 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 16.547 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 20.077 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 16.251 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 19.808 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 16.048 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,28 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,23 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,18 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 95,49 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 95,61 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,07 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 93,53 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,35 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 92,28 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 93,17 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 884 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.488 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 4.807 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 878 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.470 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 4.743 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 859 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.434 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 4.640 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.414 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 4.553 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.395 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 4.491 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,32 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,79 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,67 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,17 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,37 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,53 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,03 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,72 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,75 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 93,43 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 23.169 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 22.643 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 21.904 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 22.655 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 22.181 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 21.498 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 21.764 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 21.124 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 21.423 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 20.802 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 21.165 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 20.563 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,78 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,96 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,15 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,12 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,44 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 94,61 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 94,97 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 93,47 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,88 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 22.405 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 21.113 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 15.379 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 21.903 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 20.676 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 15.071 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 20.281 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 14.801 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 19.955 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 14.574 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 19.717 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 14.411 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,76 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,93 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,06 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,24 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 94,52 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,77 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 93,39 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,71 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 764 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.530 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 6.525 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 752 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.505 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 6.427 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.483 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 6.323 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.468 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 6.228 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.448 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 6.152 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,43 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,37 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,5 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,93 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,9 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,95 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,45 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 94,64 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,28 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 31.764 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 29.887 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 32.044 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 31.462 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 29.631 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 31.460 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 31.124 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 29.331 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 31.206 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 30.847 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 29.105 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 30.942 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 30.598 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 28.851 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 30.658 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,05 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,14 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,18 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,99 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,14 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,38 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,11 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,38 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,56 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,33 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,53 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 95,67 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 29.051 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 20.201 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 28.764 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 20.026 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 28.456 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 19.818 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 28.198 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 19.669 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 27.968 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 19.503 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,01 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,13 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,95 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,1 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,06 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,37 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,27 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,54 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2.713 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 9.686 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2.698 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 9.605 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2.668 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 9.513 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2.649 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 9.436 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2.630 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 9.348 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,45 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,16 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,34 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,21 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,64 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,42 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,94 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,51 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 32.457 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 30.280 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 30.130 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 32.174 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 30.015 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 29.931 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 31.903 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 29.770 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 29.725 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 31.590 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 29.489 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 29.494 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 29.181 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 29.198 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 09 Cataluña From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,13 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,12 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,34 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,29 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,32 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,66 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,33 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,39 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,89 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,37 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,91 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 29.781 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 21.607 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 18.093 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 29.525 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 21.415 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 17.962 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 29.274 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 21.231 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 17.849 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 28.989 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 21.023 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 17.739 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 20.788 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 17.566 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,14 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,11 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,28 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,3 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,26 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,65 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,34 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,3 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,04 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,21 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,09 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2.676 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 8.673 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 12.037 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2.649 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 8.600 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 11.969 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2.629 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 8.539 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 11.876 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2.601 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 8.466 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 11.755 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 8.393 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 11.632 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,99 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,16 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,44 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,24 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,45 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,66 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,2 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,61 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,66 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,77 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,64 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 33.738 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 31.937 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 30.572 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 33.388 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 31.618 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 30.303 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 32.736 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 31.115 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 29.942 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 30.763 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 29.641 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 30.517 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 29.388 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,96 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,12 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,03 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,43 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,94 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,32 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,95 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,55 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,13 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 32.345 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 29.070 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 21.944 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 32.008 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 28.769 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 21.735 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 31.382 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 28.307 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 21.487 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 27.985 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 21.268 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 27.752 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 21.105 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,96 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,96 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,05 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,02 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,38 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,92 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,27 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,92 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,47 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,18 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1.393 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 2.867 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 8.628 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1.380 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 2.849 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 8.568 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1.354 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 2.808 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 8.455 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 2.778 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 8.373 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 2.765 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 8.283 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,07 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,37 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,3 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,2 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,94 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,99 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,9 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,04 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,44 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 32.965 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 31.555 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 30.391 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 32.557 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 31.218 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 30.116 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 30.894 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 29.828 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 30.600 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 29.540 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 30.335 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 29.324 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,76 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,93 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,1 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,91 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,15 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,97 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,2 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,13 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,49 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 31.740 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 28.863 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 18.577 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 31.345 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 28.544 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 18.417 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 28.242 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 18.248 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 27.973 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 18.074 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 27.721 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 17.960 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,76 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,89 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,14 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,85 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,23 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,92 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,29 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,04 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,68 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1.225 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2.692 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 11.814 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1.212 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2.674 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 11.699 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2.652 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 11.580 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2.627 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 11.466 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2.614 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 11.364 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,94 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,33 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,03 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,51 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,02 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,59 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,05 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 97,1 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,19 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 1.936 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 1.861 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 1.966 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 1.928 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 1.846 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 1.953 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 1.918 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 1.839 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 1.943 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 1.909 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 1.834 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 1.934 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 1.903 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 1.827 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 1.919 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,59 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,19 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,34 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,07 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,82 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,83 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,61 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,55 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,37 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,3 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,17 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,61 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.723 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.104 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.715 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.094 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.708 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.090 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.701 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.088 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.696 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.083 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,54 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,09 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,13 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,73 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,72 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,55 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,43 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,1 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 213 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 757 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 213 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 752 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 210 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 749 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 208 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 746 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 207 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 744 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,34 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,59 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,94 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,65 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,55 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,18 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,28 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 1.972 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 1.847 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 1.883 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 1.967 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 1.845 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 1.877 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 1.958 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 1.837 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 1.872 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 1.952 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 1.829 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 1.861 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 1.820 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 1.845 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 09 Cataluña from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,75 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,89 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,68 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,29 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,46 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,42 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,99 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 99,03 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,83 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,54 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,98 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.758 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.184 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.162 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.753 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.183 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.157 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.746 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.178 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.154 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.740 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.171 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.146 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.165 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.137 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,72 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,92 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,57 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,32 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,49 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,31 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,98 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,9 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,62 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 98,4 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,85 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 214 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 663 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 721 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 214 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 662 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 720 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 212 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 659 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 718 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 212 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 658 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 715 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 655 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 708 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,85 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,86 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,07 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,4 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,58 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 99,07 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 99,25 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 99,17 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,79 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,2 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 2.075 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.893 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.849 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 2.072 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 1.890 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 1.848 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 2.064 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 1.883 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 1.838 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 1.876 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 1.822 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 1.866 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 1.816 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,86 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,84 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,95 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,47 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,47 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,41 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99,1 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,54 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,57 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,22 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.945 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.638 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.136 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.942 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.635 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.136 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.934 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.629 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.129 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.622 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.120 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.613 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.116 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,85 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,82 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,43 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,45 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 99,38 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 99,02 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,59 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,47 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98,24 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 130 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 255 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 713 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 130 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 255 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 712 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 130 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 254 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 709 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 254 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 702 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 253 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 700 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,86 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,61 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,44 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 99,61 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,46 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 99,22 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,18 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 2.071 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.908 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.874 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 2.067 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 1.901 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 1.865 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 1.892 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 1.850 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 1.884 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 1.844 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 1.878 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 1.838 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,81 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,63 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,52 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,16 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,72 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,74 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,4 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,43 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,08 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.961 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.678 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.004 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.957 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.671 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 998 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.662 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 989 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.655 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 985 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.650 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 982 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,8 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,58 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,4 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 99,05 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,51 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,63 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,11 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,33 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,81 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 110 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 230 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 870 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 110 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 230 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 867 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 230 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 861 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 229 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 859 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 228 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 856 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,66 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,97 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 99,57 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,74 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 99,13 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,39 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 1.002 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 954 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 992 09 Cataluña De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 999 09 Cataluña De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 954 09 Cataluña De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 989 09 Cataluña De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 999 09 Cataluña De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 950 09 Cataluña De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 985 09 Cataluña De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 996 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 946 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 982 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 993 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 942 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 982 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,7 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,7 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,7 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,58 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,29 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 99,4 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 99,16 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,99 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 99,1 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,74 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,99 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 894 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 523 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 891 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 523 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 891 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 519 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 888 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 516 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 886 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 515 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,66 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,66 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 99,24 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 99,33 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,66 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 99,11 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,47 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 108 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 431 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 108 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 431 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 108 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 431 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 108 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 430 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 107 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 427 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 99,77 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 99,07 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 99,07 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 1.021 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 959 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 958 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 1.020 09 Cataluña De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 954 09 Cataluña De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 955 09 Cataluña De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 1.017 09 Cataluña De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 952 09 Cataluña De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 952 09 Cataluña De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 1.016 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 949 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 952 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 945 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 950 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 09 Cataluña De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,9 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,48 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,69 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,61 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,27 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,37 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 99,51 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,96 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 99,37 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,54 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 99,16 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 902 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 551 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 601 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 901 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 547 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 600 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 898 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 546 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 597 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 898 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 546 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 597 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 542 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 596 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,89 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,27 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,83 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,56 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,09 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,33 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 99,56 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 99,09 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 99,33 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 98,37 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 99,17 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 119 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 408 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 357 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 119 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 407 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 355 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 119 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 406 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 355 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 118 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 403 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 355 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 403 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 354 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 09 Cataluña De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,75 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,44 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,51 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,44 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 99,16 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,77 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 99,44 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,77 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 99,16 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 1.037 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 973 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 930 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 1.033 09 Cataluña De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 972 09 Cataluña De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 927 09 Cataluña De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 1.031 09 Cataluña De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 968 09 Cataluña De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 926 09 Cataluña De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 965 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 924 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 965 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 921 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,61 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,9 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,68 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,42 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,49 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,57 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99,18 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 99,35 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 99,18 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 99,03 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 975 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 830 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 531 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 971 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 830 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 528 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 970 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 829 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 527 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 826 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 526 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 826 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 523 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,59 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,44 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,49 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,88 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 99,25 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 99,52 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 99,06 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 99,52 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98,49 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 62 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 143 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 399 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 62 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 142 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 399 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 61 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 139 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 399 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 139 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 398 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 139 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 398 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,3 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,39 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,2 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,2 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 99,75 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,2 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 99,75 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 1.051 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 994 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 948 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 1.049 09 Cataluña De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 991 09 Cataluña De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 948 09 Cataluña De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 987 09 Cataluña De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 946 09 Cataluña De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 987 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 942 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 982 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 939 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,81 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,7 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,3 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99,79 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 99,3 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 99,37 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,79 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 99,05 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 998 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 874 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 490 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 997 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 872 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 490 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 869 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 489 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 869 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 486 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 865 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 485 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,9 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,77 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 99,43 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 99,8 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 99,43 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 99,18 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,97 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,98 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 53 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 120 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 458 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 52 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 119 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 458 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 118 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 457 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 118 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 456 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 117 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 454 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,11 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,17 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,33 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,78 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 98,33 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 99,56 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 97,5 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 99,13 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Cataluña De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2022QI 133.340 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2021QI 129.397 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2020QI 134.876 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the first trimester 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the first trimester 2022QI 125.822 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the first trimester 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the first trimester 2021QI 120.901 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the first trimester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the first trimester 2020QI 118.187 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the second trimester 2022QII 120.202 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the second trimester 2022QI "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the second trimester 2021QII 116.198 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the second trimester 2021QI "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the second trimester 2020QII 113.889 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2022QIII 115.685 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2021QIII 112.309 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2020QIII 110.057 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2022QIV 112.194 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2021QIV 109.256 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2020QIV 106.515 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,36 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,43 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 87,63 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,15 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,8 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 84,44 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,76 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 86,79 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 81,6 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 84,14 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 84,43 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 78,97 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 126.143 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 112.564 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 118.902 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 104.713 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 113.492 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 100.400 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 109.152 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 96.823 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 105.811 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 94.139 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,26 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,03 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,97 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,19 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,53 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,02 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,88 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,63 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 7.197 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 16.833 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 6.920 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 16.188 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 6.710 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 15.798 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 6.533 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 15.486 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 6.383 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 15.117 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,15 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,17 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,23 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,85 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,77 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,69 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,81 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2022QII 134.131 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2021QII 128.108 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2020QII 124.612 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the first trimester 2022QII 127.091 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the first trimester 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the first trimester 2021QII 122.222 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the first trimester 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the first trimester 2020QII 119.441 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the second trimester 2022QIII 121.499 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the second trimester 2022QII "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the second trimester 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the second trimester 2021QIII 117.389 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the second trimester 2021QII "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the second trimester 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the second trimester 2020QIII 114.892 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the second trimester 2020QII "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2022QIV 116.993 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2021QIV 113.530 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2020QIV 110.682 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2022QI 109.424 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2021QI 105.864 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 10 Comunitat Valenciana Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,75 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,41 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,85 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,58 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,63 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,2 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,22 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,62 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,82 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,42 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 84,95 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 127.070 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 110.413 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 95.248 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 120.251 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 104.992 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 90.446 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 114.860 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 100.537 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 86.709 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 110.518 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 97.113 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 83.503 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 93.454 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 79.809 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,63 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,09 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,96 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,39 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,06 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,03 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,97 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,95 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,67 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,64 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 83,79 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 7.061 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 17.695 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 29.364 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 6.840 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 17.230 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 28.995 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 6.639 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 16.852 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 28.183 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 6.475 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 16.417 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 27.179 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 15.970 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 26.055 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,87 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,37 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,74 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,02 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,24 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,98 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,7 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 92,78 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 92,56 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,25 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 88,73 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2022QIII 136.522 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2021QIII 132.932 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2020QIII 129.201 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the first trimester 2022QIII 128.233 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the first trimester 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the first trimester 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the first trimester 2021QIII 125.180 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the first trimester 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the first trimester 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the first trimester 2020QIII 122.101 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the first trimester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the second trimester 2022QIV 122.151 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the second trimester 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the second trimester 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the second trimester 2021QIV 119.651 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the second trimester 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the second trimester 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the second trimester 2020QIV 116.435 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the second trimester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2022QI 114.800 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2021QI 110.764 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2022QII 111.331 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2021QII 107.803 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,93 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,17 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,5 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,47 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,01 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,12 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,36 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 85,73 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,75 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 83,44 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 131.932 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 127.054 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 110.351 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 123.786 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 119.472 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 103.703 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 117.814 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 114.102 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 98.609 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 109.420 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 93.612 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 106.068 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 91.059 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,83 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,03 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,98 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,3 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,81 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,36 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,12 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 84,83 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,48 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 82,52 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 4.590 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 5.878 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 18.850 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4.447 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 5.708 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 18.398 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4.337 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 5.549 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 17.826 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 5.380 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 17.152 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 5.263 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 16.744 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,88 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,11 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,6 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,49 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,4 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,57 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,53 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 90,99 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 89,54 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,83 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2022QIV 134.639 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2021QIV 132.330 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2020QIV 129.724 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the first trimester 2022QIV 127.267 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the first trimester 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the first trimester 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the first trimester 2021QIV 125.221 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the first trimester 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the first trimester 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the first trimester 2020QIV 122.171 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the first trimester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the second trimester 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the second trimester 2022QI 119.525 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the second trimester 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the second trimester 2021QI 115.428 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the second trimester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2022QII 115.235 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2021QII 111.791 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2022QIII 111.467 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2021QIII 108.635 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,52 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,63 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,18 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,32 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 88,98 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,08 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,18 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,23 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,74 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 130.809 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 124.802 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 109.263 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 123.523 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 117.934 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 102.373 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 112.498 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 96.387 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 108.405 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 93.202 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 104.846 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 90.404 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,43 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,5 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,69 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,14 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,22 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 86,86 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 85,3 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,01 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 82,74 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 3.830 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 7.528 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 20.461 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 3.744 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 7.287 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 19.798 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 7.027 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 19.041 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 6.830 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 18.589 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 6.621 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 18.231 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,75 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,8 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,76 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,34 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,06 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 90,73 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,85 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,95 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 89,1 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 99.946 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 98.226 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 101.315 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 92.882 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 90.209 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 85.896 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 87.826 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 85.974 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 82.100 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 83.731 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 82.429 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 78.714 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 80.551 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 79.654 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 75.605 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,93 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 91,84 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 84,78 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,87 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 87,53 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 81,03 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 83,78 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 83,92 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 77,69 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 80,59 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 81,09 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 74,62 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 95.416 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 89.171 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 88.593 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 81.700 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 83.719 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 77.762 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 79.777 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 74.464 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 76.726 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 71.994 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,85 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 91,62 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,74 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 87,21 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 83,61 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 83,51 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 80,41 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 80,74 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 4.530 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 9.055 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 4.289 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 8.509 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 4.107 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 8.212 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 3.954 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 7.965 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 3.825 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 7.660 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,68 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 93,97 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,66 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 90,69 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,28 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 87,96 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 84,44 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 84,59 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100.248 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 97.310 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 94.453 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 93.756 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 91.842 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 89.680 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 88.594 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 87.391 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 85.473 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 84.530 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 83.883 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 81.650 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 80.172 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 77.284 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,52 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,38 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,95 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,37 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 89,81 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 90,49 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 84,32 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,2 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 86,45 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 82,39 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 81,82 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 95.814 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 87.095 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 75.918 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 89.514 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 82.013 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 71.444 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 84.521 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 77.882 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 67.938 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 80.601 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 74.743 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 64.936 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 71.394 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 61.506 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,42 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,16 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,11 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,21 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,42 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 89,49 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,12 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 85,82 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 85,53 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 81,97 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 81,02 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 4.434 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 10.215 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 18.535 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 4.242 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 9.829 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 18.236 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 4.073 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 9.509 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 17.535 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 3.929 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 9.140 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 16.714 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 8.778 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 15.778 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,67 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,22 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,39 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,86 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,09 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,6 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,61 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 89,48 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 90,18 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 85,93 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 85,13 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 101.104 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 99.719 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 97.709 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 93.412 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 92.490 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 91.083 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 88.137 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 87.639 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 86.030 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 83.289 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 80.897 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 80.151 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 78.252 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,39 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,75 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,22 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,17 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 87,89 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,05 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 83,52 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 82,79 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 80,38 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 80,09 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 98.218 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 96.415 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 87.681 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 90.653 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 89.328 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 81.432 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 85.468 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 84.606 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 76.818 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 80.391 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 72.208 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 77.351 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 69.866 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,3 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,65 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 92,87 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,02 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,75 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 87,61 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 83,38 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 82,35 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 80,23 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 79,68 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2.886 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 3.304 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 10.028 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2.759 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 3.162 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 9.651 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2.669 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 3.033 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 9.212 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 2.898 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 8.689 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 2.800 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 8.386 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,6 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,7 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,24 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 92,48 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 91,8 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 91,86 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 87,71 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 86,65 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 84,75 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 83,63 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100.182 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 99.354 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 98.310 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 93.414 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 92.746 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 91.235 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 87.523 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 85.051 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 83.660 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 81.799 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 80.234 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 78.931 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,24 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,35 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,8 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,09 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 86,51 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,2 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 83,21 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 80,76 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 80,29 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 97.871 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 94.434 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 87.347 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 91.179 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 88.040 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 80.817 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 83.027 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 75.246 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 79.340 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 72.332 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 76.096 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 69.742 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,16 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,23 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,52 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 87,92 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 86,15 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,02 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 82,81 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 80,58 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 79,84 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2.311 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 4.920 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 10.963 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2.235 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 4.706 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 10.418 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 4.496 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 9.805 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 4.320 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 9.467 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 4.138 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 9.189 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,71 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,65 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,03 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,38 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 89,44 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 87,8 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 86,35 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 84,11 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 83,82 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 14.037 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 13.288 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 14.166 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 13.793 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 13.010 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 13.425 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 13.509 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 12.774 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 13.178 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 13.277 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 12.595 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 12.933 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 13.105 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 12.438 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 12.674 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,26 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,91 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 94,77 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,24 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,13 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 93,03 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,59 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,78 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 91,3 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,36 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 93,6 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 89,47 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 13.020 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 10.495 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 12.796 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 10.275 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 12.523 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 10.085 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 12.303 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 9.932 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 12.142 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 9.816 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,28 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,9 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,18 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,09 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,49 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 94,64 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,26 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,53 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.017 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2.793 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 997 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2.735 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 986 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.689 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 974 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.663 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 963 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.622 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,03 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,92 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,95 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,28 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 95,77 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,35 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,69 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 93,88 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 14.072 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 12.950 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 12.773 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 13.799 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 12.731 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 12.586 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 13.555 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 12.533 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 12.401 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 13.295 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 12.326 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 12.166 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 12.115 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 11.905 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,06 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,31 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,54 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,33 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,78 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,09 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,48 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,18 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,25 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,55 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 93,2 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 13.098 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 10.157 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 8.226 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 12.839 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 9.979 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 8.078 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 12.613 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 9.807 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 7.956 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 12.365 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 9.641 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 7.832 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 9.473 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 7.677 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,02 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,25 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,2 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,3 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,55 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,72 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,4 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 94,92 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,21 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,27 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 93,33 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 974 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2.793 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 4.547 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 960 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2.752 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 4.508 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 942 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2.726 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 4.445 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 930 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2.685 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 4.334 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2.642 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 4.228 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,56 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,53 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,14 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 96,71 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,6 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,76 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,48 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,13 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,32 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94,59 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 92,98 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 14.791 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 14.101 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 13.632 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 14.450 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 13.813 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 13.360 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 14.021 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 13.439 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 13.007 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 13.164 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 12.690 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 12.980 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 12.524 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,69 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,96 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 94,79 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 95,31 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 95,42 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 93,36 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 93,09 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 92,05 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 91,87 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 14.127 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 13.180 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 10.433 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 13.792 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 12.905 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 10.202 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 13.378 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 12.544 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 9.924 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 12.286 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 9.692 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 12.110 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 9.582 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,63 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,91 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 97,79 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 94,7 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 95,17 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 95,12 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 93,22 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 92,9 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 91,88 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 91,84 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 664 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 921 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 3.199 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 658 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 908 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 3.158 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 643 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 895 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3.083 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 878 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.998 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 870 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.942 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,1 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,59 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,72 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 96,84 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,18 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,37 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,33 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,72 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 94,46 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,97 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 14.373 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 13.951 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 13.504 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 14.013 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 13.664 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 13.202 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 13.412 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 12.873 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 13.187 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 12.671 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 12.980 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 12.521 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,5 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,94 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,76 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,14 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 95,33 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 94,52 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 93,83 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 93,04 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 92,72 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 13.798 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 12.945 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 10.088 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 13.444 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 12.676 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 9.855 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 12.454 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 9.609 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 12.241 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 9.462 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 12.049 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 9.344 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,43 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,92 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,69 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,21 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 95,25 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 94,56 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 93,79 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 93,08 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 92,62 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 575 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.006 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 3.416 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 569 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 988 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 3.347 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 958 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 3.264 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 946 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 3.209 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 931 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 3.177 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,96 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,21 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,98 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 95,23 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,55 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 94,04 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,94 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 92,54 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 18.113 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 16.741 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 18.212 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 17.912 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 16.555 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 17.693 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 17.643 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 16.331 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 17.444 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 17.464 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 16.177 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 17.255 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 17.331 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 16.063 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 17.086 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,89 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,89 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,15 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,41 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,55 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,78 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,42 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,63 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,75 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,68 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,95 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,82 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 16.580 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 12.159 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 16.395 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 12.011 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 16.143 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 11.833 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 15.976 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 11.717 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 15.852 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 11.625 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,88 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,78 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,36 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,32 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,36 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,36 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,61 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,61 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.533 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 4.582 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.517 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 4.544 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.500 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 4.498 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.488 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 4.460 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.479 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 4.438 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,96 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,17 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,85 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,17 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,06 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,34 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,48 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,86 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 18.549 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 16.711 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 16.280 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 18.283 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 16.520 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 16.075 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 18.111 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 16.353 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 15.932 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 17.938 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 16.219 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 15.796 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 16.039 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 15.616 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,57 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,86 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,74 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,64 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,86 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,86 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,71 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,06 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,03 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 95,98 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,92 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 17.031 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 12.394 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 10.320 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 16.779 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 12.240 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 10.145 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 16.621 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 12.103 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 10.049 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 16.455 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 11.993 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 9.984 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 11.854 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 9.886 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,52 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,76 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,3 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,59 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,65 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,37 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,62 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,76 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,74 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,64 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,79 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.518 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 4.317 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 5.960 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.504 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 4.280 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 5.930 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.490 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 4.250 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 5.883 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.483 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 4.226 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 5.812 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 4.185 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 5.730 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,08 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,14 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,5 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,16 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,45 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,71 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,69 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,89 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,52 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,94 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,14 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 19.356 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 17.971 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 16.804 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 19.106 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 17.743 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 16.610 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 18.734 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 17.445 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 16.359 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 17.225 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 16.148 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 17.084 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 16.000 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,71 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,73 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,85 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,79 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,07 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,35 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,85 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,1 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,06 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,22 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 18.380 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 16.447 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 11.621 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 18.140 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 16.233 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 11.460 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 17.772 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 15.952 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 11.267 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 15.749 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 11.119 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 15.619 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 11.020 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,69 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,7 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,61 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,69 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,99 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,95 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,76 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,68 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,97 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,83 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 976 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.524 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 5.183 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 966 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.510 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 5.150 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 962 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.493 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 5.092 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.476 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 5.029 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.465 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 4.980 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,98 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,08 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,36 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,57 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,97 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,24 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,85 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,03 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,13 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,08 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 18.817 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 17.848 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 16.807 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 18.581 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 17.642 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 16.649 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 17.428 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 16.430 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 17.236 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 16.253 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 17.109 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 16.122 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,75 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,85 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,06 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,65 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,76 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,57 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,7 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,86 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,92 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 17.932 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 16.389 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 11.172 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 17.699 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 16.192 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 11.062 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 15.998 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 10.901 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 15.815 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 10.782 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 15.700 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 10.698 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,7 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,8 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,02 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,61 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,57 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,5 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,51 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,8 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,76 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 885 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.459 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 5.635 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 882 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.450 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 5.587 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.430 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 5.529 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.421 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 5.471 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.409 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 5.424 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,66 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,38 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,15 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,01 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,12 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,4 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,09 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,57 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,26 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 842 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 753 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 788 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 836 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 746 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 782 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 829 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 741 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 778 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 825 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 737 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 772 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 820 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 731 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 770 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,29 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,07 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,24 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,46 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,41 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,73 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,98 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,88 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,97 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,39 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,08 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,72 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 763 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 494 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 757 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 488 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 750 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 483 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 746 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 480 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 742 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 475 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,21 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,79 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,3 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,77 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,77 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,17 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,25 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,15 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 79 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 259 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 79 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 258 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 79 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 258 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 79 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 257 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 78 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 256 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,61 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,61 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 99,23 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 98,73 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,84 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 852 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 757 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 740 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 846 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 752 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 735 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 839 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 739 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 726 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 830 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 732 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 715 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 729 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 711 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,3 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,34 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,32 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,47 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,62 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,11 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,42 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,7 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,62 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,3 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,08 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 761 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 517 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 519 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 755 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 512 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 514 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 748 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 501 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 506 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 740 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 495 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 495 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 492 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 491 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,21 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,03 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,04 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,29 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,91 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,5 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,24 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,74 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,38 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,16 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,61 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 91 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 240 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 221 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 91 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 240 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 221 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 91 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 238 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 220 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 90 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 237 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 220 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 237 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 220 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,17 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,55 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,9 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,75 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 99,55 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,75 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 99,55 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 875 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 768 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 717 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 870 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 761 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 709 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 864 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 757 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 704 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 754 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 698 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 751 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 697 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,43 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,09 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,88 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,74 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,57 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,19 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,18 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,35 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,79 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,21 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 827 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 683 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 416 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 822 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 677 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 409 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 817 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 673 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 404 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 670 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 400 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 667 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 399 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,4 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,12 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,32 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,79 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,54 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,12 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,1 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,15 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,66 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,91 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 48 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 85 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 301 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 48 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 84 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 300 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 47 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 84 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 300 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 84 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 298 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 84 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 298 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,82 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,67 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,92 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,82 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,67 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 98,82 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 99 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 98,82 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 99 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 854 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 787 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 737 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 848 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 782 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 725 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 778 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 718 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 772 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 715 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 767 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 711 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,3 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,36 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,37 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,86 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,42 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,09 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,01 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,46 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,47 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 812 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 695 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 438 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 807 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 690 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 427 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 686 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 422 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 680 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 419 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 675 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 416 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,38 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,28 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,49 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,71 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,35 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,84 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,66 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,12 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,98 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 42 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 92 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 299 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 41 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 92 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 298 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 92 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 296 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 92 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 296 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 92 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 295 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,62 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,67 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 99 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,66 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 402 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 389 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 395 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 399 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 381 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 391 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 395 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 378 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 389 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 388 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 371 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 383 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 387 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 370 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 380 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,25 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,94 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,99 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,26 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,17 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,48 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,52 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,37 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,96 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,27 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,12 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,2 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 364 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 245 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 361 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 239 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 357 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 237 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 350 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 230 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 349 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 229 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,18 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,55 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,08 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,73 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,15 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 93,88 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,88 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,47 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 38 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 144 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 38 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 142 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 38 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 141 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 38 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 141 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 38 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 141 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,61 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,92 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,92 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,92 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 410 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 380 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 366 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 407 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 377 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 365 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 400 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 373 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 360 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 400 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 370 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 355 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 369 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 348 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,27 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,21 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,73 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,56 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,16 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,36 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,56 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,37 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,99 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,11 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,08 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 366 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 250 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 265 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 364 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 248 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 265 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 357 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 244 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 260 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 357 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 241 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 256 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 241 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 249 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,45 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,2 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,54 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,6 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,11 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,54 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,4 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,6 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,4 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 93,96 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 44 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 130 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 101 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 43 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 129 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 100 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 43 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 129 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 100 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 43 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 129 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 99 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 128 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 99 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,73 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,23 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,01 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,73 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,23 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,01 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,73 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 99,23 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,02 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,46 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,02 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 396 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 373 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 339 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 395 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 373 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 339 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 395 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 371 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 335 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 368 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 331 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 365 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 330 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,75 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,75 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,46 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,82 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,66 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,64 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,86 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,35 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 380 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 329 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 200 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 379 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 329 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 200 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 379 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 327 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 196 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 324 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 193 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 321 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 192 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,74 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,74 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,39 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,48 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,5 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,57 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 16 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 44 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 139 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 16 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 44 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 139 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 16 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 44 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 139 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 44 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 138 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 44 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 138 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 99,28 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 99,28 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 413 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 390 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 366 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 411 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 387 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 360 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 384 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 356 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 380 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 353 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 377 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 350 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,52 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,23 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,36 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,46 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,27 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,44 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,45 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,67 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,63 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 396 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 339 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 218 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 394 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 336 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 212 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 333 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 209 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 329 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 207 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 326 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 204 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,49 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,12 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,25 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,23 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 95,87 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,05 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,95 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,17 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,58 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 17 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 51 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 148 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 17 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 51 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 148 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 51 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 147 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 51 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 146 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 51 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 146 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,32 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,65 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,65 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Comunitat Valenciana De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2022QI 23.571 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2021QI 22.784 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2020QI 23.696 11 Extremadura Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 11 Extremadura Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 11 Extremadura Total Cohort January 1 Total Survival in the first trimester 2022QII "" 11 Extremadura Total Cohort January 1 Total Survival in the first trimester 2022QI 22.001 11 Extremadura Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 11 Extremadura Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 11 Extremadura Total Cohort January 1 Total Survival in the first trimester 2021QII "" 11 Extremadura Total Cohort January 1 Total Survival in the first trimester 2021QI 21.290 11 Extremadura Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 11 Extremadura Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 11 Extremadura Total Cohort January 1 Total Survival in the first trimester 2020QII "" 11 Extremadura Total Cohort January 1 Total Survival in the first trimester 2020QI 20.160 11 Extremadura Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 11 Extremadura Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 11 Extremadura Total Cohort January 1 Total Survival in the second trimester 2022QII 20.938 11 Extremadura Total Cohort January 1 Total Survival in the second trimester 2022QI "" 11 Extremadura Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 11 Extremadura Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 11 Extremadura Total Cohort January 1 Total Survival in the second trimester 2021QII 20.407 11 Extremadura Total Cohort January 1 Total Survival in the second trimester 2021QI "" 11 Extremadura Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 11 Extremadura Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 11 Extremadura Total Cohort January 1 Total Survival in the second trimester 2020QII 19.427 11 Extremadura Total Cohort January 1 Total Survival in the second trimester 2020QI "" 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2022QIII 20.145 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2021QIII 19.722 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2020QIII 18.876 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2022QIV 19.555 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2021QIV 19.179 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2020QIV 18.325 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,34 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,44 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 85,08 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,83 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,57 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 81,98 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,47 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 86,56 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 79,66 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 82,96 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 84,18 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 77,33 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 22.826 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 20.933 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 21.282 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 19.491 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 20.243 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 18.642 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 19.472 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 17.992 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 18.892 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 17.486 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,24 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,11 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,68 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,06 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,31 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 85,95 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 82,77 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,53 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 745 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.851 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 719 11 Extremadura Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.799 11 Extremadura Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 695 11 Extremadura Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.765 11 Extremadura Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 673 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.730 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 663 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.693 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,51 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,19 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,29 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,35 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,34 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,46 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,99 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 91,46 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2022QII 23.483 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2021QII 22.686 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2020QII 21.189 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 11 Extremadura Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 11 Extremadura Total Cohort April 1 Total Survival in the first trimester 2022QII 22.116 11 Extremadura Total Cohort April 1 Total Survival in the first trimester 2022QI "" 11 Extremadura Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 11 Extremadura Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 11 Extremadura Total Cohort April 1 Total Survival in the first trimester 2021QII 21.481 11 Extremadura Total Cohort April 1 Total Survival in the first trimester 2021QI "" 11 Extremadura Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 11 Extremadura Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 11 Extremadura Total Cohort April 1 Total Survival in the first trimester 2020QII 20.268 11 Extremadura Total Cohort April 1 Total Survival in the first trimester 2020QI "" 11 Extremadura Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 11 Extremadura Total Cohort April 1 Total Survival in the second trimester 2022QIII 21.132 11 Extremadura Total Cohort April 1 Total Survival in the second trimester 2022QII "" 11 Extremadura Total Cohort April 1 Total Survival in the second trimester 2022QI "" 11 Extremadura Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 11 Extremadura Total Cohort April 1 Total Survival in the second trimester 2021QIII 20.595 11 Extremadura Total Cohort April 1 Total Survival in the second trimester 2021QII "" 11 Extremadura Total Cohort April 1 Total Survival in the second trimester 2021QI "" 11 Extremadura Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 11 Extremadura Total Cohort April 1 Total Survival in the second trimester 2020QIII 19.601 11 Extremadura Total Cohort April 1 Total Survival in the second trimester 2020QII "" 11 Extremadura Total Cohort April 1 Total Survival in the second trimester 2020QI "" 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2022QIV 20.415 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2022QI "" 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2021QIV 19.919 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2021QI "" 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2020QIV 18.965 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2022QI 19.124 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2021QI 18.239 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 11 Extremadura Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,18 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,69 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,65 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,99 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,78 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,51 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,94 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,8 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,5 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 84,3 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 86,08 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 22.758 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 21.196 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 17.387 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 21.421 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 20.030 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 16.517 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 20.471 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 19.175 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 15.928 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 19.771 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 18.529 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 15.381 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 17.772 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 14.757 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 11 Extremadura Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,13 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,5 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,95 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,47 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,61 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,87 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,42 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,46 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 83,85 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,87 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 725 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.490 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3.802 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 695 11 Extremadura Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.451 11 Extremadura Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3.751 11 Extremadura Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 661 11 Extremadura Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.420 11 Extremadura Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 3.673 11 Extremadura Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 644 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.390 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 3.584 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.352 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 3.482 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 11 Extremadura Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,86 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,38 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,66 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,17 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,3 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,61 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,83 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,29 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,27 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,74 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,58 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2022QIII 23.914 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2021QIII 23.240 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2020QIII 22.484 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 11 Extremadura Total Cohort July 1 Total Survival in the first trimester 2022QIII 22.380 11 Extremadura Total Cohort July 1 Total Survival in the first trimester 2022QII "" 11 Extremadura Total Cohort July 1 Total Survival in the first trimester 2022QI "" 11 Extremadura Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 11 Extremadura Total Cohort July 1 Total Survival in the first trimester 2021QIII 21.751 11 Extremadura Total Cohort July 1 Total Survival in the first trimester 2021QII "" 11 Extremadura Total Cohort July 1 Total Survival in the first trimester 2021QI "" 11 Extremadura Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 11 Extremadura Total Cohort July 1 Total Survival in the first trimester 2020QIII 21.302 11 Extremadura Total Cohort July 1 Total Survival in the first trimester 2020QII "" 11 Extremadura Total Cohort July 1 Total Survival in the first trimester 2020QI "" 11 Extremadura Total Cohort July 1 Total Survival in the second trimester 2022QIV 21.384 11 Extremadura Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 11 Extremadura Total Cohort July 1 Total Survival in the second trimester 2022QII "" 11 Extremadura Total Cohort July 1 Total Survival in the second trimester 2022QI "" 11 Extremadura Total Cohort July 1 Total Survival in the second trimester 2021QIV 20.822 11 Extremadura Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 11 Extremadura Total Cohort July 1 Total Survival in the second trimester 2021QII "" 11 Extremadura Total Cohort July 1 Total Survival in the second trimester 2021QI "" 11 Extremadura Total Cohort July 1 Total Survival in the second trimester 2020QIV 20.335 11 Extremadura Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 11 Extremadura Total Cohort July 1 Total Survival in the second trimester 2020QII "" 11 Extremadura Total Cohort July 1 Total Survival in the second trimester 2020QI "" 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2022QII "" 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2022QI 19.919 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2021QII "" 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2021QI 19.422 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2022QII 19.301 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2022QI "" 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2021QII 18.897 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2021QI "" 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,59 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,59 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,74 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,42 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,6 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,44 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,71 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,38 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,05 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,05 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 23.408 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 22.713 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 20.139 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 21.900 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 21.240 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 19.005 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 20.917 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 20.319 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 18.091 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 19.429 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 17.236 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 18.822 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 16.744 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,56 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,51 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,37 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,36 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,46 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,83 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,54 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 85,59 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 82,87 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,14 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 506 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 527 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.345 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 480 11 Extremadura Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 511 11 Extremadura Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.297 11 Extremadura Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 467 11 Extremadura Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 503 11 Extremadura Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2.244 11 Extremadura Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 490 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.186 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 479 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.153 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 94,86 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,96 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,95 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 92,29 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,45 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,69 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,98 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,22 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,89 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,81 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2022QIV 24.055 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2021QIV 23.235 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2020QIV 22.926 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort October 1 Total Survival in the first trimester 2022QIV 22.692 11 Extremadura Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 11 Extremadura Total Cohort October 1 Total Survival in the first trimester 2022QII "" 11 Extremadura Total Cohort October 1 Total Survival in the first trimester 2022QI "" 11 Extremadura Total Cohort October 1 Total Survival in the first trimester 2021QIV 21.917 11 Extremadura Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 11 Extremadura Total Cohort October 1 Total Survival in the first trimester 2021QII "" 11 Extremadura Total Cohort October 1 Total Survival in the first trimester 2021QI "" 11 Extremadura Total Cohort October 1 Total Survival in the first trimester 2020QIV 21.487 11 Extremadura Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 11 Extremadura Total Cohort October 1 Total Survival in the first trimester 2020QII "" 11 Extremadura Total Cohort October 1 Total Survival in the first trimester 2020QI "" 11 Extremadura Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 11 Extremadura Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 11 Extremadura Total Cohort October 1 Total Survival in the second trimester 2022QII "" 11 Extremadura Total Cohort October 1 Total Survival in the second trimester 2022QI 20.817 11 Extremadura Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 11 Extremadura Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 11 Extremadura Total Cohort October 1 Total Survival in the second trimester 2021QII "" 11 Extremadura Total Cohort October 1 Total Survival in the second trimester 2021QI 20.391 11 Extremadura Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 11 Extremadura Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 11 Extremadura Total Cohort October 1 Total Survival in the second trimester 2020QII "" 11 Extremadura Total Cohort October 1 Total Survival in the second trimester 2020QI "" 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2022QII 20.014 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2021QII 19.697 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2022QIII 19.366 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2022QII "" 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2021QIII 19.122 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2021QII "" 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,33 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,33 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,72 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,59 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 88,94 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 86,14 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 85,92 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 83,35 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,41 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 23.594 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 22.431 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 20.618 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 22.244 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 21.138 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 19.234 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 20.064 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 18.197 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 19.284 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 17.542 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 18.665 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 17.004 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,28 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,24 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,29 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,45 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,26 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,97 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 85,08 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 83,21 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 82,47 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 461 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 804 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2.308 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 448 11 Extremadura Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 779 11 Extremadura Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2.253 11 Extremadura Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 753 11 Extremadura Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.194 11 Extremadura Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 730 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.155 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 701 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.118 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,18 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,89 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,62 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,66 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,06 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 90,8 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,37 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,19 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 91,77 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 18.450 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 18.089 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 18.673 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 16.943 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 16.674 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 15.316 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 15.971 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 15.854 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 14.642 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 15.242 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 15.219 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 14.138 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 14.703 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 14.708 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 13.639 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 91,83 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,18 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 82,02 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 86,56 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 87,64 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 78,41 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 82,61 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 84,13 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 75,71 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 79,69 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 81,31 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 73,04 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 17.962 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 17.057 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 16.479 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 15.684 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 15.528 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 14.891 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 14.820 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 14.278 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 14.290 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 13.798 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 91,74 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 91,95 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 86,45 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 87,3 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 82,51 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 83,71 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 79,56 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 80,89 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 488 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.032 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 464 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 990 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 443 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 963 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 422 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 941 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 413 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 910 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,08 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,93 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,78 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,31 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 86,48 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 91,18 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 84,63 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 88,18 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 18.365 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 17.946 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 16.828 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 17.094 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 16.801 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 15.951 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 16.171 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 15.967 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 15.321 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 15.510 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 15.329 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 14.724 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 14.594 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 14.058 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 11 Extremadura From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,08 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 93,62 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,79 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,05 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 88,97 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,04 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 84,45 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 85,42 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 87,5 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 81,32 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 83,54 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 17.867 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 17.091 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 14.408 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 16.624 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 15.981 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 13.574 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 15.730 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 15.169 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 13.012 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 15.085 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 14.556 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 12.493 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 13.851 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 11.904 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,04 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 93,51 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,21 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,04 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 88,75 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,31 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,43 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 85,17 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,71 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 81,04 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 82,62 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 498 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 855 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.420 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 470 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 820 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.377 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 441 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 798 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.309 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 425 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 773 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.231 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 743 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.154 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 94,38 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 95,91 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,22 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 88,55 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,33 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,41 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 85,34 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,41 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 92,19 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 86,9 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 89,01 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 18.583 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 18.213 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 17.769 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 17.140 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 16.798 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 16.642 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 16.226 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 15.921 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 15.745 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 15.085 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 14.902 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 14.524 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 14.421 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,23 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,23 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,66 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,32 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 87,42 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,61 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 82,83 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 83,87 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 79,75 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 81,16 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 18.226 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 17.903 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 16.428 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 16.806 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 16.499 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 15.340 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 15.904 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 15.630 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 14.486 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 14.804 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 13.683 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 14.249 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 13.232 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,21 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,16 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,38 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,26 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,3 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 88,18 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 82,69 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 83,29 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 79,59 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 80,55 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 357 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 310 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.341 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 334 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 299 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.302 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 322 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 291 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.259 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 281 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.219 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 275 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.189 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 93,56 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,45 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,09 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 90,2 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,87 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,89 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90,65 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 90,9 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 88,71 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,67 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 18.740 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 18.178 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 18.114 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 17.471 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 16.911 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 16.748 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 15.878 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 15.723 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 15.159 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 15.084 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 14.561 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 14.554 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,23 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,03 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,46 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 87,35 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 86,8 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 83,39 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 83,27 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 80,1 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 80,35 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 18.426 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 17.598 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 16.822 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 17.169 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 16.355 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 15.502 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 15.347 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 14.519 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 14.647 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 13.913 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 14.074 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 13.408 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,18 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,94 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,15 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 87,21 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 86,31 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 83,23 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 82,71 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 79,97 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 79,71 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 314 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 580 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.292 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 302 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 556 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.246 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 531 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.204 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 512 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.171 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 487 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.146 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,18 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,86 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,44 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,55 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,19 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 88,28 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,63 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 83,97 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 88,7 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 2.351 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 2.174 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 2.336 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 2.312 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 2.128 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 2.227 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 2.261 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 2.085 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 2.190 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 2.233 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 2.062 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 2.165 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 2.203 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 2.046 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 2.134 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,34 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,88 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 95,33 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,17 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 95,91 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 93,75 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,98 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,85 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 92,68 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,7 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,11 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 91,35 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.233 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.852 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.195 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.810 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.146 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.770 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.119 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.755 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.090 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.742 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,3 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,73 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,1 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 95,57 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,89 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 94,76 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,6 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,06 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 118 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 322 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 117 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 318 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 115 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 315 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 114 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 307 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 113 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 304 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,15 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,76 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,46 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,83 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,61 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,34 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 95,76 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,41 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 2.329 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 2.207 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 2.019 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 2.277 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 2.172 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 1.992 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 2.253 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 2.147 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 1.972 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 2.219 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 2.123 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 1.952 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 2.081 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 1.918 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 11 Extremadura From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,77 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,41 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,66 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,74 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,28 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,67 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,28 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,19 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,68 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,29 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.234 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.956 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.425 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.184 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.923 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.401 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.164 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.903 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.386 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.130 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.882 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.374 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.843 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.357 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,76 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,31 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,32 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,87 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,29 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,26 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,34 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,22 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,42 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,22 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,23 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 95 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 251 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 594 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 93 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 249 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 591 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 89 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 244 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 586 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 89 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 241 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 578 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 238 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 561 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,89 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,2 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,49 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,68 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,21 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,65 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 93,68 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,02 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,31 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94,82 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,44 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 2.462 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 2.333 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 2.196 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 2.420 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 2.297 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 2.165 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 2.373 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 2.266 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 2.124 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 2.226 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 2.086 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 2.196 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 2.057 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,29 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,46 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,59 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,39 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,13 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,72 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,41 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,99 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,13 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,67 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.406 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.244 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.800 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.366 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.209 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.774 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.320 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.178 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.737 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.139 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.709 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.114 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.681 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,34 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,44 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,56 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,43 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,06 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,5 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,32 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,94 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,21 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 93,39 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 56 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 89 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 396 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 54 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 88 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 391 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 53 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 88 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 387 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 87 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 377 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 82 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 376 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,43 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,88 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,74 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,64 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,88 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,73 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,75 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,2 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 92,13 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 94,95 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 2.437 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 2.307 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 2.208 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 2.381 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 2.278 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 2.165 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 2.232 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 2.126 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 2.184 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 2.093 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 2.160 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 2.070 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,7 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,74 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,05 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,75 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,29 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 94,67 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 94,79 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 93,63 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,75 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.377 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.208 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.813 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.322 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.179 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.777 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.134 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.746 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.087 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.715 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.065 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.699 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,69 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,69 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,01 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,65 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,3 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 94,52 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,59 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 93,52 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,71 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 60 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 99 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 395 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 59 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 99 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 388 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 98 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 380 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 97 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 378 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 95 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 371 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,33 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,23 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,99 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,2 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,98 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,7 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,96 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,92 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 2.616 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 2.383 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 2.535 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 2.592 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 2.352 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 2.465 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 2.553 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 2.332 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 2.443 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 2.517 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 2.305 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 2.422 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 2.496 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 2.289 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 2.403 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,08 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,7 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,24 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,59 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,86 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,37 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,22 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,73 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,54 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,41 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,06 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,79 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.492 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.921 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.469 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.896 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.431 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.880 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.395 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.858 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.374 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.845 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,08 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,7 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,55 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,87 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,11 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,72 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,26 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,04 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 124 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 462 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 123 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 456 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 122 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 452 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 122 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 447 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 122 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 444 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,19 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,7 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,39 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,84 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 98,39 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,75 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 98,39 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,1 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 2.637 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 2.400 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 2.207 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 2.594 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 2.375 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 2.190 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 2.557 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 2.348 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 2.174 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 2.535 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 2.334 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 2.155 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 2.316 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 2.131 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 11 Extremadura From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,37 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,96 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,23 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,97 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,83 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,5 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,13 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,25 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,64 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,5 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,56 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.515 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.047 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.459 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.472 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.024 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.447 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.436 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.001 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.436 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.415 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.989 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.420 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.976 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.404 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,29 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,88 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,18 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,86 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,75 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,42 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,02 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,17 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,33 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,53 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,23 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 122 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 353 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 748 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 122 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 351 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 743 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 121 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 347 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 738 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 120 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 345 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 735 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 340 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 727 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,43 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,33 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,18 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,3 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,66 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,36 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,73 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,26 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,32 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,19 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 2.709 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 2.554 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 2.388 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 2.661 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 2.517 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 2.365 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 2.626 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 2.496 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 2.336 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 2.469 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 2.306 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 2.442 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 2.291 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,23 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,55 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,04 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,94 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,73 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,82 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,67 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,57 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,61 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,94 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.625 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.439 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.815 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.578 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.406 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.796 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.543 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.385 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.773 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.360 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.751 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.333 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.738 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,21 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,65 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,95 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,88 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,79 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,69 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,76 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,47 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,65 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,76 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 84 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 115 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 573 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 83 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 111 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 569 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 83 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 111 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 563 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 109 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 555 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 109 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 553 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,81 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,52 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,3 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,81 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,52 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,25 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 94,78 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,86 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 94,78 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,51 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 2.714 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 2.599 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 2.464 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 2.676 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 2.577 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 2.435 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 2.556 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 2.405 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 2.520 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 2.383 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 2.494 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 2.361 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,6 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,15 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,82 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,35 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,61 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,96 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,71 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,96 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,82 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.638 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.485 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.879 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.600 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.464 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.852 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.443 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.831 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.410 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.813 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.386 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.796 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,56 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,15 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,56 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,31 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,45 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,98 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,49 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,02 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,58 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 76 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 114 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 585 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 76 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 113 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 583 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 113 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 574 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 110 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 570 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 108 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 565 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,12 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,66 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 99,12 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,12 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,49 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,44 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 94,74 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,58 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 115 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 103 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 117 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 115 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 101 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 117 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 114 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 101 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 117 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 114 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 101 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 116 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 114 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 101 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 114 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,06 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,13 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,06 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 99,13 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,06 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 99,15 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 99,13 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,06 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,44 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 106 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 80 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 106 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 78 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 105 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 78 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 105 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 78 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 105 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 78 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,5 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,06 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,5 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 99,06 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,5 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 99,06 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,5 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 9 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 23 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 9 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 23 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 9 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 23 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 9 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 23 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 9 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 23 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 113 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 96 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 102 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 112 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 96 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 102 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 112 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 96 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 101 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 112 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 96 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 101 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 96 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 99 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 11 Extremadura from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,12 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,12 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,02 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 99,12 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 99,02 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,06 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 106 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 77 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 73 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 105 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 77 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 73 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 105 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 77 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 72 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 105 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 77 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 72 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 77 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 70 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,06 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,06 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,63 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 99,06 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,63 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,89 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 7 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 19 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 29 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 7 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 19 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 29 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 7 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 19 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 29 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 7 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 19 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 29 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 19 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 29 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 122 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 102 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 96 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 121 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 101 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 95 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 121 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 101 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 95 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 101 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 93 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 101 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 93 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,18 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,02 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,96 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,18 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,02 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,96 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99,02 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,88 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 99,02 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,88 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 115 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 93 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 74 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 114 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 92 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 73 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 114 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 92 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 73 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 92 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 71 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 92 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 71 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,13 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,92 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,65 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,13 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,92 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,65 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,92 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,95 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,92 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,95 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 7 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 9 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 22 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 7 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 9 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 22 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 7 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 9 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 22 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 9 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 22 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 9 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 22 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 126 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 109 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 103 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 126 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 109 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 102 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 109 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 100 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 109 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 100 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 109 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 100 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,03 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,09 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,09 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,09 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 117 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 102 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 79 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 117 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 102 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 78 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 102 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 76 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 102 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 76 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 102 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 76 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,73 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,2 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,2 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,2 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 9 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 7 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 24 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 9 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 7 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 24 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 7 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 24 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 7 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 24 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 7 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 24 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 39 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 35 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 35 11 Extremadura De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 39 11 Extremadura De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 35 11 Extremadura De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 35 11 Extremadura De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 39 11 Extremadura De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 35 11 Extremadura De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 35 11 Extremadura De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 39 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 35 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 35 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 39 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 35 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 35 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 33 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 23 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 33 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 23 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 33 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 23 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 33 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 23 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 33 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 23 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 6 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 12 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 6 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 12 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 6 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 12 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 6 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 12 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 6 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 12 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 39 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 37 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 33 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 39 11 Extremadura De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 37 11 Extremadura De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 33 11 Extremadura De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 39 11 Extremadura De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 37 11 Extremadura De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 33 11 Extremadura De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 39 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 37 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 33 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 37 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 33 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 11 Extremadura De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 36 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 25 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 22 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 36 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 25 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 22 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 36 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 25 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 22 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 36 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 25 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 22 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 25 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 22 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 3 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 12 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 11 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 3 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 12 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 11 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 3 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 12 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 11 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 3 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 12 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 11 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 12 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 11 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 11 Extremadura De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 38 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 38 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 35 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 38 11 Extremadura De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 38 11 Extremadura De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 35 11 Extremadura De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 38 11 Extremadura De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 38 11 Extremadura De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 35 11 Extremadura De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 38 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 35 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 38 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 35 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 36 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 34 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 22 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 36 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 34 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 22 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 36 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 34 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 22 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 34 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 22 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 34 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 22 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 4 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 13 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 4 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 13 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 4 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 13 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 4 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 13 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 4 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 13 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 38 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 42 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 37 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 38 11 Extremadura De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 42 11 Extremadura De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 37 11 Extremadura De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 42 11 Extremadura De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 37 11 Extremadura De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 42 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 37 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 42 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 37 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 36 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 38 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 25 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 36 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 38 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 25 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 38 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 25 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 38 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 25 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 38 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 25 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 4 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 12 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 4 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 12 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 4 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 12 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 4 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 12 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 4 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 12 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Extremadura De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2022QI 71.690 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2021QI 70.002 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2020QI 73.097 12 Galicia Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 12 Galicia Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 12 Galicia Total Cohort January 1 Total Survival in the first trimester 2022QII "" 12 Galicia Total Cohort January 1 Total Survival in the first trimester 2022QI 68.126 12 Galicia Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 12 Galicia Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 12 Galicia Total Cohort January 1 Total Survival in the first trimester 2021QII "" 12 Galicia Total Cohort January 1 Total Survival in the first trimester 2021QI 66.633 12 Galicia Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 12 Galicia Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 12 Galicia Total Cohort January 1 Total Survival in the first trimester 2020QII "" 12 Galicia Total Cohort January 1 Total Survival in the first trimester 2020QI 66.505 12 Galicia Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 12 Galicia Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 12 Galicia Total Cohort January 1 Total Survival in the second trimester 2022QII 65.517 12 Galicia Total Cohort January 1 Total Survival in the second trimester 2022QI "" 12 Galicia Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 12 Galicia Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 12 Galicia Total Cohort January 1 Total Survival in the second trimester 2021QII 64.607 12 Galicia Total Cohort January 1 Total Survival in the second trimester 2021QI "" 12 Galicia Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 12 Galicia Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 12 Galicia Total Cohort January 1 Total Survival in the second trimester 2020QII 64.491 12 Galicia Total Cohort January 1 Total Survival in the second trimester 2020QI "" 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2022QIII 63.429 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2021QIII 62.840 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2020QIII 62.652 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2022QIV 61.705 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2021QIV 61.372 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2020QIV 60.891 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Galicia Total Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Galicia Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 12 Galicia Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,03 12 Galicia Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,19 12 Galicia Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 90,98 12 Galicia Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,39 12 Galicia Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,29 12 Galicia Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 88,23 12 Galicia Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 88,48 12 Galicia Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,77 12 Galicia Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 85,71 12 Galicia Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 86,07 12 Galicia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 87,67 12 Galicia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 83,3 12 Galicia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 68.198 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 61.488 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 64.761 12 Galicia Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 58.318 12 Galicia Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 62.276 12 Galicia Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 56.441 12 Galicia Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 60.266 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 54.807 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 58.604 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 53.486 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,96 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,84 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 91,32 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,79 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 88,37 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,13 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 85,93 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 86,99 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 3.492 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 8.514 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 3.365 12 Galicia Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 8.315 12 Galicia Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 3.241 12 Galicia Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 8.166 12 Galicia Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 3.163 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 8.033 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 3.101 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 7.886 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,36 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,66 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,81 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,91 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,58 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,35 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,8 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,62 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2022QII 71.312 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2021QII 69.683 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2020QII 69.240 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 12 Galicia Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 12 Galicia Total Cohort April 1 Total Survival in the first trimester 2022QII 68.153 12 Galicia Total Cohort April 1 Total Survival in the first trimester 2022QI "" 12 Galicia Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 12 Galicia Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 12 Galicia Total Cohort April 1 Total Survival in the first trimester 2021QII 67.163 12 Galicia Total Cohort April 1 Total Survival in the first trimester 2021QI "" 12 Galicia Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 12 Galicia Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 12 Galicia Total Cohort April 1 Total Survival in the first trimester 2020QII 66.866 12 Galicia Total Cohort April 1 Total Survival in the first trimester 2020QI "" 12 Galicia Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 12 Galicia Total Cohort April 1 Total Survival in the second trimester 2022QIII 65.726 12 Galicia Total Cohort April 1 Total Survival in the second trimester 2022QII "" 12 Galicia Total Cohort April 1 Total Survival in the second trimester 2022QI "" 12 Galicia Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 12 Galicia Total Cohort April 1 Total Survival in the second trimester 2021QIII 65.046 12 Galicia Total Cohort April 1 Total Survival in the second trimester 2021QII "" 12 Galicia Total Cohort April 1 Total Survival in the second trimester 2021QI "" 12 Galicia Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 12 Galicia Total Cohort April 1 Total Survival in the second trimester 2020QIII 64.749 12 Galicia Total Cohort April 1 Total Survival in the second trimester 2020QII "" 12 Galicia Total Cohort April 1 Total Survival in the second trimester 2020QI "" 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2022QIV 63.590 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2022QI "" 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2021QIV 63.232 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2021QI "" 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2020QIV 62.762 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2022QI 61.168 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2021QI 60.672 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Galicia Total Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 12 Galicia Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,57 12 Galicia Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,38 12 Galicia Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,57 12 Galicia Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,17 12 Galicia Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,35 12 Galicia Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,51 12 Galicia Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 89,17 12 Galicia Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,74 12 Galicia Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,64 12 Galicia Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 87,78 12 Galicia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,63 12 Galicia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 67.928 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 60.845 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 55.259 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 64.882 12 Galicia Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 58.500 12 Galicia Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 53.060 12 Galicia Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 62.540 12 Galicia Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 56.539 12 Galicia Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 51.260 12 Galicia Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 60.474 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 54.897 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 49.613 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 53.041 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 47.889 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 12 Galicia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,52 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 96,15 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,02 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 92,07 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,92 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,76 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 89,03 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 90,22 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,78 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 87,17 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 86,66 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 3.384 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 8.838 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 13.981 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 3.271 12 Galicia Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 8.663 12 Galicia Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 13.806 12 Galicia Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 3.186 12 Galicia Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 8.507 12 Galicia Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 13.489 12 Galicia Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 3.116 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 8.335 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 13.149 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 8.127 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 12.783 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 12 Galicia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,66 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,02 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,75 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,15 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,25 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,48 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 92,08 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,31 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,05 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,96 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,43 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2022QIII 72.346 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2021QIII 71.848 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2020QIII 70.278 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 12 Galicia Total Cohort July 1 Total Survival in the first trimester 2022QIII 68.747 12 Galicia Total Cohort July 1 Total Survival in the first trimester 2022QII "" 12 Galicia Total Cohort July 1 Total Survival in the first trimester 2022QI "" 12 Galicia Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 12 Galicia Total Cohort July 1 Total Survival in the first trimester 2021QIII 68.398 12 Galicia Total Cohort July 1 Total Survival in the first trimester 2021QII "" 12 Galicia Total Cohort July 1 Total Survival in the first trimester 2021QI "" 12 Galicia Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 12 Galicia Total Cohort July 1 Total Survival in the first trimester 2020QIII 67.253 12 Galicia Total Cohort July 1 Total Survival in the first trimester 2020QII "" 12 Galicia Total Cohort July 1 Total Survival in the first trimester 2020QI "" 12 Galicia Total Cohort July 1 Total Survival in the second trimester 2022QIV 65.688 12 Galicia Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 12 Galicia Total Cohort July 1 Total Survival in the second trimester 2022QII "" 12 Galicia Total Cohort July 1 Total Survival in the second trimester 2022QI "" 12 Galicia Total Cohort July 1 Total Survival in the second trimester 2021QIV 65.732 12 Galicia Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 12 Galicia Total Cohort July 1 Total Survival in the second trimester 2021QII "" 12 Galicia Total Cohort July 1 Total Survival in the second trimester 2021QI "" 12 Galicia Total Cohort July 1 Total Survival in the second trimester 2020QIV 64.614 12 Galicia Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 12 Galicia Total Cohort July 1 Total Survival in the second trimester 2020QII "" 12 Galicia Total Cohort July 1 Total Survival in the second trimester 2020QI "" 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2022QII "" 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2022QI 63.345 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2021QII "" 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2021QI 62.316 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2022QII 61.614 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2022QI "" 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2021QII 60.937 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2021QI "" 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Galicia Total Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Galicia Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 95,03 12 Galicia Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,2 12 Galicia Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,7 12 Galicia Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 90,8 12 Galicia Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 91,49 12 Galicia Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,94 12 Galicia Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 88,17 12 Galicia Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 88,67 12 Galicia Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 85,76 12 Galicia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 86,71 12 Galicia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 70.243 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 69.161 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 59.711 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 66.705 12 Galicia Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 65.766 12 Galicia Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 56.898 12 Galicia Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 63.690 12 Galicia Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 63.157 12 Galicia Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 54.493 12 Galicia Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 60.837 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 52.444 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 59.162 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 51.226 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,96 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,09 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,29 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 90,67 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,32 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,26 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 87,96 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 87,83 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 85,54 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 85,79 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2.103 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 2.687 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 10.567 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2.042 12 Galicia Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 2.632 12 Galicia Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 10.355 12 Galicia Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1.998 12 Galicia Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 2.575 12 Galicia Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 10.121 12 Galicia Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 2.508 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 9.872 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 2.452 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 9.711 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,1 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,95 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,99 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,01 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,83 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,78 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,34 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,42 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 91,25 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,9 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2022QIV 71.639 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2021QIV 71.807 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2020QIV 70.889 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort October 1 Total Survival in the first trimester 2022QIV 67.870 12 Galicia Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 12 Galicia Total Cohort October 1 Total Survival in the first trimester 2022QII "" 12 Galicia Total Cohort October 1 Total Survival in the first trimester 2022QI "" 12 Galicia Total Cohort October 1 Total Survival in the first trimester 2021QIV 68.304 12 Galicia Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 12 Galicia Total Cohort October 1 Total Survival in the first trimester 2021QII "" 12 Galicia Total Cohort October 1 Total Survival in the first trimester 2021QI "" 12 Galicia Total Cohort October 1 Total Survival in the first trimester 2020QIV 67.202 12 Galicia Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 12 Galicia Total Cohort October 1 Total Survival in the first trimester 2020QII "" 12 Galicia Total Cohort October 1 Total Survival in the first trimester 2020QI "" 12 Galicia Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 12 Galicia Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 12 Galicia Total Cohort October 1 Total Survival in the second trimester 2022QII "" 12 Galicia Total Cohort October 1 Total Survival in the second trimester 2022QI 65.549 12 Galicia Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 12 Galicia Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 12 Galicia Total Cohort October 1 Total Survival in the second trimester 2021QII "" 12 Galicia Total Cohort October 1 Total Survival in the second trimester 2021QI 64.505 12 Galicia Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 12 Galicia Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 12 Galicia Total Cohort October 1 Total Survival in the second trimester 2020QII "" 12 Galicia Total Cohort October 1 Total Survival in the second trimester 2020QI "" 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2022QII 63.407 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2021QII 62.843 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2022QIII 61.602 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2022QII "" 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2021QIII 61.335 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2021QII "" 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Galicia Total Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Galicia Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,74 12 Galicia Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,12 12 Galicia Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,8 12 Galicia Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,28 12 Galicia Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,99 12 Galicia Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 88,3 12 Galicia Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 88,65 12 Galicia Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 85,79 12 Galicia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 86,52 12 Galicia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 69.759 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 68.096 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 62.213 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 66.030 12 Galicia Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 64.698 12 Galicia Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 58.726 12 Galicia Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 62.094 12 Galicia Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 56.230 12 Galicia Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 60.073 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 54.699 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 58.349 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 53.325 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,65 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,01 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,4 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,19 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,38 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 88,22 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 87,92 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 85,69 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 85,71 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1.880 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 3.711 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 8.676 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1.840 12 Galicia Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 3.606 12 Galicia Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 8.476 12 Galicia Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 3.455 12 Galicia Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 8.275 12 Galicia Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 3.334 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 8.144 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 3.253 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 8.010 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,87 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,17 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,69 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,1 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,38 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 89,84 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,87 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,66 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,32 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 55.675 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 55.065 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 56.985 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 52.268 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 51.848 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 50.725 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 49.889 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 50.016 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 48.848 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 47.922 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 48.363 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 47.155 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 46.322 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 46.997 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 45.552 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,88 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,16 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 89,01 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,61 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,83 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 85,72 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,07 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,83 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 82,75 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,2 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,35 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,94 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 53.302 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 50.190 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 50.015 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 47.138 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 47.745 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 45.425 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 45.846 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 43.884 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 44.304 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 42.632 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,83 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,92 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,57 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,51 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,01 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,44 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,12 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 84,94 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2.373 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 4.875 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2.253 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 4.710 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2.144 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 4.591 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2.076 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 4.479 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2.018 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 4.365 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,94 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,62 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,35 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,17 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,48 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 91,88 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 85,04 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,54 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 55.177 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 54.716 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 54.333 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 52.222 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 52.390 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 52.067 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 49.916 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 50.387 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 50.064 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 47.921 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 48.684 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 48.202 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 46.766 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 46.270 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 12 Galicia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,64 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,75 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,83 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,47 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,09 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,14 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,85 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,98 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,72 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,47 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,16 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 52.878 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 49.421 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 45.370 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 50.024 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 47.238 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 43.254 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 47.794 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 45.373 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 41.524 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 45.859 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 43.815 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 39.954 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 42.073 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 38.331 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,6 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,58 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,34 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,39 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,81 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,52 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,73 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,66 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,06 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,13 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,49 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2.299 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 5.295 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 8.963 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2.198 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 5.152 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 8.813 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2.122 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 5.014 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 8.540 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2.062 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 4.869 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 8.248 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 4.693 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 7.939 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,61 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,3 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,33 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,3 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,69 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,28 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 89,69 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 91,95 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 92,02 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 88,63 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 88,58 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 55.637 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 55.980 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 55.058 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 52.198 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 52.701 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 52.181 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 49.399 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 50.245 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 49.710 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 48.035 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 47.587 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 46.446 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 46.331 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,82 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,14 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,77 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,79 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,76 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,29 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,81 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,43 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 82,97 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,15 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 54.156 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 54.429 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 49.078 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 50.773 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 51.200 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 46.373 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 48.010 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 48.791 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 44.095 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 46.638 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 42.171 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 45.092 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 41.034 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,75 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,07 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,49 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,65 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,64 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,85 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,69 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 85,93 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 82,85 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,61 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1.481 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.551 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 5.980 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1.425 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.501 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 5.808 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1.389 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.454 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 5.615 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.397 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 5.416 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.354 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 5.297 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,22 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,78 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,12 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,79 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,75 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,9 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90,07 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 90,57 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 87,3 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,58 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 55.049 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 55.849 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 55.524 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 51.502 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 52.515 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 51.971 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 49.928 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 49.447 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 47.982 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 47.948 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 46.295 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 46.552 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,56 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,03 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,6 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,4 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,06 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,91 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,36 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 82,89 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,84 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 53.729 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 53.215 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 50.742 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 50.219 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 49.976 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 47.360 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 47.531 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 44.999 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 45.691 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 43.598 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 44.073 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 42.307 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,47 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,91 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,33 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,32 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,68 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,86 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 85,92 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 82,82 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,38 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1.320 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2.634 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 4.782 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1.283 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2.539 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 4.611 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2.397 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 4.448 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2.291 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 4.350 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2.222 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 4.245 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,2 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,39 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,42 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,02 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 86,98 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,97 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 84,36 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 88,77 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 7.189 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 6.664 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 7.242 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 7.099 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 6.593 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 7.028 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 6.969 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 6.480 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 6.947 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 6.901 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 6.419 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 6.858 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 6.830 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 6.361 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 6.758 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,75 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,93 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,05 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,94 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,24 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,93 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,99 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,32 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,7 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,01 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,45 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,32 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 6.730 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 5.299 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 6.643 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 5.241 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 6.518 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 5.144 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 6.454 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 5.095 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 6.386 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 5.053 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,71 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,91 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,85 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,07 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,9 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,15 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,89 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,36 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 459 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.365 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 456 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.352 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 451 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.336 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 447 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.324 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 444 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.308 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,35 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,05 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,26 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,88 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,39 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,73 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,82 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 7.214 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 6.652 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 6.613 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 7.092 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 6.535 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 6.546 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 7.023 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 6.469 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 6.480 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 6.947 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 6.406 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 6.398 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 6.323 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 6.319 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 12 Galicia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,31 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,24 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,99 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,35 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,25 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,99 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,3 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,3 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,75 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 95,05 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,55 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 6.781 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 5.329 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 4.484 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 6.667 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 5.230 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 4.434 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 6.604 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 5.173 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 4.397 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 6.536 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 5.121 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 4.346 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 5.051 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 4.294 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,32 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,14 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,88 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,39 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,07 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,06 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,39 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,1 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,92 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,78 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,76 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 433 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.323 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.129 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 425 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.305 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.112 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 419 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.296 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.083 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 411 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.285 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.052 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.272 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.025 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,15 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,64 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,2 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 96,77 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,96 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,84 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 94,92 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,13 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,38 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,15 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,12 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 7.473 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 7.155 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 6.848 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 7.374 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 7.047 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 6.751 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 7.213 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 6.906 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 6.641 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 6.798 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 6.557 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 6.714 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 6.493 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,68 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,49 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,58 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,52 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 96,52 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,98 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,01 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,75 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 93,84 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,82 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 7.192 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 6.751 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 5.074 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 7.096 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 6.645 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 5.005 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 6.940 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 6.508 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 4.921 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 6.405 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 4.862 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 6.330 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 4.818 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,67 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,43 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,64 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,5 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,4 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,98 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 94,87 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,82 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 93,76 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,95 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 281 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 404 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.774 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 278 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 402 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.746 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 273 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 398 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.720 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 393 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.695 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 384 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.675 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,93 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,5 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,42 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,15 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,51 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,96 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,28 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,55 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,05 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 94,42 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 7.423 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 7.142 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 6.889 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 7.281 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 7.033 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 6.799 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 6.931 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 6.719 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 6.817 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 6.634 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 6.746 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 6.580 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,09 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,47 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,69 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,05 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,53 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,45 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,3 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 94,46 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,51 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 7.194 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 6.720 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 5.478 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 7.054 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 6.617 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 5.403 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 6.519 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 5.341 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 6.413 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 5.275 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 6.352 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 5.236 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,05 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,47 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,63 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,01 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,5 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,43 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,29 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 94,52 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,58 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 229 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 422 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.411 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 227 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 416 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.396 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 412 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.378 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 404 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.359 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 394 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.344 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,13 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,58 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,94 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,63 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,66 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,73 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 96,31 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 93,36 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 95,25 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 8.263 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 7.756 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 8.295 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 8.198 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 7.679 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 8.178 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 8.101 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 7.598 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 8.123 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 8.053 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 7.545 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 8.069 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 8.001 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 7.502 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 8.014 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,21 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,01 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,59 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,04 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,96 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,93 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,46 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,28 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,28 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,83 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,73 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,61 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 7.660 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 5.647 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 7.599 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 5.589 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 7.510 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 5.522 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 7.466 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 5.478 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 7.415 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 5.452 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,2 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,97 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,04 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,79 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,47 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,01 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,8 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,55 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 603 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2.109 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 599 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2.090 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 591 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.076 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 587 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.067 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 586 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.050 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,34 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,1 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,01 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,44 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,35 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,01 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,18 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,2 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 8.337 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 7.785 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 7.748 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 8.257 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 7.708 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 7.707 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 8.210 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 7.660 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 7.662 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 8.145 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 7.613 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 7.621 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 7.553 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 7.545 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 12 Galicia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,04 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,01 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,47 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,48 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,39 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,89 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,7 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,79 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,36 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,02 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,38 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 7.735 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 5.719 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 5.040 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 7.657 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 5.656 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 5.007 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 7.612 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 5.617 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 4.976 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 7.549 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 5.586 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 4.951 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 5.544 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 4.903 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,99 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,9 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,35 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,41 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,22 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,73 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,6 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,67 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,23 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,94 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,28 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 602 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2.066 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.708 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 600 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2.052 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.700 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 598 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2.043 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.686 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 596 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2.027 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.670 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2.009 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.642 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,67 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,32 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,7 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,34 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,89 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,19 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 99 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,11 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,6 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,24 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,56 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 8.643 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 8.170 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 7.833 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 8.587 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 8.107 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 7.785 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 8.488 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 8.039 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 7.729 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 7.973 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 7.641 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 7.919 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 7.582 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,35 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,23 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,39 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,21 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,4 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,67 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,59 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,55 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,93 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,8 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 8.337 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 7.497 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 5.216 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 8.282 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 7.437 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 5.178 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 8.186 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 7.375 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 5.136 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 7.314 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 5.071 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 7.263 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 5.034 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,34 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,2 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,27 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,19 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,37 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,47 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,56 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,22 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,88 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,51 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 306 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 673 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.617 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 305 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 670 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.607 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 302 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 664 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2.593 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 659 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.570 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 656 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.548 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,67 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,55 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,62 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,69 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,66 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,08 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,92 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,2 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,47 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,36 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 8.572 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 8.263 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 7.927 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 8.492 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 8.204 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 7.885 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 8.141 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 7.795 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 8.063 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 7.717 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 8.020 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 7.659 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,07 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,29 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,47 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,52 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,33 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,58 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,35 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,06 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,62 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 8.271 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 7.658 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 5.639 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 8.192 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 7.603 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 5.611 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 7.544 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 5.539 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 7.472 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 5.475 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 7.430 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 5.431 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,04 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,28 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,5 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,51 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,23 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,57 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,09 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,02 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,31 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 301 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 605 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2.288 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 300 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 601 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2.274 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 597 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.256 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 591 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.242 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 590 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.228 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,67 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,34 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,39 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,68 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,6 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,69 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,99 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 97,52 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,38 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 357 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 321 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 376 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 356 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 318 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 375 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 355 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 318 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 374 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 351 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 318 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 372 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 350 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 318 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 370 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,72 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,07 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,73 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,44 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,07 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,47 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,32 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 99,07 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,94 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,04 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 99,07 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,4 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 321 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 218 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 320 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 217 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 320 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 217 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 317 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 217 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 316 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 217 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,69 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,54 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,69 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 99,54 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,75 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 99,54 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,44 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 99,54 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 36 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 103 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 36 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 101 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 35 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 101 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 34 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 101 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 34 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 101 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,06 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,22 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,06 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 94,44 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,06 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,44 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,06 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 381 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 334 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 355 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 380 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 334 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 355 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 376 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 334 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 353 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 376 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 334 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 352 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 331 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 350 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 12 Galicia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,74 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,69 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,44 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,69 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 99,15 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 99,1 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,59 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 349 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 242 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 231 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 349 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 242 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 231 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 345 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 242 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 230 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 345 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 242 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 230 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 240 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 230 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,85 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,57 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,85 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 99,57 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 99,17 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 99,57 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 32 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 92 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 124 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 31 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 92 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 124 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 31 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 92 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 123 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 31 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 92 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 122 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 91 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 120 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,88 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 96,88 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,19 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,88 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,39 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,91 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,77 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 390 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 343 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 347 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 386 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 343 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 345 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 386 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 343 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 344 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 341 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 342 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 339 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 342 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,97 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,42 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,97 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,14 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99,42 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,56 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,83 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,56 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 365 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 310 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 215 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 361 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 310 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 215 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 361 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 310 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 215 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 308 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 215 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 307 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 215 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,9 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,9 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 99,35 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 99,03 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 25 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 33 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 132 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 25 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 33 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 130 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 25 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 33 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 129 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 33 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 127 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 32 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 127 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,48 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,73 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,21 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,97 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,21 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 388 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 346 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 347 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 388 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 346 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 346 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 344 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 344 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 342 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 344 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 339 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 344 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,71 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,42 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99,14 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,84 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 99,14 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,98 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 99,14 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 367 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 317 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 220 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 367 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 317 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 219 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 316 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 219 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 314 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 219 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 311 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 219 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,55 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 99,68 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 99,55 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 99,05 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 99,55 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,11 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 99,55 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 21 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 29 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 127 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 21 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 29 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 127 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 28 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 125 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 28 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 125 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 28 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 125 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,55 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,43 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,55 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,43 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,55 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,43 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 206 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 196 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 199 12 Galicia De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 205 12 Galicia De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 195 12 Galicia De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 199 12 Galicia De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 203 12 Galicia De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 195 12 Galicia De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 199 12 Galicia De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 202 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 195 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 198 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 202 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 194 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 197 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Galicia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,51 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,49 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,54 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,49 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,06 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 99,49 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 99,5 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,06 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,98 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,99 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 185 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 134 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 184 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 133 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 183 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 133 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 183 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 133 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 183 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 132 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,46 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,25 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,92 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 99,25 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,92 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 99,25 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,92 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,51 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 21 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 62 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 21 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 62 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 20 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 62 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 19 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 62 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 19 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 62 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 95,24 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,48 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 90,48 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 203 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 196 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 191 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 202 12 Galicia De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 196 12 Galicia De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 191 12 Galicia De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 201 12 Galicia De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 196 12 Galicia De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 190 12 Galicia De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 201 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 195 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 189 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 195 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 188 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 12 Galicia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,51 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,01 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,48 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 99,01 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 99,49 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,95 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 99,49 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,43 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 185 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 134 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 134 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 185 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 134 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 134 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 185 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 134 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 133 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 185 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 133 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 132 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 133 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 131 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 12 Galicia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,25 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 99,25 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,51 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 99,25 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,76 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 18 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 62 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 57 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 17 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 62 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 57 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 16 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 62 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 57 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 16 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 62 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 57 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 62 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 57 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 12 Galicia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 94,44 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 88,89 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,89 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 203 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 200 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 192 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 202 12 Galicia De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 200 12 Galicia De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 191 12 Galicia De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 202 12 Galicia De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 199 12 Galicia De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 190 12 Galicia De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 198 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 189 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 196 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 189 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Galicia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,51 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,48 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,51 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,5 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,96 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,44 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,44 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 193 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 174 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 128 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 193 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 174 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 127 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 193 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 173 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 126 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 172 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 125 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 170 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 125 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,22 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,43 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,44 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,85 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,66 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,7 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,66 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 10 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 26 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 64 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 9 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 26 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 64 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 9 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 26 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 64 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 26 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 64 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 26 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 64 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 90 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 90 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 207 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 207 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 202 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 207 12 Galicia De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 206 12 Galicia De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 201 12 Galicia De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 205 12 Galicia De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 200 12 Galicia De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 203 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 200 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 202 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 200 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Galicia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,52 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,5 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,03 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99,01 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,07 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 99,01 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,58 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 99,01 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 198 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 186 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 134 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 198 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 185 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 133 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 184 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 132 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 183 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 132 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 183 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 132 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,46 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,25 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,92 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,51 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,39 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,51 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,39 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,51 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 9 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 21 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 68 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 9 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 21 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 68 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 21 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 68 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 20 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 68 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 19 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 68 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,24 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 90,48 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Galicia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2022QI 170.250 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2021QI 164.017 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2020QI 170.238 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the first trimester 2022QI 161.452 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the first trimester 2021QI 155.700 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the first trimester 2020QI 151.697 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the second trimester 2022QII 154.760 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the second trimester 2021QII 150.224 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the second trimester 2020QII 146.492 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2022QIII 149.129 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2021QIII 145.583 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2020QIII 141.850 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2022QIV 145.093 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2021QIV 141.735 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2020QIV 137.729 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,83 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,93 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 89,11 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,9 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,59 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 86,05 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 87,59 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,76 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 83,32 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 85,22 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 86,41 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 80,9 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 158.529 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 132.874 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 150.133 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 125.468 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 143.757 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 120.699 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 138.408 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 116.680 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 134.584 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 113.515 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,7 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,43 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,68 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,84 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 87,31 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,81 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 84,9 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,43 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 11.721 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 31.143 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 11.319 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 30.232 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 11.003 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 29.525 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 10.721 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 28.903 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 10.509 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 28.220 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,57 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,07 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,87 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,8 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,47 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,81 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,66 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,61 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2022QII 170.804 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2021QII 164.129 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2020QII 158.930 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the first trimester 2022QII 162.475 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the first trimester 2021QII 157.281 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the first trimester 2020QII 152.732 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the second trimester 2022QIII 155.903 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the second trimester 2021QIII 151.746 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the second trimester 2020QIII 147.454 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2022QIV 151.244 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2021QIV 147.340 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2020QIV 142.867 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2022QI 141.862 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2021QI 137.564 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 13 Madrid, Comunidad de Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,12 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,83 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,1 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,28 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,46 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,78 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 88,55 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,77 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,89 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 86,43 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 86,56 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 159.474 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 133.437 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 117.168 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 151.487 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 127.315 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 111.514 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 145.201 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 122.422 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 107.264 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 140.740 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 118.715 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 103.704 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 114.048 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 99.625 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,99 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,41 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,17 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,05 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,75 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,55 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 88,25 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,97 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,51 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,47 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,03 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 11.330 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 30.692 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 41.762 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 10.988 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 29.966 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 41.218 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 10.702 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 29.324 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 40.190 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 10.504 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 28.625 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 39.163 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 27.814 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 37.939 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,98 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,63 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,7 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,46 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,54 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,24 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 92,71 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,27 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,78 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,62 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,85 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2022QIII 171.468 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2021QIII 166.953 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2020QIII 161.758 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the first trimester 2022QIII 162.948 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the first trimester 2021QIII 159.383 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the first trimester 2020QIII 154.718 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the second trimester 2022QIV 157.368 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the second trimester 2021QIV 153.937 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the second trimester 2020QIV 149.134 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2022QI 147.776 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2021QI 143.251 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2022QII 143.241 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2021QII 139.472 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 95,03 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,47 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,65 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,78 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 92,2 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 92,2 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 88,51 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 88,56 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 85,8 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 86,22 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 165.039 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 155.931 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 127.803 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 156.695 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 148.597 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 121.548 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 151.242 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 143.395 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 116.788 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 137.526 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 111.877 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 133.230 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 108.781 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,94 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,3 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,11 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,64 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,96 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,38 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,2 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 87,54 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 85,44 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 85,12 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 6.429 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 11.022 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 33.955 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 6.253 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 10.786 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 33.170 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 6.126 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 10.542 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 32.346 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 10.250 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 31.374 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 10.011 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 30.691 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,26 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,86 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,69 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,29 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,65 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,26 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,4 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,83 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 90,39 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2022QIV 170.560 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2021QIV 167.679 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2020QIV 163.090 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the first trimester 2022QIV 163.715 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the first trimester 2021QIV 160.773 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the first trimester 2020QIV 155.882 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the second trimester 2022QI 153.765 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the second trimester 2021QI 149.146 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2022QII 148.375 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2021QII 144.677 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2022QIII 143.492 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2021QIII 140.621 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,99 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,88 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,58 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,7 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 91,45 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 88,49 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 88,71 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 85,58 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 86,22 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 164.924 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 155.357 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 127.459 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 158.189 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 148.794 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 121.162 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 142.196 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 115.456 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 137.121 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 111.733 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 132.517 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 108.375 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,92 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,78 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 95,06 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,53 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,58 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 88,26 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 87,66 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 85,3 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 85,03 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 5.636 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 12.322 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 35.631 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 5.526 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 11.979 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 34.720 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 11.569 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 33.690 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 11.254 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 32.944 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 10.975 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 32.246 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,05 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,22 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,44 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,89 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,55 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,33 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,46 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 89,07 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90,5 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 121.043 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 117.693 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 120.832 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 112.854 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 109.964 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 103.903 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 106.894 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 105.040 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 99.281 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 101.885 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 100.912 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 95.236 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 98.339 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 97.552 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 91.640 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,23 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,43 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 85,99 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,31 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,25 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 82,16 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 84,17 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 85,74 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 78,82 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 81,24 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 82,89 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 75,84 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 114.042 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 101.727 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 106.200 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 94.718 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 100.498 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 90.340 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 95.716 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 86.668 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 92.333 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 83.805 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,12 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,11 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,12 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 88,81 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 83,93 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 85,2 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 80,96 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 82,38 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 7.001 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 15.966 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 6.654 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 15.246 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 6.396 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 14.700 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 6.169 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 14.244 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 6.006 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 13.747 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,04 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,49 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 91,36 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,07 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,12 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,21 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 85,79 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 86,1 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 121.161 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 117.632 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 113.654 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 113.491 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 111.257 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 107.837 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 107.518 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 106.219 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 103.023 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 103.323 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 102.310 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 98.856 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 97.503 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 94.207 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,67 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,58 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,88 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,74 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,3 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 90,65 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 85,28 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,97 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 86,98 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 82,89 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 82,89 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 114.442 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 101.897 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 89.748 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 107.060 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 96.130 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 84.364 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 101.327 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 91.577 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 80.379 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 97.292 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 88.192 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 77.049 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 83.982 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 73.321 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,55 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,34 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,54 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,87 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 89,56 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 85,01 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,55 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 85,85 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,42 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 81,7 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 6.719 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 15.735 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 23.906 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 6.431 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 15.127 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 23.473 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 6.191 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 14.642 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 22.644 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 6.031 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 14.118 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 21.807 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 13.521 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 20.886 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,71 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,14 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,19 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,14 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,05 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,72 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 89,76 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 89,72 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,22 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 85,93 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,37 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 121.576 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 119.145 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 115.709 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 113.656 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 112.099 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 109.159 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 108.560 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 107.172 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 104.037 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 101.721 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 98.856 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 97.767 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 95.554 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,49 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,09 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,34 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,29 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,95 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 89,91 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,38 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 85,44 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 82,06 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 82,58 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 117.778 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 113.369 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 98.174 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 110.016 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 106.522 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 92.249 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 105.029 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 101.800 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 87.779 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 96.569 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 83.301 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 92.794 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 80.505 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,41 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,96 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,96 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,18 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,8 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,41 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,18 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 84,85 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 81,85 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 82 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3.798 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 5.776 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 17.535 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3.640 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 5.577 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 16.910 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3.531 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 5.372 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 16.258 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 5.152 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 15.555 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 4.973 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 15.049 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,84 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,55 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,44 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 92,97 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,01 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 92,72 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 89,2 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 88,71 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 86,1 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 85,82 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 121.037 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 119.617 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 116.940 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 114.588 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 113.140 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 110.141 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 106.797 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 104.068 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 102.037 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 100.111 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 97.738 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 96.554 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,67 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,59 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,19 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,28 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 88,99 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,3 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 85,61 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 81,71 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 82,57 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 117.795 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 112.031 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 98.600 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 111.446 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 105.867 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 92.565 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 99.880 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 87.268 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 95.388 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 83.875 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 91.318 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 80.825 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,61 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,5 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,88 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,15 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,51 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,14 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 85,07 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 81,51 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 81,97 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 3.242 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 7.586 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 18.340 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 3.142 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 7.273 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 17.576 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 6.917 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 16.800 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 6.649 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 16.236 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 6.420 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 15.729 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,92 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,87 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,83 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,18 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 91,6 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 87,65 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 88,53 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 84,63 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 85,76 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 18.535 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 17.573 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 18.507 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 18.218 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 17.267 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 17.600 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 17.840 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 16.982 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 17.309 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 17.547 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 16.728 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 16.992 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 17.295 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 16.504 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 16.725 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,29 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,26 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 95,1 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,25 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,64 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 93,53 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,67 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,19 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 91,81 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,31 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 93,92 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 90,37 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 16.845 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 12.435 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 16.560 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 12.228 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 16.211 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 12.017 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 15.943 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 11.838 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 15.715 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 11.696 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,31 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,34 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,24 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,64 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,65 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,2 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,29 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,06 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.690 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 5.138 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.658 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 5.039 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.629 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 4.965 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.604 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 4.890 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.580 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 4.808 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,11 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,07 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,39 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,63 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 94,91 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,17 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 93,49 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 93,58 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 18.672 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 17.561 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 16.862 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 18.337 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 17.299 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 16.676 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 18.039 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 17.041 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 16.426 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 17.817 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 16.799 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 16.213 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 16.469 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 15.906 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,21 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,51 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,9 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,61 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,04 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,41 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,42 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,66 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,15 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,78 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,33 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 17.059 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 12.447 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 10.032 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 16.746 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 12.252 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 9.892 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 16.473 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 12.074 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 9.762 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 16.272 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 11.915 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 9.647 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 11.679 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 9.490 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,17 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,43 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,6 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,56 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,31 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,39 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,73 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,16 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,83 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,6 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.613 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 5.114 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 6.830 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.591 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 5.047 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 6.784 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.566 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 4.967 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 6.664 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.545 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 4.884 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 6.566 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 4.790 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 6.416 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,64 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,69 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,33 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,09 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,13 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,57 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,78 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,5 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,13 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 93,66 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 93,94 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 18.584 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 18.033 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 17.445 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 18.304 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 17.778 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 17.178 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 18.074 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 17.531 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 16.937 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 17.176 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 16.598 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 16.882 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 16.360 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,49 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,59 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,47 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,26 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,22 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,09 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,25 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,14 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 93,62 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,78 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 17.629 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 16.207 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 11.842 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 17.358 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 15.967 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 11.667 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 17.137 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 15.742 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 11.510 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 15.423 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 11.291 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 15.156 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 11.135 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,46 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,52 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,52 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,21 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,13 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,2 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,16 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,35 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 93,52 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,03 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 955 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.826 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 5.603 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 946 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.811 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 5.511 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 937 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.789 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 5.427 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.753 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 5.307 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.726 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 5.225 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,06 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,18 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,36 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,12 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,97 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,86 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,72 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 94,52 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 93,25 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 18.303 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 18.045 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 17.367 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 18.113 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 17.828 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 17.142 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 17.499 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 16.805 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 17.181 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 16.554 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 16.908 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 16.318 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,96 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,8 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,7 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,97 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,76 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,21 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,32 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 93,7 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,96 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 17.460 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 16.388 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 11.476 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 17.274 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 16.189 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 11.326 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 15.891 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 11.110 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 15.588 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 10.943 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 15.335 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 10.788 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,93 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,79 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,69 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,97 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,81 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,12 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,36 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 93,57 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 843 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.657 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 5.891 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 839 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.639 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 5.816 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.608 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 5.695 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.593 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 5.611 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.573 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 5.530 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,53 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,91 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,73 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,04 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,67 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,14 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,25 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 94,93 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,87 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 27.058 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 25.345 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 27.356 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 26.799 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 25.078 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 26.679 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 26.462 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 24.821 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 26.397 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 26.159 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 24.579 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 26.132 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 25.939 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 24.338 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 25.891 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,04 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,95 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,53 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,8 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,93 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,49 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,68 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,98 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,53 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,86 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,03 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,64 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 24.374 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 16.604 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 24.136 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 16.424 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 23.828 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 16.250 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 23.552 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 16.093 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 23.357 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 15.952 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,02 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,92 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,76 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,87 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,63 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,92 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,83 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,07 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2.684 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 8.741 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2.663 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 8.654 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2.634 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 8.571 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2.607 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 8.486 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2.582 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 8.386 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,22 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,14 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,06 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,13 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,08 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,2 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,94 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 27.304 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 25.525 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 25.028 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 26.994 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 25.321 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 24.838 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 26.721 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 25.098 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 24.632 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 26.503 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 24.864 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 24.441 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 24.561 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 24.114 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,86 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,2 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,24 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,86 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,33 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,42 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,07 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,41 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,65 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,22 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,35 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 24.646 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 16.926 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 15.036 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 24.368 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 16.770 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 14.911 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 24.115 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 16.619 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 14.782 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 23.914 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 16.473 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 14.677 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 16.276 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 14.496 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,87 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,08 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,17 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,85 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,19 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,31 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,03 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,32 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,61 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,16 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,41 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2.658 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 8.599 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 9.992 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2.626 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 8.551 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 9.927 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2.606 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 8.479 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 9.850 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2.589 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 8.391 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 9.764 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 8.285 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 9.618 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,8 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,44 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,35 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,04 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,6 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,58 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,4 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,58 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,72 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,35 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,26 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 27.618 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 26.350 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 25.308 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 27.318 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 26.094 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 25.090 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 27.086 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 25.845 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 24.884 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 25.525 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 24.542 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 25.255 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 24.315 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,91 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,03 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,14 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,07 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,08 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,32 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,87 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,97 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,84 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,08 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 26.099 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 23.369 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 15.803 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 25.808 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 23.132 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 15.652 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 25.585 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 22.899 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 15.526 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 22.612 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 15.325 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 22.374 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 15.189 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,89 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,99 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,04 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,03 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,99 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,25 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,76 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,98 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,74 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,11 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1.519 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 2.981 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 9.505 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1.510 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 2.962 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 9.438 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1.501 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 2.946 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 9.358 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 2.913 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 9.217 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 2.881 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 9.126 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,41 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,36 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,3 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,82 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,83 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,45 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,72 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,97 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,65 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,01 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 27.488 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 26.502 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 25.386 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 27.298 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 26.311 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 25.215 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 26.008 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 24.907 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 25.713 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 24.656 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 25.428 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 24.411 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,31 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,28 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,33 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,14 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,11 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,02 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,12 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,95 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,16 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 26.079 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 23.787 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 15.375 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 25.895 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 23.608 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 15.268 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 23.328 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 15.087 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 23.064 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 14.930 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 22.808 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 14.787 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,29 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,25 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,3 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,07 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,13 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,96 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,11 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,88 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,18 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1.409 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2.715 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 10.011 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1.403 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2.703 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 9.947 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2.680 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 9.820 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2.649 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 9.726 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2.620 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 9.624 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,57 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,56 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,36 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,71 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,09 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,57 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,15 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,5 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,13 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 2.048 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 1.904 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 1.980 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 2.034 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 1.898 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 1.958 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 2.024 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 1.891 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 1.951 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 2.004 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 1.881 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 1.937 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 1.993 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 1.867 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 1.929 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,32 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,68 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,89 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,83 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,32 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,54 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,85 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,79 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,83 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,31 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,06 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,42 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.845 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.221 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.832 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.216 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.822 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.211 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.804 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.204 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.793 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.192 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,3 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,59 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,75 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 99,18 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,78 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,61 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,18 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,62 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 203 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 683 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 202 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 682 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 202 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 680 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 200 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 677 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 200 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 675 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,51 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,85 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 99,51 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,56 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 98,52 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 99,12 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 98,52 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,83 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 2.100 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 1.921 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 1.877 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 2.091 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 1.916 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 1.873 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 2.068 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 1.907 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 1.866 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 2.051 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 1.895 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 1.859 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 1.880 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 1.850 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,57 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,74 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,79 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,48 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,27 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,41 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,67 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,65 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 99,04 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,87 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,56 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.891 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.265 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.311 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.882 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.262 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.307 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.859 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.255 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.302 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.842 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.245 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.298 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.238 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.292 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,52 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,76 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,69 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,31 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,21 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,31 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,41 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,42 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 99,01 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,87 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 98,55 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 209 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 656 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 566 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 209 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 654 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 566 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 209 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 652 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 564 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 209 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 650 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 561 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 642 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 558 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,7 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,39 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,65 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 99,09 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 99,12 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,87 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,59 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 2.108 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.932 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.842 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 2.093 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 1.923 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 1.838 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 2.078 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 1.909 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 1.832 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 1.895 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 1.822 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 1.885 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 1.813 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,29 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,53 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,78 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,58 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,81 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,46 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,08 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,91 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,57 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,43 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.003 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.697 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.130 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.988 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.690 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.127 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.973 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.676 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.124 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.665 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.118 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.656 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.111 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,25 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,59 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,73 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,5 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,76 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 99,47 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,11 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,94 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,58 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98,32 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 105 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 235 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 712 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 105 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 233 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 711 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 105 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 233 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 708 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 230 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 704 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 229 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 702 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,15 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,86 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,15 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,44 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,87 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,88 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,45 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,6 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 2.110 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.989 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.904 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 2.100 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 1.976 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 1.900 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 1.964 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 1.892 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 1.954 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 1.885 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 1.934 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 1.874 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,53 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,35 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,79 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,74 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99,37 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,24 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 99 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,23 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,42 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.016 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.786 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.145 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.006 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.773 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.143 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.761 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.137 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.752 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.132 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.733 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.126 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,5 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,27 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,83 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,6 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 99,3 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,1 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,86 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,03 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,34 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 94 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 203 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 759 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 94 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 203 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 757 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 203 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 755 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 202 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 753 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 201 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 748 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,74 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,47 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 99,51 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 99,21 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 99,01 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,55 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 1.566 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 1.502 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 1.563 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 1.547 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 1.493 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 1.557 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 1.540 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 1.490 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 1.554 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 1.534 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 1.483 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 1.553 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 1.527 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 1.474 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 1.544 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,79 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,4 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,62 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,34 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,2 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,42 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,96 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,74 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 99,36 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,51 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,14 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,78 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.423 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 887 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.405 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 882 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.398 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 881 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.393 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 877 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.386 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 870 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,74 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,44 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,24 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 99,32 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,89 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,87 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,4 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,08 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 143 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 615 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 142 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 611 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 142 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 609 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 141 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 606 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 141 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 604 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,3 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,35 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 99,3 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,02 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 98,6 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,54 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 98,6 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,21 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 1.567 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 1.490 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 1.509 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 1.562 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 1.488 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 1.508 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 1.557 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 1.481 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 1.507 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 1.550 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 1.472 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 1.498 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 1.449 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 1.487 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,68 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,87 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,93 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,36 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,4 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,87 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,92 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,79 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 99,27 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,25 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,54 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.436 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 902 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.041 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.431 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 901 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.040 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.427 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 897 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.039 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.420 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 890 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.033 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 873 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.026 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,65 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,89 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,9 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,37 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,45 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,81 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,89 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,67 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 99,23 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,78 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 98,56 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 131 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 588 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 468 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 131 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 587 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 468 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 130 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 584 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 468 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 130 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 582 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 465 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 576 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 461 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,83 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,24 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,32 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 99,24 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,98 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 99,36 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,96 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,5 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 1.582 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 1.493 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 1.454 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 1.577 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 1.489 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 1.453 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 1.570 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 1.480 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 1.444 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 1.459 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 1.433 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 1.452 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 1.430 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,68 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,73 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,93 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,24 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,13 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,31 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,72 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,56 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,25 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,35 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.530 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.289 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 854 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.525 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.286 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 853 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.518 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.278 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 849 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.257 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 842 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.250 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 841 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,67 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,77 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,88 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,22 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,15 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 99,41 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,52 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,59 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,97 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98,48 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 52 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 204 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 600 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 52 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 203 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 600 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 52 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 202 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 595 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 202 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 591 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 202 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 589 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,51 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,02 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,17 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 99,02 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,5 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 99,02 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,17 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 1.622 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 1.526 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 1.493 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 1.616 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 1.518 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 1.484 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 1.497 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 1.474 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 1.490 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 1.471 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 1.484 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 1.464 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,63 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,48 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,4 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,1 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,73 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,64 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,53 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,25 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,06 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.574 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.365 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 863 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.568 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.357 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 860 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.336 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 854 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.329 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 853 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.323 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 849 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,62 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,41 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,65 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,88 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,96 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,36 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,84 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,92 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,38 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 48 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 161 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 630 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 48 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 161 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 624 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 161 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 620 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 161 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 618 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 161 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 615 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,05 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,41 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,1 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,62 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Madrid, Comunidad de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2022QI 35.351 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2021QI 33.961 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2020QI 35.373 14 Murcia, Región de Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the first trimester 2022QII "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the first trimester 2022QI 33.397 14 Murcia, Región de Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the first trimester 2021QII "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the first trimester 2021QI 32.056 14 Murcia, Región de Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the first trimester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the first trimester 2020QI 30.905 14 Murcia, Región de Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the second trimester 2022QII 31.869 14 Murcia, Región de Total Cohort January 1 Total Survival in the second trimester 2022QI "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the second trimester 2021QII 30.916 14 Murcia, Región de Total Cohort January 1 Total Survival in the second trimester 2021QI "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the second trimester 2020QII 29.808 14 Murcia, Región de Total Cohort January 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2022QIII 30.682 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2021QIII 29.945 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2020QIII 28.853 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2022QIV 29.801 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2021QIV 29.199 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2020QIV 28.031 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,47 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,39 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 87,37 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,15 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,03 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 84,27 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,79 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,17 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 81,57 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 84,3 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,98 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,24 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 34.007 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 31.017 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 32.104 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 29.196 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 30.617 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 28.119 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 29.465 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 27.212 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 28.616 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 26.523 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,4 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,13 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,03 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,66 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,64 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,73 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 84,15 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,51 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.344 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2.944 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.293 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2.860 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.252 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.797 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.217 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.733 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.185 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.676 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,21 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,15 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,15 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,01 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,55 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,83 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,17 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,9 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2022QII 35.420 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2021QII 34.026 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2020QII 32.456 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the first trimester 2022QII 33.491 14 Murcia, Región de Total Cohort April 1 Total Survival in the first trimester 2022QI "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the first trimester 2021QII 32.541 14 Murcia, Región de Total Cohort April 1 Total Survival in the first trimester 2021QI "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the first trimester 2020QII 31.083 14 Murcia, Región de Total Cohort April 1 Total Survival in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the second trimester 2022QIII 32.056 14 Murcia, Región de Total Cohort April 1 Total Survival in the second trimester 2022QII "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the second trimester 2022QI "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the second trimester 2021QIII 31.307 14 Murcia, Región de Total Cohort April 1 Total Survival in the second trimester 2021QII "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the second trimester 2021QI "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the second trimester 2020QIII 29.977 14 Murcia, Región de Total Cohort April 1 Total Survival in the second trimester 2020QII "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2022QIV 30.966 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2021QIV 30.345 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2020QIV 29.024 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2022QI 29.304 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2021QI 27.940 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 14 Murcia, Región de Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,55 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,64 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,77 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,5 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,01 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,36 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,43 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,18 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,43 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 86,12 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 86,09 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 34.106 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 31.055 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 26.779 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 32.228 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 29.637 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 25.491 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 30.839 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 28.474 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 24.523 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 29.775 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 27.569 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 23.748 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 26.612 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 22.840 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 14 Murcia, Región de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,49 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,43 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,19 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,42 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,69 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,58 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,3 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,77 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,68 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,69 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,29 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.314 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2.971 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 5.677 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.263 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2.904 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 5.592 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.217 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2.833 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 5.454 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.191 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2.776 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 5.276 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2.692 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 5.100 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 14 Murcia, Región de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,12 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,74 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,5 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,62 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,36 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,07 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90,64 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,44 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 92,94 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,61 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 89,84 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2022QIII 35.662 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2021QIII 34.995 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2020QIII 34.000 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the first trimester 2022QIII 33.598 14 Murcia, Región de Total Cohort July 1 Total Survival in the first trimester 2022QII "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the first trimester 2022QI "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the first trimester 2021QIII 33.068 14 Murcia, Región de Total Cohort July 1 Total Survival in the first trimester 2021QII "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the first trimester 2021QI "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the first trimester 2020QIII 32.134 14 Murcia, Región de Total Cohort July 1 Total Survival in the first trimester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the second trimester 2022QIV 32.137 14 Murcia, Región de Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the second trimester 2022QII "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the second trimester 2022QI "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the second trimester 2021QIV 31.747 14 Murcia, Región de Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the second trimester 2021QII "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the second trimester 2021QI "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the second trimester 2020QIV 30.753 14 Murcia, Región de Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the second trimester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2022QI 30.525 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2021QI 29.500 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2022QII 29.552 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2021QII 28.763 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,21 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,49 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,51 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 90,12 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,72 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,45 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 87,23 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,76 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 84,45 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,6 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 34.543 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 33.917 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 30.804 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 32.519 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 32.022 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 29.011 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 31.082 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 30.723 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 27.733 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 29.527 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 26.568 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 28.575 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 25.884 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,14 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,41 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,18 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,98 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,58 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,03 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 87,06 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,25 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 84,25 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,03 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1.119 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.078 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 3.196 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1.079 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.046 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 3.123 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1.055 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.024 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3.020 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 998 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.932 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 977 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.879 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,43 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,03 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,72 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,28 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,99 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,49 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,58 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,74 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,63 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 90,08 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2022QIV 35.285 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2021QIV 34.897 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2020QIV 33.910 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the first trimester 2022QIV 33.473 14 Murcia, Región de Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the first trimester 2022QII "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the first trimester 2022QI "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the first trimester 2021QIV 33.168 14 Murcia, Región de Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the first trimester 2021QII "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the first trimester 2021QI "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the first trimester 2020QIV 32.111 14 Murcia, Región de Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the first trimester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the second trimester 2022QII "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the second trimester 2022QI 31.730 14 Murcia, Región de Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the second trimester 2021QII "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the second trimester 2021QI 30.657 14 Murcia, Región de Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the second trimester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2022QII 30.557 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2021QII 29.773 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2022QIII 29.587 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2021QIII 28.971 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,86 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,05 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,69 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,92 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,41 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,56 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,8 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,78 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 85,43 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 34.279 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 33.478 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 30.534 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 32.487 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 31.777 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 28.849 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 30.386 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 27.494 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 29.246 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 26.674 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 28.313 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 25.943 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,77 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,92 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,48 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,76 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,04 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,36 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 87,36 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,57 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,96 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1.006 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.419 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 3.376 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 986 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.391 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 3.262 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.344 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 3.163 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.311 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 3.099 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.274 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 3.028 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,01 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,03 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,62 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,71 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,69 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 92,39 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 91,8 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 89,78 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 89,69 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 25.693 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 24.981 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 25.774 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 23.861 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 23.224 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 21.650 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 22.479 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 22.184 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 20.659 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 21.404 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 21.293 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 19.818 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 20.623 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 20.630 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 19.096 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,87 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,97 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 84 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,49 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 88,8 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 80,15 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 83,31 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 85,24 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 76,89 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 80,27 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 82,58 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 74,09 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 24.900 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 23.533 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 23.112 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 21.847 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 21.766 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 20.858 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 20.720 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 20.016 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 19.965 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 19.398 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,82 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,84 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,41 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 88,63 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 83,21 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 85,06 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 80,18 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 82,43 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 793 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.448 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 749 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.377 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 713 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.326 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 684 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.277 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 658 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.232 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,45 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,1 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 89,91 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 91,57 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 86,25 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 88,19 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 82,98 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 85,08 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 25.695 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 24.982 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 23.866 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 23.911 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 23.606 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 22.576 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 22.589 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 22.450 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 21.558 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 21.615 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 21.590 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 20.676 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 20.661 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 19.741 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,06 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,49 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,59 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 87,91 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 89,86 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 90,33 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 84,12 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,42 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 86,63 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 82,7 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 82,72 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 24.926 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 23.433 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 20.503 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 23.188 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 22.115 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 19.288 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 21.908 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 21.023 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 18.390 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 20.955 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 20.211 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 17.657 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 19.353 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 16.863 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,03 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,38 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,07 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 87,89 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,72 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 89,69 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,07 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,25 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,12 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,59 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 82,25 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 769 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.549 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3.363 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 723 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.491 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3.288 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 681 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.427 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 3.168 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 660 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.379 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 3.019 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.308 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.878 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 94,02 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,26 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,77 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 88,56 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 92,12 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,2 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 85,83 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 89,03 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 89,77 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 84,44 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 85,58 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 25.562 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 25.380 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 24.897 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 23.666 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 23.570 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 23.158 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 22.409 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 22.414 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 21.899 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 21.315 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 20.806 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 20.448 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 20.142 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,58 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,87 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,02 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,67 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 88,31 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 87,96 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 83,98 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 83,57 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 80,57 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 80,9 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 24.946 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 24.843 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 23.338 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 23.086 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 23.062 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 21.667 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 21.848 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 21.925 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 20.494 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 20.847 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 19.473 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 19.995 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 18.850 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,54 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,83 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 92,84 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,58 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 88,25 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 87,81 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 83,91 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 83,44 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 80,49 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 80,77 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 616 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 537 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.559 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 580 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 508 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.491 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 561 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 489 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.405 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 468 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.333 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 453 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.292 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 94,16 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 94,6 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 95,64 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 91,07 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 91,06 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 90,12 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 87,15 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 85,5 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 84,36 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 82,87 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 25.491 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 25.462 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 24.886 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 23.824 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 23.846 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 23.181 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 22.525 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 21.883 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 21.471 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 21.083 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 20.604 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 20.354 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,46 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,65 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,15 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,47 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,93 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,33 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 84,72 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 80,92 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 81,79 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 24.965 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 24.592 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 23.231 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 23.314 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 22.999 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 21.627 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 21.722 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 20.408 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 20.697 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 19.660 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 19.864 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 18.983 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,39 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,52 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,1 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,33 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,85 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,16 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84,63 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 80,77 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 81,71 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 526 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 870 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.655 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 510 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 847 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.554 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 803 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.475 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 774 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.423 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 740 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.371 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,96 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,36 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 93,9 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,3 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 89,12 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 88,97 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 85,98 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 85,06 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 82,84 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 4.038 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 3.819 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 4.060 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 3.981 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 3.750 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 3.849 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 3.907 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 3.693 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 3.793 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 3.854 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 3.642 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 3.729 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 3.798 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 3.600 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 3.668 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,59 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,19 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 94,8 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,76 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,7 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 93,42 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,44 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,37 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 91,85 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 94,06 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,27 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 90,34 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.824 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 3.282 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3.769 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 3.219 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3.698 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 3.168 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3.647 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 3.127 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3.594 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3.092 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,56 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,08 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,71 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,53 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,37 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,28 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,99 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,21 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 214 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 537 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 212 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 531 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 209 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 525 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 207 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 515 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 204 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 508 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,07 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,88 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,66 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,77 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,73 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,9 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 95,33 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,6 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 4.039 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 3.836 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 3.614 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 3.967 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 3.766 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 3.576 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 3.907 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 3.720 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 3.529 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 3.838 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 3.665 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 3.485 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 3.605 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 3.403 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,22 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,18 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,95 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,73 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,98 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,65 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,02 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,54 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,43 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,98 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,16 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3.827 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 3.328 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.690 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 3.758 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 3.264 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.656 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 3.701 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 3.221 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.617 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 3.633 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 3.171 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.592 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 3.117 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.527 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,2 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,08 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,74 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,71 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,78 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,29 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,93 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,28 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,36 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,66 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 93,94 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 212 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 508 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 924 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 209 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 502 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 920 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 206 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 499 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 912 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 205 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 494 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 893 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 488 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 876 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,58 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,82 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,57 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,17 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,23 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,7 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,7 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,24 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,65 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,06 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,81 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 4.201 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 4.083 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 3.889 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 4.105 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 4.015 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 3.821 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 3.984 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 3.915 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 3.741 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 3.851 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 3.659 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 3.798 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 3.610 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,71 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,33 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,25 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 94,83 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 95,89 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,19 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 94,32 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,09 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 93,02 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 92,83 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 4.022 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.895 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3.310 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3.929 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3.829 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 3.247 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3.809 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3.731 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3.175 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3.667 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3.100 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3.618 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 3.055 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,69 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,31 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,1 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 94,7 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 95,79 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 95,92 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 94,15 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 93,66 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 92,89 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 92,3 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 179 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 188 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 579 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 176 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 186 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 574 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 175 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 184 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 566 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 184 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 559 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 180 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 555 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,32 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,94 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,14 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,77 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,87 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,75 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,87 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,55 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,74 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,85 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 4.087 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 3.981 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 3.878 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 3.991 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 3.921 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 3.818 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 3.852 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 3.733 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 3.793 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 3.681 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 3.740 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 3.640 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,65 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,49 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,45 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,76 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,26 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,28 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 94,92 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 93,95 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,86 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 3.913 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3.773 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3.247 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 3.819 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3.716 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3.195 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3.650 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3.122 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3.594 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3.075 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3.542 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3.044 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,6 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,49 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,4 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,74 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,15 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,26 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,7 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 93,88 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,75 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 174 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 208 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 631 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 172 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 205 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 623 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 202 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 611 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 199 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 606 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 198 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 596 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,85 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,56 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,73 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,12 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,83 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,67 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 96,04 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,19 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,45 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 5.313 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 4.847 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 5.231 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 5.250 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 4.773 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 5.101 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 5.181 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 4.732 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 5.053 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 5.126 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 4.707 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 5.006 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 5.086 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 4.668 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 4.969 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,81 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,47 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,51 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,52 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,63 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,6 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,48 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,11 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,7 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,73 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,31 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,99 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 4.999 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 3.965 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 4.941 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 3.897 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 4.874 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 3.862 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 4.823 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 3.842 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 4.786 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3.808 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,84 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,28 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,5 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,4 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,48 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,9 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,74 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,04 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 314 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 882 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 309 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 876 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 307 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 870 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 303 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 865 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 300 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 860 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,41 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,32 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,77 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,64 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,5 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,07 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 95,54 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,51 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 5.366 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 4.901 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 4.681 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 5.298 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 4.862 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 4.638 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 5.249 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 4.836 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 4.600 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 5.206 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 4.791 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 4.575 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 4.739 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 4.512 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,73 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,2 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,08 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,82 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,67 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,27 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,02 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,76 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,74 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,69 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,39 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 5.056 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 4.059 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3.359 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 4.990 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 4.023 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3.322 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 4.941 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 4.001 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3.294 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 4.902 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 3.960 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3.279 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 3.915 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3.233 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,69 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,11 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,9 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,73 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,57 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,06 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,95 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,56 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,62 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,45 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,25 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 310 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 842 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.322 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 308 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 839 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.316 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 308 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 835 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.306 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 304 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 831 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.296 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 824 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.279 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,35 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,64 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,55 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,35 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,17 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,79 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,06 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,69 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,03 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,86 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,75 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 5.561 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 5.213 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 4.916 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 5.495 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 5.169 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 4.865 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 5.416 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 5.107 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 4.824 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 5.050 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 4.751 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 4.998 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 4.727 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,81 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,16 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,96 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,39 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,97 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,13 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,87 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,64 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,88 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,16 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 5.259 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 4.885 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3.930 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 5.193 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 4.842 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 3.879 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 5.118 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 4.781 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3.847 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 4.729 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3.782 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 4.679 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 3.766 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,75 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,12 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,7 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,32 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,87 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,89 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,81 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,23 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,78 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,83 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 302 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 328 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 986 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 302 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 327 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 986 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 298 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 326 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 977 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 321 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 969 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 319 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 961 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,7 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,68 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,39 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,09 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,87 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,28 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,26 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,46 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 5.385 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 5.153 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 4.845 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 5.340 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 5.105 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 4.812 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 5.059 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 4.745 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 5.001 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 4.715 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 4.953 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 4.686 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,16 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,07 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,32 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,18 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,94 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,05 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,32 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,12 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,72 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 5.096 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 4.830 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3.833 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 5.053 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 4.784 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3.805 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 4.738 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3.745 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 4.681 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3.722 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 4.635 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3.701 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,16 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,05 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,27 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,1 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,7 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,92 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,1 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,96 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,56 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 289 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 323 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.012 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 287 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 321 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.007 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 321 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.000 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 320 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 993 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 318 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 985 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,31 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,38 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,51 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 99,38 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,81 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 99,07 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,12 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 98,45 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,33 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 206 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 217 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 215 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 204 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 212 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 213 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 201 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 210 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 211 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 198 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 206 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 209 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 195 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 205 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 207 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,03 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,7 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,07 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,57 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,77 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,14 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,12 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,93 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,21 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 94,66 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,47 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,28 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 188 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 162 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 186 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 158 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 183 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 156 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 180 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 152 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 177 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 151 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,94 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,53 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,34 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,3 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,74 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 93,83 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,15 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,21 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 18 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 55 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 18 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 54 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 18 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 54 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 18 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 54 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 18 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 54 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,18 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,18 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,18 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,18 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 217 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 207 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 201 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 212 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 207 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 199 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 209 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 201 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 199 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 206 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 200 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 197 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 200 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 193 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,7 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,31 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,1 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,93 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,62 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,01 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,62 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,02 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 199 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 156 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 156 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 194 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 156 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 154 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 192 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 150 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 154 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 189 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 149 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 152 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 149 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 149 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,49 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,72 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,48 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,15 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,72 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,97 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,51 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,44 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,51 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,51 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 18 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 51 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 45 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 18 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 51 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 45 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 17 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 51 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 45 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 17 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 51 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 45 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 51 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 44 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,44 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 94,44 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,78 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 229 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 228 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 203 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 225 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 223 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 199 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 223 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 221 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 198 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 219 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 193 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 218 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 193 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,25 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,81 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,03 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,38 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 96,93 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,54 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,05 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,07 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,61 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,07 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 213 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 212 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 151 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 210 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 207 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 147 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 208 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 205 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 146 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 203 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 142 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 202 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 142 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,59 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,64 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 97,35 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,65 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,7 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,69 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,75 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,04 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,28 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,04 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 16 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 16 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 52 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 15 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 16 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 52 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 15 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 16 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 52 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 16 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 51 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 16 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 51 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 93,75 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,75 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,08 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,08 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 217 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 210 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 208 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 215 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 205 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 207 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 203 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 203 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 202 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 201 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 200 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 198 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,08 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,62 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,52 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,67 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,6 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,19 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,63 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,24 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,19 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 206 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 200 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 150 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 204 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 195 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 149 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 193 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 146 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 192 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 144 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 190 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 142 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,03 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,5 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,33 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,5 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,33 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,67 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 11 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 10 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 58 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 11 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 10 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 58 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 10 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 57 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 10 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 57 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 10 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 56 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,28 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,28 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,55 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 101 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 97 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 93 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 101 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 97 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 92 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 101 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 97 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 92 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 100 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 97 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 91 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 99 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 96 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 91 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,92 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,92 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 99,01 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,85 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,02 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,97 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,85 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 96 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 75 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 96 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 75 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 96 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 75 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 95 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 75 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 94 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 74 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,96 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,92 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,67 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 5 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 22 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 5 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 22 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 5 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 22 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 5 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 22 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 5 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 22 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 103 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 94 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 103 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 100 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 94 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 102 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 100 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 91 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 101 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 99 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 91 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 99 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 91 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 14 Murcia, Región de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,03 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 96,81 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,06 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 99 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,81 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 99 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,81 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 98 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 79 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 71 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 98 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 79 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 71 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 97 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 79 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 68 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 96 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 78 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 68 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 78 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 68 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,98 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 95,77 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,96 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,73 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,77 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 98,73 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,77 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 5 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 21 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 23 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 5 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 21 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 23 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 5 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 21 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 23 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 5 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 21 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 23 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 21 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 23 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 109 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 91 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 95 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 107 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 91 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 91 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 105 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 90 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 91 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 90 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 91 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 90 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 91 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,17 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,79 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,33 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,9 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 95,79 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,9 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,79 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,9 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,79 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 103 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 82 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 75 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 101 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 82 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 71 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 99 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 81 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 71 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 81 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 71 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 81 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 71 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,06 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,67 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,12 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,78 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 94,67 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,78 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,67 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,78 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,67 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 6 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 9 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 20 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 6 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 9 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 20 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 6 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 9 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 20 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 9 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 20 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 9 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 20 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 105 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 91 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 93 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 103 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 91 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 93 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 91 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 93 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 90 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 93 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 90 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 93 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,1 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,9 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,9 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 99 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 83 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 73 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 97 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 83 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 73 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 83 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 73 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 82 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 73 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 82 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 73 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,98 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,8 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,8 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 6 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 8 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 20 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 6 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 8 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 20 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 8 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 20 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 8 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 20 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 8 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 20 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Murcia, Región de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2022QI 14.719 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2021QI 14.334 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2020QI 14.803 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the first trimester 2022QI 13.988 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the first trimester 2021QI 13.696 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the first trimester 2020QI 13.609 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the second trimester 2022QII 13.410 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the second trimester 2021QII 13.163 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the second trimester 2020QII 13.140 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2022QIII 13.055 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2021QIII 12.850 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2020QIII 12.817 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2022QIV 12.713 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2021QIV 12.540 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2020QIV 12.512 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,03 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,55 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 91,93 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,11 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,83 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 88,77 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 88,69 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,65 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 86,58 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 86,37 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 87,48 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 84,52 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 14.108 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 12.698 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 13.392 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 12.092 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 12.827 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 11.589 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 12.486 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 11.302 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 12.152 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 11.019 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,92 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 95,23 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,92 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,27 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 88,5 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,01 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 86,14 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 86,78 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 611 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.636 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 596 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.604 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 583 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.574 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 569 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.548 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 561 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.521 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,55 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,04 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 95,42 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,21 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 93,13 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,62 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 91,82 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,97 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2022QII 14.673 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2021QII 14.342 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2020QII 14.120 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the first trimester 2022QII 13.946 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the first trimester 2021QII 13.690 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the first trimester 2020QII 13.567 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the second trimester 2022QIII 13.504 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the second trimester 2021QIII 13.289 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the second trimester 2020QIII 13.189 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2022QIV 13.101 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2021QIV 12.921 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2020QIV 12.845 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2022QI 12.536 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2021QI 12.472 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,05 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,45 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,08 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,03 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,66 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,41 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 89,29 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,09 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,97 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 87,41 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 88,33 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 14.078 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 12.717 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 10.727 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 13.366 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 12.096 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 10.242 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 12.932 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 11.722 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 9.927 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 12.548 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 11.382 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 9.658 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 11.036 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 9.355 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,94 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,12 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,48 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,86 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,18 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,54 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 89,13 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,5 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 90,03 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 86,78 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 87,21 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 595 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.625 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3.393 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 580 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.594 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3.325 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 572 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.567 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 3.262 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 553 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.539 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 3.187 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.500 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 3.117 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,48 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,09 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 96,13 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,43 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,14 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 92,94 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,71 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,93 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 92,31 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,87 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2022QIII 14.761 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2021QIII 14.530 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2020QIII 14.245 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the first trimester 2022QIII 14.068 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the first trimester 2021QIII 13.870 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the first trimester 2020QIII 13.693 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the second trimester 2022QIV 13.554 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the second trimester 2021QIV 13.387 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the second trimester 2020QIV 13.245 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2022QI 12.939 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2021QI 12.829 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2022QII 12.622 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2021QII 12.519 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 95,31 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,46 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 96,12 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,82 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 92,13 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 92,98 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 89,05 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 90,06 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 86,87 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 87,88 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 14.272 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 13.920 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 12.635 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 13.586 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 13.271 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 12.111 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 13.086 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 12.798 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 11.697 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 12.360 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 11.313 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 12.049 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 11.028 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 95,19 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,34 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,85 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,69 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,94 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 92,58 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,79 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 89,54 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 86,56 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 87,28 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 489 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 610 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.610 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 482 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 599 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.582 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 468 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 589 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.548 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 579 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.516 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 573 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.491 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,57 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,2 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,26 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,71 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,56 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,15 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 94,92 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,16 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,93 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,61 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2022QIV 14.686 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2021QIV 14.648 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2020QIV 14.376 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the first trimester 2022QIV 14.029 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the first trimester 2021QIV 14.017 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the first trimester 2020QIV 13.741 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the second trimester 2022QI 13.461 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the second trimester 2021QI 13.255 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2022QII 13.002 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2021QII 12.829 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2022QIII 12.704 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2021QIII 12.573 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,53 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,69 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,58 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,9 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 92,2 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 88,76 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 89,24 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 86,73 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 87,46 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 14.237 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 14.033 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 12.592 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 13.593 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 13.419 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 11.993 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 12.878 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 11.539 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 12.433 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 11.144 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 12.144 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 10.913 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,48 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,62 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 95,24 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,77 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 91,64 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 88,6 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 88,5 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 86,54 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 86,67 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 449 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 615 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.784 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 436 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 598 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.748 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 583 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.716 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 569 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.685 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 560 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.660 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,1 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,24 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,98 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,8 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,19 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 92,52 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,45 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 91,06 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,05 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 10.364 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 10.218 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 10.475 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 9.665 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 9.611 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 9.367 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 9.156 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 9.138 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 8.949 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 8.828 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 8.845 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 8.655 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 8.520 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 8.563 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 8.383 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,26 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,06 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 89,42 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,34 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,43 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 85,43 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,18 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 86,56 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 82,63 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 82,21 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 83,8 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 80,03 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 10.042 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 9.462 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 9.357 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 8.882 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 8.857 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 8.430 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 8.542 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 8.161 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 8.240 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 7.900 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,18 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,87 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,2 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,09 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,06 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,25 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 82,06 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,49 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 322 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 756 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 308 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 729 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 299 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 708 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 286 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 684 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 280 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 663 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,65 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,43 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,86 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,65 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,82 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 90,48 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 86,96 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 87,7 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 10.305 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 10.216 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 9.981 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 9.647 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 9.625 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 9.477 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 9.233 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 9.246 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 9.123 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 8.865 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 8.910 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 8.810 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 8.554 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 8.473 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,61 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,21 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,95 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,6 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,51 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,4 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,03 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,22 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,27 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 83,73 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 84,89 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 10.005 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 9.468 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 8.069 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 9.359 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 8.899 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 7.621 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 8.953 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 8.546 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 7.322 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 8.599 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 8.231 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 7.070 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 7.908 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 6.792 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,54 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 93,99 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,45 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,49 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,26 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,74 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 85,95 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,93 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,62 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 83,52 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,17 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 300 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 748 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.912 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 288 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 726 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.856 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 280 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 700 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.801 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 266 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 679 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.740 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 646 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.681 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,06 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,07 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,33 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,58 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,19 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,67 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,78 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 86,36 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,92 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 10.353 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 10.278 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 10.114 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 9.692 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 9.647 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 9.593 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 9.223 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 9.197 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 9.179 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 8.782 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 8.798 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 8.493 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 8.515 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,62 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,86 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,85 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,09 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,48 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,76 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,44 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,99 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 82,63 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,19 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 10.126 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 10.009 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 9.375 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 9.471 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 9.389 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 8.879 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 9.012 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 8.947 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 8.493 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 8.540 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 8.138 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 8.256 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 7.873 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,53 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,81 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,71 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,39 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,59 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,32 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,81 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 82,49 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,98 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 227 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 269 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 739 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 221 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 258 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 714 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 211 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 250 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 686 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 242 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 660 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 237 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 642 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,36 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,91 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,62 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 92,95 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,94 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 92,83 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 89,96 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 89,31 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 88,1 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 86,87 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 10.262 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 10.346 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 10.182 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 9.649 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 9.749 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 9.580 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 9.224 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 9.130 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 8.820 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 8.750 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 8.547 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 8.508 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,03 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,23 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,09 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,16 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,67 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,25 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 85,94 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 82,61 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,56 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 10.064 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 10.023 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 9.419 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 9.462 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 9.442 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 8.844 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 8.931 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 8.422 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 8.540 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 8.062 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 8.275 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 7.845 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,02 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,2 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,9 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,11 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,42 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,2 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 85,59 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 82,56 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,29 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 198 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 323 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 763 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 187 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 307 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 736 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 293 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 708 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 280 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 688 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 272 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 663 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 94,44 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,05 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,46 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 90,71 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,79 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 86,69 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,17 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 84,21 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 86,89 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 1.621 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 1.510 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 1.576 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 1.605 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 1.494 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 1.532 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 1.570 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 1.459 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 1.507 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 1.558 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 1.448 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 1.493 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 1.542 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 1.435 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 1.477 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,01 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,94 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,21 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,85 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,62 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,62 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,11 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,89 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,73 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,13 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,03 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,72 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.545 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.220 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.529 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.207 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.497 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.178 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.486 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.169 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.470 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.157 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,96 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,93 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,89 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,56 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,18 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,82 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,15 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,84 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 76 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 290 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 76 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 287 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 73 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 281 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 72 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 279 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 72 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 278 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,97 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,05 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,9 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 94,74 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,21 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,74 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,86 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 1.569 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 1.487 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 1.517 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 1.533 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 1.451 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 1.491 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 1.521 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 1.439 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 1.481 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 1.507 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 1.421 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 1.464 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 1.407 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 1.445 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,71 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 97,58 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,29 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,94 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,77 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,63 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,05 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,56 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,51 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,62 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,25 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.470 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.197 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 977 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.436 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.167 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 957 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.424 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.156 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 949 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.412 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.141 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 943 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.127 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 931 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,69 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,49 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 97,95 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,87 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,57 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,13 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,05 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,32 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,52 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,15 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,29 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 99 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 290 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 540 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 97 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 284 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 534 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 97 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 283 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 532 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 95 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 280 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 521 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 280 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 514 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,98 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,93 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,89 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,98 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,59 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,52 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,96 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,55 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,48 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,55 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,19 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 1.607 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 1.573 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 1.537 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 1.591 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 1.559 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 1.519 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 1.568 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 1.544 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 1.503 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 1.524 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 1.485 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 1.514 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 1.471 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,11 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,83 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,57 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,16 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,79 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,88 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,62 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,25 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,71 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.524 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.470 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.270 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.509 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.456 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.252 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.487 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.442 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.240 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.422 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.225 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.412 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.215 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,02 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,05 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,58 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,57 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,1 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,64 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,73 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,46 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,05 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,67 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 83 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 103 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 267 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 82 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 103 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 267 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 81 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 102 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 263 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 102 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 260 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 102 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 256 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,8 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,59 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,03 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,5 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 99,03 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,38 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 99,03 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,88 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 1.612 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 1.569 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 1.548 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 1.590 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 1.552 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 1.531 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 1.540 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 1.512 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 1.515 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 1.489 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 1.503 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 1.483 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,64 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,92 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,9 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,15 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,67 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,56 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,19 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,79 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,8 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.523 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.478 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.219 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.502 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.461 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.208 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.449 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.192 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.425 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.174 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.414 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.168 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,62 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,85 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,1 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,04 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,79 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,41 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,31 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,67 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,82 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 89 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 91 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 329 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 88 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 91 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 323 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 91 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 320 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 90 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 315 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 89 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 315 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,88 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,18 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,26 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 98,9 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,74 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 97,8 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 95,74 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 2.480 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 2.366 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 2.503 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 2.465 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 2.352 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 2.463 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 2.432 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 2.328 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 2.438 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 2.418 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 2.319 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 2.424 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 2.400 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 2.305 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 2.408 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,4 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,41 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,4 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,06 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,39 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,4 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,5 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,01 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,84 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,77 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,42 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,2 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.299 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.846 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.285 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.834 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.253 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.813 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.239 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.804 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.223 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.794 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,39 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,35 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,21 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,39 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,72 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,69 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,18 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 181 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 520 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 180 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 518 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 179 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 515 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 179 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 515 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 177 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 511 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,45 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,62 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,9 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,04 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 98,9 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 99,04 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,79 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,27 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 2.535 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 2.401 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 2.387 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 2.503 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 2.377 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 2.364 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 2.488 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 2.367 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 2.351 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 2.467 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 2.354 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 2.338 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 2.339 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 2.321 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,74 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,04 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,15 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,58 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,49 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,32 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,04 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,95 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,42 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,24 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.362 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.881 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.517 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.331 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.860 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.500 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.316 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.850 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.493 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.298 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.840 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.483 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.831 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.470 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,69 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,88 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,88 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,05 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,35 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,42 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,29 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,82 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,76 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,34 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,9 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 173 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 520 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 870 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 172 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 517 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 864 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 172 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 517 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 858 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 169 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 514 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 855 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 508 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 851 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,42 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,42 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,31 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,42 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,42 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,62 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,69 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,85 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,28 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,69 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,82 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 2.534 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 2.437 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 2.364 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 2.519 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 2.422 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 2.352 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 2.497 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 2.405 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 2.335 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 2.392 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 2.319 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 2.374 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 2.306 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,41 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,38 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,49 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,54 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,69 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,77 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,15 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,1 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,41 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,55 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.376 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.225 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.831 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.361 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.210 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.822 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.342 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.193 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.807 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.182 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.794 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.165 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.784 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,37 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,33 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,51 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,57 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,56 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,69 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,07 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,98 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,3 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,43 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 158 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 212 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 533 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 158 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 212 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 530 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 155 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 212 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 528 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 210 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 525 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 209 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 522 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,44 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,1 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,06 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 99,06 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,5 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 98,58 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,94 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 2.540 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 2.471 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 2.404 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 2.518 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 2.455 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 2.389 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 2.437 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 2.373 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 2.407 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 2.350 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 2.395 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 2.342 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,13 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,35 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,38 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,62 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,71 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,41 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,75 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,92 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,42 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.401 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.297 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.792 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.380 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.281 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.780 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.264 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.765 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.234 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.748 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.222 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.740 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,13 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,3 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,33 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,56 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,49 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,26 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,54 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,73 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,1 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 139 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 174 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 612 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 138 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 174 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 609 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 173 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 608 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 173 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 602 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 173 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 602 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,28 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,51 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 99,43 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,35 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 99,43 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,37 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 99,43 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,37 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 172 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 162 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 170 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 172 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 161 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 169 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 171 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 160 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 168 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 170 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 160 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 168 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 170 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 159 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 168 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,38 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,41 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,42 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,77 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,82 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,84 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,77 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,82 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,84 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,15 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,82 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 146 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 113 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 146 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 112 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 145 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 111 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 144 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 111 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 144 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 111 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,12 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,32 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,23 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,63 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,23 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,63 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,23 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 26 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 49 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 26 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 49 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 26 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 49 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 26 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 49 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 26 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 48 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,96 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 179 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 161 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 155 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 178 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 160 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 155 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 177 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 160 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 155 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 177 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 159 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 155 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 159 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 155 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,44 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,38 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,88 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,38 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,88 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,76 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,76 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 163 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 115 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 106 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 162 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 114 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 106 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 161 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 114 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 106 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 161 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 114 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 106 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 114 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 106 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,39 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,13 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,77 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,13 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,77 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 99,13 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 99,13 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 16 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 46 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 49 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 16 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 46 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 49 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 16 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 46 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 49 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 16 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 45 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 49 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 45 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 49 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,83 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,83 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 179 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 162 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 149 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 178 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 162 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 149 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 178 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 161 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 149 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 161 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 149 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 161 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 149 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,44 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,44 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,38 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99,38 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 99,38 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 164 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 143 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 103 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 163 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 143 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 103 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 163 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 143 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 103 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 143 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 103 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 143 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 103 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,39 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,39 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 15 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 19 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 46 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 15 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 19 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 46 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 15 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 18 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 46 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 18 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 46 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 18 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 46 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,74 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 94,74 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 94,74 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 184 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 181 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 163 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 184 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 180 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 163 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 180 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 163 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 180 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 163 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 179 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 163 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,45 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,45 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 99,45 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,9 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 167 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 160 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 108 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 167 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 160 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 108 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 160 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 108 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 160 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 108 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 159 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 108 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 99,38 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 17 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 21 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 55 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 17 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 20 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 55 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 20 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 55 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 20 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 55 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 20 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 55 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,24 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 95,24 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,24 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,24 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 82 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 78 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 79 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 81 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 78 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 78 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 81 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 78 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 78 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 81 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 78 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 77 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 81 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 78 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 76 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,78 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,73 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,78 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,73 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,78 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,47 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,78 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,2 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 76 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 57 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 75 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 57 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 75 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 57 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 75 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 57 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 75 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 57 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,68 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,68 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,68 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,68 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 6 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 21 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 6 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 21 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 6 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 21 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 6 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 21 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 6 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 21 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 85 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 77 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 80 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 85 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 77 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 80 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 85 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 77 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 79 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 85 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 77 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 78 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 77 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 78 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,75 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,5 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,5 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 78 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 56 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 58 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 78 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 56 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 58 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 78 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 56 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 57 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 78 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 56 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 56 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 56 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 56 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,28 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,55 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,55 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 7 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 21 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 22 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 7 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 21 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 22 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 7 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 21 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 22 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 7 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 21 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 22 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 21 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 22 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 88 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 80 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 81 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 88 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 80 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 80 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 88 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 80 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 79 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 80 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 78 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 80 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 78 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,77 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,53 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,3 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,3 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 82 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 73 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 56 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 82 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 73 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 55 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 82 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 73 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 54 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 73 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 53 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 73 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 53 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,21 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,43 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,64 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,64 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 6 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 7 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 25 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 6 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 7 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 25 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 6 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 7 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 25 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 7 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 25 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 7 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 25 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 88 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 81 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 79 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 88 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 81 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 78 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 80 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 77 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 80 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 77 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 80 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 77 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,73 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,77 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,47 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,77 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,47 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,77 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,47 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 82 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 75 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 54 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 82 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 75 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 53 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 74 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 52 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 74 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 52 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 74 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 52 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,15 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,67 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,3 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,67 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,3 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,67 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,3 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 6 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 6 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 25 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 6 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 6 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 25 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 6 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 25 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 6 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 25 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 6 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 25 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Navarra, Comunidad Foral de De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2022QI 52.663 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2021QI 52.092 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2020QI 53.710 16 País Vasco Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 16 País Vasco Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 16 País Vasco Total Cohort January 1 Total Survival in the first trimester 2022QII "" 16 País Vasco Total Cohort January 1 Total Survival in the first trimester 2022QI 50.218 16 País Vasco Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 16 País Vasco Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 16 País Vasco Total Cohort January 1 Total Survival in the first trimester 2021QII "" 16 País Vasco Total Cohort January 1 Total Survival in the first trimester 2021QI 49.844 16 País Vasco Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 16 País Vasco Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 16 País Vasco Total Cohort January 1 Total Survival in the first trimester 2020QII "" 16 País Vasco Total Cohort January 1 Total Survival in the first trimester 2020QI 49.748 16 País Vasco Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 16 País Vasco Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 16 País Vasco Total Cohort January 1 Total Survival in the second trimester 2022QII 48.060 16 País Vasco Total Cohort January 1 Total Survival in the second trimester 2022QI "" 16 País Vasco Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 16 País Vasco Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 16 País Vasco Total Cohort January 1 Total Survival in the second trimester 2021QII 48.115 16 País Vasco Total Cohort January 1 Total Survival in the second trimester 2021QI "" 16 País Vasco Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 16 País Vasco Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 16 País Vasco Total Cohort January 1 Total Survival in the second trimester 2020QII 48.213 16 País Vasco Total Cohort January 1 Total Survival in the second trimester 2020QI "" 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2022QIII 46.612 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2022QII "" 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2022QI "" 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2021QIII 46.816 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2021QII "" 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2021QI "" 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2020QIII 46.921 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2022QIV 45.496 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2022QII "" 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2022QI "" 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2021QIV 45.714 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2021QII "" 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2021QI "" 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2020QIV 45.757 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort January 1 Total Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,36 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,68 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 92,62 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,26 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,37 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 89,77 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 88,51 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,87 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 87,36 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 86,39 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 87,76 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 85,19 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 50.203 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 44.307 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 47.836 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 42.259 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 45.737 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 40.689 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 44.339 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 39.529 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 43.261 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 38.572 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,29 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 95,38 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 91,1 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,83 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 88,32 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,22 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 86,17 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 87,06 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2.460 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 7.785 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2.382 16 País Vasco Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 7.585 16 País Vasco Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2.323 16 País Vasco Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 7.426 16 País Vasco Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2.273 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 7.287 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2.235 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 7.142 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,83 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,43 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 94,43 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,39 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 92,4 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,6 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 90,85 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 91,74 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2022QII 52.362 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2021QII 51.939 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2020QII 51.683 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 16 País Vasco Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 16 País Vasco Total Cohort April 1 Total Survival in the first trimester 2022QII 49.779 16 País Vasco Total Cohort April 1 Total Survival in the first trimester 2022QI "" 16 País Vasco Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 16 País Vasco Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 16 País Vasco Total Cohort April 1 Total Survival in the first trimester 2021QII 49.824 16 País Vasco Total Cohort April 1 Total Survival in the first trimester 2021QI "" 16 País Vasco Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 16 País Vasco Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 16 País Vasco Total Cohort April 1 Total Survival in the first trimester 2020QII 49.912 16 País Vasco Total Cohort April 1 Total Survival in the first trimester 2020QI "" 16 País Vasco Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 16 País Vasco Total Cohort April 1 Total Survival in the second trimester 2022QIII 48.079 16 País Vasco Total Cohort April 1 Total Survival in the second trimester 2022QII "" 16 País Vasco Total Cohort April 1 Total Survival in the second trimester 2022QI "" 16 País Vasco Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 16 País Vasco Total Cohort April 1 Total Survival in the second trimester 2021QIII 48.278 16 País Vasco Total Cohort April 1 Total Survival in the second trimester 2021QII "" 16 País Vasco Total Cohort April 1 Total Survival in the second trimester 2021QI "" 16 País Vasco Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 16 País Vasco Total Cohort April 1 Total Survival in the second trimester 2020QIII 48.431 16 País Vasco Total Cohort April 1 Total Survival in the second trimester 2020QII "" 16 País Vasco Total Cohort April 1 Total Survival in the second trimester 2020QI "" 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2022QIV 46.783 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2022QII "" 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2022QI "" 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2021QIV 46.993 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2021QII "" 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2021QI "" 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2020QIV 47.117 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2022QII "" 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2022QI 45.447 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2021QII "" 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2021QI 45.624 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort April 1 Total Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 16 País Vasco Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,07 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,93 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,57 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,82 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,95 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,71 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 89,35 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,48 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 91,17 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 87,5 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 88,28 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 49.995 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 44.068 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 39.296 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 47.478 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 42.124 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 37.731 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 45.825 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 40.719 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 36.550 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 44.572 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 39.587 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 35.514 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 38.210 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 34.351 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 16 País Vasco Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,97 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,59 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,02 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,66 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,4 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 93,01 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 89,15 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,83 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 90,38 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 86,71 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 87,42 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2.367 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 7.871 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 12.387 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2.301 16 País Vasco Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 7.700 16 País Vasco Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 12.181 16 País Vasco Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2.254 16 País Vasco Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 7.559 16 País Vasco Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 11.881 16 País Vasco Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2.211 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 7.406 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 11.603 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 7.237 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 11.273 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 16 País Vasco Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,21 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,83 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,34 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 95,23 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,04 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,92 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 93,41 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,09 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,67 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,95 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,01 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2022QIII 52.117 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2021QIII 52.233 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2020QIII 51.841 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 16 País Vasco Total Cohort July 1 Total Survival in the first trimester 2022QIII 49.822 16 País Vasco Total Cohort July 1 Total Survival in the first trimester 2022QII "" 16 País Vasco Total Cohort July 1 Total Survival in the first trimester 2022QI "" 16 País Vasco Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 16 País Vasco Total Cohort July 1 Total Survival in the first trimester 2021QIII 50.065 16 País Vasco Total Cohort July 1 Total Survival in the first trimester 2021QII "" 16 País Vasco Total Cohort July 1 Total Survival in the first trimester 2021QI "" 16 País Vasco Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 16 País Vasco Total Cohort July 1 Total Survival in the first trimester 2020QIII 49.894 16 País Vasco Total Cohort July 1 Total Survival in the first trimester 2020QII "" 16 País Vasco Total Cohort July 1 Total Survival in the first trimester 2020QI "" 16 País Vasco Total Cohort July 1 Total Survival in the second trimester 2022QIV 48.231 16 País Vasco Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 16 País Vasco Total Cohort July 1 Total Survival in the second trimester 2022QII "" 16 País Vasco Total Cohort July 1 Total Survival in the second trimester 2022QI "" 16 País Vasco Total Cohort July 1 Total Survival in the second trimester 2021QIV 48.496 16 País Vasco Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 16 País Vasco Total Cohort July 1 Total Survival in the second trimester 2021QII "" 16 País Vasco Total Cohort July 1 Total Survival in the second trimester 2021QI "" 16 País Vasco Total Cohort July 1 Total Survival in the second trimester 2020QIV 48.298 16 País Vasco Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 16 País Vasco Total Cohort July 1 Total Survival in the second trimester 2020QII "" 16 País Vasco Total Cohort July 1 Total Survival in the second trimester 2020QI "" 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2022QII "" 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2022QI 46.770 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2021QII "" 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2021QI 46.693 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2022QII 45.440 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2022QI "" 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2021QII 45.621 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2021QI "" 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort July 1 Total Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 95,6 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,85 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 96,24 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 92,54 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 92,85 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 93,17 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 89,54 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 90,07 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 86,99 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 88 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 50.640 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 50.094 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 43.904 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 48.377 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 47.967 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 42.130 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 46.818 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 46.440 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 40.687 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 44.760 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 39.285 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 43.464 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 38.352 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 95,53 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,75 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,96 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 92,45 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 92,71 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 92,67 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 89,35 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 89,48 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 86,76 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 87,35 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1.477 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 2.139 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 7.937 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1.445 16 País Vasco Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 2.098 16 País Vasco Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 7.764 16 País Vasco Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1.413 16 País Vasco Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 2.056 16 País Vasco Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 7.611 16 País Vasco Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 2.010 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 7.408 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.976 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 7.269 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,83 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,08 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,82 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,67 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,12 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,89 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,97 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,34 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 92,38 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,58 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2022QIV 51.823 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2021QIV 52.164 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2020QIV 51.957 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort October 1 Total Survival in the first trimester 2022QIV 49.887 16 País Vasco Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 16 País Vasco Total Cohort October 1 Total Survival in the first trimester 2022QII "" 16 País Vasco Total Cohort October 1 Total Survival in the first trimester 2022QI "" 16 País Vasco Total Cohort October 1 Total Survival in the first trimester 2021QIV 50.215 16 País Vasco Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 16 País Vasco Total Cohort October 1 Total Survival in the first trimester 2021QII "" 16 País Vasco Total Cohort October 1 Total Survival in the first trimester 2021QI "" 16 País Vasco Total Cohort October 1 Total Survival in the first trimester 2020QIV 49.941 16 País Vasco Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 16 País Vasco Total Cohort October 1 Total Survival in the first trimester 2020QII "" 16 País Vasco Total Cohort October 1 Total Survival in the first trimester 2020QI "" 16 País Vasco Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 16 País Vasco Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 16 País Vasco Total Cohort October 1 Total Survival in the second trimester 2022QII "" 16 País Vasco Total Cohort October 1 Total Survival in the second trimester 2022QI 48.268 16 País Vasco Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 16 País Vasco Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 16 País Vasco Total Cohort October 1 Total Survival in the second trimester 2021QII "" 16 País Vasco Total Cohort October 1 Total Survival in the second trimester 2021QI 48.118 16 País Vasco Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 16 País Vasco Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 16 País Vasco Total Cohort October 1 Total Survival in the second trimester 2020QII "" 16 País Vasco Total Cohort October 1 Total Survival in the second trimester 2020QI "" 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2022QII 46.559 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2022QI "" 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2021QII 46.781 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2021QI "" 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2022QIII 45.327 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2022QII "" 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2022QI "" 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2021QIII 45.660 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2021QII "" 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2021QI "" 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort October 1 Total Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 96,26 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 96,26 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 96,12 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 92,53 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 92,61 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 89,26 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 90,04 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 86,89 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 87,88 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 50.550 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 49.618 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 43.299 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 48.642 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 47.733 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 41.454 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 45.852 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 39.845 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 44.210 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 38.656 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 43.032 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 37.685 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 96,23 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 96,2 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 95,74 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 92,41 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 92,02 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 89,1 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 89,28 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 86,73 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 87,03 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1.273 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2.546 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 8.658 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1.245 16 País Vasco Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2.482 16 País Vasco Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 8.487 16 País Vasco Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2.416 16 País Vasco Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 8.273 16 País Vasco Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2.349 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 8.125 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2.295 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 7.975 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,8 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,49 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,02 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,89 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,55 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 92,26 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,84 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 90,14 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,11 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 37.458 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 37.426 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 38.159 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 35.179 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 35.331 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 34.492 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 33.241 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 33.780 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 33.123 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 31.926 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 32.609 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 31.983 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 30.928 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 31.628 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 30.942 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,92 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,4 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 90,39 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,74 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,26 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 86,8 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,23 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,13 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 83,82 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 82,57 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 84,51 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 81,09 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 36.026 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 33.410 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 33.821 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 31.486 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 31.933 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 30.066 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 30.660 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 29.005 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 29.689 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 28.135 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,88 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,24 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,64 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,99 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,11 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,82 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 82,41 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 84,21 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.432 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 4.016 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.358 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 3.845 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.308 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 3.714 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.266 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 3.604 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.239 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 3.493 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,83 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,74 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 91,34 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,48 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,41 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,74 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 86,52 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 86,98 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 37.041 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 37.231 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 36.858 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 34.669 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 35.287 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 35.231 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 33.097 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 33.861 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 33.883 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 31.923 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 32.716 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 32.683 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 31.341 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 31.371 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 16 País Vasco From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,6 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,78 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,59 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,35 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,95 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,93 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,18 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,87 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,67 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 84,18 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,11 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 35.711 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 33.229 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 29.286 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 33.396 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 31.429 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 27.818 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 31.868 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 30.117 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 26.715 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 30.730 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 29.089 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 25.753 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 27.840 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 24.707 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,52 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,58 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,99 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,24 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,63 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,22 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,05 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,54 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,94 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 83,78 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,36 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.330 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 4.002 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 7.572 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.273 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 3.858 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 7.413 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.229 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 3.744 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 7.168 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.193 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 3.627 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 6.930 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 3.501 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 6.664 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,71 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,4 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,9 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,41 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,55 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,66 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 89,7 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,63 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,52 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 87,48 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 88,01 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 36.673 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 37.206 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 37.088 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 34.512 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 35.170 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 35.279 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 33.074 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 33.760 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 33.805 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 32.219 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 32.380 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 30.997 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 31.429 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,11 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,53 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,12 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 90,19 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,74 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,15 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,6 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 87,31 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,31 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,74 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 35.807 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 36.114 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 32.973 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 33.678 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 34.112 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 31.303 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 32.267 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 32.735 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 29.956 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 31.225 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 28.687 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 30.033 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 27.841 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,05 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,46 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,94 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 90,11 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,64 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,85 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,46 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 87 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,16 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,44 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 866 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.092 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 4.115 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 834 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.058 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 3.976 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 807 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.025 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3.849 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 994 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 3.693 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 964 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 3.588 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,3 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,89 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,62 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,19 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,86 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,54 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,03 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 89,74 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 88,28 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 87,19 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 36.491 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 37.188 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 37.181 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 34.678 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 35.382 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 35.281 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 33.611 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 33.634 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 32.066 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 32.435 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 30.947 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 31.437 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,03 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,14 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,89 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,38 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,46 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 86,23 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,24 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 83,22 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,55 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 35.772 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 35.676 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 32.848 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 33.983 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 33.931 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 31.094 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 32.218 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 29.620 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 30.734 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 28.538 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 29.661 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 27.654 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,11 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,66 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,31 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,17 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 86,15 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,88 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 83,14 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,19 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 719 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.512 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 4.333 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 695 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.451 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 4.187 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.393 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 4.014 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.332 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 3.897 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.286 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 3.783 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,66 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,97 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,63 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,13 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,64 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 88,1 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 89,94 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 85,05 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 87,31 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 5.709 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 5.565 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 5.864 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 5.629 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 5.490 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 5.686 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 5.516 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 5.393 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 5.601 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 5.444 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 5.327 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 5.521 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 5.382 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 5.268 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 5.463 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,6 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,65 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,96 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,62 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,91 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,52 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,36 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,72 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,15 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 94,27 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,66 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,16 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 5.390 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 4.327 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 5.310 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 4.262 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 5.198 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 4.179 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 5.129 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 4.126 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 5.073 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 4.082 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,52 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,5 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,44 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,58 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,16 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,35 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,12 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,34 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 319 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.238 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 319 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.228 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 318 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.214 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 315 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.201 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 309 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.186 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,19 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 99,69 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,06 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 98,75 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,01 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,87 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,8 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 5.749 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 5.583 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 5.552 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 5.637 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 5.493 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 5.479 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 5.567 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 5.440 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 5.415 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 5.497 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 5.364 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 5.365 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 5.274 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 5.277 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 16 País Vasco From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,05 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,39 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,69 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,83 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,44 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,53 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,62 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,08 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,63 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,47 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,05 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 5.441 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 4.289 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3.666 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 5.334 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 4.212 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3.614 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 5.265 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 4.169 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3.582 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 5.198 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 4.111 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3.553 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 4.042 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3.495 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,03 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,2 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,58 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,77 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,2 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,71 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,53 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,85 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,92 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,24 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,34 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 308 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.294 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.886 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 303 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.281 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.865 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 302 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.271 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.833 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 299 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.253 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.812 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.232 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.782 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,38 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,89 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,05 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,22 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,19 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,08 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,83 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,08 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95,21 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,49 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 5.761 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 5.738 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 5.616 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 5.690 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 5.674 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 5.546 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 5.605 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 5.596 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 5.486 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 5.494 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 5.396 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 5.441 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 5.332 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,77 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,88 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,75 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,29 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,53 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,69 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,75 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,08 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,82 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,94 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 5.575 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 5.444 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 4.338 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 5.504 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 5.380 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 4.285 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 5.421 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 5.307 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 4.237 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 5.210 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 4.165 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 5.157 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 4.119 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,73 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,82 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,78 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,24 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,48 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,67 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,7 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,01 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,73 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,95 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 186 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 294 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.278 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 186 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 294 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.261 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 184 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 289 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.249 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 284 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.231 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 284 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.213 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,67 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,92 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,3 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,73 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,6 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,32 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,6 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 94,91 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 5.716 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 5.667 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 5.610 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 5.648 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 5.587 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 5.550 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 5.492 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 5.468 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 5.409 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 5.401 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 5.342 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 5.334 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,81 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,59 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,93 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,91 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,47 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,45 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,27 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 94,27 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,08 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 5.559 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 5.345 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 4.219 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 5.493 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 5.266 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 4.171 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 5.175 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 4.105 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 5.093 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 4.051 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 5.031 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 4.000 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,81 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,52 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,86 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,82 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,3 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,29 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,02 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 94,13 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,81 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 157 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 322 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.391 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 155 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 321 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.379 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 317 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.363 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 316 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.350 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 311 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.334 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,73 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,69 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,14 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,45 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,99 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 98,14 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,05 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,58 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 95,9 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 8.711 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 8.347 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 8.880 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 8.629 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 8.271 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 8.768 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 8.523 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 8.194 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 8.689 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 8.464 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 8.135 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 8.625 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 8.412 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 8.080 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 8.565 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,06 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,09 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,74 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,84 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,17 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,85 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,16 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,46 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,13 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,57 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,8 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,45 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 8.084 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 6.078 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 8.006 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 6.021 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 7.908 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 5.958 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 7.853 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 5.914 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 7.805 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 5.877 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,04 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,06 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,82 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,03 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,14 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,3 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,55 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,69 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 627 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2.269 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 623 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2.250 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 615 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.236 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 611 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.221 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 607 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.203 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,36 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,16 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,09 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,55 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,45 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,88 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,81 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,09 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 8.782 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 8.384 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 8.501 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 8.684 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 8.306 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 8.432 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 8.628 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 8.242 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 8.371 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 8.578 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 8.184 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 8.312 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 8.107 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 8.221 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 16 País Vasco From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,88 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,07 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,19 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,25 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,31 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,47 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,68 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,61 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,78 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,7 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,71 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 8.131 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 6.070 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 5.791 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 8.037 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 6.006 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 5.747 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 7.982 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 5.958 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 5.706 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 7.935 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 5.917 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 5.666 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 5.862 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 5.609 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,84 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,95 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,24 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,17 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,15 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,53 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,59 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,48 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,84 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,57 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,86 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 651 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2.314 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.710 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 647 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2.300 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.685 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 646 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2.284 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.665 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 643 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2.267 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.646 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2.245 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.612 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,39 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,39 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,08 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,23 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,7 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,34 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,77 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,97 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,64 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,02 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,38 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 8.907 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 8.537 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 8.407 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 8.846 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 8.471 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 8.346 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 8.779 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 8.398 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 8.289 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 8.319 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 8.201 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 8.265 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 8.148 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,32 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,23 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,27 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,56 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,37 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,6 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,45 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,55 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,81 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,92 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 8.529 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 7.869 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 6.107 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 8.468 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 7.810 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 6.060 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 8.404 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 7.741 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 6.017 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 7.672 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 5.958 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 7.622 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 5.921 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,28 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,25 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,23 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,53 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,37 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,53 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,5 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,56 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,86 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,95 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 378 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 668 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.300 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 378 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 661 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.286 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 375 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 657 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2.272 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 647 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.243 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 643 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.227 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,95 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,39 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 99,21 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,35 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,78 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,86 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,52 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,26 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,83 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 8.828 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 8.543 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 8.422 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 8.775 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 8.486 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 8.370 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 8.410 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 8.278 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 8.330 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 8.210 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 8.285 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 8.156 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,4 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,33 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,38 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,44 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,29 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,51 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,48 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,98 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,84 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 8.475 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 7.918 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 5.777 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 8.423 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 7.863 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 5.738 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 7.791 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 5.671 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 7.716 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 5.621 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 7.674 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 5.586 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,39 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,31 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,32 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,4 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,17 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,45 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,3 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,92 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,69 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 353 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 625 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2.645 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 352 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 623 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2.632 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 619 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.607 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 614 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.589 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 611 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.570 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,72 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,68 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,51 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 99,04 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,56 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 98,24 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,88 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 97,76 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,16 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 551 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 518 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 548 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 549 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 516 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 544 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 548 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 513 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 542 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 546 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 511 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 537 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 542 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 506 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 536 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,64 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,61 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,27 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,46 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,03 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,91 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 99,09 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,65 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,99 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,37 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,68 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,81 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 491 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 350 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 489 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 348 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 488 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 345 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 487 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 344 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 484 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 339 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,59 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,43 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,39 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,57 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 99,19 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,29 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,57 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,86 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 60 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 168 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 60 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 168 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 60 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 168 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 59 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 167 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 58 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 167 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 98,33 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 99,4 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,67 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 99,4 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 553 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 513 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 530 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 552 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 510 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 528 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 550 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 508 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 523 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 548 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 503 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 522 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 501 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 520 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 16 País Vasco from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,82 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,42 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,62 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,46 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,03 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,68 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 99,1 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,05 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,49 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,66 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,11 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 502 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 340 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 389 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 501 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 337 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 388 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 500 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 336 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 385 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 499 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 332 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 384 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 330 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 382 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,8 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,12 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,74 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,6 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,82 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,97 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 99,4 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,65 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,71 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,06 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 98,2 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 51 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 173 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 141 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 51 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 173 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 140 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 50 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 172 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 138 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 49 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 171 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 138 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 171 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 138 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,29 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,04 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,42 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,87 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,08 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,84 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,87 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,84 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,87 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 539 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 518 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 500 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 537 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 517 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 494 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 536 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 510 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 493 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 508 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 491 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 507 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 488 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,63 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,81 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,8 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,44 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,46 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,6 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,07 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,2 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,88 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,6 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 506 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 458 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 342 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 504 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 457 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 338 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 503 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 450 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 337 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 448 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 335 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 447 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 332 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,6 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,78 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,83 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,41 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,25 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,54 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,82 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,95 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,6 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,08 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 33 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 60 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 158 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 33 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 60 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 156 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 33 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 60 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 156 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 60 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 156 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 60 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 156 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,73 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,73 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,73 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,73 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 544 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 534 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 509 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 542 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 529 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 509 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 526 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 507 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 525 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 505 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 524 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 503 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,63 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,06 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,5 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99,61 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,31 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 99,21 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,13 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,82 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 512 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 468 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 315 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 511 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 463 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 315 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 460 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 313 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 459 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 311 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 458 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 310 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,8 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,93 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,29 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 99,37 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,08 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,73 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,86 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,41 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 32 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 66 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 194 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 31 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 66 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 194 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 66 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 194 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 66 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 194 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 66 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 193 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,88 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 99,48 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 234 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 236 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 259 16 País Vasco De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 232 16 País Vasco De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 236 16 País Vasco De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 258 16 País Vasco De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 232 16 País Vasco De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 235 16 País Vasco De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 258 16 País Vasco De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 232 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 234 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 255 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 232 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 232 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 251 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,15 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,61 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,15 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,58 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,61 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 99,15 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 99,15 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,46 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 99,15 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,31 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,91 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 212 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 142 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 210 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 142 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 210 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 141 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 210 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 140 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 210 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 139 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,06 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,06 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 99,3 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 99,06 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,59 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 99,06 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,89 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 22 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 94 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 22 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 94 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 22 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 94 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 22 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 94 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 22 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 93 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,94 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 237 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 228 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 242 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 237 16 País Vasco De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 228 16 País Vasco De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 242 16 País Vasco De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 237 16 País Vasco De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 227 16 País Vasco De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 239 16 País Vasco De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 237 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 226 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 235 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 224 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 235 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 16 País Vasco De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,56 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,76 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 99,12 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,11 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,25 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,11 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 210 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 140 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 164 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 210 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 140 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 164 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 210 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 139 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 162 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 210 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 138 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 158 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 136 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 158 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,29 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,78 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,57 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,34 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,14 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,34 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 27 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 88 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 78 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 27 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 88 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 78 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 27 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 88 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 77 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 27 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 88 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 77 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 88 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 77 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 16 País Vasco De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,72 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,72 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,72 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 237 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 234 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 230 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 237 16 País Vasco De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 233 16 País Vasco De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 229 16 País Vasco De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 237 16 País Vasco De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 232 16 País Vasco De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 225 16 País Vasco De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 230 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 225 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 230 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 224 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,57 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,57 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,15 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,83 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,29 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,83 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,29 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,39 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 223 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 209 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 144 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 223 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 208 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 144 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 223 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 207 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 140 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 205 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 140 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 205 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 139 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,52 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,04 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,22 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,09 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,22 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,09 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,53 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 14 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 25 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 86 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 14 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 25 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 85 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 14 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 25 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 85 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 25 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 85 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 25 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 85 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,84 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,84 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,84 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,84 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 244 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 232 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 235 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 244 16 País Vasco De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 231 16 País Vasco De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 231 16 País Vasco De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 229 16 País Vasco De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 231 16 País Vasco De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 229 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 230 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 229 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 230 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,57 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,3 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,71 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,3 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,71 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,87 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,71 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,87 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 232 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 211 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 140 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 232 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 210 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 136 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 208 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 136 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 208 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 135 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 208 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 135 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,53 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,14 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,58 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,14 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,58 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,43 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,58 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,43 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 12 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 21 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 95 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 12 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 21 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 95 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 21 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 95 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 21 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 95 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 21 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 95 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 País Vasco De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2022QI 8.360 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2021QI 8.229 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2020QI 8.653 17 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 17 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 17 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2022QII "" 17 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2022QI 7.982 17 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 17 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 17 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2021QII "" 17 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2021QI 7.822 17 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 17 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 17 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2020QII "" 17 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2020QI 7.856 17 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 17 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 17 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2022QII 7.678 17 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2022QI "" 17 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 17 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 17 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2021QII 7.595 17 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2021QI "" 17 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 17 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 17 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2020QII 7.629 17 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2022QIII 7.441 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2021QIII 7.390 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2020QIII 7.413 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2022QIV 7.277 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2021QIV 7.254 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2020QIV 7.211 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,48 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,05 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 90,79 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,84 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,3 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 88,17 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 89,01 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,8 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 85,67 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 87,05 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 88,15 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 83,34 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 7.781 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 7.262 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 7.420 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 6.885 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 7.138 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 6.675 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 6.916 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 6.490 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 6.762 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 6.376 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,36 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,81 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 91,74 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,92 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 88,88 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,37 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 86,9 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 87,8 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 579 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 967 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 562 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 937 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 540 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 920 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 525 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 900 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 515 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 878 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,06 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,9 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,26 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,14 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,67 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,07 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,95 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,8 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2022QII 8.375 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2021QII 8.140 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2020QII 8.115 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 17 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 17 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2022QII 7.987 17 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2022QI "" 17 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 17 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 17 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2021QII 7.840 17 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2021QI "" 17 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 17 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 17 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2020QII 7.838 17 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2020QI "" 17 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 17 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2022QIII 7.708 17 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2022QII "" 17 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2022QI "" 17 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 17 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2021QIII 7.604 17 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2021QII "" 17 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2021QI "" 17 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 17 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2020QIII 7.595 17 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2020QII "" 17 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2022QIV 7.507 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2021QIV 7.432 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2020QIV 7.378 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2022QI 7.231 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2021QI 7.123 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 17 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,37 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,31 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,59 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,04 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,42 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,59 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 89,64 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 91,3 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,92 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 88,83 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,78 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 7.829 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 6.935 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 6.386 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 7.459 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 6.658 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 6.142 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 7.197 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 6.449 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 5.931 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 7.007 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 6.302 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 5.753 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 6.127 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 5.552 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 17 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,27 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 96,01 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,18 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,93 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,99 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,88 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 89,5 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 90,87 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 90,09 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 88,35 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 86,94 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 546 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.205 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.729 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 528 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.182 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.696 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 511 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.155 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.664 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 500 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.130 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.625 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.104 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.571 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 17 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,7 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,09 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,09 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,59 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,85 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,24 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,58 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,78 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,98 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,62 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,86 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2022QIII 8.401 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2021QIII 8.266 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2020QIII 8.260 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 17 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2022QIII 8.002 17 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2022QII "" 17 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2022QI "" 17 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 17 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2021QIII 7.883 17 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2021QII "" 17 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2021QI "" 17 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 17 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2020QIII 7.905 17 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2020QII "" 17 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2020QI "" 17 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2022QIV 7.732 17 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 17 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2022QII "" 17 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2022QI "" 17 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2021QIV 7.647 17 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 17 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2021QII "" 17 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2021QI "" 17 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2020QIV 7.631 17 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 17 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2020QII "" 17 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2022QI 7.421 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2021QI 7.348 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2022QII 7.240 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2021QII 7.212 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 95,25 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,37 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,7 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 92,04 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 92,51 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 92,38 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 89,78 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 88,96 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 87,59 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 87,31 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 7.920 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 7.903 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 7.345 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 7.538 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 7.529 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 7.006 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 7.277 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 7.301 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 6.747 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 7.078 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 6.490 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 6.907 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 6.368 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 95,18 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,27 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,38 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,88 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 92,38 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,86 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 89,56 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 88,36 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 87,4 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 86,7 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 481 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 363 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 915 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 464 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 354 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 899 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 455 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 346 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 884 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 343 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 858 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 333 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 844 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,47 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,52 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,25 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,59 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,32 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,61 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 94,49 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,77 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 91,74 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,24 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2022QIV 8.336 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2021QIV 8.243 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2020QIV 8.271 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2022QIV 7.988 17 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 17 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2022QII "" 17 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2022QI "" 17 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2021QIV 7.908 17 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 17 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2021QII "" 17 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2021QI "" 17 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2020QIV 7.884 17 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 17 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2020QII "" 17 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2020QI "" 17 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 17 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 17 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2022QII "" 17 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2022QI 7.643 17 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 17 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 17 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2021QII "" 17 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2021QI 7.562 17 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 17 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 17 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2020QII "" 17 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2022QII 7.415 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2021QII 7.389 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2022QIII 7.227 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2021QIII 7.226 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,83 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,94 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,32 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 92,72 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 91,43 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 89,96 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 89,34 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 87,67 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 87,37 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 7.913 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 7.660 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 7.065 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 7.572 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 7.336 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 6.703 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 7.085 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 6.419 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 6.882 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 6.264 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 6.707 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 6.120 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,69 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,77 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,88 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 92,49 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,86 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 89,84 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 88,66 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 87,56 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 86,62 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 423 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 583 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.206 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 416 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 572 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.181 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 558 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.143 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 533 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.125 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 520 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.106 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,35 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,11 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,93 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 95,71 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,78 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,42 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,28 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 89,19 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 91,71 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 6.141 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 6.166 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 6.381 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 5.776 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 5.780 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 5.634 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 5.521 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 5.580 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 5.440 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 5.307 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 5.396 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 5.251 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 5.161 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 5.271 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 5.069 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,06 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,74 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 88,29 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,9 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,5 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 85,25 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,42 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,51 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 82,29 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 84,04 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,48 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,44 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 5.744 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 5.698 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 5.394 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 5.333 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 5.155 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 5.144 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 4.954 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 4.977 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 4.816 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 4.867 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,91 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,59 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,75 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,28 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,25 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,35 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,84 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,42 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 397 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 468 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 382 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 447 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 366 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 436 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 353 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 419 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 345 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 404 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,22 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,51 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,19 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,16 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,92 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,53 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 86,9 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 86,32 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 6.109 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 6.083 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 6.031 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 5.770 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 5.811 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 5.783 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 5.514 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 5.595 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 5.564 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 5.330 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 5.438 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 5.362 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 5.253 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 5.126 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 17 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,45 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,53 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,89 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,26 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,98 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,26 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,25 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,4 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,91 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 86,36 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 84,99 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 5.739 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 5.416 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 5.038 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 5.415 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 5.161 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 4.813 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 5.173 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 4.969 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 4.618 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 4.997 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 4.830 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 4.451 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 4.669 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 4.259 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,35 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,29 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,53 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,14 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,75 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,66 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,07 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,18 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,35 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 86,21 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,54 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 370 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 667 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 993 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 355 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 650 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 970 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 341 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 626 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 946 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 333 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 608 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 911 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 584 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 867 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,95 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,45 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,68 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,16 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,85 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,27 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 91,15 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,74 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 87,56 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,31 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 6.143 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 6.137 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 6.168 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 5.767 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 5.777 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 5.837 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 5.515 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 5.560 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 5.582 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 5.356 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 5.319 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 5.194 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 5.197 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,88 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,13 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,63 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,78 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,6 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,5 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 87,27 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,24 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 84,63 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,26 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 5.819 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 5.936 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 5.729 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 5.458 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 5.585 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 5.408 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 5.213 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 5.375 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 5.164 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 5.174 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 4.920 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 5.021 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 4.807 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,8 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,09 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,4 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,59 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,55 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,14 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 87,16 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 85,88 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 84,59 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,91 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 324 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 201 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 439 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 309 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 192 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 429 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 302 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 185 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 418 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 182 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 399 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 173 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 390 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,37 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,52 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,72 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,21 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,04 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,22 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90,55 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 90,89 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 86,07 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,84 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 6.084 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 6.082 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 6.171 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 5.765 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 5.768 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 5.803 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 5.522 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 5.501 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 5.326 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 5.345 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 5.154 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 5.194 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,76 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,84 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,04 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,79 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,14 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,57 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,61 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,74 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,17 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 5.810 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 5.682 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 5.576 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 5.496 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 5.379 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 5.227 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 5.147 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 4.951 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 4.969 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 4.806 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 4.805 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 4.671 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,6 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,67 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,74 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,58 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,79 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,45 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,19 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,57 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,77 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 274 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 400 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 595 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 269 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 389 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 576 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 375 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 550 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 357 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 539 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 349 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 523 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,18 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,25 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,81 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,75 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,44 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 89,25 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,59 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,25 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 87,9 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 926 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 821 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 939 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 919 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 811 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 903 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 892 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 800 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 884 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 879 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 788 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 866 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 869 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 778 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 854 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,24 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,78 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,17 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,33 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,44 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 94,14 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,92 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,98 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 92,23 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,84 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,76 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 90,95 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 841 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 635 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 836 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 628 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 813 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 619 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 801 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 607 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 792 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 604 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,41 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,9 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,67 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,48 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,24 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,59 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,17 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,12 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 85 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 186 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 83 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 183 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 79 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 181 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 78 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 181 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 77 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 174 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,65 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,39 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,94 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,31 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,76 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,31 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 90,59 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 93,55 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 940 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 825 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 847 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 916 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 811 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 832 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 901 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 802 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 817 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 891 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 789 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 811 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 778 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 802 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,45 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,3 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,23 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 95,85 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,21 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 96,46 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,79 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,64 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,75 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,3 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,69 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 861 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 623 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 547 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 837 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 611 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 536 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 824 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 602 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 525 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 816 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 596 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 520 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 586 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 515 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,21 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,07 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 97,99 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 95,7 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,63 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 95,98 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,77 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,67 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,06 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,06 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,15 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 79 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 202 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 300 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 79 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 200 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 296 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 77 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 200 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 292 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 75 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 193 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 291 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 192 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 287 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,01 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,67 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,47 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,01 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,33 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 94,94 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,54 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95,05 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,67 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 920 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 880 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 853 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 906 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 868 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 837 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 899 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 854 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 828 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 837 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 817 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 825 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 809 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,48 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,64 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,12 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,72 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,05 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,07 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,11 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,78 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 93,75 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,84 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 853 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 814 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 678 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 840 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 802 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 665 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 834 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 789 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 657 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 772 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 648 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 761 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 644 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,48 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,53 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,08 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,77 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,93 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,9 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 94,84 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,58 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 93,49 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,99 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 67 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 66 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 175 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 66 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 66 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 172 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 65 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 65 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 171 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 65 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 169 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 64 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 165 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,51 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,29 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,01 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,48 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,71 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 98,48 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,57 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,97 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 94,29 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 909 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 874 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 821 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 890 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 862 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 813 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 849 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 803 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 830 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 795 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 823 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 787 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,91 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,63 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,03 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,14 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,81 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 94,97 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,83 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 94,16 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,86 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 844 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 791 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 602 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 826 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 779 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 597 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 766 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 593 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 751 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 588 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 744 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 581 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,87 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,48 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,17 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,84 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,5 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 94,94 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,67 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 94,06 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,51 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 65 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 83 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 219 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 64 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 83 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 216 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 83 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 210 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 79 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 207 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 79 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 206 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,46 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,63 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,89 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,18 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,52 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,18 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,06 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 1.220 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 1.169 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 1.255 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 1.214 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 1.159 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 1.241 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 1.192 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 1.143 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 1.227 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 1.182 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 1.134 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 1.219 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 1.174 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 1.133 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 1.212 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,51 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,14 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,88 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,7 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,78 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,77 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,89 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,01 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,13 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,23 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,92 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,57 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.130 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 882 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.124 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 878 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.104 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 866 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.095 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 860 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.088 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 859 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,47 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,55 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,7 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,19 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,9 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,51 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,28 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,39 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 90 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 287 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 90 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 281 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 88 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 277 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 87 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 274 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 86 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 274 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,91 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,78 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,52 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,67 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,47 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 95,56 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,47 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 1.251 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 1.163 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 1.162 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 1.226 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 1.149 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 1.148 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 1.218 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 1.138 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 1.140 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 1.211 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 1.136 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 1.132 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 1.131 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 1.122 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 17 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,8 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,8 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,36 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,85 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,11 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,8 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,68 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,42 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,25 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,56 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.161 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 853 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 748 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.139 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 843 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 740 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.132 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 835 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 735 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.126 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 833 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 730 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 829 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 726 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,11 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,83 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,93 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,5 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,89 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,26 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,99 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,66 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,59 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,19 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,06 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 90 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 310 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 414 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 87 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 306 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 408 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 86 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 303 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 405 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 85 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 303 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 402 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 302 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 396 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,67 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,71 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,55 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 95,56 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,74 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,83 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 94,44 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,74 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,1 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,42 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,65 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 1.262 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.177 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.167 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 1.253 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 1.166 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 1.160 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 1.242 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 1.161 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 1.151 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 1.156 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 1.143 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 1.149 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 1.137 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,29 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,07 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,4 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,42 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,64 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,63 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,22 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,94 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,62 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,43 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.179 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.091 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 892 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.171 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.080 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 887 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.161 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.075 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 881 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.070 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 878 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.063 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 873 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,32 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,99 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,44 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,47 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,53 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,77 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,08 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,43 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,43 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,87 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 83 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 86 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 275 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 82 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 86 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 273 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 81 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 86 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 270 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 86 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 265 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 86 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 264 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,8 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,27 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,59 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,18 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,36 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.263 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.215 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.205 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 1.253 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 1.206 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 1.195 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 1.200 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 1.186 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 1.187 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 1.177 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 1.178 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 1.173 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,21 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,26 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,17 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,77 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,42 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,7 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,68 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,95 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,34 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.186 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.123 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 837 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.177 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.114 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 830 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.108 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 827 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.098 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 822 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.094 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 820 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,24 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,2 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,16 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,66 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,81 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,77 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,21 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,42 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,97 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 77 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 92 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 368 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 76 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 92 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 365 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 92 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 359 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 89 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 355 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 84 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 353 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,7 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,18 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,55 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,74 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 96,47 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 91,3 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 95,92 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 53 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 58 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 60 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 53 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 57 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 60 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 53 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 57 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 60 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 53 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 57 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 60 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 53 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 57 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 60 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,28 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,28 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,28 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,28 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 48 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 37 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 48 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 36 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 48 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 36 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 48 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 36 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 48 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 36 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,3 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,3 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,3 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,3 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 5 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 21 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 5 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 21 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 5 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 21 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 5 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 21 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 5 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 21 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 54 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 52 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 58 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 54 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 52 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 58 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 54 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 52 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 58 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 54 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 52 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 57 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 52 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 57 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 17 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,28 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,28 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 50 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 31 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 42 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 50 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 31 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 42 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 50 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 31 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 42 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 50 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 31 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 41 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 31 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 41 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,62 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,62 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 4 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 21 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 16 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 4 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 21 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 16 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 4 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 21 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 16 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 4 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 21 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 16 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 21 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 16 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 55 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 54 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 55 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 55 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 54 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 54 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 55 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 54 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 53 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 54 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 52 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 54 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 52 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,18 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,36 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,55 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,55 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 51 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 46 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 35 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 51 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 46 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 35 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 51 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 46 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 34 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 46 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 33 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 46 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 33 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,14 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,29 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,29 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 4 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 8 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 20 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 8 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 19 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 8 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 19 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 8 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 19 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 8 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 19 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 95 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 57 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 54 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 58 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 57 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 54 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 57 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 54 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 56 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 54 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 56 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 54 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 56 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,28 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,55 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,55 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,55 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 52 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 47 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 40 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 52 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 47 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 39 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 47 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 38 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 47 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 38 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 47 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 38 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,5 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 95 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 5 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 7 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 18 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 5 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 7 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 18 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 7 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 18 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 7 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 18 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 7 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 18 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 20 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 15 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 18 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 20 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 15 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 18 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 20 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 15 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 18 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 20 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 15 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 17 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 20 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 15 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 16 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,44 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 88,89 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 18 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 10 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 18 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 10 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 18 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 10 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 18 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 10 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 18 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 10 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 5 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 5 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 5 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 5 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 5 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 21 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 17 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 17 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 21 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 17 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 17 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 21 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 17 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 16 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 21 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 17 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 16 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 17 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 16 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 17 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 94,12 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 94,12 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,12 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 18 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 12 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 11 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 18 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 12 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 11 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 18 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 12 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 11 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 18 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 12 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 11 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 12 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 11 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 3 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 5 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 6 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 3 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 5 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 6 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 3 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 5 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 5 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 3 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 5 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 5 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 5 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 5 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 83,33 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 83,33 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 83,33 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 21 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 18 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 17 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 21 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 18 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 17 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 21 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 18 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 17 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 18 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 17 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 18 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 17 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 18 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 16 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 11 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 18 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 16 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 11 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 18 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 16 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 11 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 16 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 11 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 16 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 11 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 2 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 6 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 2 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 6 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 2 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 6 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 2 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 6 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 2 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 6 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 23 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 18 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 16 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 23 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 18 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 16 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 18 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 16 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 18 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 16 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 18 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 16 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 21 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 17 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 10 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 21 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 17 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 10 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 17 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 10 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 17 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 10 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 17 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 10 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 6 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 6 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 6 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 6 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 6 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2022QI 1.504 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2021QI 1.500 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2020QI 1.543 18 Ceuta Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 18 Ceuta Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 18 Ceuta Total Cohort January 1 Total Survival in the first trimester 2022QII "" 18 Ceuta Total Cohort January 1 Total Survival in the first trimester 2022QI 1.425 18 Ceuta Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 18 Ceuta Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 18 Ceuta Total Cohort January 1 Total Survival in the first trimester 2021QII "" 18 Ceuta Total Cohort January 1 Total Survival in the first trimester 2021QI 1.409 18 Ceuta Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 18 Ceuta Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 18 Ceuta Total Cohort January 1 Total Survival in the first trimester 2020QII "" 18 Ceuta Total Cohort January 1 Total Survival in the first trimester 2020QI 1.379 18 Ceuta Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 18 Ceuta Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 18 Ceuta Total Cohort January 1 Total Survival in the second trimester 2022QII 1.346 18 Ceuta Total Cohort January 1 Total Survival in the second trimester 2022QI "" 18 Ceuta Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 18 Ceuta Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 18 Ceuta Total Cohort January 1 Total Survival in the second trimester 2021QII 1.350 18 Ceuta Total Cohort January 1 Total Survival in the second trimester 2021QI "" 18 Ceuta Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 18 Ceuta Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 18 Ceuta Total Cohort January 1 Total Survival in the second trimester 2020QII 1.343 18 Ceuta Total Cohort January 1 Total Survival in the second trimester 2020QI "" 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2022QIII 1.291 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2021QIII 1.310 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2020QIII 1.297 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2022QIV 1.243 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2021QIV 1.258 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2020QIV 1.262 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,75 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,93 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 89,37 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,49 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 87,04 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,84 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,33 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 84,06 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 82,65 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 83,87 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 81,79 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.444 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.329 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.369 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.242 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.295 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.185 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.241 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.151 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.195 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.105 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,81 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,45 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,68 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,16 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,94 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,61 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 82,76 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,15 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 60 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 171 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 56 18 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 167 18 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 51 18 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 165 18 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 50 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 159 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 48 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 153 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 93,33 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,66 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 85 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,49 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 83,33 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,98 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 80 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,47 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2022QII 1.517 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2021QII 1.482 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2020QII 1.480 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 18 Ceuta Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 18 Ceuta Total Cohort April 1 Total Survival in the first trimester 2022QII 1.424 18 Ceuta Total Cohort April 1 Total Survival in the first trimester 2022QI "" 18 Ceuta Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 18 Ceuta Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 18 Ceuta Total Cohort April 1 Total Survival in the first trimester 2021QII 1.408 18 Ceuta Total Cohort April 1 Total Survival in the first trimester 2021QI "" 18 Ceuta Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 18 Ceuta Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 18 Ceuta Total Cohort April 1 Total Survival in the first trimester 2020QII 1.431 18 Ceuta Total Cohort April 1 Total Survival in the first trimester 2020QI "" 18 Ceuta Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 18 Ceuta Total Cohort April 1 Total Survival in the second trimester 2022QIII 1.356 18 Ceuta Total Cohort April 1 Total Survival in the second trimester 2022QII "" 18 Ceuta Total Cohort April 1 Total Survival in the second trimester 2022QI "" 18 Ceuta Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 18 Ceuta Total Cohort April 1 Total Survival in the second trimester 2021QIII 1.361 18 Ceuta Total Cohort April 1 Total Survival in the second trimester 2021QII "" 18 Ceuta Total Cohort April 1 Total Survival in the second trimester 2021QI "" 18 Ceuta Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 18 Ceuta Total Cohort April 1 Total Survival in the second trimester 2020QIII 1.372 18 Ceuta Total Cohort April 1 Total Survival in the second trimester 2020QII "" 18 Ceuta Total Cohort April 1 Total Survival in the second trimester 2020QI "" 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2022QIV 1.296 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2022QI "" 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2021QIV 1.304 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2021QI "" 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2020QIV 1.331 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2022QI 1.252 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2021QI 1.265 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 18 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,87 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,01 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,69 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,39 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,84 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,7 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 85,43 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,99 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,93 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 84,48 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,47 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.466 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.329 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.232 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.377 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.257 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.184 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.310 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.216 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.132 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.251 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.165 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.096 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.120 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.038 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 18 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,93 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,58 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,1 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,36 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,5 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,88 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 85,33 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,66 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,96 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,27 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,25 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 51 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 153 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 248 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 47 18 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 151 18 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 247 18 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 46 18 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 145 18 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 240 18 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 45 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 139 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 235 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 132 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 227 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 18 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 92,16 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,69 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,6 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 90,2 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,77 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,77 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,24 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,85 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,76 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 86,27 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,53 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2022QIII 1.496 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2021QIII 1.497 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2020QIII 1.486 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 18 Ceuta Total Cohort July 1 Total Survival in the first trimester 2022QIII 1.410 18 Ceuta Total Cohort July 1 Total Survival in the first trimester 2022QII "" 18 Ceuta Total Cohort July 1 Total Survival in the first trimester 2022QI "" 18 Ceuta Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 18 Ceuta Total Cohort July 1 Total Survival in the first trimester 2021QIII 1.426 18 Ceuta Total Cohort July 1 Total Survival in the first trimester 2021QII "" 18 Ceuta Total Cohort July 1 Total Survival in the first trimester 2021QI "" 18 Ceuta Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 18 Ceuta Total Cohort July 1 Total Survival in the first trimester 2020QIII 1.414 18 Ceuta Total Cohort July 1 Total Survival in the first trimester 2020QII "" 18 Ceuta Total Cohort July 1 Total Survival in the first trimester 2020QI "" 18 Ceuta Total Cohort July 1 Total Survival in the second trimester 2022QIV 1.337 18 Ceuta Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 18 Ceuta Total Cohort July 1 Total Survival in the second trimester 2022QII "" 18 Ceuta Total Cohort July 1 Total Survival in the second trimester 2022QI "" 18 Ceuta Total Cohort July 1 Total Survival in the second trimester 2021QIV 1.355 18 Ceuta Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 18 Ceuta Total Cohort July 1 Total Survival in the second trimester 2021QII "" 18 Ceuta Total Cohort July 1 Total Survival in the second trimester 2021QI "" 18 Ceuta Total Cohort July 1 Total Survival in the second trimester 2020QIV 1.367 18 Ceuta Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 18 Ceuta Total Cohort July 1 Total Survival in the second trimester 2020QII "" 18 Ceuta Total Cohort July 1 Total Survival in the second trimester 2020QI "" 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2022QII "" 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2022QI 1.300 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2021QII "" 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2021QI 1.298 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2022QII 1.245 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2022QI "" 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2021QII 1.264 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2021QI "" 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,25 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,26 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,15 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,37 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,51 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,99 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,84 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 87,35 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,17 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 85,06 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.484 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.434 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.303 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.398 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.365 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.236 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.325 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.297 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.194 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.247 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.130 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.193 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.098 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,2 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,19 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,86 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,29 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,45 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,63 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,96 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,72 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,19 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,27 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 12 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 63 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 183 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 12 18 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 61 18 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 178 18 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 12 18 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 58 18 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 173 18 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 53 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 168 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 52 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 166 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,83 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,27 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,06 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,54 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 84,13 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,8 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 82,54 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 90,71 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2022QIV 1.486 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2021QIV 1.503 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2020QIV 1.489 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort October 1 Total Survival in the first trimester 2022QIV 1.399 18 Ceuta Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 18 Ceuta Total Cohort October 1 Total Survival in the first trimester 2022QII "" 18 Ceuta Total Cohort October 1 Total Survival in the first trimester 2022QI "" 18 Ceuta Total Cohort October 1 Total Survival in the first trimester 2021QIV 1.418 18 Ceuta Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 18 Ceuta Total Cohort October 1 Total Survival in the first trimester 2021QII "" 18 Ceuta Total Cohort October 1 Total Survival in the first trimester 2021QI "" 18 Ceuta Total Cohort October 1 Total Survival in the first trimester 2020QIV 1.430 18 Ceuta Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 18 Ceuta Total Cohort October 1 Total Survival in the first trimester 2020QII "" 18 Ceuta Total Cohort October 1 Total Survival in the first trimester 2020QI "" 18 Ceuta Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 18 Ceuta Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 18 Ceuta Total Cohort October 1 Total Survival in the second trimester 2022QII "" 18 Ceuta Total Cohort October 1 Total Survival in the second trimester 2022QI 1.355 18 Ceuta Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 18 Ceuta Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 18 Ceuta Total Cohort October 1 Total Survival in the second trimester 2021QII "" 18 Ceuta Total Cohort October 1 Total Survival in the second trimester 2021QI 1.351 18 Ceuta Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 18 Ceuta Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 18 Ceuta Total Cohort October 1 Total Survival in the second trimester 2020QII "" 18 Ceuta Total Cohort October 1 Total Survival in the second trimester 2020QI "" 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2022QII 1.289 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2021QII 1.306 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2022QIII 1.239 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2022QII "" 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2021QIII 1.270 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2021QII "" 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,15 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,34 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 96,04 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,15 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,73 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,76 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,71 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 82,44 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 85,29 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.480 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.418 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.316 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.393 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.335 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.261 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.279 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.187 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.216 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.144 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.169 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.113 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,12 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,15 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 95,82 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,2 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,2 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,75 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,93 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 82,44 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,57 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 6 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 85 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 173 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 6 18 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 83 18 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 169 18 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 76 18 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 164 18 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 73 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 162 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 70 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 157 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,65 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,69 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 89,41 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,8 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 85,88 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,64 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 82,35 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90,75 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 1.175 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 1.179 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 1.222 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 1.097 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 1.092 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 1.067 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 1.026 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 1.038 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 1.033 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 976 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 1.000 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 988 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 932 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 949 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 955 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,36 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,62 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 87,32 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,32 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 88,04 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 84,53 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 83,06 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 84,82 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 80,85 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 79,32 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 80,49 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 78,15 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.136 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.081 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.062 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 997 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 995 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 945 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 946 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 913 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 904 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 868 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,49 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,23 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,59 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 87,42 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 83,27 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 84,46 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 79,58 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 80,3 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 39 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 98 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 35 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 95 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 31 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 93 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 30 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 87 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 28 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 81 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 89,74 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,94 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 79,49 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,9 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 76,92 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 88,78 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 71,79 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 82,65 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 1.187 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 1.165 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 1.172 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 1.101 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 1.095 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 1.127 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 1.040 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 1.048 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 1.072 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 985 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 995 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 1.031 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 945 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 969 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 18 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 92,75 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 93,99 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,16 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 87,62 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 89,96 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,47 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 82,98 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 85,41 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 87,97 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 81,12 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 82,68 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.152 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.075 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.010 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.070 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.007 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 966 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.010 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 966 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 918 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 956 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 919 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 882 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 876 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 826 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 92,88 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 93,67 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,64 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 87,67 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,86 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,89 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 82,99 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 85,49 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,33 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 81,49 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 81,78 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 35 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 90 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 162 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 31 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 88 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 161 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 30 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 82 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 154 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 29 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 76 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 149 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 69 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 143 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 88,57 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,78 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,38 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 85,71 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 91,11 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,06 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 82,86 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 84,44 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,98 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 76,67 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 88,27 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 1.157 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.166 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.160 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 1.081 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 1.098 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 1.094 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 1.016 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 1.034 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 1.048 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 982 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 982 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 934 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 951 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,43 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,17 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,31 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,81 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 88,68 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,34 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 84,22 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 84,66 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 80,1 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 81,98 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.151 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.128 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.052 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.075 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.062 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 991 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.010 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.001 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 950 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 954 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 888 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 906 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 859 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,4 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,15 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,2 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,75 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 88,74 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,3 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 84,57 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 84,41 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 80,32 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 81,65 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 6 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 38 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 108 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 6 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 36 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 103 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 6 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 33 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 98 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 28 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 94 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 28 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 92 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 94,74 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 95,37 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 86,84 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 90,74 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 73,68 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 87,04 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 73,68 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 85,19 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.145 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.176 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.162 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 1.064 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 1.096 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 1.107 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 1.034 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 1.032 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 975 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 992 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 928 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 958 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,93 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,2 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,27 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 87,93 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 88,81 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 82,91 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 85,37 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 78,91 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 82,44 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.144 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.113 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.062 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.063 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.035 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.011 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 980 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 940 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 924 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 902 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 880 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 873 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,92 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,99 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 95,2 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,05 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,51 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 83,02 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84,93 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 79,07 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 82,2 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 63 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 61 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 96 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 54 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 92 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 51 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 90 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 48 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 85 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,83 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 85,71 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 80,95 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 76,19 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 85 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 141 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 145 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 139 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 140 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 143 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 134 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 134 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 140 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 133 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 130 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 138 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 132 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 127 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 137 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 131 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,29 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,62 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,4 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,04 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,55 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,68 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 92,2 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,17 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,96 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 90,07 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,48 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,24 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 132 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 117 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 131 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 116 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 126 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 113 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 122 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 111 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 119 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 110 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,24 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,15 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 95,45 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,58 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 92,42 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 94,87 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 90,15 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,02 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 9 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 28 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 9 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 27 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 8 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 27 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 8 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 27 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 8 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 27 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,43 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 88,89 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,43 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,89 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,43 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,89 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,43 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 134 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 130 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 129 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 129 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 129 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 127 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 124 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 129 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 125 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 122 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 125 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 125 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 123 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 122 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 18 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 96,27 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,23 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,45 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,54 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,23 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 96,9 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 91,04 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,15 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,9 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,62 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,57 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 128 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 110 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 92 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 123 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 109 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 90 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 118 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 109 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 88 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 116 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 105 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 88 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 103 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 87 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 96,09 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,09 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 97,83 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 92,19 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,09 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 95,65 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 90,63 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,45 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,65 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,64 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,57 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 6 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 20 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 37 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 6 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 20 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 37 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 6 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 20 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 37 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 6 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 20 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 37 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 20 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 35 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,59 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 143 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 133 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 146 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 135 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 130 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 142 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 131 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 124 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 142 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 122 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 140 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 118 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 139 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,41 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,74 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 97,26 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,61 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 93,23 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,26 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 91,73 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,89 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 88,72 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,21 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 140 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 124 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 116 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 132 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 121 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 112 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 128 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 115 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 112 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 113 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 111 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 109 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 110 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,29 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,58 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 96,55 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,43 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 92,74 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,55 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 91,13 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,69 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 87,9 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,83 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 9 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 30 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 9 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 30 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 9 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 30 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 9 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 29 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 9 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 29 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,67 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,67 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 146 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 138 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 145 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 143 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 134 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 142 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 133 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 140 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 127 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 138 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 125 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 136 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,95 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,1 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,93 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,38 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,55 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 92,03 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,17 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 90,58 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,79 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 145 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 130 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 116 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 142 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 126 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 113 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 125 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 112 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 119 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 110 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 117 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 108 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,93 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 96,92 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,41 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,15 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,55 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 91,54 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,83 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 90 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,1 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 8 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 29 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 8 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 29 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 8 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 28 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 8 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 28 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 8 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 28 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,55 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 96,55 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,55 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 175 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 166 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 174 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 175 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 164 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 170 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 173 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 162 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 169 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 172 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 162 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 169 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 171 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 162 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 168 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,8 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,7 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,86 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,59 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,13 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,29 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,59 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,13 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,71 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,59 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,55 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 163 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 122 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 163 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 120 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 161 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 118 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 160 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 118 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 159 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 118 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,36 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,77 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,72 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,16 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,72 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,55 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,72 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 12 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 44 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 12 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 44 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 12 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 44 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 12 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 44 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 12 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 44 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 183 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 176 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 169 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 181 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 173 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 167 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 179 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 173 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 165 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 176 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 173 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 165 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 173 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 164 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 18 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,91 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,3 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,82 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,81 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,3 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,63 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,17 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,3 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,63 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,3 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,04 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 173 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 134 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 120 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 171 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 131 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 118 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 169 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 131 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 116 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 166 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 131 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 116 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 131 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 115 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,84 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,76 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,33 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,69 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,76 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,67 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,95 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,76 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,67 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,76 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,83 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 10 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 42 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 49 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 10 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 42 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 49 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 10 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 42 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 49 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 10 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 42 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 49 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 42 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 49 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 182 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 186 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 169 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 180 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 186 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 167 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 176 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 185 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 166 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 184 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 165 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 181 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 163 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,9 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,82 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,7 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,46 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,22 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,92 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,63 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,31 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,45 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 179 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 171 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 125 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 177 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 171 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 123 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 173 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 170 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 122 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 169 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 121 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 167 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 119 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,88 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,4 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,65 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,42 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,6 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,83 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,8 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,66 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,2 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 15 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 44 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 15 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 44 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 15 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 44 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 15 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 44 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 14 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 44 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,33 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 181 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 176 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 170 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 178 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 175 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 169 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 175 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 167 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 174 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 164 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 173 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 164 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,34 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,43 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,41 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,43 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,24 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,86 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,47 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,3 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,47 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 177 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 162 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 127 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 174 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 161 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 126 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 161 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 124 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 160 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 121 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 159 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 121 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,31 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,38 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,21 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 99,38 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,64 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,77 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,28 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,15 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,28 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 14 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 43 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 14 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 43 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 14 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 43 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 14 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 43 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 14 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 43 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 10 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 8 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 5 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 10 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 8 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 5 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 10 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 8 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 5 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 10 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 8 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 5 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 10 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 8 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 5 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 10 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 7 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 10 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 7 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 10 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 7 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 10 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 7 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 10 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 7 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 0 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 0 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 0 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 0 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 0 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI .. 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI .. 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII .. 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 0 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 0 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 11 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 9 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 7 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 11 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 9 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 7 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 11 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 9 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 7 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 11 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 9 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 7 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 9 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 7 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 18 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 11 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 8 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 7 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 11 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 8 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 7 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 11 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 8 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 7 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 11 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 8 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 7 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 8 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 7 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 0 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 0 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 0 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 0 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 0 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII .. 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII .. 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 0 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII .. 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV .. 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI .. 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 11 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 9 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 8 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 11 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 9 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 8 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 11 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 9 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 8 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 9 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 8 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 9 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 8 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 11 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 8 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 8 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 11 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 8 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 8 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 11 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 8 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 8 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 8 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 8 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 8 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 8 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 0 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 0 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 0 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 0 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 0 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII .. 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 0 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII .. 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV .. 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI .. 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII .. 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 12 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 10 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 10 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 12 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 10 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 10 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 10 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 10 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 10 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 10 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 10 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 10 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 12 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 10 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 9 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 12 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 10 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 9 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 10 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 9 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 10 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 9 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 10 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 9 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 0 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 0 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 0 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 0 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 0 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV .. 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV .. 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI .. 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII .. 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 0 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 3 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 2 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 3 18 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 3 18 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 2 18 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 3 18 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 3 18 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 2 18 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 3 18 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 3 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 2 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 3 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 3 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 2 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 3 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 0 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 0 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 0 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 0 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 0 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 0 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 0 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 0 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 0 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 0 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI .. 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI .. 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI .. 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI .. 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII .. 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII .. 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 0 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII .. 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 0 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV .. 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 2 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 2 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 3 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 2 18 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 2 18 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 3 18 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 2 18 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 2 18 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 3 18 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 2 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 2 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 3 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 2 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 3 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 18 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 0 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 0 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 0 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 0 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 0 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 0 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 0 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 0 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 0 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 0 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII .. 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII .. 18 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII .. 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII .. 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 0 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII .. 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII .. 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV .. 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV .. 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI .. 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI .. 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 3 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 3 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 3 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 3 18 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 3 18 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 3 18 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 3 18 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 3 18 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 3 18 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 3 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 3 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 3 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 3 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 0 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 0 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 0 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 0 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 0 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII .. 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 0 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII .. 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV .. 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI .. 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII .. 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 2 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 3 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 2 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 2 18 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 3 18 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 2 18 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 3 18 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 2 18 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 3 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 2 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 3 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 2 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 0 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 0 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 0 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 0 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 0 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 0 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 0 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 0 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 0 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 0 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV .. 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV .. 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV .. 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV .. 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI .. 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI .. 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII .. 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII .. 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 0 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII .. 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2022QI 1.535 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2021QI 1.485 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2020QI 1.691 19 Melilla Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 19 Melilla Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 19 Melilla Total Cohort January 1 Total Survival in the first trimester 2022QII "" 19 Melilla Total Cohort January 1 Total Survival in the first trimester 2022QI 1.409 19 Melilla Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 19 Melilla Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 19 Melilla Total Cohort January 1 Total Survival in the first trimester 2021QII "" 19 Melilla Total Cohort January 1 Total Survival in the first trimester 2021QI 1.387 19 Melilla Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 19 Melilla Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 19 Melilla Total Cohort January 1 Total Survival in the first trimester 2020QII "" 19 Melilla Total Cohort January 1 Total Survival in the first trimester 2020QI 1.465 19 Melilla Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 19 Melilla Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 19 Melilla Total Cohort January 1 Total Survival in the second trimester 2022QII 1.319 19 Melilla Total Cohort January 1 Total Survival in the second trimester 2022QI "" 19 Melilla Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 19 Melilla Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 19 Melilla Total Cohort January 1 Total Survival in the second trimester 2021QII 1.317 19 Melilla Total Cohort January 1 Total Survival in the second trimester 2021QI "" 19 Melilla Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 19 Melilla Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 19 Melilla Total Cohort January 1 Total Survival in the second trimester 2020QII 1.342 19 Melilla Total Cohort January 1 Total Survival in the second trimester 2020QI "" 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2022QIII 1.254 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2021QIII 1.252 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2020QIII 1.266 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2022QIV 1.211 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2021QIV 1.201 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2020QIV 1.211 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Melilla Total Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Melilla Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 19 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 91,79 19 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,4 19 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 86,64 19 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 85,93 19 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 88,69 19 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 79,36 19 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 81,69 19 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 84,31 19 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 74,87 19 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 78,89 19 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 80,88 19 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 71,61 19 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.462 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.280 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.341 19 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.185 19 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.258 19 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.122 19 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.198 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.061 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.155 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.016 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 91,72 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,58 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 86,05 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 87,66 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 81,94 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 82,89 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 79 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 79,38 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 73 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 205 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 68 19 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 202 19 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 61 19 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 195 19 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 56 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 191 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 56 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 185 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 93,15 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,54 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 83,56 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,12 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 76,71 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,17 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 76,71 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,24 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2022QII 1.517 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2021QII 1.501 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2020QII 1.570 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 19 Melilla Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 19 Melilla Total Cohort April 1 Total Survival in the first trimester 2022QII 1.406 19 Melilla Total Cohort April 1 Total Survival in the first trimester 2022QI "" 19 Melilla Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 19 Melilla Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 19 Melilla Total Cohort April 1 Total Survival in the first trimester 2021QII 1.400 19 Melilla Total Cohort April 1 Total Survival in the first trimester 2021QI "" 19 Melilla Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 19 Melilla Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 19 Melilla Total Cohort April 1 Total Survival in the first trimester 2020QII 1.421 19 Melilla Total Cohort April 1 Total Survival in the first trimester 2020QI "" 19 Melilla Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 19 Melilla Total Cohort April 1 Total Survival in the second trimester 2022QIII 1.323 19 Melilla Total Cohort April 1 Total Survival in the second trimester 2022QII "" 19 Melilla Total Cohort April 1 Total Survival in the second trimester 2022QI "" 19 Melilla Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 19 Melilla Total Cohort April 1 Total Survival in the second trimester 2021QIII 1.325 19 Melilla Total Cohort April 1 Total Survival in the second trimester 2021QII "" 19 Melilla Total Cohort April 1 Total Survival in the second trimester 2021QI "" 19 Melilla Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 19 Melilla Total Cohort April 1 Total Survival in the second trimester 2020QIII 1.335 19 Melilla Total Cohort April 1 Total Survival in the second trimester 2020QII "" 19 Melilla Total Cohort April 1 Total Survival in the second trimester 2020QI "" 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2022QIV 1.273 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2022QI "" 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2021QIV 1.268 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2021QI "" 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2020QIV 1.273 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2022QI 1.199 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2021QI 1.224 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Melilla Total Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 19 Melilla Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 92,68 19 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 93,27 19 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 90,51 19 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 87,21 19 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 88,27 19 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 85,03 19 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 83,92 19 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 84,48 19 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 81,08 19 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 79,88 19 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 77,96 19 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.461 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.304 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.308 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.355 19 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.210 19 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.162 19 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.276 19 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.139 19 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.083 19 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.226 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.087 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.027 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.029 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 982 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 19 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 92,74 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 92,79 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 88,84 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 87,34 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 87,35 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 82,8 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 83,92 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 83,36 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 78,52 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 78,91 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 75,08 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 56 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 197 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 262 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 51 19 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 190 19 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 259 19 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 47 19 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 186 19 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 252 19 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 47 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 181 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 246 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 170 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 242 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 19 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 91,07 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,45 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,85 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 83,93 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,42 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,18 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 83,93 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 91,88 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,89 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 86,29 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 92,37 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2022QIII 1.500 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2021QIII 1.489 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2020QIII 1.484 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 19 Melilla Total Cohort July 1 Total Survival in the first trimester 2022QIII 1.397 19 Melilla Total Cohort July 1 Total Survival in the first trimester 2022QII "" 19 Melilla Total Cohort July 1 Total Survival in the first trimester 2022QI "" 19 Melilla Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 19 Melilla Total Cohort July 1 Total Survival in the first trimester 2021QIII 1.403 19 Melilla Total Cohort July 1 Total Survival in the first trimester 2021QII "" 19 Melilla Total Cohort July 1 Total Survival in the first trimester 2021QI "" 19 Melilla Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 19 Melilla Total Cohort July 1 Total Survival in the first trimester 2020QIII 1.380 19 Melilla Total Cohort July 1 Total Survival in the first trimester 2020QII "" 19 Melilla Total Cohort July 1 Total Survival in the first trimester 2020QI "" 19 Melilla Total Cohort July 1 Total Survival in the second trimester 2022QIV 1.331 19 Melilla Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 19 Melilla Total Cohort July 1 Total Survival in the second trimester 2022QII "" 19 Melilla Total Cohort July 1 Total Survival in the second trimester 2022QI "" 19 Melilla Total Cohort July 1 Total Survival in the second trimester 2021QIV 1.336 19 Melilla Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 19 Melilla Total Cohort July 1 Total Survival in the second trimester 2021QII "" 19 Melilla Total Cohort July 1 Total Survival in the second trimester 2021QI "" 19 Melilla Total Cohort July 1 Total Survival in the second trimester 2020QIV 1.306 19 Melilla Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 19 Melilla Total Cohort July 1 Total Survival in the second trimester 2020QII "" 19 Melilla Total Cohort July 1 Total Survival in the second trimester 2020QI "" 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2022QII "" 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2022QI 1.257 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2021QII "" 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2021QI 1.255 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2022QII 1.206 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2022QI "" 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2021QII 1.209 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2021QI "" 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Melilla Total Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Melilla Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,13 19 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,22 19 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 92,99 19 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,73 19 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,72 19 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,01 19 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 84,42 19 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 84,57 19 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 80,99 19 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 81,47 19 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.483 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.426 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.295 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.383 19 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.342 19 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.194 19 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.317 19 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.277 19 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.126 19 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.203 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.079 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.155 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.039 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,26 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,11 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 92,2 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,81 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,55 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 86,95 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 84,36 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 83,32 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 81 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 80,23 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 17 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 63 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 189 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 14 19 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 61 19 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 186 19 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 14 19 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 59 19 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 180 19 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 54 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 176 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 51 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 170 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 82,35 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,83 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,41 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 82,35 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,65 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,24 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 85,71 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,12 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 80,95 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 89,95 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2022QIV 1.493 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2021QIV 1.485 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2020QIV 1.483 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort October 1 Total Survival in the first trimester 2022QIV 1.404 19 Melilla Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 19 Melilla Total Cohort October 1 Total Survival in the first trimester 2022QII "" 19 Melilla Total Cohort October 1 Total Survival in the first trimester 2022QI "" 19 Melilla Total Cohort October 1 Total Survival in the first trimester 2021QIV 1.405 19 Melilla Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 19 Melilla Total Cohort October 1 Total Survival in the first trimester 2021QII "" 19 Melilla Total Cohort October 1 Total Survival in the first trimester 2021QI "" 19 Melilla Total Cohort October 1 Total Survival in the first trimester 2020QIV 1.388 19 Melilla Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 19 Melilla Total Cohort October 1 Total Survival in the first trimester 2020QII "" 19 Melilla Total Cohort October 1 Total Survival in the first trimester 2020QI "" 19 Melilla Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 19 Melilla Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 19 Melilla Total Cohort October 1 Total Survival in the second trimester 2022QII "" 19 Melilla Total Cohort October 1 Total Survival in the second trimester 2022QI 1.315 19 Melilla Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 19 Melilla Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 19 Melilla Total Cohort October 1 Total Survival in the second trimester 2021QII "" 19 Melilla Total Cohort October 1 Total Survival in the second trimester 2021QI 1.327 19 Melilla Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 19 Melilla Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 19 Melilla Total Cohort October 1 Total Survival in the second trimester 2020QII "" 19 Melilla Total Cohort October 1 Total Survival in the second trimester 2020QI "" 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2022QII 1.254 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2021QII 1.272 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2022QIII 1.201 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2022QII "" 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2021QIII 1.216 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2021QII "" 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Melilla Total Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Melilla Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,04 19 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,61 19 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,59 19 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,55 19 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,48 19 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,44 19 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 85,77 19 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 80,88 19 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 82 19 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.479 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.376 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.299 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.390 19 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.301 19 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.209 19 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.217 19 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.151 19 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.166 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.101 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.116 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.048 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,98 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,55 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,07 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,44 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,61 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,74 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84,76 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 81,1 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 80,68 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 14 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 109 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 184 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 14 19 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 104 19 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 179 19 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 98 19 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 176 19 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 88 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 171 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 85 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 168 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,41 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,28 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 89,91 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,65 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 80,73 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,93 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 77,98 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 91,3 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 1.133 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 1.120 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 1.324 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 1.018 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 1.028 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 1.106 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 942 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 967 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 986 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 887 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 907 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 913 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 847 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 865 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 863 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 89,85 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 91,79 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 83,53 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 83,14 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 86,34 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 74,47 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 78,29 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 80,98 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 68,96 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 74,76 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 77,23 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 65,18 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.079 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 996 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 968 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 907 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 898 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 852 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 847 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 796 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 807 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 759 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 89,71 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 91,06 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 83,23 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 85,54 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 78,5 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 79,92 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 74,79 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 76,2 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 54 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 124 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 50 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 121 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 44 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 115 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 40 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 111 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 40 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 106 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 92,59 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,58 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 81,48 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,74 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 74,07 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,52 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 74,07 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 85,48 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 1.125 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 1.142 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 1.232 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 1.026 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 1.049 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 1.086 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 956 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 980 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 1.001 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 909 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 931 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 944 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 867 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 900 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 19 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 91,2 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 91,86 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 88,15 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 84,98 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 85,81 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 81,25 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 80,8 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 81,52 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 76,62 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 75,92 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 73,05 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.089 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.021 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.060 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 994 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 934 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 916 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 928 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 869 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 837 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 881 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 825 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 784 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 771 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 743 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 91,28 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 91,48 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 86,42 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 85,22 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 85,11 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 78,96 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 80,9 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 80,8 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 73,96 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 75,51 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 70,09 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 36 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 121 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 172 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 32 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 115 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 170 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 28 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 111 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 164 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 28 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 106 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 160 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 96 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 157 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 88,89 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 95,04 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,84 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 77,78 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 91,74 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,35 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 77,78 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 87,6 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,02 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 79,34 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,28 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 1.119 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.127 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.134 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 1.025 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 1.046 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 1.032 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 961 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 988 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 962 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 915 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 915 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 868 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 875 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 91,6 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,81 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 91,01 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 85,88 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 87,67 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 84,83 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 81,19 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 80,69 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 77,02 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 77,16 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.108 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.081 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.022 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.017 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.002 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 922 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 953 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 946 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 856 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 878 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 812 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 834 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 778 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 91,79 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,69 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 90,22 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 86,01 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,51 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 83,76 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 81,22 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 79,45 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 77,15 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 76,13 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 11 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 46 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 112 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 8 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 44 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 110 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 8 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 42 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 106 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 37 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 103 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 34 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 97 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 72,73 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,65 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,21 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 72,73 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 91,3 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,64 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 80,43 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,96 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 73,91 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 86,61 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.110 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.126 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.128 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 1.024 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 1.054 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 1.037 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 969 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 980 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 916 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 932 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 870 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 881 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,25 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,61 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 91,93 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 86,06 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 86,88 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 81,35 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 82,62 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 77,26 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 78,1 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.102 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.046 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.017 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.016 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 978 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 930 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 898 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 875 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 855 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 832 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 812 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 784 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,2 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,5 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 91,45 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 85,85 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 86,04 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 81,74 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 81,81 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 77,63 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 77,09 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 8 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 80 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 111 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 8 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 76 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 107 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 71 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 105 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 61 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 100 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 58 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 97 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,4 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 88,75 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,59 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 76,25 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,09 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 72,5 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 87,39 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 195 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 173 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 184 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 186 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 172 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 178 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 180 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 167 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 176 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 173 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 166 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 174 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 170 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 160 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 170 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,38 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,42 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,74 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 92,31 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,53 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,65 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 88,72 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,95 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,57 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 87,18 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 92,49 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 92,39 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 187 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 138 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 178 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 137 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 173 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 133 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 167 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 132 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 164 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 126 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,19 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,28 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 92,51 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,38 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 89,3 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,65 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 87,7 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 91,3 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 8 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 35 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 8 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 35 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 7 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 34 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 6 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 34 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 6 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 34 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 87,5 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,14 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 75 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,14 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 75 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,14 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 202 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 170 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 171 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 196 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 166 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 170 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 189 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 162 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 170 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 186 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 158 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 166 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 154 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 163 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 19 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,03 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 97,65 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,42 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 93,56 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 95,29 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,42 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 92,08 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 92,94 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,08 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 90,59 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,32 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 192 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 138 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 124 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 187 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 134 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 123 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 180 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 130 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 123 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 177 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 126 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 121 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 122 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 119 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,4 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,1 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,19 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 93,75 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 94,2 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,19 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 92,19 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 91,3 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,58 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 88,41 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,97 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 10 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 32 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 47 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 9 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 32 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 47 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 9 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 32 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 47 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 9 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 32 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 45 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 32 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 44 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 90 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 90 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,74 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 93,62 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 195 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 177 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 180 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 190 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 174 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 179 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 188 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 168 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 175 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 164 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 174 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 162 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 169 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,44 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,31 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,44 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,41 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 94,92 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,22 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 92,66 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,67 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 91,53 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,89 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 193 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 173 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 143 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 188 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 170 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 142 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 186 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 164 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 140 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 160 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 140 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 158 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 135 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,41 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,27 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,3 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,37 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 94,8 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,9 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 92,49 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,9 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 91,33 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,41 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 4 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 37 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 4 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 37 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 4 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 35 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 4 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 34 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 4 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 34 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,59 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,89 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,89 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 196 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 171 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 168 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 193 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 166 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 164 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 161 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 163 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 157 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 160 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 151 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 157 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,47 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,08 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,62 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 94,15 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,02 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 91,81 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,24 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 88,3 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,45 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 194 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 157 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 138 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 191 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 153 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 135 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 149 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 135 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 145 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 132 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 139 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 129 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,45 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,45 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,83 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 94,9 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,83 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 92,36 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,65 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 88,54 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,48 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 14 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 30 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 13 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 29 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 12 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 28 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 12 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 28 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 12 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 28 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 92,86 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,67 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 85,71 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,33 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 85,71 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,33 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 85,71 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,33 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 201 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 187 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 176 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 199 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 182 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 174 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 191 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 178 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 173 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 188 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 174 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 172 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 188 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 171 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 171 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,33 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,86 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,02 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 95,19 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,3 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 93,53 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 93,05 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,73 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,53 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 91,44 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,16 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 190 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 142 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 189 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 137 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 181 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 133 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 178 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 129 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 178 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 127 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,47 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 96,48 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 95,26 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 93,66 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 93,68 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 90,85 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,68 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 89,44 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 11 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 45 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 10 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 45 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 10 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 45 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 10 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 45 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 10 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 44 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 90,91 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,91 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,91 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 90,91 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,78 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 185 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 183 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 161 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 179 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 179 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 159 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 173 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 177 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 158 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 173 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 173 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 157 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 172 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 155 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 19 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 96,76 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 97,81 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,76 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 93,51 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,72 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,14 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 93,51 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 94,54 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,52 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,99 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,27 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 175 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 140 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 119 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 169 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 137 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 118 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 163 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 135 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 118 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 163 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 131 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 117 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 131 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 115 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 96,57 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,86 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,16 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 93,14 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,43 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,16 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 93,14 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 93,57 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,32 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,57 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,64 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 10 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 43 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 42 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 10 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 42 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 41 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 10 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 42 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 40 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 10 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 42 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 40 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 41 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 40 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,67 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,62 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,67 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,24 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,67 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,24 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95,35 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,24 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 180 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 181 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 164 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 176 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 179 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 163 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 176 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 176 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 163 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 174 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 160 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 172 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 159 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,78 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,9 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,39 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,78 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,24 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,39 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,13 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,56 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,03 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,95 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 177 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 168 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 126 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 173 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 166 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 126 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 173 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 163 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 126 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 161 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 123 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 159 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 122 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,74 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,81 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,74 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,02 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,83 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,62 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,64 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,83 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 13 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 38 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 13 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 37 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 13 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 37 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 13 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 37 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 13 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 37 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,37 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,37 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,37 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,37 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 181 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 184 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 182 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 181 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 181 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 182 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 181 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 179 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 177 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 175 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 176 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 173 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,37 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,37 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,35 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,2 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,15 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,65 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,05 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 177 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 169 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 139 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 177 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 166 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 139 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 166 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 136 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 162 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 132 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 161 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 130 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,22 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,22 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,84 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,86 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,96 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,27 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,53 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 15 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 43 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 15 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 43 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 15 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 43 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 15 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 43 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 15 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 43 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 4 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 3 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 6 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 4 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 3 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 6 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 4 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 3 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 6 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 4 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 3 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 6 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 4 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 3 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 6 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 4 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 4 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 4 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 4 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 4 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 0 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 0 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 0 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 0 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 0 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI .. 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI .. 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII .. 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 0 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 0 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 3 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 4 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 4 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 3 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 4 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 4 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 3 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 4 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 4 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 3 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 4 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 4 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 4 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 4 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 19 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 3 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 3 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 3 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 3 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 3 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 3 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 3 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 3 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 0 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 5 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 2 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 5 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 5 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 2 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 5 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 5 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 2 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 5 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 2 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 5 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 2 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 5 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 4 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 4 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 3 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 4 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 3 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 0 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 0 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 0 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 0 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 0 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII .. 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII .. 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV .. 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI .. 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII .. 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 5 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 3 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 3 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 5 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 3 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 3 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 3 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 3 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 3 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 3 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 3 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 3 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 5 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 5 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 0 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 0 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 0 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 0 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 0 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 0 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 0 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 0 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 0 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 0 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV .. 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV .. 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV .. 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV .. 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI .. 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI .. 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII .. 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII .. 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 0 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII .. 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 2 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 2 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 1 19 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 2 19 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 2 19 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 1 19 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 2 19 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 2 19 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 1 19 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 2 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 2 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 1 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 2 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 2 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 1 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 0 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 0 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 0 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 0 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 0 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 0 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 0 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 0 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 0 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 0 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI .. 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI .. 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI .. 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI .. 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII .. 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII .. 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 0 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII .. 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 0 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV .. 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 2 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 2 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 2 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 2 19 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 2 19 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 2 19 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 2 19 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 2 19 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 2 19 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 2 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 2 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 2 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 2 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 2 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 19 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 19 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 0 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 0 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 0 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 0 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 0 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 0 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 0 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 0 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 0 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 0 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII .. 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII .. 19 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII .. 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII .. 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 0 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII .. 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII .. 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV .. 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV .. 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI .. 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI .. 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 1 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 2 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 1 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 1 19 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 2 19 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 1 19 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 1 19 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 2 19 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 1 19 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 2 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 1 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 2 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 1 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 0 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 0 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 0 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 0 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 0 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 0 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 0 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 0 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 0 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 0 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII .. 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII .. 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 0 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII .. 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII .. 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV .. 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV .. 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI .. 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI .. 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII .. 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII .. 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 1 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 1 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 2 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 1 19 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 1 19 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 2 19 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 1 19 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 2 19 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 1 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 2 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 1 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 2 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 0 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 0 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 0 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 0 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 0 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 0 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 0 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 0 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 0 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 0 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV .. 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV .. 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV .. 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV .. 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI .. 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI .. 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII .. 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII .. 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 0 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII .. 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI ""